10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________

FORM 10-K

________________________________ 

CHECK ONE:

ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2013

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             .

Commission file No.: 1-12996

________________________________ 

Diversicare Healthcare Services, Inc.

(exact name of registrant as specified in its charter)

 ________________________________

Delaware	62-1559667
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

1621 Galleria Boulevard, Brentwood, TN	37027
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (615) 771-7575

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each Exchange on which registered
Common Stock, $0.01 par value per share	The NASDAQ Capital Market

Securities registered pursuant to Section 12(g) of the Act:

None.

Indicate by check mark if the registrant is a well-known seasoned issuer, asdefined in Rule 405 of the Securities Act.

Yes ¨ No þ

Indicate by check mark if the registrant is not required to file reportspursuant to Section 13 or Section 15(d) of the Act.

Yes ¨ No þ

Indicate by check mark whether the registrant (1) has filed all reportsrequired to be filed by Section 13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that theregistrant was required to file such reports), and (2) has been subject to suchfiling requirements for the past 90 days. Yes þNo ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þNo ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405of Regulation S-K is not contained herein, and will not be contained, to thebest of registrant's knowledge, in definitive proxy or information statementsincorporated by reference in Part III of this Form 10-K or any amendment tothis Form 10-K. ¨

Indicate by check mark whether the registrant is a large accelerated filer, anaccelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “acceleratedfiler” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting companyþ

Indicate by check mark whether the registrant is a shell company (as defined inRule 12b-2 of the Act). Yes ¨ No þ

The aggregate market value of Common Stock held by non-affiliates on June 30, 2013 (based on the closing price of such shares on the NASDAQ Capital Market) was approximately$18,480,000. For purposes of the foregoing calculation only, all directors,named executive officers and persons known to the registrant to be holders of5% or more of the registrant's Common Stock have been deemed affiliates of theregistrant.

On February 14, 2014, 6,086,344 shares of the registrant's $0.01 par value CommonStock were outstanding.

Documents Incorporated by Reference

Registrant's definitive proxy materials for its 2014 annual meeting of shareholders are incorporated by reference into Part III, Items 10, 11, 12, 13 and 14 of this Form 10-K.

Table of Contents
		Page
Part I
Item 1.	Business	1
Item 1A.	Risk Factors	12
Item 1B.	Unresolved Staff Comments	16
Item 2.	Properties	16
Item 3.	Legal Proceedings	17
Item 4.	Mine Safety Disclosures	18
Part II
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	18
Item 6.	Selected Financial Data	19
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	38
Item 8.	Financial Statements and Supplementary Data	38
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	38
Item 9A.	Controls and Procedures	38
Item 9B.	Other Information	39
Part III
Item 10.	Directors, Executive Officers and Corporate Governance	39
Item 11.	Executive Compensation	39
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	39
Item 13.	Certain Relationships and Related Transactions, and Director Independence	39
Item 14.	Principal Accountant Fees and Services	39
Part IV
Item 15.	Exhibits and Financial Statement Schedules	40

PART 1

ITEM 1. BUSINESS

Introductory Summary.

Diversicare Healthcare Services, Inc. provides long-term care services to nursing center patients in nine states, primarily in the Southeast and Southwest United States. Unless the context indicates otherwise, references herein to “Diversicare,” “the Company,” “we,” “us” and “our” include Diversicare Healthcare Services, Inc. and all of our consolidated subsidiaries. Diversicare Healthcare Services, Inc. was incorporated as a Delaware corporation in 1994.

The long-term care profession encompasses a broad range of non-institutional and institutional services. For those among the elderly requiring temporary or limited special services, a variety of home care options exist. As needs for assistance in activities of daily living develop, assisted living facilities become the most viable and cost effective option. For those among the elderly requiring much more intensive care, skilled nursing center care may become the only viable option. We have chosen to focus our business primarily on the skilled nursing centers sector and to specialize in this aspect of the long-term care continuum.

Principal Address and Website.

Our principal executive offices are located at 1621 Galleria Boulevard, Brentwood, Tennessee 37027. Our telephone number at that address is 615.771.7575, and our facsimile number is 615.771.7409. Our website is located at www.dvcr.com. The information on our website does not constitute part of this Annual Report on Form 10-K.

Operating and Growth Strategy.

Our operating objective is to optimize market position in the delivery of health care and related services to the elderly in the communities in which we operate. Our strategic operations development plan focuses on (i) providing a broad range of cost-effective elder care services; (ii) improving skilled mix in our nursing centers; (iii) building clinical competencies and programs consistent with marketplace needs; and (iv) clustering our operations on a regional basis. Interwoven into our objectives and operating strategy is our mission:

• Improve Every Life We Touch

• Provide Exceptional Healthcare

• Exceed Expectations

• Increase Shareholder Value

Strategic operating initiatives. Our key strategic operating initiatives include improving skilled mix in our nursing centers by enhancing our registered nurse coverage and adding specialized clinical care. The investments in nursing and clinical care were conducted in concert with additional investments in nursing center based marketing representatives to develop referral and Managed Care relationships. These investments have attracted and are expected to continue to attract payor sources for patients covered by Medicare, Managed Care as well as certain private pay individuals. These marketing and nurse coverage efforts have already enabled us admit referrals of higher acuity patients.

Another strategic operating initiative was to implement Electronic Medical Records (“EMR”). See description of EMR implementation below. We completed the implementation of Electronic Medical Records in all our nursing centers in December 2011, and implement EMR at all new facilities near the time operations commence.

As part of our strategic operating initiatives we have continued our program for improving our physical plants. Since 2005, we have been completing strategic renovations of certain facilities that improve quality of care and profitability. We plan to continue these nursing center renovation projects and accelerate this strategy using the knowledge obtained in the first few years of this program. Our strategic operating initiatives will also include pursuing and investigating opportunities to acquire, lease or develop new facilities, focusing primarily on opportunities within our existing areas of operation.

To achieve our objectives we:

Provide a broad range of quality cost-effective services. Our objective is to provide a variety of services to meet the needs of the elderly requiring skilled nursing care. Our service offerings currently include skilled nursing, comprehensive rehabilitation services, programming for Life Steps and Lighthouse units (described below) and other specialty programming. By addressing varying levels of acuity, we work to meet the needs of the elderly population we serve. We seek to establish a reputation as the provider of choice in each of our markets. Furthermore, we believe we are able to deliver quality services cost-effectively, compared to other healthcare providers along the spectrum of care, thereby expanding the elderly population base that can benefit from our services.

1

Improve skilled mix in our nursing centers. By enhancing our registered nurse coverage and adding specialized clinical care, we believe we can improve skilled mix and reimbursement. The investments in nursing and clinical care are being conducted in concert with additional investments in nursing center based marketing representatives to develop referral and Managed Care relationships. These investments will better attract quality payor sources for patients covered by Medicare, Managed Care (including Health Maintenance Organizations (“HMO's”) and Medicare replacement payors) as well as certain private pay individuals. We will also continue our program for the renovation and improvement of our nursing centers to attract and retain patients.

Cluster operations on a regional basis. We have developed regional concentrations of operations in order to achieve operating efficiencies, generate economies of scale and capitalize on marketing opportunities created by having multiple operations in a regional market area.

Key elements of our growth strategy are to:

Increase revenues and profitability at existing facilities. Our strategy includes increasing center revenues and profitability through improving payor mix, providing an increasing level of higher acuity care, obtaining appropriate reimbursement for the care we provide, and providing high quality patient care. In addition to our nursing center renovation program, ongoing investments are being made in expanded nursing and clinical care. We continue to enhance nursing center based marketing initiatives to promote higher occupancy levels and improved skilled mix at our nursing centers.

Improve physical plants. Our nursing centers have an average age of approximately 35 years as of December 31, 2013. During 2005, we began an initiative to complete strategic renovations of certain facilities to improve occupancy, quality of care and profitability. We developed a plan to identify those facilities with the greatest potential for benefit and began the renovation program during the third quarter of 2005. Major renovations result in significant cosmetic upgrades, including new flooring, wall coverings, lighting, ceilings and furniture throughout the nursing center. Renovations also usually include certain external work to improve curb appeal, such as concrete work, landscaping, roof and signage enhancements. Many of our renovation projects will include adding functionality and space for our rehabilitation therapy offerings.

Development of additional specialty services. Our strategy includes the development of additional specialty units and programming in facilities that could benefit from these services. The specialty programming will vary depending on the needs of the specific marketplace, and may include Life Steps and Lighthouse units and other specialty programming. These services allow our facilities to improve census and payor mix. A center specific assessment of the market and the current programming being offered is conducted related to specialty programming to determine if unmet needs exist as a predictor of the success of particular niche offerings and services.

Acquisition, leasing and development of new centers. We continue to pursue and investigate opportunities to acquire, lease or develop new facilities, focusing primarily on opportunities that can leverage our existing infrastructure.

Nursing Centers and Services.

Diversicare provides a broad range of long-term care services to the elderly including skilled nursing, ancillary health care services and assisted living. In addition to the nursing and social services usually provided in long-term care centers, we offer a variety of rehabilitative, nutritional, respiratory, and other specialized ancillary services. As of December 31, 2013, our continuing operations consist of 47 nursing centers with 5,318 licensed nursing beds. Our nursing centers range in size from 48 to 320 licensed nursing beds. The licensed nursing bed count does not include 308 licensed assisted living beds.

• The nursing center and licensed nursing bed count includes the Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013.

• The nursing center and licensed bed count includes the 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicaid and Medicare certification processes for this facility are currently underway and expected to be complete in the first quarter of 2014.

• The nursing center and licensed nursing bed count also includes 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes are currently under way for these four leased facilities and expected to be complete in the first half of 2014. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count.

2

• Our continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Ohio, Tennessee, Texas and West Virginia.

The following table summarizes certain information with respect to the nursing centers we own or lease as of December 31, 2013:

	Number of Centers	Licensed Nursing Beds (1)	Available Nursing Beds (1)
Operating Locations:
Alabama	6	711	703
Florida	1	79	79
Indiana	1	158	158
Kansas	5	418	413
Kentucky	9	838	834
Ohio	4	404	394
Tennessee	5	617	563
Texas	13	1,853	1,726
West Virginia	3	240	240
	47	5,318	5,110
Classification:
Owned	13	1,224	1,188
Leased	34	4,094	3,922
Total	47	5,318	5,110

____________

(1) The number of Licensed Nursing Beds is based on the licensed capacity of the nursing center. The Company reports its occupancy based on licensed nursing beds. The number of Available Nursing Beds represents Licensed Nursing Beds reduced by beds removed from service. Available Nursing Beds is subject to change based upon the needs of the facilities, including configuration of patient rooms, common usage areas and offices, status of beds (private, semi-private, ward, etc.) and renovations. The number of Licensed and Available Nursing Beds does not include 308 Licensed Assisted Living/Residential Beds, all of which are also available. These beds are excluded from the bed counts as our operating statistics such as occupancy are calculated using Nursing Beds only.

Our nursing centers provide skilled nursing health care services, including room and board, nutrition services, recreational therapy, social services, housekeeping and laundry services. Our nursing centers dispense medications prescribed by the patients' physicians, and a plan of care is developed by professional nursing staff for each patient. We also provide for the delivery of ancillary medical services at the nursing centers we operate. These specialty services include rehabilitation therapy services, such as audiology, speech, occupational and physical therapies, which are provided through licensed therapists and registered nurses, and the provision of medical supplies, nutritional support, infusion therapies and related clinical services. The majority of these services are provided using our internal resources and clinicians.

Within the framework of a nursing center, we may provide other specialty care, including:

Life Steps Unit. Many of our nursing centers have units designated as Life Steps Units, our designation for patients requiring short-term rehabilitation following an acute stay in the hospital. These units specialize in short-term rehabilitation with the goal of returning the patient to their highest potential level of functionality. These units provide enhanced services with emphasis on upgraded amenities often including electric beds, Wi-Fi, and feature a separate entrance for guests and visitors. The design and programming of the units generally appeal to the clinical and hospitality needs of individuals as they progress to the next appropriate level of care. Specialized therapeutic treatment regimens include orthopedic rehabilitation, neurological rehabilitation and complex medical rehabilitation. While these patients generally have a shorter length of stay, the intensive level of rehabilitation required by these patients typically results in higher levels of reimbursement.

Lighthouse Unit. Like our Life Step Units, many of our nursing centers have Lighthouse Units, our designation for advanced care for dementia related disorders including Alzheimer's disease. The goal of the units is to provide a safe, homelike and supportive environment for cognitively impaired patients, utilizing an interdisciplinary team approach. Family and community involvement compliment structured programming in the secure environment instrumental in fostering as much patient independence as possible despite diminished capacity.

3

Enhanced Therapy Services. We have complimented our traditional therapy services with programs that provide electrotherapy, ultrasound and shortwave diathermy therapy treatments that promote pain management, wound healing, and contractures management, improving the results of therapy treatments for our patients.

Other Specialty Programming. We implement other specialty programming based on a center's specific needs. We have developed two adult day care centers on nursing center campuses. We have developed specialty programming for bariatric patients (generally, patients weighing more than 350 pounds) at one of these facilities as these individuals have unique psychosocial and equipment needs.

Continuous Quality Improvement. We have in place a Continuous Quality Improvement (“CQI”) program, which is focused on identifying opportunities for improvement of all aspects of the care provided in a center, as well as overseeing the initiation and effectiveness of interventions. The CQI program was designed to support and drive nursing center efforts to meet accreditation standards and to exceed state and federal government regulations. We conduct audits to monitor adherence to the standards of care established by the CQI program at each center which we operate. The center administrator, with assistance from regional nursing personnel, is primarily responsible for adherence to our quality improvement standards. In that regard, the annual operational objectives established by each center administrator include specific objectives with respect to quality of care. Performance of these objectives is evaluated quarterly by the regional vice president or manager and each center administrator's incentive compensation is based, in part, on the achievement of the specified quality objectives. A major component of our CQI program is employee empowerment initiatives, with particular emphasis placed on selection, recruitment, retention and recognition programs. Our administrators and managers include employee retention and turnover goals in the annual center, regional and personal objectives. We also have established a quality improvement committee consisting of nursing representatives from each region and our corporate quality personnel. This committee periodically reviews our quality improvement programs and conducts center audits.

Implement Electronic Medical Records. We completed the initial implementation of EMR in our nursing centers in December 2011. EMR improves our ability to accurately record the care provided to our patients and quickly respond to areas of need. We now add EMR near the time of acquisition for new centers. EMR improves customer and employee satisfaction, nursing center regulatory compliance and provides real-time monitoring and scheduling of care delivery. We believe our EMR system supports our quality initiatives and positions us for higher acuity service offerings. Our EMR system includes three primary components:

• Tracking Activities of Daily Living (“ADLs”). ADLs are the routine functions that each person must perform on a daily basis including, but not limited to, getting dressed, bathing, and eating. The ADL tracking allows us to improve the documentation of the activities of our nursing, dietary and housekeeping staff in assisting with ADLs quickly, efficiently and electronically.

• Nursing Notes. Nursing notes are an important component of our medical records. Licensed nursing professionals make notes on the care and condition of each patient. The EMR system has a module for nursing notes and results in improved capture, monitoring and review of patient records.

• Medications. Our patients often receive a number of daily medications. This module assists with tracking the required medications and documenting the administration of those medications.

For all three modules, the EMR system provides a dashboard that can be reviewed at a number of kiosks throughout the nursing center, allowing our staff to securely access a list of upcoming patient care tasks and providing our supervisors a tool to help manage and monitor staff performance. We believe the EMR system provides better support and improves the quality of care for our patients. Our deployment schedule resulted in full EMR in 8 centers and ADL tracking in 13 others during 2010 and the remaining implementations were completed during 2011, at a rate of approximately five to six centers every two months. We invested approximately $112,000 per nursing center to deploy EMR in all our facilities at the time of implementation. We currently implement EMR at each of the facilities we acquire or at which we assume operations during the transition process.

Organization. Our long-term care facilities are currently organized into eight regions, each of which is supervised by a regional vice president. The regional vice president is generally supported by specialists in several functions, including nursing, human resources, marketing, accounts receivable management and administration, all of whom are employed by us. The day-to-day operations of each of our nursing centers are led by an on-site, licensed administrator. The administrator of each nursing center is supported by other professional personnel, including a medical director, who assists in the medical management of the nursing center, and a director of nursing, who supervises a staff of registered nurses, licensed practical nurses and nurse aides. Other personnel include those providing therapy, dietary, activities and social service, housekeeping, laundry and maintenance and office services. The majority of personnel at our facilities, including the administrators, are our employees.

Marketing.

At a local level, our sales and marketing efforts are designed to promote higher occupancy levels, promote optimal payor mix and inform the local referral community of our high-acuity capabilities. We believe that the long-term care profession is fundamentally

4

a local business in which both patients and their referral sources are based in the immediate geographic area in which the nursing center is located. Our marketing plan and related support activities emphasize the role and performance of administrators, admissions coordinators and social services directors of each nursing center, all of whom are responsible for contacting various referral sources such as doctors, hospitals, hospital discharge planners, churches and various community organizations. As part of our operating strategy we have increased the number of nursing center based marketing personnel to further develop relationships with physicians as well as Managed Care organizations. We believe these relationships with Managed Care organizations will provide us with greater exposure to referral sources and an ability to provide increased levels of high-acuity care.

In addition to soliciting admissions from these sources, we emphasize involvement in community affairs in order to promote a public awareness of our nursing centers and services. We have ongoing family councils and community based “family night” functions where organizations come to the center to educate the public on various topics such as Medicare benefits, powers of attorney, and other matters of interest. We also promote effective customer relations and seek feedback through resident and family surveys. We typically host “open house” events once we complete a renovation of a center where members of the local community are invited to visit and see the improvements. In addition, we have regional marketing coordinators to support the overall marketing program in each local center, in order to promote higher occupancy levels and improved payor and case mixes at our nursing centers. Regional and local marketing personnel and efforts are supported by our corporate marketing personnel.

We have an internally-developed marketing program that focuses on the identification and provision of services needed by the community. The program assists each nursing center administrator in analysis of local demographics and competition with a view toward complementary service development. We believe that the primary referral area in the long-term care industry generally lies within a five-to-fifteen-mile radius of each nursing center depending on population density; consequently, local marketing efforts are more beneficial than broad-based advertising techniques.

Acquisitions, Development Projects and Divestitures.

Acquisitions and Development

In March 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities closed on May 1, 2013. As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000.

In August 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT and the lease provides for an initial 15-year lease term with a 5-year renewal option. This additional skilled nursing center increases the Company's footprint in Kentucky to nine nursing centers. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.

In October 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana, and increasing our presence in Ohio to four nursing centers. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.

In April 2012, the Company entered into a lease agreement to operate an 88-bed skilled nursing center in Clinton, Kentucky. The center is subject to a mortgage insured through the United States Department of Housing and Urban Development. The lease has an initial ten year term with two five year renewal options and contains an option to purchase the property for $3.3 million during the first five years. Prior to our leasing of the facility, the center had not had residents since April 2011 after being de-certified by Medicare and Medicaid. The lease agreement called for a $125,000 lease commencement fee and the transaction is considered a lease agreement.

Separate from the above lease transaction, in September 2012, the Company announced it entered into a lease agreement to operate a 154-bed skilled nursing center in Louisville, Kentucky. The nursing center is owned by a real estate investment trust and the lease provides for an initial fifteen-year lease term with a five-year renewal option. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.

Discontinued Operations

Effective September 1, 2013, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Thirteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000. In addition to the expenses associated with the discontinued operations, the Company also incurred $1,446,000 in restructuring expenses in 2013 that represent corporate expenses and exit costs associated with the Arkansas disposition, but not classified as discontinued operations. The Company will continue to defend, and make cash payments related to, professional liability claims asserted against these nursing centers for events occurring prior to September 1, 2013.

Additionally, effective September 1, 2012, we sold an owned skilled nursing center in Arkansas to an unrelated party and have reclassified the operations of this facility as discontinued operations for all periods presented in the accompanying consolidated financial statements. The operating margins and the long term business prospects of the nursing center did not meet our strategic goals. The gain on disposal, net of taxes, of $174,000 was primarily the amount of sales price in excess of the net carrying value of the fixed assets sold. The assets and liabilities of the disposed skilled nursing center have been reclassified and are segregated in the consolidated balance sheets as assets and liabilities of discontinued operations.

Nursing Center Profession.

We believe there are a number of significant trends within the long-term care industry that will support the continued growth of the nursing home profession. These trends are also likely to impact our business. These factors include:

Demographic trends. The primary market for our long-term health care services is comprised of persons aged 75 and older. This age group is one of the fastest growing segments of the United States population. As the number of persons aged 75 and over continues to grow, we believe that there will be corresponding increases in the number of persons who need skilled nursing care.

Cost containment pressures. In response to rapidly rising health care costs, governmental and other third-party payors have adopted cost-containment measures to reduce admissions and encourage reduced lengths of stays in hospitals and other acute care settings. The federal government had previously acted to curtail increases in health care costs under Medicare by limiting acute care hospital reimbursement for specific services to pre-established fixed amounts. Other third-party payors have begun to limit reimbursement for medical services in general to predetermined reasonable charges, and Managed Care organizations (such as health maintenance organizations) are attempting to limit hospitalization costs by negotiating for discounted rates for hospital and acute care services and by monitoring and reducing hospital use. In response, hospitals are discharging patients earlier and referring elderly patients, who may be too sick or frail to manage their lives without assistance, to nursing centers where the cost of providing care is typically lower than hospital care. In addition, third-party payors are increasingly becoming involved in determining the appropriate health care settings for their insureds or clients based primarily on cost and quality of care.

Limited supply of centers. As the nation's elderly population continues to grow, life expectancy continues to expand, and there continue to be limitations on granting Certificates of Need (“CON”) for new skilled nursing centers, so we believe that there will be continued demand for skilled nursing beds in the markets in which we operate. The majority of states have adopted CON or similar statutes requiring that prior to adding new skilled beds or any new services, or making certain capital expenditures, a state agency must determine that a need exists for the new beds or proposed activities. We believe that this CON process tends to restrict the supply and availability of licensed skilled nursing center beds. High construction costs, limitations on state and federal government reimbursement for the full costs of construction, and start-up expenses also act to restrict growth in the supply for such centers. At the same time, skilled nursing center operators are continuing to focus on improving occupancy and expanding services to include high acuity patients who require significantly higher levels of skilled nursing personnel and care.

Reduced reliance on family care. Historically, the family has been the primary provider of care for seniors. We believe that the increase in the percentage of dual income families, the reduction of average family size and the increased mobility in society will reduce the role of the family as the traditional care-giver for aging parents. We believe that this trend will make it necessary for many seniors to look outside the family for assistance as they age.

6

Competition.

The long-term care business is highly competitive. We face direct competition for additional centers, and our centers face competition for employees and patients. Some of our present and potential competitors for acquisitions are significantly larger and have or may obtain greater financial and marketing resources. Competing companies may offer new or more modern centers or new or different services that may be more attractive to patients than some of the services we offer.

The nursing centers operated by us compete with other facilities in their respective markets, including rehabilitation hospitals and other “skilled” and personal care residential facilities. In the few urban markets in which we operate, some of the long-term care providers with which our facilities compete are significantly larger and have or may obtain greater financial and marketing resources than our facilities. Some of these providers are not-for-profit organizations with access to sources of funds not available to our centers. Construction of new long-term care facilities near our existing centers could adversely affect our business. We believe that the most important competitive factors in the long-term care business are: a nursing center's local reputation with referral sources, such as acute care hospitals, physicians, religious groups, other community organizations, Managed Care organizations, and a patient's family and friends; physical plant condition; the ability to identify and meet particular care needs in the community; the availability of qualified personnel to provide the requisite care; and the rates charged for services. There is limited, if any, price competition with respect to Medicaid and Medicare patients, since revenues for services to such patients are strictly controlled and are based on fixed rates and cost reimbursement principles. Although the degree of success with which our centers compete varies from location to location, we believe that our centers generally compete effectively with respect to these factors.

Revenue Sources

We classify our revenues from patients and residents into four major categories: Medicaid, Medicare, Managed Care, and private pay and other. Medicaid revenues are composed of the traditional Medicaid program established to provide benefits to those in need of financial assistance in the securing of medical services. Medicare revenues include revenues received under both Part A and Part B of the Medicare program. Managed Care revenues include payments for patients who are insured by a third-party entity, typically called a Health Maintenance Organization, often referred to as an HMO plan, or are Medicare beneficiaries who assign their Medicare benefits to a Managed Care replacement plan often referred to as Medicare replacement products. The private pay and other revenues are composed primarily of individuals or parties who directly pay for their services. Included in the private pay and other are patients who are hospice beneficiaries as well as the recipients of Veterans Administration benefits. Veterans Administration payments are made pursuant to renewable contracts negotiated with these payors.

The following table sets forth net patient revenues related to our continuing operations by payor source for the periods presented (dollar amounts in thousands):

	Year Ended December 31,
	2013				2012				2011
Medicaid	$	150,752	53.5	%	$	130,738	53.1	%	$	123,392	50.2	%
Medicare	77,103		27.3	%	74,218		30.1	%	83,131		33.8	%
Managed Care	16,786		6.0	%	12,495		5.1	%	10,995		4.5	%
Private Pay and other	37,278		13.2	%	28,839		11.7	%	28,359		11.5	%
Total	$	281,919	100.0	%	$	246,290	100.0	%	$	245,877	100.0	%

The following table sets forth average daily skilled nursing census by payor source for our continuing operations for the periods presented:

	Year Ended December 31,
	2013			2012			2011
Medicaid	2,553	69.9	%	2,283	70.0	%	2,221	69.0	%
Medicare	425	11.6	%	417	12.8	%	438	13.6	%
Managed Care	110	3.0	%	83	2.5	%	70	2.2	%
Private Pay and other	566	15.5	%	478	14.7	%	492	15.2	%
Total	3,654	100.0	%	3,261	100.0	%	3,221	100.0	%

Consistent with the nursing center industry in general, changes in the mix of a center's patient population among Medicaid, Medicare, Managed Care, and private pay and other can significantly affect the profitability of the center's operations.

7

Medicare and Medicaid Reimbursement

A significant portion of our revenues are derived from government-sponsored health insurance programs. Our nursing centers derive revenues under Medicaid, Medicare, Managed Care, Private Pay and other third party sources. We employ third-party specialists in reimbursement and also use these services to monitor regulatory developments to comply with reporting requirements and to ensure that proper payments are made to our operated nursing centers. It is generally recognized that all government-funded programs have been and will continue to be under cost containment pressures, but the extent to which these pressures will affect our future reimbursement is unknown.

Medicare

Effective October 1, 2011, Medicare rates were reduced by a nationwide average of 11.1%, the net effect of a reduction to restore overall payments to their intended levels on a prospective basis and the application of a 2.7% market basket increase and a negative 1.0% productivity adjustment required by the Affordable Care Act. The final Centers for Medicare and Medicaid Services (“CMS”) rule also adjusts the method by which group therapy is counted for reimbursement purposes and, for patients receiving therapy, changes the timing of reassessment for purposes of determining patient RUG categories. These October 2011 Medicare reimbursement changes decreased our Medicare revenue and our Medicare rate per patient day. The new regulations also resulted in an increase in costs to provide therapy services to our patients.

The Budget Control Act of 2011 (“BCA”), enacted on August 2, 2011, increased the United States debt ceiling and linked the debt ceiling increase to corresponding deficit reductions through 2021. The BCA also established a 12 member joint committee of Congress known as the Joint Select Committee on Deficit Reduction (“Super Committee”). The Super Committee’s objective was to create proposed legislation to reduce the United States federal budget deficit by $1.5 trillion for fiscal years 2012 through 2021. Part of the BCA required this legislation to be enacted by December 23, 2011, or approximately $1.2 trillion in spending reductions would automatically begin through sequestration on January 1, 2013, split between domestic and defense spending. As no legislation was passed that would achieve the targeted savings outlined in the BCA, payments to Medicare providers have been reduced by 2% from planned levels effective April 1, 2013. As a result of sequestration, we experienced an approximate decrease in revenue of $1,315,000 for the year ended December 31, 2013.

In July 2013, CMS issued Medicare payment rates, effective October 1, 2013, that increased reimbursement to skilled nursing centers by approximately 0.6% compared to the fiscal year ending September 30, 2013. The increase is the net effect of a 2.5% inflation increase as measured by the SNF market basket, offset by a 0.7% negative productivity adjustment required by the Affordable Care Act, and a 1.2% budget neutrality adjustment. This adjustment is further offset by the ongoing sequestration from the BCA as mentioned above. The 2% sequestration is not applied to the payment rate, but rather it is applied to Medicare claims after determining coinsurance, any applicable deductibles, and any applicable Medicare secondary payment adjustments.

Therapy Services. There are annual Medicare Part B reimbursement limits on therapy services that can be provided to an individual. The limits impose a $1,920 per patient annual ceiling on physical and speech therapy services, and a separate $1,920 per patient annual ceiling on occupational therapy services. CMS established an exception process to permit therapy services in certain situations and we provide services that are reimbursed under the exceptions process. The exceptions process has been extended several times, most recently by the Pathway for SGR Reform Act of 2013, which extended this exception process through March 31, 2014.

Related to the exceptions process discussed above, for services provided with dates of service between January 1, 2013, through March 31, 2013, providers were required to submit a request for an exception for therapy services above the threshold of $3,700 which will then be manually medically reviewed. Similar to the therapy cap exceptions process, the threshold process will have a $3,700 per patient threshold on physical and speech therapy services, and a separate $3,700 per patient threshold on occupational therapy services. The exception reviews were conducted by Medicare Administrative Contractors during this period. Effective April 1, 2013, Recovery Auditors began conducting prepayment and postpayment reviews of claims dated April 1, 2013 and later.

It is unknown if any further extension of the therapy cap exceptions or the new threshold process will be included in future legislation or CMS policy decisions. If the exception process is discontinued or if the manual review process for therapy in excess of $3,700 negatively impacts our Medicare Part B reimbursement, we would likely see a reduction in our therapy revenues which would negatively impact our operating results and cash flows.

On November 2, 2010, CMS released a final proposed rule as part of the Medicare Physician Fee Schedule (“MPFS”) that was effective January 1, 2011. The policy impacts the reimbursement we receive for Medicare Part B therapy services in our facilities. The policy provides that Medicare Part B pay the full rate for the therapy unit of service that has the highest Practice Expense ("PE") component for each patient on each day they receive multiple therapy treatments. Reimbursement for the

8

second and subsequent therapy units for each patient each day they receive multiple therapy treatments is reimbursed at a rate equal to 75% of the applicable PE component through March 31, 2013. Effective April 1, 2013, the rate at which these services are reimbursed was reduced to 50% of the applicable PE component.

Medicare Part B therapy services in our centers are determined according to MPFS. Annually since 1997, the MPFS has been subject to a Sustainable Growth Rate Adjustment (“SGR”) intended to keep spending growth in line with allowable spending. Each year since the SGR was enacted, this adjustment produced a scheduled negative update to payment for physicians, therapists and other healthcare providers paid under the MPFS. Congress has stepped in with so-called “doc fix” legislation numerous times to stop payment cuts to physicians, most recently by the Middle Class Tax Relief and Job Creation Act of 2012, which stopped these payment cuts through December 31, 2012. Effective April 1, 2013, MPFS included a reduction of Medicare Part B therapy services reimbursements of 7%. As a result of this reduction in reimbursements, we experienced an approximate decrease in revenue of $698,000 for the year ended December 31, 2013.

The Middle Class Tax Relief and Job Creation Act of 2012 also resulted in a reduction of bad debt treated as an allowable cost. Prior to this act, Medicare reimbursed providers for beneficiaries’ unpaid coinsurance and deductible amounts after reasonable collection efforts at a rate between 70 and 100 percent of beneficiary bad debt. This provision reduced bad debt reimbursement exposure for all providers to 65 percent.

Medicaid

Several states in which we operate face budget shortfalls, which could result in reductions in Medicaid funding for nursing centers. The federal government made an effort to address the financial challenges state Medicaid programs are facing by increasing the amount of Medicaid funding available to states. Pressures on state budgets are expected to continue in the future and are expected to result in Medicaid rate reductions.

We receive the majority of our annual Medicaid rate increases during the third quarter of each year. The rate changes received in the third quarters of 2013 and 2012, along with increased Medicaid acuity in our acuity based states, were the primary contributor to our 3.0% increase in average rate per day for Medicaid patients in 2013 compared to 2012. Based on the rate changes received during the third quarter of 2013, we expect our rate per day for Medicaid patients to remain relatively flat on a consolidated basis as we move into 2014 due to offsetting increases and decreases in many of the states within which we operate.

We are unable to predict what, if any, reform proposals or reimbursement limitations will be implemented in the future, or the effect such changes would have on our operations. For the year ended December 31, 2013, we derived 27.3% and 53.5% of our total patient revenues related to continuing operations from the Medicare and Medicaid programs, respectively.  Any health care reforms that significantly limit rates of reimbursement under these programs could, therefore, have a material adverse effect on our profitability. 

We will attempt to increase revenues from non-governmental sources to the extent capital is available to do so. However, private payors, including Managed Care payors, are increasingly demanding that providers accept discounted fees or assume all or a portion of the financial risk for the delivery of health care services. Such measures may include capitated payments, which can result in significant losses to health care providers if patients require expensive treatment not adequately covered by the capitated rate.

Employees.

As of February 1, 2014, we employed approximately 5,400 individuals in connection with our continuing operations, approximately 3,900 of which are considered full-time employees. We believe that our employee relations are good. Approximately 150 of our employees are represented by a labor union.

Although we believe we are able to employ sufficient nurses and therapists to provide our services, a shortage of health care professional personnel in any of the geographic areas in which we operate could affect our ability to recruit and retain qualified employees and could increase our operating costs. We compete with other health care providers for both professional and non-professional employees and with non-health care providers for non-professional employees. This competition contributed to a significant increase in the salaries that we had to pay to hire and retain these employees. As is common in the health care industry, we expect the salary and wage increases for our skilled healthcare providers will continue to be higher than average salary and wage increases nationally.

Supplies and Equipment.

We purchase drugs, solutions and other materials and lease certain equipment required in connection with our business from many suppliers. We have not experienced, and do not anticipate that we will experience, any significant difficulty in purchasing supplies or leasing equipment from current suppliers. In the event that such suppliers are unable or fail to sell us supplies or lease equipment,

9

we believe that other suppliers are available to adequately meet our needs at comparable prices. National purchasing contracts are in place for all major supplies, such as food, linens and medical supplies. These contracts assist in maintaining quality, consistency and efficient pricing. Based on contract pricing for food and other supplies, we expect cost increases in 2014 to be relatively the same or slightly lower than the increases we experienced in 2013.

Government Regulation.

The health care industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government health care program participation requirements, reimbursement for patient services, quality of patient care and Medicare and Medicaid fraud and abuse. Over the last several years, government activity has increased with respect to investigations and allegations concerning possible violations by health care providers of fraud and abuse statutes and regulations, false claims statutes as well as laws and regulations governing quality of care issues in the skilled nursing profession in general. Violations of these laws and regulations could result in exclusion from government health care programs together with the imposition of significant fines and penalties, as well as significant repayments for patient services previously billed. Compliance with such laws and regulations is subject to ongoing government review and interpretation, as well as regulatory actions in which government agencies seek to impose fines and penalties. The Company is involved in regulatory actions of this type from time to time.

Licensure and Certification. All our nursing centers must be licensed by the state in which they are located in order to accept patients, regardless of payor source. In most states, nursing centers are subject to CON laws, which require us to obtain government approval for the construction of new nursing centers or the addition of new licensed beds to existing centers. Our nursing centers must comply with detailed statutory and regulatory requirements on an ongoing basis in order to qualify for licensure, as well as for certification as a provider eligible to receive payments from the Medicare and Medicaid programs. Generally, the requirements for licensure and Medicare/Medicaid certification are similar and relate to quality and adequacy of personnel, quality of medical care, record keeping, dietary services, patient rights, and the physical condition of the nursing center and the adequacy of the equipment used therein. Each center is subject to periodic inspections, known as “surveys” by health care regulators, to determine compliance with all applicable licensure and certification standards. Such requirements are both subjective and subject to change. If the survey concludes that there are deficiencies in compliance, the center is subject to various sanctions, including but not limited to monetary fines and penalties, suspension of new admissions, non-payment for new admissions and loss of licensure or certification. Generally, however, once a center receives written notice of any compliance deficiencies, it may submit a written plan of correction and is given a reasonable opportunity to correct the deficiencies. There can be no assurance that, in the future, we will be able to maintain such licenses and certifications for our facilities or that we will not be required to expend significant sums in order to comply with regulatory requirements.

Health care and health insurance reform. In March 2010, significant legislation concerning health care and health insurance was passed, including the “Patient Protection and Affordable Care Act”, (“Patient Protection Act”) along with the “Health Care and Education Reconciliation Act of 2010” (“Reconciliation Act”) collectively defined as the “Legislation.” We expect this Legislation to impact our Company, our employees and our patients in a variety of ways. Some aspects of these new laws have been implemented while others will be phased in over the next several years when all mandates become effective. This Legislation significantly changes the future responsibility of employers with respect to providing health care coverage to employees in the United States. We have not estimated the financial impact of the Legislation and the costs associated with complying with the increased levels of health insurance we will be required to provide our employees and their dependents in future years. We expect the Legislation will result in increased operating expenses.

We also anticipate this Legislation will continue to impact our Medicaid and Medicare reimbursement as well, though the timing and ultimate level of that impact is currently unknown as we anticipate that many of the provisions of the Legislation may be subject to further clarification and modification through the rule making process. The Legislation expands the role of home-based and community services, which may place downward pressure on our sustaining population of Medicaid patients. The provisions of the Legislation discussed above are examples of recently-enacted federal health reform provisions that we believe may have a material impact on the long-term care industry and on our business. However, the foregoing discussion is not intended to constitute, nor does it constitute, an exhaustive review and discussion of the Legislation.

Medicare and Medicaid. Medicare is a federally-funded and administered health insurance program for the aged and for certain chronically disabled individuals. Part A of the Medicare program covers inpatient hospital services and certain services furnished by other institutional providers such as skilled nursing facilities. Part B covers the services of doctors, suppliers of medical items, various types of outpatient services and certain ancillary services of the type provided by long-term and acute care facilities. Medicare payments under Part A and Part B are subject to certain caps and limitations, as provided in Medicare regulations. Medicare benefits are not available for intermediate and custodial levels of nursing center care or for assisted living center arrangements.

10

Medicaid is a medical assistance program for the indigent, operated by individual states with financial participation by the federal government. Criteria for medical indigence and available Medicaid benefits and rates of payment vary somewhat from state to state, subject to certain federal requirements. Basic long-term care services are provided to Medicaid beneficiaries, including nursing, dietary, housekeeping and laundry, restorative health care services, room and board and medications. Federal law requires that a state Medicaid program must provide for a public process for determination of Medicaid rates of payment for nursing center services. Under this process, proposed rates, the methodologies underlying the establishment of such rates and the justification for the proposed rates are published. This public process gives providers, beneficiaries and concerned state patients a reasonable opportunity for review and comment. Certain of the states in which we now operate are actively seeking ways to reduce Medicaid spending for nursing center care by such methods as capitated payments and substantial reductions in reimbursement rates.

As a component of CMS administration of the government's reimbursement programs, a new ratings system was implemented in December 2008 to assist the public in choosing a skilled care provider. While data for the consumer has been available for several years, the display of quality with a “Star” ranking with a “5 Star” ranking being the highest and a “1 Star” ranking being the lowest was new in 2008. The “5 Star” system is an attempt to simplify all the data for each nursing center to a “Star” ranking. The overall Star rating is determined by three components (three years survey results, quality measure calculations, and staffing data), with each of the components receiving star rankings as well. As this initiative becomes a bigger part of our business environment we remain diligent in continuing to provide outstanding patient care to achieve high rankings for our facilities, as well as assuring that our rankings are correct and appropriately reflect our quality results.

Health Insurance Portability and Accountability Act of 1996 Compliance. The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) has mandated an extensive set of regulations to standardize electronic patient health, administrative and financial data transactions, and to protect the privacy of individually identifiable health information. We have a HIPAA compliance committee and designated privacy and security officers.

The HIPAA transaction standards are intended to simplify the electronic claims process and other healthcare transactions by encouraging electronic transmission rather than paper submission. These regulations provide for uniform standards for data reporting, formatting and coding that we must use in certain transactions with health plans. The HIPAA security regulations establish detailed requirements for safeguarding protected health information that is electronically transmitted or electronically stored. Some of the security regulations are technical in nature, while others are addressed through policies and procedures. We implemented or upgraded computer and information systems as we believe necessary to comply with the new regulations.

The HIPAA regulations related to privacy establish comprehensive federal standards relating to the use and disclosure of individually identifiable health information (“protected health information”). The privacy regulations establish limits on the use and disclosure of protected health information, provide for patients' rights, including rights to access, to request amendment of, and to receive an accounting of certain disclosures of protected health information, and require certain safeguards for protected health information. In addition, each covered entity must contractually bind individuals and entities that furnish services to the covered entity or perform a function on its behalf, and to which the covered entity discloses protected health information, to restrictions on the use and disclosure of that protected health information. In general, the HIPAA regulations do not supersede state laws that are more stringent or grant greater privacy rights to individuals. Thus, we must reconcile the HIPAA regulations and other state privacy laws.

Although we believe that we are in material compliance with these HIPAA regulations, the HIPAA regulations are expected to continue to impact us operationally and financially and may pose increased regulatory risk.

Self-Referral and Anti-Kickback Legislation. The health care industry is subject to state and federal laws which regulate the relationships of providers of health care services, physicians and other clinicians. These self-referral laws impose restrictions on physician referrals to any entity with which they have a financial relationship, which is a broadly defined term. We believe our relationships with physicians are in compliance with the self-referral laws. Failure to comply with self-referral laws could subject us to a range of sanctions, including civil monetary penalties and possible exclusion from government reimbursement programs. There are also federal and state laws making it illegal to offer anyone anything of value in return for referral of patients. These laws, generally known as “anti-kickback” laws, are broad and subject to interpretations that are highly fact dependent. Given the lack of clarity of these laws, there can be no absolute assurance that any health care provider, including us, will not be found in violation of the anti-kickback laws in any given factual situation. Strict sanctions, including fines and penalties, exclusion from the Medicare and Medicaid programs and criminal penalties, may be imposed for violation of the anti-kickback laws.

Reporting Obligations under Section 111 of the Medicare, Medicaid and SCHIP Extension Act of 2007 (“MMSEA”). Since January 1, 2010, we have reported specific information regarding all claimants and claim settlements involving Medicare participants so CMS can recover Medicare funds expended to provide healthcare treatment to the claimant. The requirements are to ensure that CMS is notified so that it may recoup the amounts paid for services from the settlement proceeds. This does not result in us making additional payments to CMS for these services provided and does not result in an incremental cost to us. Strict sanctions, including

11

fines and penalties, exclusion from the Medicare and Medicaid programs and criminal penalties, may be imposed for non-compliance with these reporting obligations.

Available Information.

We file reports with the Securities and Exchange Commission (“SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Copies of our reports filed with the SEC may be obtained by the public at the SEC's Public Reference Room located at 100 F Street, NE, Washington, DC 20549 on official business days during the hours of 10 a.m. to 3 p.m. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains electronic versions of the Company's reports on its website at www.sec.gov. We also make available, free of charge through our website, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and other materials filed with the SEC as soon as reasonably practical after such material is electronically filed with or furnished to the SEC via a link to the SEC's EDGAR system. Our website address is www.dvcr.com. The information provided on our website is not part of this report, and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this report.

In addition, copies of the Company's annual report will be made available, free of charge, upon written request.

Corporate Governance Principles.

The Company has adopted Corporate Governance Principles relating to the conduct and operations of the Board of Directors. The Corporate Governance Principles are posted on the Company's website (www.dvcr.com) and are available in print to any stockholder who requests a copy.

Committee Charters.

The Board of Directors has an Audit Committee, Compensation Committee, Corporate Governance Committee and Executive Committee. The Board of Directors has adopted written charters for each committee, except for the Executive Committee, which are posted on the Company's website (www.dvcr.com) and are available in print to any stockholder who requests a copy.

ITEM 1A. RISK FACTORS

There have been a number of material developments both within the Company and the long-term care industry. These developments have had and are likely to continue to have a material impact on us. This section summarizes these developments, as well as other risks that should be considered by our shareholders and prospective investors.

We are substantially self-insured and have significant potential professionalliability exposure.

The provision of health care services entails an inherent risk of liability. Participants in the health care industry are subject to an increasing number of lawsuits alleging malpractice, negligence, product liability or related legal theories, many of which involve large claims and significant defense costs. Like many other companies engaged in the long-term care profession in the United States, we have numerous pending liability claims, disputes and legal actions for professional liability and other related issues. We expect to continue to be subject to such suits as a result of the nature of our business. See “Item 3. Legal Proceedings” for further descriptions of pending claims and see “Item 7. Management's Discussion and Analysis of Financial Condition - Accounting Policies and Judgments - Professional Liability and Other Self-Insurance Reserves” for discussion of our reserve for self-insured claims and of our ability to meet our anticipated cash needs.

For claims made after March 9, 2001, we have purchased professional liability insurance coverage for our nursing centers that, based on historical claims experience, is likely to be substantially less than the amount required to satisfy claims that are expected to be incurred.

We have seen an increase in the number of suits filed in professional liability matters and have had substantial adjustments to our accrual for professionalliability claims which has caused significant changes in our net earnings.

In recent periods we have seen an increase in the number of suits filed for professional liability matters. Each year, we record adjustments to our accrual for self-insured risks associated with professional liability claims. While these adjustments to the accrual result in changes to reported expenses and income, they are not directly related to changes in cash because the accrual is not funded. These self-insurance reserves are assessed on a quarterly basis, with changes in estimated losses being recorded in the consolidated statements of operations in the period identified. Any increase in the accrual decreases income in the period, and any reduction in the accrual increases income during the period. Our actual professional liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to

12

fluctuate by a material amount in any given quarter. For the years ended December 31, 2013, 2012 and 2011, we recorded professional liability expense of $7.3 million, $6.1 million and $3.6 million, respectively.

Our outstanding indebtedness is subject to various financial covenants and floatingrates of interest which could be subject to fluctuations based on changinginterest rates.

We have long-term indebtedness of $52.9 million at December 31, 2013. Certain of our debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. As of December 31, 2013, we were in compliance with these financial covenants. Our failure to comply with those covenants could result in an event of default, which, if not cured or waived, could result in the acceleration of some or all of our debts. Such non-compliance could result in a material adverse impact to our financial position, results of operations and cash flows. See “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources” for additional discussion of our covenants.

In connection with the refinancing transaction in April 2013 discussed in “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources,” we entered into an interest rate swap with respect to a portion of the mortgage loan to mitigate the floating interest rate risk of such borrowing. The interest rate swap converted the variable rate on our mortgage indebtedness to a fixed interest rate for the five year term of this indebtedness, decreasing our exposure to risks of variable rates of interest. While limiting our risk to increases in interest rates by utilizing the interest rate swap, we forgo benefits that might result from downward fluctuations in interest rates. We also are exposed to the risk that our counterpart to the swap agreement will default on its obligations.

Our accrual for professional liability claims is not funded, and if a material judgment is entered against us in any lawsuit, we may lack adequate cash to pay the judgment.

As of December 31, 2013, we are engaged in 54 professional liability lawsuits. Although we work diligently to limit the cash required to settle and defend professional liability claims, a significant judgment entered against us in one or more legal actions could have a material adverse impact on our cash flows and could result in our being unable to meet all of our cash needs as they become due.

Our operational and strategic flexibility is limited due to the number of our facilities that are leased from third parties.

A substantial majority of our facilities are leased from third parties. The terms of such leases generally require us to operate such facilities as skilled nursing facilities, and generally do not allow us to assign the lease to a third party without the applicable landlord’s consent. Therefore our ability to divest such leased properties is limited, and we may be forced to continue operating such facilities as skilled nursing facilities even if doing so becomes unprofitable.

We are highly dependent on reimbursement by third-party payors.

Substantially all of our nursing center revenues are directly or indirectly dependent upon reimbursement from third-party payors, including the Medicare and Medicaid programs, and private insurers. For the year ended December 31, 2013, our patient revenues from continuing operations derived from Medicaid, Medicare, Managed Care and private pay (including private insurers) sources were approximately 53.5%, 27.3%, 6.0%, and 13.2%, respectively. Changes in the mix of our patients among Medicare, Medicaid, Managed Care and private pay categories and among different types of private pay sources may affect our net revenues and profitability. Our net revenues and profitability are also affected by the continuing efforts of all payors to contain or reduce the costs of health care. Efforts to impose reduced payments, greater discounts and more stringent cost controls by government and other payors are expected to continue.

The Federal Government makes frequent changes to the reimbursement provided under the Medicare program and future changes could significantly reduce the reimbursement we receive. Also, a number of state governments, including several of the states in which we operate, have announced projected budget shortfalls and/or deficit spending situations. Possible actions by these states include reductions of Medicaid reimbursement to providers such as us or the failure to increase Medicaid reimbursements to cover increased operating costs, or implementation of alternatives to long-term care, such as community and home-based services.

Any changes in reimbursement levels or in the timing of payments under Medicare, Medicaid or private pay programs and any changes in applicable government regulations could have a material adverse effect on our net revenues, net income (loss) and cash flows. We are unable to predict what reform proposals or reimbursement limitations will be adopted in the future or the effect such changes will have on our operations. We are limited in our ability to reduce the direct costs of providing care when decreases in reimbursement rates are imposed. No assurance can be given that such reforms will not have a material adverse effect on us. See “Item 1. Business - Government Regulation and Reimbursement.”

13

We are subject to significant government regulation.

The health care industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government health care program participation requirements, reimbursement for patient services, quality of patient care and Medicare and Medicaid fraud and abuse. Various federal and state laws regulate relationships among providers of services, including employment or service contracts and investment relationships. The operation of long-term care centers and the provision of services are also subject to extensive federal, state, and local laws relating to, among other things, the adequacy of medical care, distribution of pharmaceuticals, equipment, personnel, operating policies, environmental compliance, compliance with the Americans with Disabilities Act, fire prevention and compliance with building codes.

Long-term care facilities are subject to periodic inspection to assure continued compliance with various standards and licensing requirements under state law, as well as with Medicare and Medicaid conditions of participation. The failure to obtain or renew any required regulatory approvals or licenses could adversely affect our growth and could prevent us from offering our existing or additional services. In addition, health care is an area of extensive and frequent regulatory change. Changes in the laws or new interpretations of existing laws can have a significant effect on methods and costs of doing business and amounts of payments received from governmental and other payors. Our operations could be adversely affected by, among other things, regulatory developments such as mandatory increases in the scope and quality of care to be afforded patients and revisions in licensing and certification standards. We attempt at all times to comply with all applicable laws; however, there can be no assurance that we will remain in compliance at all times with all applicable laws and regulations or that new legislation or administrative or judicial interpretation of existing laws or regulations will not have a material adverse effect on our operations or financial condition. Federal or state proceedings seeking to impose fines and penalties for violations of applicable laws and regulations, as well as federal and state changes in these laws and regulations may negatively impact us. See “Item 1. Business - Government Regulation.” See also “Item 3. Legal Proceedings.”

The health care industry has been the subject of increased regulatory scrutinyrecently.

The Office of Inspector General (“OIG”), the enforcement arm of the Medicare and Medicaid programs, formulates a formal work plan each year for nursing centers. The OIG's most recent work plan indicates that quality of care, assessment and monitoring, poorly performing nursing facilities, hospitalizations, criminal background checks, Medicare part B services, accuracy of nursing facilities Minimum Data, transparency of ownership, and civil monetary penalty fundswill be an investigative focus in 2014. We cannot predict the likelihood, scope or outcome of any such investigations on our facilities.

We may be subject to claims under the self-referral, false claims, and anti-kickback legislation.

In the United States, various state and federal laws regulate the relationships between providers of health care services, physicians, and other clinicians. These self-referral laws impose restrictions on physician referrals for designated health services to entities with which they have financial relationships. These laws also prohibit the offering, payment, solicitation or receipt of any form of remuneration in return for the referral of Medicare or state health care program patients or patient care opportunities for the purchase, lease or order of any item or service that is covered by the Medicare and Medicaid programs. The false claims act authorizes individuals to file legal actions to recover improper reimbursement received from governmental payors. To the extent that we, any of our facilities with which we do business, or any of the owners or directors have a financial relationship with each other or with other health care entities providing services to long-term care patients, such relationships could be subject to increased scrutiny. There can be no assurance that our operations will not be subject to review, scrutiny, penalties or enforcement actions under these laws, or that these laws will not change in the future. Violations of these laws may result in substantial damage awards, civil or criminal penalties for individuals or entities, including large civil monetary penalties and exclusion from participation in the Medicare or Medicaid programs. Such awards, exclusion or penalties, if applied to us, could have a material adverse effect on our profitability.

We are subject to laws governing the confidentiality of patient health information.

Both federal and state laws impose certain requirements regarding maintaining the confidentiality of patient health information. In particular, HIPAA rules and regulations require us to protect the medical records and other personal health information of our patients, limit our use of and ability to disclose such information except under certain circumstances, and give patients a right to access and amend their personal health information. A violation of HIPAA or any other federal or state laws regarding the confidentiality or use of such information could subject us to civil or criminal penalties, and could in turn damage our reputation, affect our ability to attract new patients, and thereby have a material adverse effect on our revenues, financial position, results of operations and cash flows.

14

We operate in an industry that is highly competitive.

The long-term care industry generally, and the nursing home business particularly, is highly competitive. We face direct competition for the acquisition of facilities. In turn, our facilities face competition for patients. Our ability to compete is based on several factors and include, but are not limited to building age, appearance, reputation, relationships with referral sources, availability of patients, survey history and CMS rankings. Some of our present and potential competitors are significantly larger and have or may obtain greater financial and marketing resources than we can. Some hospitals that provide long-term care services are also a potential source of competition. In addition, we may encounter substantial competition from new market entrants. Consequently, there can be no assurance that we will not encounter increased competition in the future, which could limit our ability to attract patients or expand our business, and could materially and adversely affect our business or decrease our market share.

Increased competition for qualified healthcare professionals could affect our costs.

In many of the regions where we operate the market for qualified nurses and other healthcare professionals has been and continues to be very competitive. In order to hire and retain such qualified professionals going forward, we may be required to offer higher wages or greater benefits, and in such event higher average labor costs may result. Wages represent the largest component of our operating expenses. Therefore our ability to manage labor costs will significantly influence our results of operations and cash flow.

Healthcare reform legislation could adversely affect our revenue and financial condition.

In recent years, there have been initiatives on the federal and state levels for comprehensive reforms affecting the availability, payment and reimbursement of healthcare services in the United States. In March 2010, significant legislation concerning health care and health insurance was passed which will significantly change the future of health care in the United States. If the reforms are phased in over the next ten years as currently enacted, they may significantly increase our costs to provide employee health insurance and have an adverse effect on our financial condition and results of operations. It is also expected that this new legislation will impact our operations and reimbursement from Federal programs such as Medicare and Medicaid as well as private insurance. The timing and ultimate level of that impact is currently unknown as we anticipate that many of the provisions of such legislation may be subject to further clarification and modification through the rule making process.

Investing in our business initiatives and development could adversely impact our results of operations and financial condition.

We plan to invest in business initiatives and development that will increase our operating expenses. These initiatives may or may not be successful in growing our census or revenues. There is typically a time delay between incurring such expenses and the attaining of revenues and cash flows expected from these initiatives and development. As a result, our revenue and operating cash flow may not increase enough during a reporting period to cover these increased expenses. Such additional revenues may not materialize at the level we anticipate, if at all.

The success of previous and future investments in acquisitions cannot be guaranteed and such acquisitions may consume substantial capital and other resources.

We have in the past and plan to in the future make investments in additional facilities, whether by opening new facilities or acquiring existing facilities. Such acquisitions may require substantial cash investments and incurrence of additional debt. Our ability to make future acquisitions will therefore depend on our being able to obtain the necessary capital through equity or debt financing on reasonable terms. Our ability to make future acquisitions will also depend on our being able to identify strategic acquisitions that meet our criteria for expansion and to negotiate such acquisitions on reasonable terms. The success of future acquisitions will depend on our ability to efficiently integrate newly acquired businesses into our own as well as on whether such acquired businesses ultimately achieve our goals for financial performance. The process of acquiring and integrating new businesses may divert management time that would otherwise be spent on our existing operations. Acquisitions that prove unsuccessful may have a material adverse effect on our financial position, results of operations, and cash flows.

Our ability and intent to pay cash dividends in the future may be limited.

We currently pay a $0.055 quarterly dividend on our common shares and while the Board of Directors intends to pay quarterly dividends, the Board will make the determination of the amount of future cash dividends, if any, to be declared and paid based on, among other things, our financial condition, funds from operations, the level of our capital expenditures and future business prospects. The Company is restricted by its debt agreements in its ability to pay dividends.

We have a number of policies in place that could be considered anti-takeover protections.

15

We have adopted a shareholder rights plan (the “Plan”). On August 14, 2009, our board of directors (“Board”) amended the Plan to change the definition of “Acquiring Person” to be such person that acquires 20% or more of the shares of Common Stock of the Company, up from the 15% that previously defined an acquiring person. The Plan is intended to encourage potential acquirers to negotiate with our Board and to discourage coercive, discriminatory and unfair proposals. Our Certificate of Incorporation (the “Certificate”) provides for the classification of our Board into three classes, with each class of directors serving staggered terms of three years. Our Certificate requires the approval of the holders of two-thirds of the outstanding shares to amend certain provisions of the Certificate. Section 203 of the Delaware General Corporate Law restricts the ability of a Delaware corporation to engage in any business combination with an interested shareholder. We are also authorized to issue up to 795,000 shares of preferred stock, the rights of which may be fixed by our Board without shareholder approval. Provisions in certain of our executive officers' employment agreements provide for post-termination compensation, including payment of amounts up to two times their annual salary, following certain changes in control (as defined in such agreements). Our stock incentive plans provide for the acceleration of the vesting of options in the event of certain changes in control (as defined in such plans). Certain changes in control also constitute an event of default under our bank credit facility. The foregoing matters may, together or separately, have the effect of discouraging or making more difficult an acquisition or change of control of the company.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

We own 13 and lease 34 long-term care facilities as discussed in “Item 1 Business - Nursing Centers and Services.” A description of our lease agreements follows.

Description of Lease Agreements.

Our current operations include 34 nursing centers subject to operating leases, including 25 owned by Omega REIT, six owned by Aviv REIT, and three owned by other parties. In our role as lessee, we are responsible for the day-to-day operations of all operated centers. These responsibilities include recruiting, hiring and training all nursing and other personnel, and providing patient care, nutrition services, marketing, quality improvement, accounting, and data processing services for each center. The lease agreements pertaining to our 34 leased facilities are “triple net” leases, requiring us to maintain the premises, provide insurance, pay taxes and pay for all utilities. The average remaining term of our lease agreements, including renewal options, is approximately 19 years.

Omega Master Lease. We lease 17 nursing centers from Omega pursuant to one lease agreement dated October 1, 2000 (the “Omega Master Lease”). The Omega Master Lease has an initial term, as amended, that expires September 30, 2018, provides for a renewal option of an additional twelve years, assuming no defaults, and provides for annual increases in lease payments equal to the lesser of two times the increase in the Consumer Price Index or 3.0%.

Effective August 11, 2007, we completed the acquisition of the leases and leasehold interests in seven facilities from Senior Management Services of America North Texas (“SMSA”) which are leased from a subsidiary of Omega. In connection with this acquisition, we amended the Omega Master Lease to include the seven SMSA facilities (“SMSA Amendment”), increasing the number of facilities under the Omega Master Lease to 24. The substantive terms of the previous SMSA lease, including payment provisions and lease period including renewal options, were not changed by the SMSA Amendment. The SMSA Amendment provides for an initial term and renewal periods at our option through May 31, 2035 for the seven SMSA facilities. The SMSA Amendment provides for annual increases in lease payments equal to the increase in the Consumer Price Index, not to exceed 2.5%.

In August 2009, we completed the construction of a 119-bed skilled nursing center, Brentwood Terrace, located in Paris, Texas, replacing an existing 102-bed nursing center leased from Omega. The replacement center was financed with funding from Omega and is leased from Omega under a long-term operating lease with renewal options through 2035. Annual rent was approximately $0.8 million for the year ended December 31, 2013 and is based on a calculation of 10.25% of the total cost of the replacement center. The Brentwood Terrace nursing center lease provides for annual increases in lease payments equal to the increase in the Consumer Price Index, not to exceed 2.5%.

The Omega Master Lease requires us to fund annual capital expenditures currently equal to $427 per licensed bed, subject to adjustment for increases in the Consumer Price Index. Upon expiration of, or in the event of a default under the Omega Master Lease, we are required to transfer all of the leasehold improvements, equipment, furniture and fixtures of the leased facilities to Omega.

16

In January 2013, we entered into an amendment to the Omega Master Lease under which Omega agreed to provide an additional $5.0 million to fund renovations to two nursing centers located in Texas that are leased from Omega. The annual base rent related to these facilities will be increased to reflect the amount of capital improvements to the respective facilities as the related expenditures are made. The increase is based on a rate of 10.25% per year of the amount financed under this amendment. This arrangement is similar to amendments entered into in 2011, 2009, 2006 and 2005 that provided financing totaling $20.0 million that was used to fund renovations at fourteen nursing centers leased from Omega. As of December 31, 2013, renovation projects using these funds have been completed at fourteen leased facilities. Approximately $22.4 million allotted by Omega to fund renovations has been used. Plans are being developed for additional renovation projects including those that would potentially be funded through Omega.

The Omega Master Lease prohibits us from operating any additional facilities within a certain radius of each leased nursing center. We are generally required to maintain comprehensive insurance covering the facilities we lease as well as personal and real property damage insurance and professional liability insurance. The failure to pay rentals within a specified period or to comply with the required operating and financial covenants generally constitutes a default, and, if uncured, such a default would permit Omega to terminate the lease and assume the property and the contents within the facilities.

In August 2013, we entered into another amendment to the Omega Master Lease in order to terminate our lease with respect to eleven nursing centers located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. This Thirteenth Amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.

Other Leases. We operate a 150-bed nursing center located in Tennessee subject to a lease with a term that expires March 2019 and renewal options through March 2026.

We operate the Rose Terrace nursing center in West Virginia subject to a lease with an initial lease term that expires December 2031 and renewal options through December 2041. The lease agreement grants us the right to purchase the center beginning in December 2012 and continuing through December 2016 for a purchase price ranging from 110% to 120% of the total project cost.

In September 2013, we assumed operations of a 107-bed facility in Louisville, Kentucky subject to a lease with an initial 15-year lease term that expires in August 2028 with a renewal option through August 2033.

In October 2013, we assumed operations at four nursing centers, three in Ohio and one in Indiana, subject to a lease with an initial 15-year lease term that expires in September 2028 with a renewal option through September 2033.

We lease approximately 29,000 square feet of office space in Brentwood, Tennessee that houses our executive offices, and centralized management support functions. In addition, we lease our regional office with approximately 4,000 square feet of office space in Ashland, Kentucky. Lease periods on these facilities range up to three years. Regional executives for Alabama and Kansas work from offices of up to 1,500 square feet each. We believe that our leased properties are adequate for our present needs and that suitable additional or replacement space will be available as required.

ITEM 3. LEGAL PROCEEDINGS

The provision of health care services entails an inherent risk of liability. Participants in the health care industry are subject to lawsuits alleging malpractice, violations of false claims acts, product liability, or related legal theories, many of which involve large claims and significant defense costs. Like many other companies engaged in the long-term care profession in the United States, we have numerous pending liability claims, disputes and legal actions for professional liability and other related issues. It is expected that we will continue to be subject to such suits as a result of the nature of our business. Further, as with all health care providers, we are periodically subject to regulatory actions seeking fines and penalties for alleged violations of health care laws and are potentially subject to the increased scrutiny of regulators for issues related to compliance with health care fraud and abuse laws and with respect to the quality of care provided to residents of our facility. Like other health care providers, in the ordinary course of our business, we are also subject to claims made by employees and other disputes and litigation arising from the conduct of our business.

As of December 31, 2013, we are engaged in 54 professional liability lawsuits. Five lawsuits are currently scheduled for trial or arbitration during the next twelve months, and it is expected that additional cases will be set for trial or hearing. The ultimate results of any of our professional liability claims and disputes cannot be predicted. We have limited, and sometimes no, professional liability insurance with regard to most of these claims. A significant judgment entered against us in one or more of these legal actions could have a material adverse impact on our financial position and cash flows.

On May 16, 2012, a purported stockholder class action complaint was filed in the U.S. District Court for the Middle District of Tennessee, against the Company's Board of Directors. This action alleges that the Board of Directors breached its fiduciary duties

17

to stockholders related to its response to certain expressions of interest in a potential strategic transaction from Covington Investments, LLC (“Covington”). The complaint asserts that the Board failed to negotiate or otherwise appropriately consider Covington's proposals. In November, 2012, the lawsuit was dismissed without prejudice for lack of subject matter jurisdiction. The action was refiled in the Chancery Court for Williamson County, Tennessee (21^st Judicial District) on November 30, 2012. The lawsuit remains in its early stages and has not yet been certified by the court as a class action. We intend to defend the matter vigorously.

In June 2012, a collective action complaint was filed in the U.S. District Court for the U.S. District Court for the Western District of Arkansas against us and certain of our subsidiaries.  The complaint alleges that the defendants violated the Fair Labor Standards Act (FLSA) and seeks unpaid overtime wages as well as liquidated damages.  The Court conditionally certified a nationwide class of all of the Company's hourly employees.  The Company will defend the lawsuit vigorously.

In January 2009, a purported class action complaint was filed in the Circuit Court of Garland County, Arkansas against the Company and certain of its subsidiaries and Garland Nursing & Rehabilitation Center (the “Facility”). The complaint alleges that the defendants breached their statutory and contractual obligations to the patients of the Facility over the past five years.The lawsuit remains in its early stages and has not yet been certified by the court as a class action. The Company intends to defend the lawsuit vigorously.

We cannot currently predict with certainty the ultimate impact of any of the above cases on our financial condition, cash flows or results of operations. Our reserve for professional liability expenses does not include any amounts for the collective actions, the purported class action against the Facility or the lawsuit filed against our directors. An unfavorable outcome in any of these lawsuits or any of our professional liability actions, any regulatory action, any investigation or lawsuit alleging violations of fraud and abuse laws or of elderly abuse laws or any state or Federal False Claims Act case could subject us to fines, penalties and damages, including exclusion from the Medicare or Medicaid programs, and could have a material adverse impact on our financial condition, cash flows or results of operations.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDERMATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information. Our common stock is traded on the NASDAQ Capital Market and began trading there on September 12, 2006 under the symbol “AVCA.” Effective March 15, 2013, the Company changed its name from Advocat Inc. to Diversicare Healthcare Services, Inc. as a result of a merger of the Company and a wholly-owned subsidiary. In connection with the name change, the Company changed its NASDAQ ticker symbol from “AVCA” to “DVCR” effective with the market open on

Monday March 18, 2013. The following table sets forth the high and low bid prices of our common stock, as reported by NASDAQ.com, for each quarter in 2013 and 2012:

Period				High		Low		Dividends
2012	—	1st	Quarter	$	6.90	$	5.15	$	0.055
2012	—	2nd	Quarter	$	7.54	$	4.01	$	0.055
2012	—	3rd	Quarter	$	6.91	$	5.09	$	0.055
2012	—	4th	Quarter	$	6.11	$	4.82	$	0.055
2013	—	1st	Quarter	$	5.91	$	4.87	$	0.055
2013	—	2nd	Quarter	$	5.37	$	4.45	$	0.055
2013	—	3rd	Quarter	$	5.74	$	4.67	$	0.055
2013	—	4th	Quarter	$	5.30	$	4.56	$	0.055

18

Our common stock has been traded since May 10, 1994. On February 14, 2014, the closing price for our common stock was $5.28, as reported by NASDAQ.com.

Holders. On February 14, 2014, there were approximately 312 holders of record. Most of our shareholders have their holdings in the street name of their broker/dealer.

Dividends. For each of the two most recent fiscal years, we have paid a quarterly dividend of $0.055 per common share. While the Board of Directors intends to continue to pay quarterly dividends, the Board will make the determination of the amount of future cash dividends, if any, to be declared and paid based on, among other things, the Company's financial condition, funds from operations, the level of its capital expenditures and its future business prospects. The Company is restricted by its debt agreements in its ability to pay dividends. We are required to pay dividends at an annual rate of 7.0% of the stated value on our outstanding Series C Redeemable Preferred Stock, payable quarterly. As a result, we have paid a quarterly dividend on the outstanding Series C Redeemable Preferred Stock of $86,000.

Equity Compensation Plan Information

The following table provides aggregate information as of December 31, 2013, with respect to shares of our common stock that may be issued under our existing equity compensation plans:

Plan Category	Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a)	Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights (b)	Number of Securities Available for Future Issuance Under Equity Compensation Plans (excluding Securities Reflected in Column (a)) (c)(1)
Equity Compensation Plans Approved  by Security Holders	333,000	$6.64	435,000
Equity Compensation Plans Not Approved by Security Holders	None	None	None
Total	333,000	$6.64	435,000

(1) Includes 63,000 shares available for issuance under the 2005 Long-Term Incentive Plan, 42,000 shares reserved for issuance under the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel and 330,000 shares available for issuance under the 2010 Long-Term Incentive Plan. The 2010 Long-Term Incentive Plan was approved in 2010 and allows for the granting of options and stock appreciation rights for our common stock and is administered by the compensation committee of the Board.

ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA

The selected financial data of Diversicare presented in the following table have been derived from our consolidated financial statements, and should be read in conjunction with the annual financial statements and related notes and Management's Discussion and Analysis of Financial Condition and Results of Operations. This selected financial data for all periods shown have been reclassified to present the effects of certain divestitures as discontinued operations.

19

	Year Ended December 31,
	2013			2012			2011			2010			2009
Statement of Operations Data				(in thousands, except per share amounts)
REVENUES:
Patient revenues, net	$	281,919		$	246,290		$	245,877		$	225,034		$	214,722
EXPENSES:
Operating	228,342			197,960			194,152			181,835			173,136
Lease	21,542			19,050			18,064			17,726			16,917
Professional liability	7,336			6,102			3,618			1,943			3,269
General and administrative	20,940			19,515			21,024			15,892			16,555
Depreciation and amortization	6,972			6,276			5,607			5,023			4,612
Asset Impairment	—			—			344			—			—
Restructuring	1,446			—			—			—			—
	286,578			248,903			242,809			222,419			214,489
OPERATING INCOME (LOSS)	(4,659		)	(2,613		)	3,068			2,615			233
OTHER INCOME (EXPENSE):
Foreign currency transaction gain (loss)	—			—			—			—			191
Other income	—			—			—			—			549
Equity in net losses of unconsolidated affiliate	(183		)	(280		)	—			—			—
Interest expense, net	(3,620		)	(2,809		)	(2,356		)	(1,633		)	(1,716		)
Debt retirement costs	(320		)	—			(112		)	(127		)	—
	(4,123		)	(3,089		)	(2,468		)	(1,760		)	(976		)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(8,782		)	(5,702		)	600			855			(743		)
BENEFIT (PROVISION) FOR INCOME TAXES	3,305			2,027			(162		)	(274		)	274
INCOME (LOSS) FROM CONTINUING OPERATIONS	(5,477		)	(3,675		)	438			581			(469		)
DISCONTINUED OPERATIONS, net of taxes	(2,985		)	755			929			3,267			3,070
NET INCOME (LOSS)	$	(8,462	)	$	(2,920	)	$	1,367		$	3,848		$	2,601
INCOME (LOSS) PER COMMON SHARE:
Basic
Continuing operations	$	(1.00	)	$	(0.71	)	$	0.02		$	0.04		$	(0.14	)
Discontinued operations	(0.51		)	0.13			0.16			0.57			0.54
Net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.18		$	0.61		$	0.40
Diluted
Continuing operations	$	(1.00	)	$	(0.71	)	$	0.02		0.04			(0.14		)
Discontinued operations	(0.51		)	0.13			0.15			0.56			0.53
Net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.17		$	0.60		$	0.39
CASH DIVIDENDS DECLARED PER COMMON SHARE	$	0.22		$	0.22		$	0.22		$	0.22		$	0.22
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	5,899			5,821			5,774			5,732			5,678
Diluted	5,899			5,821			5,906			5,854			5,797

20

	December 31,
	2013		2012		2011		2010		2009
Balance Sheet Data	(in thousands)
Working capital	$	8,044	$	15,663	$	15,435	$	16,228	$	12,334
Total assets	$	137,744	$	114,963	$	116,744	$	105,596	$	105,451
Long-term debt and capitalized lease obligations, including current portion	$	53,577	$	29,462	$	29,899	$	24,401	$	24,829
Preferred Stock - Series C (including unamortized premium)	$	4,918	$	4,918	$	4,918	$	4,918	$	6,192
Total Shareholders' Equity of Diversicare Healthcare Services, Inc.	$	8,129	$	17,178	$	21,315	$	22,205	$	19,693
Total Shareholders' Equity	$	9,566	$	18,751	$	22,969	$	22,205	$	19,693

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTSOF OPERATIONS

Overview

Diversicare Healthcare Services, Inc. provides long-term care services to nursing center patients in nine states, primarily in the Southeast and Southwest. Our centers provide a range of health care services to their patients and residents. In addition to the nursing, personal care and social services usually provided in long-term care centers, we offer a variety of comprehensive rehabilitation services as well as nutritional support services. As of December 31, 2013, our continuing operations consist of 47 nursing centers with 5,318 licensed nursing beds. We own 13 and lease 34 of our nursing centers included in continuing operations. The nursing center and licensed nursing bed count includes the Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013. The nursing center and licensed bed count includes the 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicaid and Medicare certification processes for this facility are currently underway and we expect these to be completed in the first quarter of 2014. The nursing center and licensed nursing bed count also includes 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes are currently under way for these four leased facilities. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Ohio, Tennessee, Texas and West Virginia.

Divestitures

Effective September 1, 2013, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in the state of Arkansas, and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying consolidated financial statements. These centers contributed revenues of $40.2 million, $61.8 million, and $63.6 million, during the twelve months ended December 31, 2013, 2012, and 2011, respectively. Further, these centers contributed net loss of $2.9 million during the twelve months ended December 31, 2013, and net income of $0.5 million and $0.5 million during the twelve months ended December 31, 2012 and 2011, respectively.  The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations. In addition to the expenses associated with the discontinued operations, the Company also incurred $1.4 million in restructuring expenses that represent corporate expenses and exit costs associated with the Arkansas lease termination, but not classified as discontinued operations. The Company will continue to defend, and make cash payments related to, professional liability claims asserted against these nursing centers for events occurring prior to September 1, 2013.

Effective September 1, 2012, we sold an owned skilled nursing center in Arkansas to an unrelated party and have reclassified the operations of this facility as discontinued operations for all periods presented in the accompanying consolidated financial statements. The operating margins and the long term-business prospects of the nursing center did not meet our strategic goals. This skilled nursing center had no revenues during the twelve months ended December 31, 2013, but contributed revenues of $3.5 million,

21

and $5.2 million for the twelve months ended December 31, 2012 and 2011, respectively. Additionally, there was net income (loss) from this facility of $(0.1) million, $0.1 million, and $0.2 million during the twelve months ended December 31, 2013, 2012 and 2011, respectively.  The net income (loss) for the nursing center included in discontinued operations does not reflect any allocation of regional or corporate general and administrative expense or any allocation of corporate interest expense. We considered these additional costs along with the future prospects of this nursing center when determining the contribution of the skilled nursing center to our operations. The gain on disposal, net of taxes, of $0.2 million was primarily the amount of sales price in excess of the net carrying value of the fixed assets sold.

The Company owns land related to a North Carolina assisted living facility it closed in April 2006. The net assets of discontinued operations presented in property and equipment on the accompanying consolidated balance sheet of $1.1 million represents the real estate related to this assisted living facility. The Company is continuing its efforts to sell this land. The fair value of the subject property was determined based on comparable properties in the area and considered a level 2 calculation under the fair value hierarchy as discussed in Note 2.

Strategic Operating Initiatives

During the third quarter of 2010, we identified several key strategic objectives to increase shareholder value through improved operations and business development. These strategic operating initiatives included: improving skilled mix in our nursing centers, improving our average Medicare rate, implementing Electronic Medical Records (“EMR”) to improve Medicaid capture, accelerating center renovations and completing strategic acquisitions. We have experienced success in these initiatives and expect to continue to build on these improvements. We describe each of these below as well as provide metrics for our most recent quarter versus the third quarter of 2010, the quarter before we embarked on our strategic operating initiatives.

Improving skilled mix and average Medicare rate:

Our strategic operating initiatives of improving our skilled mix and our average Medicare rate required investing in nursing and clinical care to treat more acute patients along with nursing center-based marketing representatives to attract these patients. These initiatives developed referral and Managed Care relationships that have attracted and are expected to continue to attract payor sources for patients covered by Medicare and Managed Care. A comparison of our most recent quarter versus the third quarter of 2010, the quarter before we embarked on our strategic operating initiatives, reflects our success with these strategic operating initiatives:

	Three Months Ended
	December 31, 2013			September 30, 2010
As a percent of total census:
Medicare census	11.5		%	12.3		%
Managed Care census	2.9		%	1.3		%
Total skilled mix census	14.4		%	13.6		%
As a percent of total revenues:
Medicare revenues	27.0		%	29.3		%
Managed Care revenues	5.8		%	2.8		%
Total skilled mix revenues	32.8		%	32.1		%
Medicare average rate per day:	$	436.96		$	394.23

Implementing Electronic Medical Records to improve Medicaid acuity capture:

As another part of our strategic operating initiatives, we implemented EMR to improve Medicaid acuity capture, primarily in our states where the Medicaid payments are acuity based. We completed the implementation of Electronic Medical Records in all our nursing centers in December 2011, on time and under budget, and since implementation have increased our average Medicaid rate despite rate cuts in certain acuity based states by accurately and timely capture of care delivery. A comparison of our most recent quarter versus the third quarter of 2010 reflects our success with increasing our average Medicaid rate per day:

	Three Months Ended
	December 31, 2013		September 30, 2010
Medicaid average rate per day:	$	162.91	$	147.93

22

Accelerating center renovations:

As part of our strategic operating initiatives we have accelerated our program for improving our physical plants. Since 2005, we have been completing strategic renovations of certain facilities that improve quality of care and profitability. We plan to continue these nursing center renovation projects and accelerate this strategy using the knowledge obtained in the first few years of this program. A comparison of our most recent quarter versus the third quarter of 2010 reflects our success with accelerating center renovations:

	December 31, 2013*		September 30, 2010
Renovated nursing centers	17		14
Amounts expended on renovations (in millions)	$	29.1	$	20.9

*The amounts above include renovations which were performed on six homes within the state of Arkansas that have since been disposed of and recorded within discontinued operations. Renovation spending on these facilities totaled $7.3 million.

Completing strategic acquisitions:

Our strategic operating initiatives include a renewed focus on completing strategic acquisitions. We continue to pursue and investigate opportunities to acquire, lease or develop new centers, focusing primarily on opportunities within our existing areas of operation. We expect to announce additional development projects in the near future. We have added three skilled nursing centers in Kentucky, one in West Virginia, five in Kansas, one in Indiana, and three in Ohio. As detailed further in our results of operations, we experienced a significant amount of expenses related to start-up activities during 2012 at our two newly opened centers.

These investments in business initiatives have increased our operating expenses during 2013 and 2012. While we expect to see additional start-up losses at some of these centers, we also expect our investments to create additional revenue and improved profitability over the next several quarters.

As part of our strategic efforts, we have also performed thorough analysis on our existing centers in order to determine whether continuing operations within certain markets or regions was in line with the short-term and long-term strategy of the business. As a result, we disposed of an owned building in Arkansas in 2012, and reached an agreement to terminate our lease for eleven other facilities in Arkansas in 2013. As a result of these transactions, we no longer operate within the state of Arkansas.

Basis of Financial Statements.

Our patient revenues consist of the fees charged for the care of patients in the nursing centers we own and lease. Our operating expenses include the costs, other than lease, depreciation and amortization expenses, incurred in the operation of the nursing centers we own and lease. Our general and administrative expenses consist of the costs of the corporate office and regional support functions. Our interest, depreciation and amortization expenses include all such expenses across the range of our operations.

Selected Financial and Operating Data

The following table summarizes the Diversicare statements of continuing operations for the years ended December 31, 2013, 2012 and 2011, and sets forth this data as a percentage of revenues for the same years:

23

	Year Ended December 31,
	(Dollars in thousands)
	2013					2012					2011
Revenues:
Patient revenues, net	$	281,919		100.0	%	$	246,290		100.0	%	$	245,877		100.0	%
Expenses:
Operating	228,342			81.0	%	197,960			80.4	%	194,152			79.0	%
Lease	21,542			7.6	%	19,050			7.7	%	18,064			7.3	%
Professional liability	7,336			2.6	%	6,102			2.5	%	3,618			1.5	%
General & administrative	20,940			7.4	%	19,515			7.9	%	21,024			8.6	%
Depreciation and amortization	6,972			2.5	%	6,276			2.5	%	5,607			2.3	%
Asset impairment	—			—	%	—			—	%	344			0.1	%
Restructuring	1,446			0.5	%	—			—	%	—			—	%
	286,578			101.6	%	248,903			101.0	%	242,809			98.8	%
Operating income (loss)	(4,659		)	(1.6	)%	(2,613		)	(1.0	)%	3,068			1.2	%
Other income (expense):
Equity in net losses of unconsolidated affiliate	(183		)	(0.1	)%	(280		)	(0.1	)%	—			—	%
Interest expense, net	(3,620		)	(1.3	)%	(2,809		)	(1.1	)%	(2,356		)	(1.0	)%
Debt retirement costs	(320		)	(0.1	)%	—			—	%	(112		)	—	%
	(4,123		)	(1.5	)%	(3,089		)	(1.2	)%	(2,468		)	(1.0	)%
Income (loss) from continuing operations before income taxes	(8,782		)	(3.1	)%	(5,702		)	(2.2	)%	600			0.2	%
Benefit (provision) for income taxes	3,305			1.2	%	2,027			0.8	%	(162		)	(0.1	)%
Income (loss) from continuing operations	$	(5,477	)	(1.9	)%	$	(3,675	)	(1.4	)%	$	438		0.1	%

The following table presents data about the facilities we operated as part of our continuing operations as of the dates:

	December 31,
	2013	2012	2011
Licensed Nursing Center Beds:
Owned	1,224	806	806
Leased	4,094	3,551	3,328
Total	5,318	4,357	4,134
Facilities:
Owned	13	8	8
Leased	34	29	27
Total	47	37	35

Critical Accounting Policies and Judgments

A “critical accounting policy” is one which is both important to the understanding of our financial condition and results of operations and requires management's most difficult, subjective or complex judgments, often of the need to make estimates about the effect of matters that are inherently uncertain. Actual results could differ from those estimates and cause our reported net income (loss) to vary significantly from period to period. Our accounting policies that fit this definition include the following:

Revenues

Patient Revenues, net

The fees we charge patients in our nursing centers are recorded on an accrual basis. These rates are contractually adjusted with respect to individuals receiving benefits under federal and state-funded programs and other third-party payors. Our net revenues are derived substantially from Medicare, Medicaid and other government programs (approximately 80.8%, 83.2% and 84.0% for 2013, 2012, and 2011, respectively). Medicare intermediaries make retroactive adjustments based on changes in allowed claims.

24

In addition, certain of the states in which we operate require complicated detailed cost reports which are subject to review and adjustments. In the opinion of management, adequate provision has been made for adjustments that may result from such reviews. Retroactive adjustments, if any, are recorded when objectively determinable, generally within three years of the close of a reimbursement year depending upon the timing of appeals and third-party settlement reviews or audits.

Allowance for Doubtful Accounts

We evaluate the collectibility of our accounts receivable by reviewing current aging summaries of accounts receivable, historical collections data and other factors. As a percentage of revenue, our provision for doubtful accounts was approximately 1.5%, 1.2%, and 0.7% for 2013, 2012 and 2011, respectively. Historical bad debts have generally resulted from uncollectible private pay balances, some uncollectible coinsurance and deductibles and other factors. Receivables that are deemed to be uncollectible are written off.

Professional Liability and Other Self-Insurance Reserves

Accrual for Professional and General Liability Claims

For claims made after March 9, 2001, we have purchased professional liability insurance coverage for our nursing centers that, based on historical claims experience, is likely to be substantially less than the amount required to satisfy claims that were incurred.

The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”), to replace some of the expiring commercial policies. SHC covers losses up to specified limits per occurrence. All of the Company's nursing centers in Florida, Ohio, Tennessee, and West Virginia are now covered under the captive insurance policies along with most of the nursing centers in Alabama, Kentucky, and Texas. The insurance coverage provided for these centers under the SHC policy include coverage limits of $500,000 per medical incident with a sublimit per center of $1,000,000 and total annual aggregate policy limits of $5,000,000. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers. 

Because our actual liability for existing and anticipated professional liability and general liability claims will exceed our limited insurance coverage, we have recorded total liabilities for reported professional liability claims and estimates for incurred but unreported claims of $27.1 million as of December 31, 2013, including $4.2 million for settlements that are expected to be paid in 2014, estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, and estimates of related legal costs incurred and expected to be incurred. All losses are projected on an undiscounted basis.

The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this reserve. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished as of November 30. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company's past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company's ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, we obtain reports of asserted claims and lawsuits from our insurers and a third party claims administrator. These reports contain information relevant to the liability actually incurred to date with that claim as well as the third-party administrator's estimate of the anticipated total cost of the claim. This information is reviewed by us quarterly and provided to the actuary semi-annually. We use this information to determine the timing of claims reporting and the development of reserves, and compare the information obtained to our previously recorded estimates of liability. Based on the actual claim information obtained, the semi-annual estimates received from the actuary and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Final determination of our actual liability for claims incurred in any given period is a process that takes years.

The Company's cash expenditures for self-insured professional liability costs from continuing operations were $5.4 million, $2.7 million and $3.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.

Although we retain a third-party actuarial firm to assist us, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of our actual liability for claims incurred in any given period is a process that takes years. As a result, our actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given quarter.

25

Professional liability costs are material to our financial position, and changes in estimates, as well as differences between estimates and the ultimate amount of loss, may cause a material fluctuation in our reported results of operations. Our professional liability expense was $7.3 million, $6.1 million and $3.6 million for the years ended December 31, 2013, 2012 and 2011, respectively. These amounts are material in relation to our reported income (loss) from continuing operations for the related periods of $(5.5) million, $(3.7) million and $0.4 million, respectively. The total liability recorded at December 31, 2013 was $27.1 million, compared to current assets of $50.2 million and total assets of $137.7 million.

Accrual for Other Self-Insured Claims

With respect to workers' compensation insurance, substantially all of our employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. We are completely self-insured for workers' compensation exposures prior to May 1997. We have been and remain a non-subscriber to the Texas workers' compensation system and are, therefore, completely self-insured for employee injuries with respect to our Texas operations. From June 30, 2003 until June 30, 2007, our workers' compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July 1, 2008 through December 31, 2013, we are covered by a prefunded deductible policy. Under this policy, we are self-insured for the first $500,000 per claim, subject to an aggregate maximum of $3,000,000. We fund a loss fund account with the insurer to pay for claims below the deductible. We account for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred.

We are self-insured for health insurance benefits for certain employees and dependents for amounts up to $175,000 per individual annually. We provide reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate, based on known claims and estimates of unknown claims based on historical information. The differences between actual settlements and reserves are included in expense in the period finalized. Our reserves for health insurance benefits can fluctuate materially from one year to the next depending on the number of significant health issues of our covered employees and their dependents.

Asset Impairment

We evaluate our property, equipment and other long-lived assets on a quarterly basis to determine if facts and circumstances suggest that the assets may be impaired or that the estimated depreciable life of the asset may need to be changed for significant physical changes in the property, or significant adverse changes in general economic conditions, and significant deteriorations of the underlying cash flows or fair values of the property.The need to recognize impairment is based on estimated undiscounted future cash flows from a property compared to the carrying value of that property. If recognition of impairment is necessary, it is measured as the amount by which the carrying amount of the property exceeds the fair value of the property. Our asset impairment analysis is consistent with the fair value measurements described in the accounting guidance for “Fair Value Measurements and Disclosures.”

On July 29, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its final rule for skilled nursing facilities effective October 1, 2011, reducing Medicare reimbursement rates for skilled nursing facilities by 11.1% and also making changes to rehabilitation therapy regulations. This final rule has had a negative effect on our revenue in Medicare's fiscal year ended September 30, 2012 as compared to Medicare's fiscal year ended September 30, 2011. As a result of this negative impact, we determined that the carrying value of the long-lived assets of one of our leased nursing centers exceeded the fair value. As a result, we recorded a fixed asset impairment charge during 2011 of $0.3 million to reduce the carrying value of these assets.

No impairment of long lived assets was recognized during 2013 or 2012. If our estimates or assumptions with respect to a property change in the future, we may be required to record additional impairment charges for our assets.

Business Combinations

For business combination transactions, we recognize and measure the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree, as well as the goodwill acquired or gain recognized in a bargain purchase, and we make certain valuations to determine the fair value of assets acquired and the liabilities assumed. These valuations are subject to retroactive adjustment during the twelve-month period subsequent to the acquisition date. Such valuations require us to make significant estimates, judgments and assumptions, including projections of future events and operating performance.

Stock-Based Compensation

We recognize compensation cost for all share-based payments granted after January 1, 2006, on a straight-line basis over the vesting period. We calculated the recognized and unrecognized stock-based compensation using the Black-Scholes-Merton option valuation method, which requires us to use certain key assumptions to develop the fair value estimates. These key assumptions include expected volatility, risk-free interest rate, expected dividends and expected term. During the years ended December 31, 2013, 2012 and 2011, we recorded charges of approximately $1.0 million, $0.6 million and $0.5 million in stock-based

26

compensation, respectively. Stock-based compensation expense is a non-cash expense and such amounts are included as a component of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees.

Income Taxes

We determine deferred tax assets and liabilities based upon differences between financial reporting and tax bases of assets and liabilities and measure them using the enacted tax laws that will be in effect when the differences are expected to reverse. We maintain a valuation allowance of approximately $1.3 million to reduce the deferred tax assets to amounts we believe can be realized on a more likely than not basis in accordance with generally accepted accounting principles. In future periods, we will continue to assess the need for and adequacy of the remaining valuation allowance. We follow the relevant guidance found in the FASB codification, ASC 740: Accounting for Uncertainty in Income Taxes. The guidance provides information and procedures for financial statement recognition and measurement of tax positions taken, or expected to be taken, in tax returns.

Contractual Obligations and Commercial Commitments

We have certain contractual obligations of continuing operations as of December 31, 2013, summarized by the period in which payment is due, as follows (dollar amounts in thousands):

Contractual Obligations	Total		Less than 1  year		1 to 3 Years		3 to 5 Years		After 5 Years
Long-term debt obligations (1)	$	66,986	$	8,093	$	13,607	$	45,286	$	—
Settlement obligations (2)	4,208		4,208		—		—		—
Series C Preferred Stock (3)	4,918		4,918		—		—		—
Elimination of Preferred Stock Conversion feature (4)	3,263		687		1,374		1,202		—
Operating leases (5)	591,502		26,508		56,416		58,811		449,767
Required capital expenditures under operating leases (6)	7,336		248		495		495		6,098
Total	$	678,213	$	44,662	$	71,892	$	105,794	$	455,865

(1) Long-term debt obligations include scheduled future payments of principal and interest of long-term debt and amounts outstanding on our capital lease obligations.

(2) Settlement obligations relate to professional liability cases that are expected to be paid within the next twelve months. The professional liabilities are included in our current portion of self-insurance reserves.

(3) Series C Preferred Stock equals the redemption value at the preferred shareholder’s earliest optional redemption date.

(4) Payments to Omega Health Investors ("Omega"), from whom we lease 25 nursing centers, for the elimination of the preferred stock conversion feature in connection with restructuring the preferred stock and master lease agreements. Monthly payments of approximately $57,000 will be made through the end of the initial lease period that ends in September 2018.

(5) Represents lease payments under our operating lease agreements. Assumes all renewals periods.

(6) Includes annual expenditure requirements under operating leases.

We have employment agreements with certain members of management that provide for the payment to these members of amounts up to two times their annual salary in the event of a termination without cause, a constructive discharge (as defined), or upon a change of control of the Company (as defined). The maximum contingent liability under these agreements is approximately $1.3 million as of December 31, 2013. The terms of such agreements are for one year and automatically renew for one year if not terminated by us or the employee. In addition, upon the occurrence of any triggering event, those certain members of management may elect to require that we purchase equity awards granted to them for a purchase price equal to the difference in the fair market value of our common stock at the date of termination versus the stated equity award exercise price. Based on the closing price of our common stock on December 31, 2013, there is no contingent liability for the repurchase of the equity grants. No amounts have been accrued for these contingent liabilities.

Revenue Sources

We classify our revenues from patients and residents into four major categories: Medicaid, Medicare, Managed Care, and private pay and other. Medicaid revenues are composed of the traditional Medicaid program established to provide benefits to those in need of financial assistance in the securing of medical services. Medicare revenues include revenues received under both Part A and Part B of the Medicare program. Managed Care revenues include payments for patients who are insured by a third-party entity,

27

typically called a Health Maintenance Organization, often referred to as an HMO plan, or are Medicare beneficiaries who assign their Medicare benefits to a Managed Care replacement plan often referred to as Medicare replacement products. The private pay and other revenues are composed primarily of individuals or parties who directly pay for their services. Included in the private pay and other are patients who are hospice beneficiaries as well as the recipients of Veterans Administration benefits. Veterans Administration payments are made pursuant to renewable contracts negotiated with these payors.

The following table sets forth net patient revenues related to our continuing operations by payor source for the periods presented (dollar amounts in thousands):

	Year Ended December 31,
	2013				2012				2011
Medicaid	$	150,752	53.5	%	$	130,738	53.1	%	$	123,392	50.2	%
Medicare	77,103		27.3	%	74,218		30.1	%	83,131		33.8	%
Managed Care	16,786		6.0	%	12,495		5.1	%	10,995		4.5	%
Private Pay and other	37,278		13.2	%	28,839		11.7	%	28,359		11.5	%
Total	$	281,919	100.0	%	$	246,290	100.0	%	$	245,877	100.0	%

The following table sets forth average daily skilled nursing census by payor source for our continuing operations for the periods presented:

	Year Ended December 31,
	2013			2012			2011
Medicaid	2,553	69.9	%	2,283	70.0	%	2,221	69.0	%
Medicare	425	11.6	%	417	12.8	%	438	13.6	%
Managed Care	110	3.0	%	83	2.5	%	70	2.2	%
Private Pay and other	566	15.5	%	478	14.7	%	492	15.2	%
Total	3,654	100.0	%	3,261	100.0	%	3,221	100.0	%

Consistent with the nursing center industry in general, changes in the mix of a nursing center's patient population among Medicaid, Medicare, Managed Care and private pay can significantly affect the profitability of the center's operations.

Results of Operations

As discussed in the overview at the beginning of Management's Discussion and Analysis of Financial Condition and Results of Operations, we have completed certain divestitures, acquisitions and entered a new lease agreement. We have reclassified our Consolidated Financial Statements to present certain divestitures as discontinued operations for all periods presented.

28

(in thousands)	Year Ended December 31,
	2013			2012			Change			%
PATIENT REVENUES, net	$	281,919		$246,290			$	35,629		14.5	%
EXPENSES:
Operating	228,342			197,960			30,382			15.3	%
Lease	21,542			19,050			2,492			13.1	%
Professional liability	7,336			6,102			1,234			20.2	%
General and administrative	20,940			19,515			1,425			7.3	%
Depreciation and amortization	6,972			6,276			696			11.1	%
Asset impairment	—			—			—			—	%
Restructuring	1,446			—			1,446			100.0	%
Total expenses	286,578			248,903			37,675			15.1	%
OPERATING INCOME (LOSS)	(4,659		)	(2,613		)	(2,046		)	78.3	%
OTHER INCOME (EXPENSE):
Equity in net losses of unconsolidated affiliate	(183		)	(280		)	97			(34.6	)%
Interest expense, net	(3,620		)	(2,809		)	(811		)	28.9	%
Debt retirement costs	(320		)	—			(320		)	100.0	%
	(4,123		)	(3,089		)	(1,034		)	33.5	%
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(8,782		)	(5,702		)	(3,080		)	54.0	%
BENEFIT FOR INCOME TAXES	3,305			2,027			1,278			63.0	%
LOSS FROM CONTINUING OPERATIONS	$	(5,477	)	$	(3,675	)	$	(1,802	)	49.0	%

(in thousands)	Year Ended December 31,
	2012			2011			Change			%
PATIENT REVENUES, net	$	246,290		$	245,877		$	413		0.2	%
EXPENSES:
Operating	197,960			194,152			3,808			2	%
Lease	19,050			18,064			986			5.5	%
Professional liability	6,102			3,618			2,484			68.7	%
General and administrative	19,515			21,024			(1,509		)	(7.2	)%
Depreciation and amortization	6,276			5,607			669			11.9	%
Asset impairment	—			344			(344		)	(100	)%
Total expenses	248,903			242,809			6,094			2.5	%
OPERATING INCOME (LOSS)	(2,613		)	3,068			(5,681		)	(185.2	)%
OTHER INCOME (EXPENSE):
Equity in net losses of investee	(280		)	—			(280		)	—
Interest expense, net	(2,809		)	(2,356		)	(453		)	19.2	%
Debt retirement costs	—			(112		)	112			(100	)%
	(3,089		)	(2,468		)	(621		)	25.2	%
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(5,702		)	600			(6,302		)	—
BENEFIT (PROVISION) FOR INCOME TAXES	2,027			(162		)	2,189			—
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	(3,675	)	$	438		$	(4,113	)	(939	)%

29

Year Ended December 31, 2013 Compared With Year Ended December 31, 2012

Patient Revenues

Patient revenues were $281.9 million in 2013 and $246.3 million in 2012. This increase is primarily attributable to the acquisition of new facilities during the period. The following table summarizes the revenue increases attributable to our portfolio growth (in thousands):

	Year Ended December 31,
	2013		2012		Change
Same-store revenue	$	240,859	$	243,499	$	(2,640	)
2012 acquisition revenue	12,908		2,791		10,117
2013 acquisition revenue	28,152		—		28,152
Total revenue	$	281,919	$	246,290	35,629

The overall increase in revenue $35.6 million is primarily attributable to revenue contributions from acquisition activity in 2013 of $28.2 million, as well as an incremental increase in revenues from 2012 acquisitions of $10.1 million as a result of having a full year in operation during 2013. These increases in revenue from acquisitions were partially offset by a decrease in same-store revenue of $2.6 million which is explained in more detail below.

The following table summarizes key revenue and census statistics for continuing operations for each period:

	Year Ended December 31,
	2013				2012
Skilled nursing occupancy	77.0		%	(1)	78.0		%
As a percent of total census:
Medicare census	11.6		%		12.8		%
Managed Care census	3.0		%		2.5		%
As a percent of total revenues:
Medicare revenues	53.5		%		53.1		%
Medicaid revenues	27.3		%		30.1		%
Managed Care revenues	6.0		%		5.1		%
Average rate per day:
Medicare	$	431.57			$	428.48
Medicaid	$	161.67			$	157.03
Managed Care	$	381.19			$	377.28

(1) Skilled nursing occupancy excludes our Clinton, Kentucky facility which is licensed to operate and is in the process of growing its occupancy as a percentage of licensed beds as a result of the decertification that occurred prior to the Company's assumption of operations.

The average Medicaid rate per patient day for 2013 increased 3.0% compared to 2012, resulting in an increase in revenue of $3.5 million for our same-store nursing centers. This average rate per day for Medicaid patients is the result of rate increases in certain states and increasing patient acuity levels. The average Medicare rate per patient day for 2013 increased 0.7% compared to 2012, resulting in an increase in revenue of $0.7 million for our same-store nursing centers also related to our ability to attract patients with increased acuity levels.

Our total average daily census increased by approximately 12.1% compared to 2012 on a consolidated basis, but was primarily attributable to the aforementioned acquisition activity. On a same-store basis, our Medicare average daily census for 2013 decreased compared to 2012, resulting in a decrease in revenue of $8.0 million. Further, our Medicaid average daily census for 2013 decreased compared to 2012, resulting in a decrease in revenue of $1.9 million. The decrease in same-store revenue as a result of decreased Medicare census was partially offset by our continued increase in Managed Care average daily census which contributed additional revenues of $2.6 million compared to 2012 due to census increase at same-store nursing centers. Same-store Managed Care rate per patient day for 2013 also experienced favorable results compared to 2012 resulting in a $0.2 million increase in revenue.

30

Operating Expense

Operating expense increased to $228.3 million in 2013 from $198.0 million in 2012, driven primarily by the $24.3 million in operating costs at the nursing centers added in 2013, and a $7.3 million incremental increase from the facilities acquired in 2012 due to a full year of operation. Operating expense increased to 81.0% of revenue in 2013, compared to 80.4% of revenue in 2012.

	Year Ended December 31,
	2013		2012		Change
Same-store operating expenses	$	193,753	$	194,934	$	(1,181	)
2012 acquisition operating expenses	10,302		3,026		7,276
2013 acquisition operating expenses	24,287		—		24,287
Total revenue	$	228,342	$	197,960	30,382

The largest component of operating expenses is wages, which increased to $134.5 million in 2013 from $123.6 million in 2012, an increase of $10.9 million, or 8.8%. We continued to see improvements in our labor costs as a percentage of revenues as this decreased to 47.7% in 2013, an improvement from 50.2% in 2012. On a same-store basis, salaries decreased by $7.6 million due to operating initiatives which include outsourcing housekeeping and laundry services, as well as centralizing certain business office responsibilities creating efficiencies. The same-store decrease in salaries was partially offset by an increase of $5.8 million in external housekeeping and laundry services as a result of the aforementioned outsourcing effort.

Employee health insurance costs were approximately $1.6 million higher in 2013 compared to 2012. The Company is self-insured for the first $175,000 in claims per employee each year. Employee health insurance costs can vary significantly from year to year, and we continually evaluate the provisions of these plans.

Workers compensation insurance expense increased approximately $0.5 million in 2013 compared to 2012. The increase is the result of less favorable claims experience in 2013 compared to 2012.

Bad debt expense increased approximately $1.1 million in 2013 compared to 2012 driven significantly by the growth in Medicaid patients undergoing the initial qualification process.

Lease Expense

Lease expense increased to $21.5 million in 2013 from $19.1 million in 2012. The increase in lease expense was primarily driven by $1.3 million in combined lease expense for the newly leased nursing center in Louisville, Kentucky and the four recently leased nursing centers in the Ohio region, three in Ohio and one in Indiana. We also incurred an incremental increase in lease expense of $0.9 million over the prior year associated the Louisville, Kentucky facility and the facility in Clinton, Kentucky, both of which we leased in 2012. The remaining increase was the result of regular rent adjustments at existing facilities.

Professional Liability

Professional liability expense was $7.3 million in 2013 compared to $6.1 million in 2012, an increase of $1.2 million. We were engaged in 54 professional liability lawsuits as of December 31, 2013, compared to 49 as of December 31, 2012. Our cash expenditures for professional liability costs of continuing operations were $5.4 million and $2.7 million for 2013 and 2012, respectively. Professional liability expense and cash expenditures fluctuate from year to year based respectively on the results of our third-party professional liability actuarial studies and on the costs incurred in defending and settling existing claims. See “Liquidity and Capital Resources” for further discussion of the accrual for professional liability.

General and Administrative Expense

General and administrative expenses were approximately $20.9 million in 2013 compared to $19.5 million in 2012, an increase of $1.4 million. The overall increase in general and administrative expenses were primarily attributable to a $0.5 million in wages. We also experienced a $0.4 million increase in stock-based incentive expense, and a $0.3 million increase in legal and consulting expenses related to our acquisition activities.

Depreciation and Amortization

Depreciation and amortization expense was approximately $7.0 million in 2013 and $6.3 million in 2012. The increase in 2013 is primarily due to $0.5 million in depreciation and amortization expenses related to the newly acquired Kansas facilities.

31

Restructuring

We incurred certain charges in connection with the termination of our existing lease for 11 Arkansas nursing centers, including one-time separation costs of $0.3 million. These expenses were classified as restructuring expenses on the consolidated statement of operations. As these expenses related to the transaction which occurred in 2013, the $1.4 million in restructuring expense represents an increase from the same period in 2012.

Interest Expense, Net

Interest expense has increased to $3.6 million in 2013 compared to $2.8 million in 2012, an increase of $0.8 million. The increase was primarily attributable to higher debt balances in 2013 as a result of the amended Mortgage Loan, which increased the balance of outstanding debt as a result of the acquisition of the Kansas centers.

Loss from Continuing Operations before Income Taxes; Loss from Continuing Operations per Common Share

As a result of the above, continuing operations reported loss before income taxes of $8.8 million and $5.7 million in 2013 and 2012, respectively. The benefit for income taxes was $3.3 million in 2013, an effective rate of 37.6% and a benefit of $2.0 million in 2012, an effective rate of 35.5%. The basic and diluted loss per common share from continuing operations were both $(1.00) in 2013 compared to $(0.71) in 2012.

Year Ended December 31, 2012 Compared With Year Ended December 31, 2011

Patient Revenues

Patient revenues were $246.3 million in 2012 and $245.9 million in 2011, an increase of $0.4 million, or 0.2%.

The following table summarizes key revenue and census statistics for continuing operations for each period:

	Year Ended December 31,
	2012				2011
Skilled nursing occupancy	78.0		%	(1)	79.5		%
As a percent of total census:
Medicare census	12.8		%		13.6		%
Managed Care census	2.5		%		2.2		%
As a percent of total revenues:
Medicare revenues	30.1		%		33.8		%
Medicaid revenues	53.1		%		50.2		%
Managed Care revenues	5.1		%		4.5		%
Average rate per day:
Medicare	$	428.48			$	465.19
Medicaid	$	157.03			$	151.85
Managed Care	$	377.28			$	405.78

(1) Skilled nursing occupancy excludes our Clinton, Kentucky facility which is licensed to operate and is in the process of growing its occupancy as a percentage of licensed beds as a result of the decertification that occurred prior to the Company's assumption of operations.

The average Medicaid rate per patient day for 2012 increased 3.4% compared to 2011, resulting in an increase in revenue of $4.3 million. This average rate per day for Medicaid patients is the result of rate increases in certain states and increasing patient acuity levels. The average Medicare rate per patient day for 2012 decreased 7.9% compared to 2011, resulting in a decrease in revenue of $5.6 million. This decrease is primarily attributable to the October 1, 2011 CMS implemented Medicare rate decrease of 11.1% offset by investments we have made to improve our skilled care offerings. The decrease is further offset by the new Medicare rates issued by CMS at October 1, 2012 that increased rates by 1.8%.

Our Medicaid average daily census increased in 2012 by approximately 2.8% compared to 2011, resulting in an increase in revenue of $3.8 million. Our Medicare average daily census for 2012 decreased by 4.8% resulting in a decrease in revenue of $3.3 million. Managed Care rates and census contributed approximately $1.0 million of the total revenue increase, primarily due to an increase in Managed Care average daily census of 18.6%.

32

Operating Expense

Operating expense increased to $198.0 million in 2012 from $194.2 million in 2011, an increase of $3.8 million, or 2.0%. We have experienced a significant amount of expenses related to start-up activities during 2012 at our newly-opened centers in Clinton, Kentucky and newly leased center in Louisville, Kentucky. Operating expense increased to 80.4% of revenue in 2012, compared to 79.0% of revenue in 2011 due significantly to the decrease in Medicare rates.

The largest component of operating expenses is wages, which increased to $123.6 million in 2012 from $122.7 million in 2011, an increase of $0.8 million, or 0.7%.

Provider taxes increased approximately $1.1 million in 2012, primarily due to increases in tax rates and higher census in certain states in which we operate.

Workers compensation insurance expense decreased approximately $0.3 million in 2012 compared to 2011. The increase is the result of better claims experience in 2012 compared to 2011.

Employee health insurance costs were approximately $0.1 million lower in 2012 compared to 2011, a decrease of 1.9%. The Company is self-insured for the first $175,000 in claims per employee each year, and we experienced a lower level of claims costs during 2012. Employee health insurance costs can vary significantly from year to year, and we continually evaluate the provisions of these plans.

Bad debt expense increased approximately $1.3 million in 2012 compared to 2011 driven significantly by the growth in Medicaid patients undergoing the initial qualification process.

Lease Expense

Lease expense increased to $19.1 million in 2012 from $18.1 million in 2011. The increase in lease expense was rent for lessor- funded property renovations and $0.5 million in combined lease expense for the newly leased nursing centers in Louisville and Clinton, Kentucky.

Professional Liability

Professional liability expense was $6.1 million in 2012 and $3.6 million in 2011. We were engaged in 49 professional liability lawsuits as of December 31, 2012, compared to 38 as of December 31, 2011. Our cash expenditures for professional liability costs of continuing operations were $2.7 million and $3.8 million for 2012 and 2011, respectively. Professional liability expense and cash expenditures fluctuate from year to year based respectively on the results of our third-party professional liability actuarial studies and on the costs incurred in defending and settling existing claims. See “Liquidity and Capital Resources” for further discussion of the accrual for professional liability.

General and Administrative Expense

General and administrative expenses were approximately $19.5 million in 2012 compared to $21.0 million in 2011, a decrease of $1.5 million, or 7.2%. The significant improvement relates to a decrease in performance-based incentive expense of $1.8 million and a decrease of approximately $0.5 million in severance and nonrecurring general and administrative costs. We experienced a $0.7 million decrease in implementation costs of EMR. These decreases were offset by a $0.5 million increase in consulting and legal expenses related to our acquisition efforts

Depreciation and Amortization

Depreciation and amortization expense was approximately $6.3 million in 2012 and $5.6 million in 2011. The increase in 2012 is primarily due to depreciation and amortization expenses related to capital expenditures for additions to property and equipment, including equipment related to our EMR initiative.

Asset Impairment

During the third quarter of 2011, we determined that the carrying value of the long-lived assets of one of our leased nursing centers exceeded the fair value. As a result, we recorded a fixed asset impairment charge of $0.3 million to reduce the carrying value of these assets.

33

Interest Expense, Net

Interest expense increased to $2.8 million in 2012 compared to $2.4 million in 2011. The increase in interest expense relates to the nursing center in West Virginia that was purchased in 2011, and was responsible for an incremental increase of $0.4 million in our 2012 interest expense.

Loss from Continuing Operations before Income Taxes; Loss from Continuing Operations per Common Share

As a result of the above, continuing operations reported loss before taxes of $5.7 million and income before taxes of $0.6 million in 2012 and 2011, respectively. The benefit for income taxes was $2.0 million in 2012, an effective rate of 35.5% and a provision of $0.2 million in 2011, an effective rate of 27.0%. The basic and diluted loss per common share from continuing operations were both $0.71 in 2012 compared to income per common share from continuing operations of $0.02 for both basic and diluted in 2011.

Liquidity and Capital Resources

Liquidity

Our primary source of liquidity is the net cash flow provided by the operating activities of our facilities. We believe that these internally generated cash flows will be adequate to service existing debt obligations, fund required capital expenditures as well as provide cash flows for investing opportunities. In determining priorities for our cash flow, we evaluate alternatives available to us and select the ones that we believe will most benefit us over the long term. Options for our cash include, but are not limited to, capital improvements, dividends, purchase of additional shares of our common stock, acquisitions, payment of existing debt obligations, preferred stock redemptions as well as initiatives to improve nursing center performance. We review these potential uses and align them to our cash flows with a goal of achieving long-term success.

Net cash used in operating activities of continuing operations totaled $3.9 million in 2013, compared to net cash provided by operating activities of continuing operations of $1.0 million and $7.1 million in 2012 and 2011, respectively. One primary driver of the decline in cash provided by operating activities from continuing operations is the acquisition activity throughout the year. The Company is required to complete a Change in Ownership ("CHOW") process for each of the nursing centers for which we assumed operations during the year which results in limited cash inflows from the operations at these facilities during this initial process. As of December 31, 2013, five of the facilities for which we assumed operations during 2013 continue to progress through the CHOW process, and we expect this process to be completed early in 2014. Operating activities of discontinued operations provided cash of $2.7 million, $2.3 million and $2.9 million in 2013, 2012 and 2011, respectively.

Our cash expenditures related to professional liability claims of continuing operations were $5.4 million, $2.7 million and $3.8 million for 2013, 2012 and 2011, respectively. We also continue to experience cash expenditures related to professional liability claims of discontinued operations, primarily associated with the disposition of Arkansas. Our cash expenditures related to professional liability claims of discontinued operations were $3.3 million, $5.6 million, and $5.0 million for 2013, 2012 and 2011, respectively. The Company will continue to defend, and make cash payments related to, professional liability claims asserted against discontinued operations. Although we work diligently to limit the cash required to settle and defend professional liability claims, a significant judgment entered against us in one or more legal actions could have a material adverse impact on our cash flows and could result in our being unable to meet all of our cash needs as they become due.

Investing activities of continuing operations used cash of $23.5 million, $0.3 million and $13.4 million in 2013, 2012 and 2011, respectively. These amounts primarily represent cash used for purchases of property and equipment. We used $14.7 million in cash to purchase the five Kansas nursing facilities in May 2013. We have used between $4.4 million and $12.4 million for capital expenditures of continuing operations in each of the three calendar years ended December 31, 2013, with certain years experiencing higher expenditures as a result of renovation projects at our facilities. We used $3.5 million in restricted cash to fund capital improvements at the four owned nursing centers that secure the mortgage loan during 2013 and saw a net increase in these restricted funds of $0.8 million during 2012 when the funds were borrowed.

Financing activities of continuing operations used cash of $3.2 million in 2012, and provided cash of $20.7 million and $2.2 million in 2013 and 2011, respectively. Financing activities in 2013 reflect the proceeds received from refinancing our credit facility resulting in proceeds of $54.5 million, offset by the repayment of the existing mortgage loan and other debt payments during the year of $30.4 million. Cash provided in 2011 primarily resulted from the refinancing of our mortgage loan facility resulting in $29.6 million of proceeds offset by the payment of existing debt obligations of $24.6 million and write-off of $0.8 million of financing costs. Financing activities reflect $1.3 million in common stock and preferred stock dividends in 2013 and $1.6 million in 2012 and 2011.

Dividends

34

On February 28, 2014, the Board of Directors declared a quarterly dividend on common shares of $0.055 per share. While the Board of Directors intends to pay quarterly dividends, the Board will make the determination of the amount of future cash dividends, if any, to be declared and paid based on, among other things, the Company’s financial condition, funds from operations, the level of its capital expenditures and its future business prospects and opportunities. The Company is restricted by its debt agreements in its ability to pay dividends.

Redeemable Preferred Stock

At December 31, 2013, we have outstanding 5,000 shares of Series C Redeemable Preferred Stock (“Preferred Stock”) that has a stated value of approximately $4.9 million which pays an annual dividend rate of 7% of its stated value. Dividends on the Preferred Stock are paid quarterly in cash. The Preferred Stock was issued to Omega in 2006 and is not convertible, but has been redeemable at its stated value at Omega’s option since September 30, 2010, and since September 30, 2007, has been redeemable at its stated value at our option. Redemption under our option or Omega’s is subject to certain limitations. We believe we have adequate resources to redeem the Preferred Stock if Omega were to elect to redeem it.

Professional Liability

The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”), to replace some of the expiring commercial policies. SHC covers losses up to specified limits per occurrence. All of the Company's nursing centers in Florida, Ohio, Tennessee, and West Virginia are now covered under the captive insurance policies along with most of the nursing centers in Alabama, Kentucky, and Texas. The insurance coverage provided for these centers under the SHC policy include coverage limits of $500,000 per medical incident with a sublimit per center of $1.0 million and total annual aggregate policy limits of $5.0 million. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers. 

As of December 31, 2013, we have recorded total liabilities for reported and settled professional liability claims and estimates for incurred, but unreported claims of $27.1 million. Our calculation of this estimated liability is based on an assumption that the Company will not incur a severely adverse judgment with respect to any asserted claim; however, a significant judgment could be entered against us in one or more of these legal actions, and such a judgment could have a material adverse impact on our financial position and cash flows.

Capital Resources

As of December 31, 2013, we had $53.6 million of outstanding long-term debt and capital lease obligations. The $53.6 million total includes $0.7 million in capital lease obligations and $5.5 million in a note payable for the nursing center that was recently constructed in West Virginia. The balance of the long-term debt is comprised of $44.4 million owed on our collateralized mortgage debt and $3.0 million currently outstanding on the revolving credit facility.

We have agreements with a syndicate of banks for a mortgage loan and our revolving credit facility. Under the terms of the agreements, the syndicate of banks provided mortgage debt (“Mortgage Loan”) with an original balance of $45.0 million with a five year maturity through March 2016 and a $20.0 million revolving credit facility (“Revolver”) through March 2016. The Mortgage Loan has a term of five years with principal and interest payable monthly based on a 25 year amortization. Interest is based on LIBOR plus 4.5% but is a portion is fixed at 6.87% based on the interest rate swap described below. The Mortgage Loan is secured by 13 owned nursing centers, related equipment and a lien on the accounts receivable of these facilities. The Mortgage Loan and the Revolver are cross-collateralized.

The Revolver is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions. As of December 31, 2013, we had $3.0 million outstanding under the revolving credit facility as of December 31, 2013. Annual fees for letters of credit issued under this revolver are 3.0% of the amount outstanding. We have a letter of credit of $4.6 million to serve as a security deposit for our Omega lease. We also have a $1.0 million letter of credit outstanding related to the Company's wholly-owned captive insurance entity. Finally, we have three letters of credit to serve as security deposits at certain facilities. Considering the balance of eligible accounts receivable at December 31, 2013, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $20.0 million, the balance available for borrowing under the revolving credit facility is $10.0 million. Eligible accounts receivable are calculated as defined and consider 80% of certain net receivables while excluding receivables from private pay patients, those pending approval by Medicaid and receivables greater than 90 days. Our Revolver has an interest rate of LIBOR plus 4.5%.

35

Our lending agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. We are in compliance with all such covenants at December 31, 2013.

Our calculated compliance with financial covenants is presented below:

	Requirement	Level at December 31, 2013
Minimum fixed charge coverage ratio	1.00:1.10	1.00:1.18
Minimum adjusted EBITDA	7,500,000	10,142,000
EBITDAR (mortgaged facilities)	3,850,000	4,616,000

The covenants above are based on a trailing three quarters as of December 31, 2013, as a result of the refinancing of our credit facility during the second quarter of 2013. Beginning in the first quarter of 2014, the covenant requirements and respective levels will be based on trailing four quarters results for that quarter and each quarter thereafter.

We have consolidated $5.5 million in debt that is owed by the consolidated variable interest entity that owns our recently opened West Virginia nursing center. The borrower is subject to covenants concerning total liabilities to tangible net worth as well as current assets compared to current liabilities. The borrower is in compliance with all such covenants at December 31, 2013. The borrower’s liabilities do not provide creditors with recourse to our general assets.

As part of the debt agreements entered into in March 2011, we entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. As part of the refinancing of the Mortgage Loan above, we amended the existing swap agreement in order to ensure the terms of the swap agreement remained consistent with the underlying Mortgage Loan. The amended interest rate swap agreement has the same effective date and maturity date as the Mortgage Loan, and includes a notional amount of 50% of the outstanding balance on the Mortgage Loan. The interest rate swap agreement requires us to make fixed rate payments to the bank calculated on the applicable notional amount at an annual fixed rate of 6.87% while the bank is obligated to make payments to us based on LIBOR on the same notional amounts. We entered into the interest rate swap agreement to mitigate the variable interest rate risk on our outstanding mortgage borrowings.

Capitalized Lease Obligations

In September 2012, we assumed a lease which financed furniture and equipment for our new facility in Louisville, Kentucky. During 2011, the Company entered into a series of lease agreements to finance the purchase of certain equipment primarily for the implementation of EMR in its nursing centers.

As a result of the lease agreements above, we have recorded the underlying lease assets and capitalized lease obligations of $0.7 million, $1.5 million, and $1.9 million as of December 31, 2013, 2012, and 2011, respectively. These lease agreements provide terms of three to five years.

Nursing Center Renovations

During 2005, we began an initiative to complete strategic renovations of certain facilities to improve occupancy, quality of care and profitability. We developed a plan to begin with those facilities with the greatest potential for benefit, and began the renovation program during the third quarter of 2005. As of December 31, 2013, we have completed renovations at seventeen facilities. We are currently implementing plans for renovation projects at two of our Texas facilities.

A total of $29.1 million has been spent on these renovation programs to date, with $22.4 million financed through Omega, $6.0 million financed with internally generated cash, and $0.7 million financed with long-term debt.

For the eleven facilities in our continuing operations with renovations completed as of the beginning of the fourth quarter 2013 compared to the last twelve months prior to the commencement of renovation, average occupancy increased from 82.0% to 82.3%.

36

Receivables

Our operations could be adversely affected if we experience significant delays in reimbursement from Medicare, Medicaid and other third-party revenue sources. Our future liquidity will continue to be dependent upon the relative amounts of current assets (principally cash, accounts receivable and inventories) and current liabilities (principally accounts payable and accrued expenses). In that regard, accounts receivable can have a significant impact on our liquidity. Continued efforts by governmental and third-party payors to contain or reduce the acceleration of costs by monitoring reimbursement rates, by increasing medical review of bills for services, or by negotiating reduced contract rates, as well as any delay by us in the processing of our invoices, could adversely affect our liquidity and results of operations.

Accounts receivable attributable to patient services of continuing operations totaled $39.1 million at December 31, 2013 compared to $27.8 million at December 31, 2012, representing approximately 43 days and 39 days revenue in accounts receivable, respectively. The increase in accounts receivable is due primarily to accounts associated with facilities still in the change in ownership process which is addressed below, but also attributable to increased receivables from payor sources with longer payment cycles, including Managed Care payors, as well as an increase in Medicaid patients undergoing the initial qualification process.

Our accounts receivable at December 31, 2013 included approximately $5.1 million of accounts for the newly leased facility in Louisville, Kentucky for which we assumed operations in August 2013, and also the four facilities, three in Ohio and one in Indiana, for which we assumed operations in October 2013.  During the change of ownership process, we are required to hold these accounts while waiting for final Medicare and Medicaid approvals.  We expect these accounts to be collectible as soon as we are able to submit them for payment.

The allowance for bad debt was $4.0 million and $3.1 million at December 31, 2013 and 2012, respectively. We continually evaluate the adequacy of our bad debt reserves based on patient mix trends, aging of older balances, payment terms and delays with regard to third-party payors, collateral and deposit resources, as well as other factors. We continue to evaluate and implement additional procedures to strengthen our collection efforts and reduce the incidence of uncollectible accounts.

Inflation

Based on contract pricing for food and other supplies and recent market conditions, we expect cost increases in 2014 to be relatively the same or slightly lower than the increases in 2013. We expect salary and wage increases for our skilled health care providers to continue to be higher than average salary and wage increases, as is common in the health care industry.

Off-Balance Sheet Arrangements

We have five letters of credit outstanding totaling approximately $7.0 million as of December 31, 2013. Four of these letters of credit serve as a security deposits for certain facility leases, while one was issued in conjunction with the initial funding of our wholly-owned captive insurance company. The letters of credit were issued under our revolving credit facility. Our accounts receivable serve as the collateral for this revolving credit facility.

Forward-Looking Statements

The foregoing discussion and analysis provides information deemed by management to be relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion and analysis should be read in conjunction with our consolidated financial statements included herein. Certain statements made by or on behalf of us, including those contained in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere, are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those contemplated by the forward-looking statements made herein. In addition to any assumptions and other factors referred to specifically in connection with such statements, other factors, many of which are beyond our ability to control or predict, could cause our actual results to differ materially from the results expressed or implied in any forward-looking statements including, but not limited to, our ability to successfully operate the new nursing centers in Kansas, Kentucky, Ohio, and Indiana, our ability to increase census at our renovated facilities, changes in governmental reimbursement including reductions related to sequestration, the impact of and our ability to mitigate the impact of rate reductions, government regulation, the impact of the recently adopted federal health care reform or any future health care reform, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of laws and regulations governing quality of care or violations of other laws and regulations applicable to our business, impacts associated with the implementation of our electronic medical records plan, the costs of investing in our business initiatives and development, our ability to control costs, changes to our valuation of deferred tax assets, changes in occupancy rates in our facilities, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of

37

operations, the effect of changes in accounting policies as well as others. Investors also should refer to the risks identified in this “Management's Discussion and Analysis of Financial Condition and Results of Operations” as well as risks identified in “Part I. Item 1A. Risk Factors” for a discussion of various risk factors of the Company and that are inherent in the health care industry. Given these risks and uncertainties, we can give no assurances that these forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. These assumptions may not materialize to the extent assumed, and risks and uncertainties may cause actual results to be different from anticipated results. These risks and uncertainties also may result in changes to the Company's business plans and prospects. Such cautionary statements identify important factors that could cause our actual results to materially differ from those projected in forward-looking statements. In addition, we disclaim any intent or obligation to update these forward-looking statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The chief market risk factor affecting our financial condition and operating results is interest rate risk. As of December 31, 2013, we had outstanding borrowings of approximately $52.9 million, $25.2 million of which were subject to variable interest rates. In connection with our May 2013 financing agreement, we entered into an interest rate swap with respect to one half of the Amended Mortgage Loan to mitigate the floating interest rate risk of such borrowing. In the event that interest rates were to change 1%, the impact on future pre-tax cash flows would be approximately $252,000 annually, representing the impact of increased or decreased interest expense on variable rate debt.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Audited financial statements are contained on pages F-1 through F-35 of this Annual Report on Form 10-K and are incorporated herein by reference. Audited supplemental schedule data is contained on pages S-1 through S-2 of this Annual Report on Form 10-K and is incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING ANDFINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Diversicare, with the participation of our principal executive and financial officers, has evaluated the effectiveness of our disclosure controls and procedures, as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of December 31, 2013. Based on this evaluation, the principal executive and financial officers have determined that such disclosure controls and procedures are effective to ensure that information required to be disclosed in our filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities Exchange Commission's rules and forms.

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended). Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2013. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. Our management has concluded that, as of December 31, 2013, our internal control over financial reporting is effective based on these criteria.

Changes in Internal Control over Financial Reporting

There has been no change (including corrective actions with regard to significant deficiencies or material weaknesses) in our internal control over financial reporting that has occurred during our fiscal quarter ended December 31, 2013 that has materially affected, or is reasonably likely to materially affect our internal control over financial reporting.

Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the

38

controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

ITEM 9B. OTHER INFORMATION

None.

39

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information concerning our Directors, Executive Officers and Corporate Governance is incorporated herein by reference to our definitive proxy statement for our 2014 Annual Meeting of Shareholders, which we will file within 120 days of the end of the fiscal year to which this Report relates.

ITEM 11. EXECUTIVE COMPENSATION

Information concerning Executive Compensation is incorporated herein by reference to our definitive proxy statement for our 2014 Annual Meeting of Shareholders, which we will file within 120 days of the end of the fiscal year to which this Report relates.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ANDRELATED SHAREHOLDER MATTERS

Information concerning Security Ownership of Certain Beneficial Owners and Management is incorporated herein by reference to our definitive proxy statement for our 2014 Annual Meeting of Shareholders, which we will file within 120 days of the end of the fiscal year to which this Report relates.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Information concerning Certain Relationships and Related Transactions, and Director Independence is incorporated herein by reference to our definitive proxy statement for our 2014 Annual Meeting of Shareholders, which we will file within 120 days of the end of the fiscal year to which this Report relates.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Information concerning the fees and services provided by our principal accountant is incorporated herein by reference to our definitive proxy statement for our 2014 Annual Meeting of Shareholders, which we will file within 120 days of the end of the fiscal year to which this Report relates.

40

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

The Financial statements and schedule for us and our subsidiaries required to be included in Part II, Item 8 are listed below.

	Form 10-K Pages
Financial Statements
Report of Independent Registered Public Accounting Firm	F-1
Consolidated Balance Sheets as of December 31, 2013 and 2012	F-2
Consolidated Statements of Operations for the Years Ended December 31, 2013, 2012 and 2011	F-3
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2013, 2012 and 2011	F-4
Consolidated Statements of Shareholders' Equity for the Years Ended December 31, 2013, 2012 and 2011	F-5
Consolidated Statements of Cash Flows for the Years Ended December 31, 2013, 2012 and 2011	F-6
Notes to Consolidated Financial Statements as of December 31, 2013, 2012 and 2011	F-8 to F-35
Financial Statement Schedule
Schedule II - Valuation and Qualifying Accounts	S-1 to S-2

Exhibits

The exhibits filed as part of this Report on Form 10-K are listed in the Exhibit Index immediately following the financial statement pages.

41

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DIVERSICARE HEALTHCARE SERVICES, INC.

/s/ Wallace E. Olson

Wallace E. Olson

Chairman of the Board

March 6, 2014

/s/ Kelly J. Gill

Kelly J. Gill

President and Chief Executive Officer

(Principal Executive Officer)

March 6, 2014

/s/ James R. McKnight, Jr.

James R. McKnight, Jr.

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

March 6, 2014

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

/s/ Wallace E. Olson	/s/ Robert Z. Hensley
Wallace E. Olson	Robert Z. Hensley
Chairman of the Board and Director	Director
March 6, 2014	March 6, 2014
/s/ Chad A. McCurdy	/s/ William C. O'Neil. Jr.
Chad A. McCurdy	William C. O'Neil, Jr.
Vice Chairman of the Board and Director	Director
March 6, 2014	March 6, 2014
/s/ Kelly J. Gill	/s/ Richard M. Brame
Kelly J. Gill	Richard M. Brame
President and Chief Executive Officer	Director
Director	March 6, 2014
March 6, 2014

42

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

Consolidated Financial Statements

For the Years Ended December 31, 2013, 2012 and 2011

Together with Report of Independent Registered Public Accounting Firm

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm	F-1
Consolidated Balance Sheets	F-2
Consolidated Statements of Operations	F-3
Consolidated Statements of Comprehensive Income (Loss)	F-4
Consolidated Statements of Shareholders' Equity	F-5
Consolidated Statements of Cash Flows	F-6
Notes to Consolidated Financial Statements	F-8
Schedule II - Valuation and Qualifying Accounts	S-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders

Diversicare Healthcare Services, Inc.

Brentwood, Tennessee

We have audited the accompanying consolidated balance sheets of Diversicare Healthcare Services, Inc. and subsidiaries as of December 31, 2013 and 2012 and the related consolidated statements of operations, comprehensive income (loss), shareholders' equity, and cash flows for each of the three years in the period ended December 31, 2013. In connection with our audits of the financial statements, we have also audited the financial statement schedule listed in the accompanying index. These financial statements and schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and schedule. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Diversicare Healthcare Services, Inc. and subsidiaries at December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America.

Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

/s/ BDO USA, LLP

Nashville, Tennessee

March 6, 2014

F-1

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2013 AND 2012

ASSETS	2013			2012			LIABILITIES AND SHAREHOLDERS' EQUITY	2013			2012
CURRENT ASSETS:							CURRENT LIABILITIES:
Cash and cash equivalents	$	3,784,000		$	5,930,000
Receivables, less allowance for doubtful accounts of $3,999,000 and $3,143,000, respectively	35,119,000			24,631,000			Current portion of long-term debt and capitalized lease obligations (variable interest entity nonrecourse – 2013: $217,000; 2012: $206,000)	$	4,766,000		$	1,436,000
Other receivables	1,118,000			1,397,000			Trade accounts payable	7,545,000			3,603,000
Prepaid expenses and other current assets	2,507,000			3,729,000			Current liabilities of discontinued operations	236,000			2,209,000
Income tax refundable	763,000			1,215,000			Accrued expenses:
Current assets of discontinued operations	341,000			4,649,000			Payroll and employee benefits	12,633,000			11,048,000
Deferred income taxes	6,579,000			5,305,000			Self-insurance reserves, current portion	11,711,000			9,175,000
Total current assets	50,211,000			46,856,000			Other current liabilities	5,276,000			3,722,000
							Total current liabilities	42,167,000			31,193,000
							NONCURRENT LIABILITIES:
							Long-term debt and capitalized lease obligations, less current portion (variable interest entity nonrecourse – 2013: $5,259,000; 2012: $5,472,000)	48,811,000			28,026,000
							Self-insurance reserves, noncurrent portion	16,375,000			14,531,000
PROPERTY AND EQUIPMENT, at cost	103,689,000			82,675,000			Other noncurrent liabilities	15,907,000			17,544,000
Less accumulated depreciation and amortization	(50,699,000		)	(43,938,000		)	Total noncurrent liabilities	81,093,000			60,101,000
Discontinued operations, net	1,053,000			3,185,000			COMMITMENTS AND CONTINGENCIES
Property and equipment, net (variable interest entity restricted – 2013: $6,831,000; 2012: $7,144,000)	54,043,000			41,922,000			SERIES C REDEEMABLE PREFERRED STOCK
							$.10 par value, 5,000 shares authorized, issued and outstanding	4,918,000			4,918,000
							SHAREHOLDERS’ EQUITY:
							Series A preferred stock, authorized 200,000 shares, $.10 par value, none issued and outstanding	—			—
OTHER ASSETS:							Common stock, authorized 20,000,000 shares, $.01 par value, 6,307,000 and 6,161,000 shares issued, and 6,075,000 and 5,929,000 shares outstanding, respectively	63,000			62,000
Deferred income taxes	15,912,000			12,352,000			Treasury stock at cost, 232,000 shares of common stock	(2,500,000		)	(2,500,000		)
Deferred financing and other costs, net	2,071,000			1,438,000			Paid-in capital	19,570,000			18,757,000
Investment in unconsolidated affiliate	487,000			420,000			Retained earnings (accumulated deficit)	(8,435,000		)	1,779,000
Other noncurrent assets	6,782,000			3,317,000			Accumulated other comprehensive loss	(569,000		)	(920,000		)
Acquired leasehold interest, net	8,228,000			8,612,000			Total shareholders’ equity of Diversicare Healthcare Services, Inc.	8,129,000			17,178,000
Noncurrent assets of discontinued operations	10,000			46,000			Noncontrolling interests	1,437,000			1,573,000
Total other assets	33,490,000			26,185,000			Total shareholders’ equity	9,566,000			18,751,000
	$	137,744,000		$	114,963,000			$	137,744,000		$	114,963,000

The accompanying notes are an integral part of these consolidated financial statements.

F-2

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

	Years Ended December 31,
	2013			2012			2011
PATIENT REVENUES, net	$	281,919,000		$	246,290,000		$	245,877,000
EXPENSES:
Operating	228,342,000			197,960,000			194,152,000
Lease and rent expense	21,542,000			19,050,000			18,064,000
Professional liability	7,336,000			6,102,000			3,618,000
General and administrative	20,940,000			19,515,000			21,024,000
Depreciation and amortization	6,972,000			6,276,000			5,607,000
Asset impairment	—			—			344,000
Restructuring	1,446,000			—			—
Total expenses	286,578,000			248,903,000			242,809,000
OPERATING INCOME (LOSS)	(4,659,000		)	(2,613,000		)	3,068,000
OTHER INCOME (EXPENSE):
Equity in net losses of unconsolidated affiliate	(183,000		)	(280,000		)	—
Interest expense, net	(3,620,000		)	(2,809,000		)	(2,356,000		)
Debt retirement costs	(320,000		)	—			(112,000		)
	(4,123,000		)	(3,089,000		)	(2,468,000		)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(8,782,000		)	(5,702,000		)	600,000
BENEFIT (PROVISION) FOR INCOME TAXES	3,305,000			2,027,000			(162,000		)
INCOME (LOSS) FROM CONTINUING OPERATIONS	(5,477,000		)	(3,675,000		)	438,000
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating income (loss), net of tax provision (benefit) of $(1,754,000), $291,000 and $341,000, respectively	(2,985,000		)	581,000			929,000
Gain on disposal and impairment, net of tax provision of $0, $107,000 and $0, respectively	—			174,000			—
DISCONTINUED OPERATIONS	(2,985,000		)	755,000			929,000
NET INCOME (LOSS)	(8,462,000		)	(2,920,000		)	1,367,000
Less: net income attributable to noncontrolling interests	(72,000		)	(126,000		)	—
NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.	(8,534,000		)	(3,046,000		)	1,367,000
PREFERRED STOCK DIVIDENDS	(344,000		)	(344,000		)	(344,000		)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
NET INCOME (LOSS) PER COMMON SHARE FOR DIVERSICARE HEALTHCARE SERVICES, INC. SHAREHOLDERS:
Per common share – basic
Continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Discontinued operations	(0.51		)	0.13			0.16
	$	(1.51	)	$	(0.58	)	$	0.18
Per common share – diluted
Continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Discontinued operations	(0.51		)	0.13			0.15
	$	(1.51	)	$	(0.58	)	$	0.17
DIVIDENDS DECLARED PER SHARE OF COMMON STOCK	$	0.22		$	0.22		$	0.22
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	5,899,000			5,821,000			5,774,000
Diluted	5,899,000			5,821,000			5,906,000

The accompanying notes are an integral part of these consolidated financial statements.

F-3

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

	Years Ended December 31,
	2013			2012			2011
NET INCOME (LOSS)	$	(8,462,000	)	$	(2,920,000	)	$	1,367,000
OTHER COMPREHENSIVE INCOME (LOSS):
Change in fair value of cash flow hedge, net of tax	666,000			354,000			(661,000		)
Less: reclassification adjustment for amounts recognized in net income	(315,000		)	(329,000		)	(284,000		)
Total other comprehensive income (loss)	351,000			25,000			(945,000		)
COMPREHENSIVE INCOME (LOSS)	(8,111,000		)	(2,895,000		)	422,000
Less: comprehensive income attributable to noncontrolling interest	(72,000		)	(126,000		)	—
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.	$	(8,183,000	)	$	(3,021,000	)	$	422,000

The accompanying notes are an integral part of these consolidated financial statements.

F-4

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

	Common Stock			Treasury Stock				Paid-in Capital			Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Loss			Total Shareholders' Equity of Diversicare Healthcare Services, Inc.			Non- Controlling Interests			Total Shareholders' Equity
	Shares Issued	Amount		Shares	Amount
BALANCE, DECEMBER 31, 2010	5,976,000	$	60,000	232,000	$	(2,500,000	)	$	17,896,000		$	6,749,000		$	—		$	22,205,000		$	—		$	22,205,000
Net income (loss)	—	—		—	—			—			1,367,000			—			1,367,000			—			1,367,000
Preferred stock dividends	—	—		—	—			—			(344,000		)	—			(344,000		)	—			(344,000		)
Common stock dividends declared	—	—		—	—			21,000			(1,292,000		)	—			(1,271,000		)	—			(1,271,000		)
Issuance/redemption of equity grants, net	85,000	1,000		—	—			39,000			—			—			40,000			—			40,000
Interest rate cash flow hedge	—	—		—	—			—			—			(945,000		)	(945,000		)	—			(945,000		)
Tax impact of equity grant exercises	—	—		—	—			(162,000		)	—			—			(162,000		)	—			(162,000		)
Consolidation of non-controlling interests of variable interest entity	—	—		—	—			—			—			—			—			1,654,000			1,654,000
Stock based compensation	—	—		—	—			425,000			—			—			425,000			—			425,000
BALANCE, DECEMBER 31, 2011	6,061,000	61,000		232,000	(2,500,000		)	18,219,000			6,480,000			(945,000		)	21,315,000			1,654,000			22,969,000
Net income (loss)	—	—		—	—			—			(3,046,000		)	—			(3,046,000		)	126,000			(2,920,000		)
Preferred stock dividends	—	—		—	—			—			(344,000		)	—			(344,000		)	—			(344,000		)
Common stock dividends declared	—	—		—	—			29,000			(1,311,000		)	—			(1,282,000		)	—			(1,282,000		)
Issuance/redemption of equity grants, net	100,000	1,000		—	—			54,000			—			—			55,000			—			55,000
Interest rate cash flow hedge	—	—		—	—			—			—			25,000			25,000			—			25,000
Tax impact of equity grant exercises	—	—		—	—			(26,000		)	—			—			(26,000		)	—			(26,000		)
Consolidation of non-controlling interests of variable interest entity	—	—		—	—			—			—			—			—			(207,000		)	(207,000		)
Stock based compensation	—	—		—	—			481,000			—			—			481,000			—			481,000
BALANCE, DECEMBER 31, 2012	6,161,000	62,000		232,000	(2,500,000		)	18,757,000			1,779,000			(920,000		)	17,178,000			1,573,000			18,751,000
Net income (loss)	—	—		—	—			—			(8,534,000		)	—			(8,534,000		)	72,000			(8,462,000		)
Preferred stock dividends	—	—		—	—			—			(344,000		)	—			(344,000		)	—			(344,000		)
Common stock dividends declared	—	—		—	—			35,000			(1,336,000		)	—			(1,301,000		)	—			(1,301,000		)
Issuance/redemption of equity grants, net	146,000	1,000		—	—			21,000			—			—			22,000			—			22,000
Interest rate cash flow hedge	—	—		—	—			—			—			351,000			351,000			—			351,000
Tax impact of equity grant exercises	—	—		—	—			(20,000		)	—			—			(20,000		)	—			(20,000		)
Distributions to noncontrolling interest	—	—		—	—			—			—			—			—			(208,000		)	(208,000		)
Stock based compensation	—	—		—	—			777,000			—			—			777,000			—			777,000
BALANCE, DECEMBER 31, 2013	6,307,000	$	63,000	232,000	$	(2,500,000	)	$	19,570,000		$	(8,435,000	)	$	(569,000	)	$	8,129,000		$	1,437,000		$	9,566,000

The accompanying notes are an integral part of these consolidated financial statements.

F-5

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Years Ended December 31,
	2013			2012			2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(8,462,000	)	$	(2,920,000	)	$	1,367,000
Discontinued operations	(2,985,000		)	755,000			929,000
Income (loss) from continuing operations	(5,477,000		)	(3,675,000		)	438,000
Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities:
Depreciation and amortization	6,972,000			6,276,000			5,607,000
Provision for doubtful accounts	4,191,000			3,064,000			1,780,000
Deferred income tax provision (benefit)	(5,068,000		)	(1,412,000		)	801,000
Provision for self-insured professional liability, net of cash payments	1,162,000			2,935,000			(742,000		)
Stock based compensation	950,000			573,000			528,000
Debt retirement costs	320,000			—			—
Provision for leases net of cash payments	(631,000		)	(148,000		)	320,000
Asset impairment	—			—			344,000
Equity in net losses of unconsolidated affiliate	(67,000		)	(420,000		)	—
Other	516,000			455,000			415,000
Changes in other assets and liabilities affecting operating activities:
Receivables, net	(14,313,000		)	(6,404,000		)	(4,904,000		)
Prepaid expenses and other assets	862,000			(447,000		)	1,128,000
Trade accounts payable and accrued expenses	6,672,000			155,000			1,389,000
Net cash provided (used) by continuing operations	(3,911,000		)	952,000			7,104,000
Discontinued operations	2,685,000			2,266,000			2,937,000
Net cash provided (used) by operating activities	(1,226,000		)	3,218,000			10,041,000
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(5,293,000		)	(4,353,000		)	(12,386,000		)
Acquisition of property and equipment through business combination	(14,742,000		)	—			—
Proceeds from sale of discontinued operations	—			3,632,000			—
Change in restricted cash	(3,480,000		)	752,000			(1,029,000		)
Deposits and other deferred balances	—			(319,000		)	(31,000		)
Net cash used in continuing operations	(23,515,000		)	(288,000		)	(13,446,000		)
Discontinued operations	1,904,000			(497,000		)	(970,000		)
Net cash used in investing activities	(21,611,000		)	(785,000		)	(14,416,000		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of debt obligations	(30,385,000		)	(1,364,000		)	(24,583,000		)
Proceeds from issuance of debt and sale leaseback transaction	54,500,000			634,000			29,554,000
Financing costs	(1,341,000		)	(118,000		)	(797,000		)
Issuance and redemption of employee equity awards	22,000			55,000			194,000
Payment of common stock dividends	(972,000		)	(1,282,000		)	(1,272,000		)
Payment of preferred stock dividends	(344,000		)	(344,000		)	(344,000		)
Distributions to noncontrolling interests	(208,000		)	(206,000		)	—
Payment for preferred stock restructuring	(581,000		)	(563,000		)	(546,000		)
Net cash (used in) provided by financing activities	20,691,000			(3,188,000		)	2,206,000

(Continued)

F-6

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(continued)

	Years Ended December 31,
	2013			2012			2011
NET DECREASE IN CASH AND CASH EQUIVALENTS	$	(2,146,000	)	$	(755,000	)	$	(2,169,000	)
CASH AND CASH EQUIVALENTS, beginning of period	5,930,000			6,685,000			8,854,000
CASH AND CASH EQUIVALENTS, end of period	$	3,784,000		$	5,930,000		$	6,685,000
SUPPLEMENTAL INFORMATION:
Cash payments of interest, net of amounts capitalized	$	2,937,000		$	1,776,000		$	1,875,000
Cash payments of income taxes	$	88,000		$	176,000		$	627,000

As discussed in Note 7 the Company entered into capitalized lease agreements and recorded $0, $293,000 and $527,000 in 2013, 2012 and 2011, respectively, in fixed assets and capital lease obligations. These non-cash investing and financing transactions have been excluded from the consolidated statements of cash flows.

The accompanying notes are an integral part of these consolidated financial statements.

F-7

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2013, 2012, and 2011

1. COMPANY AND ORGANIZATION

Diversicare Healthcare Services, Inc. (together with its consolidated subsidiaries, “Diversicare” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast and Southwest. The Company’s centers provide a range of health care services to their patients and residents. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers offer a variety of comprehensive rehabilitation services as well as nutritional support services.

As of December 31, 2013, the Company’s continuing operations consist of 47 nursing centers with 5,318 licensed nursing beds. The Company owns 13 and leases 34 of its nursing centers. The nursing center and licensed nursing bed count includes the Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013. The nursing center and licensed bed count includes the 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicaid and Medicare certification processes for this facility are currently in progress and expected to be completed in the first quarter of 2014. The nursing center and licensed nursing bed count also includes 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes are currently under way for these four leased facilities. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Ohio, Tennessee, Texas and West Virginia.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation

The consolidated financial statements include the financial position, operations and accounts of Diversicare and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (“VIEs”) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company has one variable interest entity and it relates to a nursing center in West Virginia described in Note 7.

The investment in unconsolidated affiliate reflected on the consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns a 50% interest. The joint venture partnership is accounted for using the equity method. An equity method investment is the Company’s investment in an entity over which the Company lacks control, but otherwise has the ability to exercise significant influence over operating and financial policies. The Company’s share of the profits and losses from this investment are reported in equity in earnings of unconsolidated affiliates in the accompanying consolidated statement of operations. The Company monitors this investment for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the company and will record reductions in carrying value when or if necessary. Under the equity method, the investment, originally recorded at cost, is adjusted to recognize the Company’s share of the net earnings or losses of the affiliate as they occur. The investment in unconsolidated affiliate balance relates to this partnership and was $487,000 at December 31, 2013, and $420,000 at December 31, 2012 .

Revenues

Patient Revenues

The fees charged by the Company to patients in its nursing centers are recorded on an accrual basis. These rates are contractually adjusted with respect to individuals receiving benefits under federal and state-funded programs and other third-party payors. Rates under federal and state-funded programs are determined prospectively for each facility and may be based on the acuity of the care and services provided. These rates may be based on facility's actual costs subject to program ceilings and other limitations or on established rates based on acuity and services provided as determined by the federal and state-funded programs. Amounts earned under federal and state programs with respect to nursing home patients are subject to review by the third-party payors which may result in retroactive adjustments. In the opinion of management, adequate provision has been made for any adjustments that may result from such reviews. Retroactive adjustments, if any, are recorded when objectively determinable, generally within three years of the close of a reimbursement year depending upon the timing of appeals and third-party settlement reviews or audits. During the years ended December 31, 2013, 2012 and 2011, the Company recorded $151,000, $(273,000) and $630,000 of net favorable (unfavorable) estimated settlements from federal and state programs for periods prior to the beginning of fiscal 2013, 2012 and 2011, respectively.

F-8

Allowance for Doubtful Accounts

The Company's allowance for doubtful accounts is estimated utilizing current agings of accounts receivable, historical collections data and other factors. Management monitors these factors and determines the estimated provision for doubtful accounts. Historical bad debts have generally resulted from uncollectible private balances, some uncollectible coinsurance and deductibles and other factors. Receivables that are deemed to be uncollectible are written off. The allowance for doubtful accounts balance is assessed on a quarterly basis, with changes in estimated losses being recorded in the Consolidated Statements of Operations in the period identified.

The Company includes the provision for doubtful accounts in operating expenses in its Consolidated Statements of Operations. The provisions for doubtful accounts of continuing operations were $4,191,000, $3,064,000, and $1,780,000 for 2013, 2012 and 2011, respectively. The provision for doubtful accounts of continuing operations was 1.5%, 1.2%, and 0.7% of net revenue during 2013, 2012, and 2011, respectively.

Lease Expense

As of December 31, 2013, the Company operates 34 nursing centers under operating leases, including 25 owned by Omega REIT, six owned by AVIV REIT, and three owned by other parties. The Company's operating leases generally require the Company to pay stated rent, subject to increases based on changes in the Consumer Price Index, a minimum percentage increase, or increases in the net revenues of the leased properties. The Company's Omega leases require the Company to pay certain scheduled rent increases. Such scheduled rent increases are recorded as additional lease expense on a straight-line basis recognized over the term of the related leases and the difference between the amounts recorded for rent expense as compared to rent payments as an accrued liability.

See Notes 3, 4, and 12 for a discussion regarding the Company's Master Lease with Omega, the termination of leases for certain facilities and the addition of certain leased facilities.

Classification of Expenses

The Company classifies all expenses (except lease, interest, depreciation and amortization expenses) that are associated with its corporate and regional management support functions as general and administrative expenses. All other expenses (except lease, professional liability, interest, depreciation and amortization expenses) incurred by the Company at the facility level are classified as operating expenses.

Property and Equipment

Property and equipment are recorded at cost with depreciation and amortization being provided over the shorter of the remaining lease term (where applicable) or the assets' estimated useful lives on the straight-line basis as follows:

Buildings and improvements	-	5 to 40 years
Leasehold improvements	-	2 to 10 years
Furniture, fixtures and equipment	-	2 to 15 years

Interest incurred during construction periods for qualifying expenditures is capitalized as part of the building cost. Maintenance and repairs are expensed as incurred, and major betterments and improvements are capitalized. Property and equipment obtained through business combinations are stated at their estimated fair value determined on the respective dates of acquisition.

In accordance with the Financial Accounting Standards Board ("FASB") guidance on “Property, Plant and Equipment,” specifically the discussion around the accounting for the impairment or disposal of long-lived assets, the Company routinely evaluates the recoverability of the carrying value of its long-lived assets, including when significant adverse changes in the general economic conditions and significant deteriorations of the underlying undiscounted cash flows or fair values of the property indicate that the carrying amount of the property may not be recoverable. The need to recognize impairment is based on estimated undiscounted future cash flows from a property compared to the carrying value of that property.

On July 29, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its final rule for skilled nursing facilities effective October 1, 2011, reducing Medicare reimbursement rates for skilled nursing facilities by 11.1% and also making changes to rehabilitation therapy regulations. This final rule had a negative effect on the Company's revenue and costs in Medicare's fiscal year ended September 30, 2012 as compared to Medicare's fiscal year ended September 30, 2011. As a result of this negative impact, an interim impairment analysis was conducted in 2011, and the Company determined that the carrying value of the long-lived assets of one of its leased nursing centers exceeded the fair value. As a result, the Company recorded a fixed asset impairment charge during 2011 of $344,000 to reduce the carrying value of these assets.

F-9

Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with banks and all highly liquid investments with original maturities of three months or less when purchased. Our cash on deposit with banks was subject to the Federal Deposit Insurance Corporation ("FDIC") minimum insurance levels. Effective January 1, 2013, the coverage provided by the FDIC that had been unlimited under the Dodd-Frank Deposit Insurance Provision is limited to the legal maximum which is generally $250,000 per ownership category.

Deferred Financing and Other Costs

The Company records deferred financing and lease costs for direct and incremental expenditures related to entering into or amending debt and lease agreements. These expenditures include lenders and attorneys fees. Financing costs are amortized using the effective interest method over the term of the related debt. The amortization is reflected as interest expense in the accompanying consolidated statements of operations. Deferred lease costs are amortized on a straight-line basis over the term of the related leases. See Note 7 for further discussion.

Acquired Leasehold Interest

The Company has recorded an acquired leasehold interest intangible asset related to an acquisition completed during 2007. The intangible asset is accounted for in accordance with the FASB's guidance on goodwill and other intangible assets, and is amortized on a straight-line basis over the remaining life of the acquired lease, including renewal periods, the original period of which is approximately 28 years from the date of acquisition. The lease terms for the seven centers this intangible relates to provide for an initial term and renewal periods at the Company's option through May 31, 2035. As the renewal periods of the acquired leased facilities are solely based on the Company's option, it is expected that costs (if any) to renew the lease through its current amortization period would be nominal and the decision to continue to lease the acquired facilities lies solely within the Company's intent to continue to operate the seven facilities. Any renewal costs would be included in deferred lease costs and amortized over the renewal period. Amortization expense of approximately $384,000 related to this intangible asset was recorded during each of the years ended December 31, 2013, 2012 and 2011, respectively.

The carrying value of the acquired leasehold interest intangible and the accumulated amortization are as follows:

	December 31,
	2013			2012
Intangible assets	$	10,652,000		$	10,652,000
Accumulated amortization	(2,424,000		)	(2,040,000		)
Net intangible assets	$	8,228,000		$	8,612,000

The Company evaluates the recoverability of the carrying value of the acquired leasehold intangible in accordance with the FASB's guidance on accounting for the impairment or disposal of long-lived assets. Included in this evaluation is whether significant adverse changes in general economic conditions, and significant deteriorations of the underlying cash flows or fair values of the intangible asset, indicate that the carrying amount of the intangible asset may not be recoverable. The need to recognize an impairment charge is based on estimated future undiscounted cash flows from the asset compared to the carrying value of that asset. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying amount of the intangible asset exceeds the fair value of the intangible asset.

The expected amortization expense for the acquired leasehold interest intangible asset is as follows:

2014	$	384,000
2015	384,000
2016	384,000
2017	384,000
2018	384,000
Thereafter	6,308,000
	$	8,228,000

Self-Insurance

Self-insurance liabilities primarily represent the unfunded accrual for self insured risks associated with general and professional liability claims, employee health insurance and workers' compensation. The Company's health insurance liability is based on

F-10

known claims incurred and an estimate of incurred but unreported claims determined by an analysis of historical claims paid. The Company's workers' compensation liability relates primarily to periods of self insurance prior to May 1997 and consists of an estimate of the future costs to be incurred for the known claims.

Final determination of the Company's actual liability for incurred general and professional liability claims is a process that takes years. The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this unfunded accrual. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished by the Company. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company's past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company's ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company's insurers and a third party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator's estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company's evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual has an unfavorable impact on results of operations in the period and any reduction in the accrual increases results of operations during the period.

All losses are projected on an undiscounted basis. The self-insurance liabilities include estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of related legal costs incurred and expected to be incurred.

One of the key assumptions in the actuarial analysis is that historical losses provide an accurate forecast of future losses. Changes in legislation such as tort reform, changes in our financial condition, changes in our risk management practices and other factors may affect the severity and frequency of claims incurred in future periods as compared to historical claims.

The facts and circumstances of each claim vary significantly, and the amount of ultimate liability for an individual claim may vary due to many factors, including whether the case can be settled by agreement, the quality of legal representation, the individual jurisdiction in which the claim is pending, and the views of the particular judge or jury deciding the case.

Although the Company adjusts its unfunded accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company's actual liability for claims incurred in any given period is a process that takes years. As a result, the Company's actual liabilities may vary significantly from the unfunded accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company's reported earnings and financial position for the period in which the change in accrual is made.

Income Taxes

The Company follows the FASB's guidance on Accounting for Income Taxes, which requires the asset and liability method of accounting for income taxes whereby deferred income taxes are recorded for the future tax consequences attributable to differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided against any estimated non-realizable deferred tax assets where necessary.

Where the Company believes that a tax position is supportable for income tax purposes, the item is included in its income tax returns. Where treatment of a position is uncertain, liabilities are recorded based upon the Company’s evaluation of the “more likely than not” outcome considering the technical merits of the position. While the judgments and estimates made by the Company are based on management’s evaluation of the technical merits of a matter, historical experience and other assumptions that management believes are appropriate and reasonable under current circumstances, actual resolution of these matters may differ from recorded estimated amounts, resulting in charges or credits that could materially affect future financial statements. See Note 11 for additional information related to the provision for income taxes.

Disclosure of Fair Value of Financial Instruments

F-11

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. The carrying amounts of cash and cash equivalents, receivables, trade accounts payable and accrued expenses approximate fair value because of the short-term nature of these accounts. The Company's self-insurance liabilities are reported on an undiscounted basis as the timing of estimated settlements cannot be determined.

The Company follows the FASB's guidance on Fair Value Measurements and Disclosures which provides rules for using fair value to measure assets and liabilities as well as a fair value hierarchy that prioritizes the information used to develop the measurements. It applies whenever other guidance requires (or permits) assets or liabilities to be measured at fair value and gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

A summary of the fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels is described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

The Company has not elected to expand the use of fair value measurements for assets and liabilities. It is noted that the assessment of carrying value compared to fair value for impairment analysis, as discussed in Note 2 “Property and Equipment,” follow these fair value principles and hierarchy.

As further discussed in Note 7, in conjunction with the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The applicable guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value in a company's balance sheets.

As the Company's interest rate swap, a cash flow hedge, is not traded on a market exchange, the fair value is determined using a valuation model based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The fair value of the Company's interest rate swap is the net difference in the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates and are observable inputs available to a market participant. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy. The debt balances as presented in the consolidated balance sheets approximate the fair value of the respective instruments, the estimates of which are considered Level 2 fair value calculations within the fair value hierarchy.

The following table presents by level, within the fair value hierarchy, assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012:

December 31, 2013	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(918,000	)	$	—	$	(918,000	)	$	—
December 31, 2012	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(1,484,000	)	$	—	$	(1,484,000	)	$	—

The change in fair value of the Company's cash flow hedge is detailed in the Company's Consolidated Statements of Comprehensive Income (Loss).

F-12

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Net Income (Loss) per Common Share

The Company follows the FASB's guidance on Earnings Per Share for the financial reporting of net income (loss) per common share. Basic earnings per common share excludes dilution and restricted shares and is computed by dividing income available to common shareholders by the weighted-average number of common shares, excluding restricted shares, outstanding for the period. Diluted earnings per common share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise resulted in the issuance of common stock that then shared in the earnings of the Company. See Note 9 for additional disclosures about the Company's Net Income (Loss) per Common Share.

Stock Based Compensation

The Company follows the FASB's guidance on Stock Compensation to account for share-based payments granted to employees and recorded non-cash stock based compensation expense of $950,000, $573,000 and $528,000 during the years ended December 31, 2013, 2012 and 2011, respectively. Such amounts are included as components of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. See Note 8 for additional disclosures about the Company's stock based compensation plans.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive income consists of other comprehensive income (loss). Comprehensive income (loss) is a more inclusive financial reporting method that includes disclosure of financial information that historically has not been recognized in the calculation of net income (loss). The Company has chosen to present the components of other comprehensive income in a separate statement of comprehensive income (loss). Currently, the Company's other comprehensive income (loss) consists of the change in fair value of the Company's interest rate swap transaction accounted for as a cash flow hedge.

Recent Accounting Guidance

In June 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Comprehensive Income – Presentation of Comprehensive Income,” to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The update eliminates the option to present the components of other comprehensive income as part of the statement of equity. The Company adopted this guidance effective January 1, 2012 and has applied it retrospectively. There was no significant impact to the Company’s consolidated financial statements.

In July 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Health Care Entities: Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities.” This guidance impacts health care entities that recognize significant amounts of patient service revenue at the time the services are rendered even though they do not assess the patient’s ability to pay. This updated guidance requires an impacted health care entity to present its provision for doubtful accounts as a deduction from revenue, similar to contractual discounts. Accordingly, patient service revenue for entities subject to this updated guidance will be required to be reported net of both contractual discounts and provision for doubtful accounts. The updated guidance also requires certain qualitative disclosures about the entity’s policy for recognizing revenue and bad debt expense for patient service transactions. The guidance was effective for the Company starting January 1, 2012. Based on the Company’s assessment of its admission procedures, the Company is not an impacted health care entity under this guidance since it assesses each patient’s ability or the patient’s payor source’s ability to pay. As a result of this assessment, the Company will continue to record bad debt expense as a component of operating expense, and adoption did not have an impact on the Company’s consolidated financial statements.

In July 2012, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Intangibles-Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment.” This guidance is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. This new guidance is an extension of guidance from September 2011 related to the testing of goodwill for impairment. The updated guidance allows an entity the option to first qualitatively assess whether it is more likely than not (that is, a likelihood of more than 50-percent) that an indefinite-lived intangible asset is impaired. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test for other non-amortized intangible

F-13

assets is required. An entity is not required to perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. It is an entity's option to bypass the qualitative assessment and proceed directly to performing the quantitative impairment test for other non-amortized intangible assets.The guidance is effective for annual and interim impairment tests performed by the Company after January 1, 2013, with earlier implementation permitted. The Company is currently assessing the potential impact and timing of the implementation and believes the adoption will not have a material impact on the Company's consolidated financial statements.

Reclassifications

As discussed in Note 4, the consolidated financial statements of the Company have been retroactively reclassified for all periods presented to reflect as discontinued operations certain divestitures and lease terminations.

3. BUSINESS DEVELOPMENT

Kansas Acquisition

On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities commenced on May 1, 2013. The five facilities acquired under the Agreement include the following:

• 77-bed skilled nursing facility known as Chanute HealthCare Center

• 80-bed skilled nursing facility known as Council Grove HealthCare Center

• 119-bed skilled nursing facility known as Haysville HealthCare Center

• 80-bed skilled nursing facility known as Larned HealthCare Center

• 62-bed skilled nursing facility known as Sedgwick HealthCare Center

As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired identifiable net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The Company also incurred $338,000 in acquisition-related expenses that were expensed as incurred. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

	As of May 1, 2013
Purchase Price	$	15,500,000
Land	2,130,000
Buildings	12,127,000
Furniture, fixtures, and equipment	1,200,000
Inventory	43,000
Less: Liabilities assumed	758,000
Total cash paid	$	14,742,000

Since finalizing the purchase, the aforementioned facilities have contributed $15,440,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Lease Agreements

On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT and the lease provides for an initial 15-year lease term with a 5-year renewal option. This additional skilled nursing center increases the Company's footprint in Kentucky to nine nursing centers. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement

F-14

for this skilled nursing center. Since assuming operations at this facility, the aforementioned facility has contributed $3,487,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Additionally, on October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana, and increasing our presence in Ohio to four nursing centers. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. Since assuming operations at this facility, the aforementioned facilities have contributed $9,225,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

In April 2012, the Company entered into a lease agreement to operate an 88-bed skilled nursing center in Clinton, Kentucky. The center is subject to a mortgage insured through the United States Department of Housing and Urban Development. The lease has an initial ten-year term with twofive-year renewal options and contains an option to purchase the property for $3.3 million during the first five years. The center had not had residents since April 2011 after being de-certified by Medicare and Medicaid. The lease agreement called for a $125,000 lease commencement fee and the transaction is considered a lease agreement.

Separate from the above lease transaction, in September 2012, the Company announced it entered into a lease agreement to operate a 154-bed skilled nursing center in Louisville, Kentucky. The nursing center is owned by a real estate investment trust and the lease provides for an initial fifteen-year lease term with a five-year renewal option. This additional skilled nursing center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.

4. DISCONTINUED OPERATIONS

Effective September 1, 2013, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in the state of Arkansas, and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Thirteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.

As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying consolidated financial statements. These centers contributed revenues of $40,151,000, $61,782,000, and $63,589,000 during the twelve months ended December 31, 2013, 2012, and 2011, respectively. Further, these centers contributed net loss of $2,865,000 during the twelve months ended December 31, 2013, and net income of $457,000 and $540,000 during the twelve months ended December 31, 2012 and 2011, respectively.  The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations. In addition to the expenses associated with the discontinued operations, the Company also incurred $1,446,000 in restructuring expenses that represent corporate expenses and exit costs associated with the Arkansas lease termination, but not classified as discontinued operations.

Effective September 1, 2012, we sold an owned skilled nursing center in Arkansas to an unrelated party and have reclassified the operations of this facility as discontinued operations for all periods presented in the accompanying consolidated financial statements. The operating margins and the long-term business prospects of the nursing center did not meet our strategic goals. This skilled nursing center contributed revenues of $0, $3,463,000, and $5,249,000, and net income (loss) of $(85,000), $68,000, and $198,000 during the twelve months ended December 31, 2013, 2012, and 2011, respectively.  The net income (loss) for the nursing center included in discontinued operations does not reflect any allocation of regional or corporate general and administrative expense or any allocation of corporate interest expense. We considered these additional costs along with the future prospects of this nursing center when determining the contribution of the skilled nursing center to our operations. The gain on disposal, net of taxes, of $174,000 was primarily the amount of sales price in excess of the net carrying value of the fixed assets sold.

The Company owns land related to a North Carolina assisted living facility it closed in April 2006. The net assets of discontinued operations presented in property and equipment on the accompanying consolidated balance sheet of $1,053,000 represents the real estate related to this assisted living facility. The Company is continuing its efforts to sell this land. The fair value of the

F-15

subject property was determined based on comparable properties in the area and considered a level 2 calculation under the fair value hierarchy as discussed in Note 2.

A summary of the discontinued operations for the periods presented is as follows (in thousands):

	December 31,
	2013			2012			2011
Net revenues	$	40,151,000		$	65,245,000		$	68,838,000
Operating expenses	(44,890,000		)	(64,373,000		)	(67,568,000		)
Gain from disposal of assets	—			281,000			—
Income (loss) from discontinued operations	(4,739,000		)	1,153,000			1,270,000
Benefit (provision) for income taxes	1,754,000			(398,000		)	(341,000		)
Income (loss) from discontinued operations, net of tax	$	(2,985,000	)	$	755,000		$	929,000

5. RECEIVABLES

Receivables, before the allowance for doubtful accounts, consist of the following components:

	December 31,
	2013		2012
Medicare	$	13,806,000	$	8,606,000
Medicaid and other non-federal government programs	14,121,000		11,128,000
Other patient and resident receivables	11,191,000		8,040,000
	$	39,118,000	$	27,774,000
Other receivables and advances	$	1,118,000	$	1,397,000

The other receivables and advances balance are composed of $843,000 and $982,000 related to renovation projects funded by Omega at December 31, 2013 and 2012, respectively. See Note 12 for additional discussion of these receivables and leased facility construction projects.

Our accounts receivable at December 31, 2013 included approximately $5.1 million of accounts for the newly leased facility in Louisville, Kentucky for which we assumed operations in August 2013, and also the four facilities, three in Ohio and one in Indiana, for which we assumed operations in October 2013.  During the change of ownership process, we are required to hold these accounts while waiting for final Medicare and Medicaid approvals.  We expect these accounts to be collectible as soon as we are able to submit them for payment.

The Company provides credit for a substantial portion of its revenues and continually monitors the credit-worthiness and collectability from its patients, including proper documentation of third-party coverage. The Company is subject to accounting losses from uncollectible receivables in excess of its reserves.

Substantially all receivables are pledged as collateral on the Company's debt obligations.

6. PROPERTY AND EQUIPMENT

Property and equipment, at cost, consists of the following:

F-16

	December 31,
	2013			2012
Land	$	4,644,000		$	2,364,000
Buildings and leasehold improvements	70,572,000			55,371,000
Furniture, fixtures and equipment	28,473,000			24,940,000
	103,689,000			82,675,000
Less: accumulated depreciation	(50,699,000		)	(43,938,000		)
Net property and equipment	$	52,990,000		$	38,737,000

As discussed further in Note 7, the property and equipment of certain skilled nursing centers are pledged as collateral for mortgage debt obligations. In addition, the Company has assets recorded as capital leased assets purchased through capitalized lease obligations. The Company capitalizes leasehold improvements which will revert back to the lessor of the property at the expiration or termination of the lease, and depreciates these improvements over the shorter of the remaining lease term or the assets' estimated useful lives.

As discussed further in Note 8, the Company has consolidated the assets and liabilities of a real estate developer's interest in a center the Company leases.

7. LONG-TERM DEBT, INTEREST RATE SWAP AND CAPITALIZED LEASE OBLIGATIONS

Long-term debt consists of the following:

	December 31,
	2013			2012
Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below.	$	44,434,000		$	22,313,000
Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR.	3,000,000			—
Commercial loan of consolidated VIE, payable by variable interest entity landlord to a bank; issued in January 2011; payable monthly, fixed interest rate of 5.3%.	5,476,000			5,678,000
	52,910,000			27,991,000
Less current portion	(4,211,000		)	(631,000		)
	$	48,699,000		$	27,360,000

As of December 31, 2013, the Company's weighted average interest rate on long-term debt, including the impact of the interest rate swap, was approximately 6.61%.

The Company has agreements with a syndicate of banks for a mortgage term loan ("Original Mortgage Loan") and the Company’s revolving credit agreement ("Original Revolver"). On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to $65,000,000 allocated between a $45,000,000 Mortgage Loan ("Amended Mortgage Loan") and a $20,000,000 Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of $1,341,000 and are being amortized over the 5-year term of the agreements. Loan acquisition costs of $320,000 associated with the Original Mortgage Loan were written off as a result of this transaction, and are recorded in Debt Retirement Costs in the Consolidated Statement of Operations.

F-17

Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of $45,000,000 with a 5-year maturity through April 30, 2018, and a $20,000,000 Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of 5 years, with principal and interest payable monthly based on a 25-year amortization. Interest is based on LIBOR plus 4.5%. A portion of the Amended Mortgage Loan is effectively fixed at 6.87% pursuant to an interest rate swap with a notional amount of $22,217,000. As of December 31, 2013, the interest rate related to the Amended Mortgage Loan was 4.67%. The Amended Mortgage Loan is secured by 13 owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized.

The Amended Revolver is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions. As of December 31, 2013, the Company had $3,000,000 borrowings outstanding under the revolving credit facility. Annual fees for letters of credit issued under this Revolver are 3.00% of the amount outstanding. The Company has five letters of credit with a total value of $6,957,000 outstanding as of December 31, 2013. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $20,000,000, the balance available for borrowing under the revolving credit center is $10,043,000 at December 31, 2013. The Company’s Amended Revolver has an interest rate of LIBOR plus 4.5%.

The Company’s debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. Compliance with financial covenants restricts the Company's ability to pay dividends. The Company is in compliance with all such covenants at December 31, 2013.

The Company has consolidated $5,476,000 and $5,678,000 at December 31, 2013 and 2012, respectively, in debt that is owed by the variable interest entity that owns the West Virginia nursing center described in Note 8. The borrower is subject to covenants concerning total liabilities to tangible net worth as well as current assets compared to current liabilities. The borrower is in compliance with all such covenants at December 31, 2013. The borrower’s liabilities do not provide creditors with recourse to the general assets of the Company.

In connection with the Company's 2013 and 2012 financing agreements the Company recognized the following debt retirement costs related to the write off of deferred financing on the existing financing agreements and recorded new deferred loan costs related the new financing agreements as follows:

	2013		2012
Write-off of deferred financing costs	$	320,000	$	—
Deferred financing costs capitalized	$	1,341,000	$	34,000

Scheduled principal payments of long-term debt are as follows:

2014	$	4,211,000
2015	1,268,000
2016	6,119,000
2017	1,145,000
2018	40,167,000
Thereafter	—
Total	$	52,910,000

Interest Rate Swap Cash Flow Hedge

As part of the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The Company entered into the interest rate swap agreement to mitigate the variable interest rate risk on its outstanding mortgage borrowings. The Company designated its interest rate swap as a cash flow hedge and the effective portion of the hedge, net of taxes, is reflected as a component of other comprehensive income (loss). In conjunction with the aforementioned amendment to the Credit Agreement that occurred in May 2013, the Company retained the previously agreed upon interest rate swap modifying the terms of the swap to reflect the amended Credit Agreement. The Company redesignated the interest rate swap as a cash flow hedge. The interest rate swap agreement has the same effective date and maturity date as the Amended Mortgage Loan, and carries a notional amount of $22,217,000 as of December 31, 2013. The interest rate swap agreement requires the Company to make fixed rate payments to the bank calculated on the applicable notional amount at

F-18

an annual fixed rate of 6.87% while the bank is obligated to make payments to the Company based on LIBOR on the same notional amounts. The applicable guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value in a company's balance sheets.

The Company assesses the effectiveness of its interest rate swap on a quarterly basis and at December 31, 2013, the Company determined that the interest rate swap was effective. The interest rate swap valuation model indicated a net liability of $918,000 at December 31, 2013. The fair value of the interest rate swap is included in “other noncurrent liabilities” on the Company's consolidated balance sheet. The balance of accumulated other comprehensive loss at December 31, 2013, is $569,000 and reflects the liability related to the interest rate swap, net of the income tax benefit of $349,000. As the Company's interest rate swap is not traded on a market exchange, the fair value is determined using a valuation model based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The fair value of the Company's interest rate swap is the net difference in the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates and are observable inputs available to a market participant. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy, in accordance with the FASB's guidance on Fair Value Measurements and Disclosures.

Capitalized Lease Obligations

In September 2012, we assumed a lease which financed furniture and equipment for our new facility in Louisville, Kentucky. During 2011, the Company entered into a series of lease agreements to finance the purchase of certain equipment primarily for the implementation of Electronic Medical Records (“EMR”) in its nursing centers. The Company determined the leases were capital in nature, and as a result, we have recorded the underlying lease assets and capitalized lease obligations of $667,000 and $1,471,000 as of December 31, 2013 and 2012, respectively. These lease agreements provide three to five year terms.

Scheduled payments of the capitalized lease obligations are as follows:

2014	$	575,000
2015	47,000
2016	47,000
2017	27,000
2018	—
Total	696,000
Amounts related to interest	(29,000		)
Principal payments on capitalized lease obligation	$	667,000

8. VARIABLE INTEREST ENTITY

On December 28, 2011, the Company completed construction of Rose Terrace Health and Rehabilitation Center (“Rose Terrace”), its third health care center in West Virginia. The 90-bed skilled nursing center is located in Culloden, West Virginia, along the Huntington-Charleston corridor, and offers 24-hour skilled nursing care designed to meet the care needs of both short and long term nursing patients. The Rose Terrace nursing center utilizes a Certificate of Need the Company obtained in June 2009, when the Company completed the acquisition of certain assets of a skilled nursing center in West Virginia. The new nursing center is licensed to operate by the state of West Virginia and obtained itsMedicare and Medicaidcertifications in the first quarter of 2012.

The Company has a lease agreement with the real estate developer that constructed, furnished, equipped and currently owns Rose Terrace that provides an initial lease term of 20 years and the option to renew the lease for two additional five-year periods. The agreement provides the Company the right to purchase the center beginning at the end of the first year of the initial term of the lease and continuing through the fifth year for a purchase price ranging from 110% to 120% of the total project cost.

The Company has no equity interest in the entity that constructed the new facility and does not guarantee any debt obligations of the entity. The owners of the facility have provided guarantees of the debt of the entity and, based on those guarantees, the entity is considered to be a variable interest entity (“VIE”). The Company owns the underlying Certificate of Need that is required for operation as a skilled nursing center. During 2011, the Company determined it is the primary beneficiary of the VIE based primarily on the ownership of the Certificate of Need, the fixed price purchase option described above, the Company’s ability to direct the activities that most significantly impact the economic performance of the VIE and the right to receive potentially significant benefits from the VIE. Accordingly, as the primary beneficiary, the Company consolidates the balance sheet and results of operations of the VIE.

F-19

The following table summarizes the accounts and amounts included in the Company’s Consolidated Balance Sheet that are associated with the real estate developer’s interests in the VIE. These assets can be used only to settle obligations of the VIE and none of these liabilities provide creditors with recourse to the general assets of the Company.

	December 31, 2013		December 31, 2012
Land	$	787,000	$	787,000
Building and improvements, net	5,613,000		5,857,000
Furniture, fixtures and equipment, net	431,000		501,000
Other assets	80,000		107,000
	$	6,911,000	$	7,252,000
Current accruals	$	—	$	1,000
Notes payable, including current portion	5,476,000		5,678,000
Non-controlling interests	1,435,000		1,573,000
	$	6,911,000	$	7,252,000

	Year Ended December 31, 2013			Year Ended December 31, 2012
Beginning non-controlling interests	$	1,573,000		$	1,654,000
Comprehensive income attributable to non-controlling interests	72,000			126,000
Distributions to non-controlling interest owners	(208,000		)	(207,000		)
Ending non-controlling interests	$	1,437,000		$	1,573,000

9. SHAREHOLDERS' EQUITY, STOCK PLANS AND PREFERRED STOCK

Shareholders' Rights Plan

On August 14, 2009, the Company's Board of Directors amended its current Amended and Restated Rights Agreement (the “Rights Agreement”) which was originally adopted in 1995. The amendment changes the definition of “Acquiring Person” to be such person that acquires 20% or more of the shares of Common Stock of the Company up from the 15% that previously defined an acquiring person. On August 1, 2008, another amendment was approved which provided for an increase of the exercise price of the rights under the Rights Agreement (the “Rights”) to $50 from $15 and for the extension of the expiration date of the Rights to August 2, 2018.

In addition, the amendment includes a share exchange feature that provides the Company's Board of Directors the option of exchanging, in whole or in part, each Right, other than those of the hostile acquiring holder, for one share of the Company's common stock. This provision is intended to avoid requiring Rights holders to pay cash to exercise their Rights and to alleviate the uncertainty as to whether holders will exercise their Rights. The Plan is designed to protect the Company's shareholders from unfair or coercive takeover tactics. The rights may be exercised only upon the occurrence of certain triggering events, including the acquisition of, or a tender offer for, 20% or more of the Company's common stock without the Company's prior approval.

Stock Based Compensation Plans

The Company follows the FASB's guidance on Stock Compensation to account for stock based payments granted to employees and non-employee directors.

Overview of Plans

In December 2005, the Compensation Committee of the Board of Directors adopted the 2005 Long-Term Incentive Plan (“2005 Plan”). The 2005 Plan allows the Company to issue stock options and other share and cash based awards. Under the 2005 Plan, 700,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted thereunder. All grants under this plan expire 10 years from the date the grants were authorized by the Board of Directors.

In June 2008, the Company adopted the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel (“Stock Purchase Plan”). The Stock Purchase Plan provides for the granting of rights to purchase shares of the Company's common stock to directors and officers and 150,000 shares of the Company's common stock has been reserved for issuance under the Stock Purchase Plan. The Stock

F-20

Purchase Plan allows participants to elect to utilize a specified portion of base salary, annual cash bonus, or director compensation to purchase restricted shares or restricted share units (“RSU's”) at 85% of the quoted market price of a share of the Company's common stock on the date of purchase. The restriction period under the Stock Purchase Plan is generally two years from the date of purchase and during which the shares will have the rights to receive dividends, however, the restricted share certificates will not be delivered to the shareholder and the shares cannot be sold, assigned or disposed of during the restriction period. No grants can be made under the Stock Purchase Plan after April 25, 2018.

In April 2010, the Compensation Committee of the Board of Directors adopted the 2010 Long-Term Incentive Plan (“2010 Plan”), followed by approval by the Company's shareholders in June 2010. The 2010 Plan allows the Company to issue stock appreciation rights, stock options and other share and cash based awards. Under the 2010 Plan, 380,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted.

Equity Grants and Valuations

During 2013, the Compensation Committee of the Board of Directors approved grants totaling approximately 69,000 shares of restricted common stock to certain employees and members of the Board of Directors. These restricted shares vest one-third on the first, second and third anniversaries of the grant date. Also during 2012, the Compensation Committee of the Board of Directors approved grants of shares of restricted common stock to certain employees and members of the Board of Directors. A portion of these restricted shares vest 33% on the first, second and third anniversaries of the grant date, while another portion vested 33% upon grant and on the first and second anniversaries of the grant date. Unvested shares may not be sold or transferred. During the vesting period, dividends accrue on the restricted shares, but are paid in additional shares of common stock upon vesting, subject to the vesting provisions of the underlying restricted shares. The restricted shares are entitled to the same voting rights as other common shares. Upon vesting, all restrictions are removed.

During 2012 and 2011, the Compensation Committee of the Board of Directors approved the grant of Stock Only Stock Appreciation Rights (“SOSARs”) at the market price of the Company's common stock on the grant date. The SOSARs vest one-third on the first, second and third anniversaries of the grant date. The SOSARs are valued and recorded in the same manner as stock options, and will be settled with issuance of new stock for the difference between the market price on the date of exercise and the exercise price.

The Company recorded non-cash stock-based compensation expense from continuing operations for equity grants and RSU's issued under the Plans of $950,000, $573,000, and $528,000 during the years ended December 31, 2013, 2012, and 2011, respectively. Such amounts are included as components of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. As of December 31, 2013, there was $254,000 in unrecognized compensation costs related to stock-based compensation to be recognized over the applicable remaining vesting periods. The Company estimated the total recognized and unrecognized compensation using the Black-Scholes-Merton equity grant valuation model.

The table below shows the weighted average assumptions the Company used to develop the fair value estimates under its option valuation model:

	Year Ended December 31,
	2013	2012	2011
Expected volatility (range)	N/A(1)	58% - 59%	59% - 60%
Risk free interest rate (range)	N/A(1)	0.80% - 1.03%	1.02% - 1.30%
Expected dividends	N/A(1)	3.75%	3.93%
Weighted average expected term (years)	N/A(1)	6	6

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

In computing the fair value estimates using the Black-Scholes-Merton valuation model, the Company took into consideration the exercise price of the equity grants and the market price of the Company's stock on the date of grant. The Company used an expected volatility that equals the historical volatility over the most recent period equal to the expected life of the equity grants. The risk free interest rate is based on the U.S. treasury yield curve in effect at the time of grant. The Company used the expected dividend yield at the date of grant, reflecting the level of annual cash dividends currently being paid on its common stock.

In computing the fair value of these equity grants, the Company estimated the equity grants' expected term based on the average of the vesting term and the original contractual terms of the grants, consistent with the Securities and Exchange Commission's

F-21

interpretive guidance often referred to as the “Simplified Method.” The Company continues to use the Simplified Method since the Company's exercise history is not representative of the expected term of the equity granted in 2011. The Company's recent exercise history is primarily from options granted in 2005 that were vested at grant date and were significantly in-the-money due to an increase in stock price during the period between grant date and formal approval by shareholders, and from older options granted several years ago that had fully vested.

The table below describes the resulting weighted average grant date fair values calculated as well as the intrinsic value of options exercised under the Company's equity awards during each of the following years:

	Year Ended December 31,
	2013(1)		2012		2011
Weighted average grant date fair value	—		$	2.29	$	2.19
Total intrinsic value of exercises	$	53,000	$	12,000	$	87,000

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

The following table summarizes information regarding stock options and SOSAR grants outstanding as of December 31, 2013:

	Weighted
	Average			Intrinsic			Intrinsic
Range of	Exercise		Grants	Value-Grants		Grants	Value-Grants
Exercise Prices	Prices		Outstanding	Outstanding		Exercisable	Exercisable
$10.40 to $11.59	$	11.14	73,000	$	—	73,000	$	—
$2.37 to $6.21	$	5.37	260,000	48,000		200,000	48,000
			333,000			273,000

As of December 31, 2013, the outstanding equity grants have a weighted average remaining life of 5.33 years and those outstanding equity grants that are exercisable have a weighted average remaining life of 4.79 years. During the year ended December 31, 2013, approximately 18,000 stock option and SOSAR grants were exercised under these plans. All of the equity grants exercised were net settled, therefore no proceeds were contributed.

Summarized activity of the equity compensation plans is presented below:

			Weighted
			Average
	Shares		Exercise Price
Outstanding, December 31, 2012	461,000		$	6.62
Granted	—		—
Exercised	(18,000	)	2.37
Expired or cancelled	(110,000	)	7.25
Outstanding, December 31, 2013	333,000		$	6.64
Exercisable, December 31, 2013	273,000		$	6.84

F-22

			Weighted
			Average
	Restricted		Grant Date
	Shares		Fair Value
Outstanding, December 31, 2012	94,000		$	6.00
Granted	69,000		5.01
Dividend Equivalents	6,000		4.85
Vested	(37,000	)	6.02
Cancelled	(14,000	)	5.53
Outstanding December 31, 2013	118,000		$	5.41

Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:

			Weighted
			Average
	Restricted		Grant Date
	Share Units		Fair Value
Outstanding, December 31, 2012	52,000		$	6.24
Granted	23,000		5.01
Dividend Equivalents	2,000		4.85
Vested	(36,000	)	6.40
Cancelled	—		—
Outstanding December 31, 2013	41,000		$	5.35

Series A Preferred Stock

The Company is authorized to issue up to 200,000 shares of Series A Preferred Stock. The Company's Board of Directors is authorized to establish the terms and rights of each series, including the voting powers, designations, preferences, and other special rights, qualifications, limitations, or restrictions thereof.

Series B and Series C Redeemable Preferred Stock

As part of the consideration paid to Omega for restructuring the terms of the Omega Master Lease in November 2000, the Company issued to Omega 393,658 shares of the Company's Series B Redeemable Convertible Preferred Stock (“Series B Preferred Stock”) with a stated value of $3,300,000 and an annual dividend rate of 7% of the stated value. In October 2006, the Company and Omega entered into a Restructuring Stock Issuance and Subscription Agreement (“Restructuring Agreement”) to restructure the Series B Preferred Stock, eliminating the option of Omega to convert the Series B Preferred Stock into shares of Diversicare (formerly Advocat) common stock.

At the time of the Restructuring Agreement, the Series B Preferred Stock had a recorded value (including accrued dividends) of approximately $4,918,000 and was convertible into approximately 792,000 shares of common stock. The Company issued 5,000 shares of a new Series C Redeemable Preferred Stock (“Series C Preferred Stock”) to Omega in exchange for the 393,658 shares of Series B Preferred Stock held by Omega. The new Series C Preferred Stock has a stated value of approximately $4,918,000 and an annual dividend rate of 7% of its stated value payable quarterly in cash. The Series C Preferred Stock is not convertible, but has been redeemable at its stated value at Omega's option since September 30, 2010, and since September 30, 2007, has been redeemable at its stated value at the Company's option. Redemption under the Company's or Omega's option is subject to certain limitations.

In connection with the termination of the conversion feature, the Company agreed to pay Omega an additional $687,000 per year under the Lease Amendment. The additional annual payments of $687,000 were discounted over the twelve year term of the renewal to arrive at a net present value of $6,701,000, the preferred stock premium. The Company recorded the fair value of the elimination of the conversion feature as a reduction in Paid In Capital with an offsetting increase to record a premium on the Series C Preferred Stock. As a result, the Series C Preferred Stock was initially recorded at a total value of $11,619,000, equal to the stated value of the Series B Preferred Stock, $4,918,000, plus the value of the conversion feature, $6,701,000 which was fully amortized in 2010. The stated value of the preferred stock is classified as temporary equity and the additional obligation is classified

F-23

as a noncurrent in the accompanying consolidated balance sheet. As the related cash payments were made, the preferred stock premium was reduced and interest expense was recorded.

The Series C Preferred Stock shares have preference in liquidation but do not have voting rights. The total redemption value is equal to the stated value plus any accrued but unpaid dividends. The liquidation preference value is equal to the redemption value. The following table reflects activity in the Series C Preferred Stock:

Series C Preferred Stock
	2013	2012	2011
Balance at the beginning of the period	$4,918,000	$4,918,000	$4,918,000
Amortization of preferred stock premium	—	—	—
Balance at the end of the period	$4,918,000	$4,918,000	$4,918,000

10. NET INCOME (LOSS) PER COMMON SHARE

Information with respect to the calculation of basic and diluted net income (loss) per common share is presented below:

	Years Ended December 31,
	2013			2012			2011
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
Income (loss) from continuing operations	$	(5,477,000	)	$	(3,675,000	)	$	438,000
Less: net income attributable to noncontrolling interests	(72,000		)	(126,000		)	—
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.	(5,549,000		)	(3,801,000		)	438,000
Preferred stock dividends	(344,000		)	(344,000		)	(344,000		)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Denominator: Basic Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,774,000
Basic net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.16
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.16
Basic net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.18

F-24

	2013			2012			2011
Numerator: Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Basic weighted average common shares outstanding	5,899,000			5,821,000			5,774,000
Incremental shares from assumed exercise of options, SOSARS and Restricted Stock Units	—			—			132,000
Denominator: Diluted Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,906,000
Diluted net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.15
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.15
Diluted net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.17

The dilutive effects of the Company's stock options, SOSARs, Restricted Shares and Restricted Share Units are included in the computation of diluted income per common share during the periods they are considered dilutive.

The following table reflects the weighted average outstanding SOSARs and Options that were excluded from the computation of diluted earnings per share, as they would have been anti-dilutive:

	2013	2012	2011
SOSARs/Options Excluded	310,000	348,000	202,000

The weighted average common shares for basic and diluted earnings for common shares were the same due to the losses in 2013 and 2012.

11. INCOME TAXES

Overview

For the year ended December 31, 2013, the Company recorded a benefit for income taxes from continuing operations of $3,305,000 compared to a benefit of $2,027,000 in 2012 and a provision of $162,000 in 2011. The provision (benefit) for income taxes of continuing operations is composed of the following components:

	Year Ended December 31,
	2013			2012			2011
Current provision (benefit) :
Federal	$	(61,000	)	$	(349,000	)	$	55,000
State	23,000			13,000			171,000
	(38,000		)	(336,000		)	226,000
Deferred provision (benefit):
Federal	(3,467,000		)	(1,450,000		)	(76,000		)
State	200,000			(241,000		)	12,000
	(3,267,000		)	(1,691,000		)	(64,000		)
Provision (benefit) for income taxes of continuing operations
	$	(3,305,000	)	$	(2,027,000	)	$	162,000

A reconciliation of taxes computed at statutory income tax rates on income (loss) from continuing operations is as follows:

F-25

	Year Ended December 31,
	2013			2012			2011
Provision (benefit) for federal income taxes at statutory rates	$	(2,986,000	)	$	(1,967,000	)	$	277,000
Provision (benefit) for state income taxes, net of federal benefit	(147,000		)	(175,000		)	128,000
Resolution with tax authorities	—			—			(79,000		)
Valuation allowance changes affecting the provision for income taxes	448,000			(7,000		)	(8,000		)
Employment tax credits	(1,124,000		)	(130,000		)	(1,000,000		)
Nondeductible expenses	334,000			254,000			437,000
Stock based compensation expense	9,000			13,000			410,000
Other	161,000			(15,000		)	(3,000		)
Provision (benefit) for income taxes of continuing operations	$	(3,305,000	)	$	(2,027,000	)	$	162,000

F-26

Deferred Taxes

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets are reduced by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will realize only some portion of the deferred tax assets. The net deferred tax assets and liabilities, at the respective income tax rates, are as follows:

	December 31,
	2013			2012
Current deferred tax assets:
Credit carryforwards	$	—		$	251,000
Net operating loss and other carryforwards	643,000			352,000
Allowance for doubtful accounts	1,788,000			1,447,000
Accrued liabilities	5,126,000			4,236,000
	7,557,000			6,286,000
Less valuation allowance	(377,000		)	(242,000		)
	7,180,000			6,044,000
Current deferred tax liabilities:
Prepaid expenses	(601,000		)	(739,000		)
	$	6,579,000		$	5,305,000

	December 31,
	2013			2012
Noncurrent deferred tax assets:
Net operating loss and other carryforwards	$	3,389,000		$	1,365,000
Credit carryforwards	2,210,000			964,000
Deferred lease costs	289,000			356,000
Depreciation	(634,000		)	(2,036,000		)
Tax goodwill and intangibles	(879,000		)	(739,000		)
Stock-based compensation	882,000			1,238,000
Accrued rent	4,219,000			4,538,000
Kansas acquisition costs	125,000			—
Impairment of long-lived assets	472,000			659,000
Interest rate swap	349,000			564,000
Noncurrent self-insurance liabilities	6,422,000			6,062,000
	16,844,000			12,971,000
Less valuation allowance	(932,000		)	(619,000		)
	$	15,912,000		$	12,352,000

Deferred Tax Valuation Allowance

The assessment of the amount of value assigned to our deferred tax assets under the applicable accounting standards is highly judgmental. We are required to consider all available positive and negative evidence in evaluating the likelihood that we will be able to realize the benefit of our deferred tax assets in the future. Such evidence includes scheduled reversals of deferred tax assets and liabilities, projected future taxable income, tax-planning strategies, and the results of recent operations. Since this evaluation requires consideration of historical and future events, there is significant judgment involved, and our conclusion could be materially different should certain of our expectations not transpire.

When assessing all available evidence, we consider the weight of the evidence, both positive and negative, based on the objectivity of the underlying evidence and the extent to which it can be verified. For the three-year period ended December 31, 2013, the Company has a cumulative pre-tax loss from continuing operations of $13,884,000, of which $8,782,000 is attributable to the year ended December 31, 2013. Additionally, the Company recognized governmental and regulatory changes have put downward revenue pressure on the long-term care industry as a piece of negative evidence in our analysis. As a result of this negative evidence, the Company performed a thorough assessment of the available positive and negative evidence in order to ascertain whether it is more-likely-than-not that in future periods the Company will generate sufficient pre-tax income to utilize all of our

F-27

federal deferred tax assets and our net operating loss and other carryforwards and credits. State deferred tax assets are considered for valuation separately and on a state-by-state basis.

The Company also identified several pieces of objective positive evidence which were considered and weighed in the analysis performed regarding the valuation of deferred tax assets, including, but not limited to the degree to which nonrecurring expenses caused the last three year cumulative pre-tax loss, the expected accretive strategic acquisitions completed by us during 2012 and 2013, corporate and regional restructuring expected to reduce costs while maintaining revenue levels, our results from operations for the fourth quarter of 2013, the long-term expiration dates of a majority of the net operating losses and credits, our history of not having carryforwards or credits expire unutilized, and the completed divestiture of the facilities in Arkansas in 2013. The operations in the state of Arkansas demonstrated a trend of growing losses in recent years primarily as a result of disproportionate amount of professional liability expense relative to the revenue contributed.

In performing the analysis, the Company contemplated utilization of the deferred tax assets under multiple scenarios. After consideration of these factors, the Company determined that it was more likely than not that future taxable income would be sufficient to realize substantially all of the recorded value of the Company's deferred tax assets for federal income tax purposes.

Realization of the deferred tax assets is not assured and future events could result in a change in judgment. If future events result in a conclusion that realization is no longer more likely than not to occur, the Company would be required to establish a valuation allowance on the deferred tax assets at that time, which would result in a charge to income tax expense and a potentially material decrease in net income in the period in which the factors change our judgment.

At December 31, 2013, the Company had $15,148,000 of net operating losses, which expire at various dates beginning in 2019 and continue through 2033. The use of a portion of these loss carryforwards is limited by change in ownership provisions of the Federal tax code to a maximum of approximately $10,282,000. The Company has reduced the deferred tax asset and the corresponding valuation allowances for net operating loss deductions permanently lost as a result of the change in ownership provisions.

With respect to state deferred tax assets, the Company recorded an additional valuation allowance of approximately $448,000 in 2013, primarily related to existing deferred tax assets for the state of Arkansas that will not be utilized as a result of our exit from the state as explained in Note 4. In 2012 and 2011, the Company recorded a deferred tax benefit to reverse approximately $7,000 and $8,000, respectively, of the valuation allowance on state deferred tax assets. The changes in valuation allowance were based on the Company's assessment of the realization of certain individual tax assets. The Company has recorded a total valuation allowance of approximately $1,309,000 at December 31, 2013 to reduce the deferred tax assets by the amount management believes is more likely than not to not be realized through the turnaround of existing temporary differences, future earnings, or a combination thereof.

During 2011, the Company recorded an estimated $400,000 in employment tax credits under the Hiring Incentives to Restore Employment (HIRE) Act which provided a one-time tax credit. In addition, under the Work Opportunity Tax Credit ("WOTC") program the Company recorded $1,124,000, $130,000 and $600,000 in Work Opportunity Tax Credits during 2013, 2012 and 2011, respectively. In January 2013, the American Taxpayer Relief Act of 2012 (Act) was signed into law. The Act retroactively reinstated the federal Work Opportunity Tax Credit for qualifying costs paid during 2012. Pursuant to ASC 740-10-25-47 the effect of changes in the tax laws including retroactive changes are recognized in the period the law was enacted. As a result of the retroactive treatment, the Company claimed the WOTC on its 2012 tax return, and the benefit of the credit was recognized in the financial statements during 2013. The remaining WOTC credit carryforwards expire at various dates beginning in 2030 and continue through 2033.

Unrecognized Tax Benefits and Liabilities

The Company follows the FASB's guidance on financial statement recognition and measurement of tax positions taken, or expected to be taken, in tax returns evaluating the need to recognize or unrecognize uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2013		2012			2011
Balance at the beginning of the period	$	—	$	86,000		$	84,000
Changes in tax positions for prior years	—		(86,000		)	2,000
Balance at the end of the period	$	—	$	—		$	86,000

The Company records the liabilities associated with our unrecognized tax benefits in “other current liabilities” on the consolidated balance sheet. The net change in the amount of unrecognized tax benefits during the years ended December 31, 2012 and 2011

F-28

was related primarily to the adjustment of the estimated liability. Further, the Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statements of operations.

As of December 31, 2013, the Company has no open or pending audits underway by regulatory authorities.

12. COMMITMENTS AND CONTINGENCIES

Lease Commitments

The Company is committed under long-term operating leases with various expiration dates and varying renewal options. Minimum annual rentals, including renewal option periods (exclusive of taxes, insurance, and maintenance costs) under these leases beginning January 1, 2014, are as follows:

2014	$	26,165,000
2015	27,077,000
2016	27,825,000
2017	28,521,000
2018	29,459,000
Thereafter	467,387,000
	$	606,434,000

Under lease agreements with Omega and others, the Company's lease payments are subject to periodic annual escalations as described below and in Note 2. Total lease expense for continuing operations was $21,542,000, $19,050,000 and $18,064,000 for 2013, 2012 and 2011, respectively. The accrued liability related to straight line rent was $10,759,000 and $11,389,000 at December 31, 2013 and 2012, respectively, and is included in “Other noncurrent liabilities” on the accompanying consolidated balance sheets.

Omega Leases

General Terms

The Company leases 25 nursing centers from Omega under a Master Lease. On October 20, 2006, the Company and Omega entered into a Third Amendment to Consolidated Amended and Restated Master Lease (“Lease Amendment”) to extend the term of its facilities leased from Omega. The Lease amendment extended the term to September 30, 2018 and provided a renewal option of an additional twelve years. Consistent with prior terms, the lease provides for annual increases in lease payments equal to the lesser of two times the increase in the consumer price index or 3 percent. Under generally accepted accounting principles, the Company is required to report these scheduled rent increases on a straight line basis over the term of the lease including the 12 year term of the renewal period. These scheduled increases had no effect on cash rent payments at the start of the lease term and only result in additional cash outlay as the annual increases take effect each year.

As previously mentioned in Note 4, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. In connection with the closing of this transaction, the Company and Omega entered into the Thirteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.

The Master Lease requires the Company to fund annual capital expenditures related to the leased facilities at an amount currently equal to $427 per licensed bed. These amounts are subject to adjustment for increases in the Consumer Price Index. The Company is in compliance with the capital expenditure requirements. Total required capital expenditures during the remaining lease term and renewal options are $7,336,000. These capital expenditures are being depreciated on a straight-line basis over the shorter of the asset life or the appropriate lease term.

Upon expiration of the Master Lease or in the event of a default under the Master Lease, the Company is required to transfer all of the leasehold improvements, equipment, furniture and fixtures of the leased facilities to Omega. The assets to be transferred to Omega are being amortized on a straight-line basis over the shorter of the remaining lease term or estimated useful life, and will be fully depreciated upon the expiration of the lease. All of the equipment, inventory and other related assets of the facilities leased pursuant to the Master Lease have been pledged as security under the Master Lease. In addition, the Company has a letter of credit of $4,551,000 as a security deposit for the Company's leases with Omega, as described in Note 7.

F-29

Brentwood Terrace

In August 2009, the Company completed the construction of a 119-bed skilled nursing facility, Brentwood Terrace, located in Paris, Texas, replacing an existing 102-bed facility leased from Omega. The new facility was financed with funding from Omega and is leased from Omega under a long-term operating lease with renewal options through 2035. Annual rent was $789,000 initially, equal to 10.25% of $7,702,000, the total cost of the replacement facility, and is subject to the annual escalation provisions described above.

Texas Leased Nursing Centers

Effective August 11, 2007, the Company acquired the leases and leasehold interests of seven facilities which are leased from a subsidiary of Omega. In connection with this acquisition, the Company amended the Master Lease to include these seven facilities. The substantive terms of the lease of these centers, including payment provisions and lease period including renewal options were not changed by the amendment. The lease terms for the seven facilities provide for an initial term and renewal periods at the Company's option through May 31, 2035. The lease provides for annual increases in lease payments equal to the increase in the consumer price index, not to exceed 2.5%.

Renovation Funding

In January 2013, we entered into an amendment to the Master lease with Omega under which Omega agreed to provide an additional $5,000,000 to fund renovations to two nursing centers located in Texas that are leased from Omega. The annual base rent related to these facilities will be increased to reflect the amount of capital improvements to the respective facilities as the related expenditures are made. The increase is based on a rate of 10.25% per year of the amount financed under this amendment. This arrangement is similar to amendments entered into in previous years that provided financing totaling $20,000,000 that was used to fund renovations at fourteen nursing centers leased from Omega.

The Company completed an expansion to one of its facilities by making use of fifteen licensed beds it acquired in 2005. This expansion project was funded by Omega with the renovation funding previously described. This project increased capacity and footprint compared to the Company's previous lessor-funded facility projects which included renovations of existing facilities, but did not increase capacity. Accordingly, the costs incurred to expand the facility are recorded as a leasehold improvement asset with the amounts reimbursed by Omega for this project included as a long-term liability and amortized to rent expense over the remaining term of the lease. The capitalized leasehold improvements and lessor reimbursed costs are being amortized over the initial lease term ending in September 2018. The leasehold improvement asset and accumulated amortization are as follows:

	December 31
	2013			2012
Leasehold improvement	$	921,000		$	921,000
Accumulated Amortization	(421,000		)	(316,000		)
Net Intangible	$	500,000		$	605,000

Insurance Matters

Professional Liability and Other Liability Insurance

The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”), to replace some of the expiring commercial policies. SHC covers losses up to specified limits per occurrence. All of the Company's nursing centers in Florida, Ohio, Tennessee, and West Virginia are now covered under the captive insurance policies along with most of the nursing centers in Alabama, Kentucky, and Texas. The insurance coverage provided for these centers under the SHC policy includes coverage limits of at least $500,000 per medical incident with a sublimit per center of $1,000,000 and total annual aggregate policy limits of $5,000,000. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers. 

Reserve for Estimated Self-Insured Professional Liability Claims

Because the Company’s actual liability for existing and anticipated professional liability and general liability claims will exceed the Company’s limited insurance coverage, the Company has recorded total liabilities for reported and estimated future claims of

F-30

$27,067,000 as of December 31, 2013. This accrual includes estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of legal costs related to these claims. All losses are projected on an undiscounted basis and are presented without regard to any potential insurance recoveries. Amounts are added to the accrual for estimates of anticipated liability for claims incurred during each period, and amounts are deducted from the accrual for settlements paid on existing claims during each period.

The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this reserve. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished as of November 30. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company’s past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company’s ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company’s insurers and a third party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator’s estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company’s evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual decreases results of operations in the period and any reduction in the accrual increases results of operations during the period.

The Company’s cash expenditures for self-insured professional liability costs from continuing operations were $5,367,000, $2,682,000, and $3,811,000 for the years ended December 31, 2013, 2012 and 2011, respectively.

The Company follows the FASB Accounting Standards Update, “Presentation of Insurance Claims and Related Insurance Recoveries,” that clarifies that a health care entity should not net insurance recoveries against a related professional liability claim and that the amount of the claim liability should be determined without consideration of insurance recoveries. Accordingly, the Company has assets and equal liabilities of $440,000 at December 31, 2013 and $1,238,000 at December 31, 2012, respectively.

Although the Company adjusts its accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company’s actual liability for claims incurred in any given period is a process that takes years. As a result, the Company’s actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company’s reported earnings and financial position for the period in which the change in accrual is made.

Other Insurance

With respect to workers’ compensation insurance, substantially all of the Company’s employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. The Company is completely self-insured for workers’ compensation exposures prior to May 1997. The Company has been and remains a non-subscriber to the Texas workers’ compensation system and is, therefore, completely self-insured for employee injuries with respect to its Texas operations. From June 30, 2003 until June 30, 2007, the Company’s workers’ compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July 1, 2008 through December 31, 2013, the Company is covered by a prefunded deductible policy. Under this policy, the Company is self-insured for the first $500,000 per claim, subject to an aggregate maximum of $3,000,000. The Company funds a loss fund account with the insurer to pay for claims below the deductible. The Company accounts for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred. The liability for workers’ compensation claims is $176,000 at December 31, 2013. The Company has a non-current receivable for workers’ compensation policies covering previous years of $833,000 as of December 31, 2013. The non-current receivable is a function of payments paid to the Company’s insurance carrier in excess of the estimated level of claims expected to be incurred.

As of December 31, 2013, the Company is self-insured for health insurance benefits for certain employees and dependents for amounts up to $175,000 per individual annually. The Company provides reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate. The liability for reported claims and estimates for incurred but unreported claims is $843,000 at December 31, 2013. The differences between actual settlements and reserves are included in expense in the period finalized.

F-31

Employment Agreements

Current Employment Agreements

The Company has employment agreements with certain members of management that provide for the payment to these members of amounts up to 2.0 times their annual salary in the event of a termination without cause, a constructive discharge (as defined in each employee agreement), or upon a change in control of the Company (as defined in each employee agreement). The maximum contingent liability under these agreements is $1,260,000 as of December 31, 2013. The terms of such agreements are from 1 to 3 years and automatically renew for 1 year if not terminated by the employee or the Company. In addition, upon the occurrence of any triggering event, these certain members of management may elect to require the Company to purchase equity awards granted to them for a purchase price equal to the difference in the fair market value of the Company's common stock at the date of termination versus the stated equity award exercise price. Based on the closing price of the Company's common stock on December 31, 2013, there is no contingent liability for the repurchase of the equity grants. No amounts have been accrued for these contingent liabilities for members of management the Company currently employs.

Changes in Executive Officers

On August 13, 2012, the Company appointed James R. McKnight, Jr. as Executive Vice President and Chief Financial Officer. In connection with the appointment of Mr. McKnight, the Company entered into an employment agreement which provides for an initial base salary of $225,000.

On January 2, 2013, the Company announced the appointment of Leslie Campbell as Executive Vice President and Chief Operating Officer. In connection with the appointment of Ms. Campbell, the Company entered into an employment agreement which provides for an initial base salary of $275,000.

Health Care Industry and Legal Proceedings

The health care industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government health care program participation requirements, reimbursement for patient services, quality of resident care and Medicare and Medicaid fraud and abuse. Over the last several years, government activity has increased with respect to investigations and allegations concerning possible violations by health care providers of fraud and abuse statutes and regulations as well as laws and regulations governing quality of care issues in the skilled nursing profession in general. Violations of these laws and regulations could result in exclusion from government health care programs together with the imposition of significant fines and penalties, as well as significant repayments for patient services previously billed. Compliance with such laws and regulations is subject to ongoing government review and interpretation, as well as regulatory actions which may be unknown or unasserted at this time. The Company is involved in regulatory actions of this type from time to time.

All of the Company's nursing centers must be licensed by the state in which they are located in order to accept patients, regardless of payor source. In most states, nursing homes are subject to certificate of need laws, which require the Company to obtain government approval for the construction of new nursing homes or the addition of new licensed beds to existing homes. The Company's nursing centers must comply with detailed statutory and regulatory requirements on an ongoing basis in order to qualify for licensure, as well as for certification as a provider eligible to receive payments from the Medicare and Medicaid programs. Generally, the requirements for licensure and Medicare/Medicaid certification are similar and relate to quality and adequacy of personnel, quality of medical care, record keeping, dietary services, resident rights, and the physical condition of the facility and the adequacy of the equipment used therein. Each facility is subject to periodic inspections, known as “surveys” by health care regulators, to determine compliance with all applicable licensure and certification standards. Such requirements are both subjective and subject to change. If the survey concludes that there are deficiencies in compliance, the facility is subject to various sanctions, including but not limited to monetary fines and penalties, increased staffing requirements, suspension of new admissions, non-payment for new admissions and loss of licensure or certification. Generally, however, once a facility receives written notice of any compliance deficiencies, it may submit a written plan of correction and is given a reasonable opportunity to take mutually agreeable measures to correct the deficiencies. There can be no assurance that, in the future, the Company will be able to maintain such licenses and certifications for its facilities or that the Company will not be required to expend significant sums in order to comply with regulatory requirements. Recently, the Company has experienced an increase in the severity of survey citations and the size of monetary penalties, consistent with industry trends.

As of December 31, 2013, the Company is engaged in 54 professional liability lawsuits. Five lawsuits are currently scheduled for trial or mediation during the next year, and it is expected that additional cases will be set for trial. The ultimate results of any of the Company's professional liability claims and disputes cannot be predicted. The Company has limited, and sometimes no,

F-32

professional liability insurance with regard to most of these claims. A significant judgment entered against the Company in one or more of these legal actions could have a material adverse impact on the Company's financial position and cash flows.

On May 16, 2012, a purported stockholder class action complaint was filed in the U.S. District Court for the Middle District of Tennessee, against the Company's Board of Directors. This action alleges that the Board of Directors breached its fiduciary duties to stockholders related to its response to certain expressions of interest in a potential strategic transaction from Covington Investments, LLC (“Covington”). The complaint asserts that the Board failed to negotiate or otherwise appropriately consider Covington's proposals. In November, 2012, the lawsuit was dismissed without prejudice for lack of subject matter jurisdiction. The action was refiled in the Chancery Court for Williamson County, Tennessee (21^st Judicial District) on November 30, 2012. The lawsuit remains in its early stages and has not yet been certified by the court as a class action. We intend to defend the matter vigorously.

In June 2012, a collective action complaint was filed in the U.S. District Court for the U.S. District Court for the Western District of Arkansas against us and certain of our subsidiaries.  The complaint alleges that the defendants violated the Fair Labor Standards Act (FLSA) and seeks unpaid overtime wages as well as liquidated damages.  The Court conditionally certified a nationwide class of all of the Company's hourly employees.  The Company will defend the lawsuit vigorously.

In January 2009, a purported class action complaint was filed in the Circuit Court of Garland County, Arkansas against the Company and certain of its subsidiaries and Garland Nursing & Rehabilitation Center (the “Facility”). The complaint alleges that the defendants breached their statutory and contractual obligations to the patients of the Facility over the past five years.The lawsuit remains in its early stages and has not yet been certified by the court as a class action. The Company intends to defend the lawsuit vigorously.

We cannot currently predict with certainty the ultimate impact of any of the above cases on our financial condition, cash flows or results of operations. Our reserve for professional liability expenses does not include any amounts for the collective actions, the purported class action against the Facility or the lawsuit filed against our directors. An unfavorable outcome in any of these lawsuits or any of our professional liability actions, any regulatory action, any investigation or lawsuit alleging violations of fraud and abuse laws or of elderly abuse laws or any state or Federal False Claims Act case could subject us to fines, penalties and damages, including exclusion from the Medicare or Medicaid programs, and could have a material adverse impact on our financial condition, cash flows or results of operations.

Reimbursement

The Company is unable to predict what, if any, reform proposals or reimbursement limitations will be implemented in the future, or the effect such changes would have on its operations. For the year ended December 31, 2013, the Company derived 27.3% and 53.5% of its total patient and resident revenues related to continuing operations from the Medicare and Medicaid programs, respectively.

The Company will attempt to increase revenues from non-governmental sources to the extent capital is available to do so, if at all. However, private payors, including Managed Care payors, are increasingly demanding that providers accept discounted fees or assume all or a portion of the financial risk for the delivery of health care services. Such measures may include capitated payments, which can result in significant losses to health care providers if patients require expensive treatment not adequately covered by the capitated rate.

13. SUBSEQUENT EVENT

Effective March 1, 2014, the Company assumed operations of one skilled nursing center in Huntsville, Alabama. The 135-bed nursing center is expected to produce annual revenues of $10.5 million and annual rent expense of $1.2 million.

14. QUARTERLY FINANCIAL INFORMATION (Unaudited)

Selected quarterly financial information for each of the quarters in the years ended December 31, 2013 and 2012 is as follows:

F-33

	Quarter
2013	First			Second			Third			Fourth
Net revenues	$	63,280,000		$	66,869,000		$	70,353,000		$	81,417,000
Professional liability expense (1)	1,985,000			2,315,000			1,382,000			1,654,000
Loss from continuing operations	(990,000		)	(2,002,000		)	(2,344,000		)	(141,000		)
Income (loss) from discontinued operations	43,000			(177,000		)	(2,421,000		)	(430,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,051,000	)	$	(2,281,000	)	$	(4,868,000	)	$	(678,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2013 is set forth in the table above.

	Quarter
2012	First			Second			Third			Fourth
Net revenues	$	60,464,000		$	60,510,000		$	61,824,000		$	63,492,000
Professional liability expense (1)	1,133,000			1,122,000			1,348,000			2,499,000
Loss from continuing operations	(1,496,000		)	(807,000		)	(498,000		)	(874,000		)
Income (loss) from discontinued operations	121,000			374,000			518,000			(258,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,540,000	)	$	(534,000	)	$	(82,000	)	$	(1,234,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

F-34

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2012 is set forth in the table above.

F-35

DIVERSICARE HEALTHCARE SERVICES, INC.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

OF CONTINUING OPERATIONS

(in thousands)

Column A	Column B		Column C			Column D	Column E
			Additions			Deductions
Description	Balance at Beginning of Period	Charged to Costs and Expenses		Charged to Other Accounts	Other	(Write-offs) net of Recoveries	Balance at End of Period
Year ended December 31, 2013: Allowance for doubtful accounts	$3,143		$4,191	$—	$—	$(3,335)	$3,999
Year ended December 31, 2012: Allowance for doubtful accounts	$2,233		$3,064	$—	$—	$(2,154)	$3,143
Year ended December 31, 2011: Allowance for doubtful accounts	$2,277		$1,780	$—	$—	$(1,824)	$2,233

S-1

DIVERSICARE HEALTHCARE SERVICES, INC.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Column A	Column B	Column C			Column D	Column E
			Additions		Deductions
Description	Balance at Beginning of Period	Charged to Costs and Expenses	Charged to Other Accounts (2)	Other	Payments (1)	Balance at End of Period
Year ended December 31, 2013:
Professional Liability Reserve	$22,740	$6,530	$3,163	$—	$(5,366)	$27,067
Workers Compensation Reserve	$287	$473	$—	$(87)	$(497)	$176
Health Insurance Reserve	$679	$9,095	$105	$—	$(9,036)	$843
Year ended December 31, 2012:
Professional Liability Reserve	$19,357	$5,617	$448	$—	$(2,682)	$22,740
Workers Compensation Reserve	$309	$142	$—	$311	$(475)	$287
Health Insurance Reserve	$853	$7,207	$—	$—	$(7,381)	$679
Year ended December 31, 2011:
Professional Liability Reserve	$17,251	$3,069	$2,848	$—	$(3,811)	$19,357
Workers Compensation Reserve	$346	$1,323	$—	$(257)	$(1,103)	$309
Health Insurance Reserve	$1,003	$7,247	$—	$—	$(7,397)	$853

(1) Payments for the Professional Liability Reserve include amounts paid for claims settled during the period as well as payments made under structured arrangements for claims settled in earlier periods.

(2) As discussed in Note 4 of the Consolidated Financial Statements, the Company has presented the results of certain divestiture and lease termination transactions as discontinued operations. The amounts charged to Other Accounts represent the amounts charged to discontinued operations.

S-2

Exhibit
Number	Description of Exhibits

3.1	Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Company's Registration Statement No. 33-76150 on Form S-1).
3.2	Certificate of Designation of Registrant (incorporated by reference to Exhibit 3.5 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2006).
3.3	Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company's Registration Statement No. 33-76150 on Form S-1).
3.4	Bylaw Amendment adopted November 5, 2007 (incorporated by reference to Exhibit 3.4 to the Company's annual report on Form 10-K for the year ended December 31, 2007).
3.5	Amendment to Certificate of Incorporation dated March 23, 1995 (incorporated by reference to Exhibit A of Exhibit 1 to the Company's Form 8-A filed March 30, 1995).
3.6	Certificate of Designation of Registrant (incorporated by reference to Exhibit 3.4 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2001).
3.7	Certificate of Ownership and Merger of Diversicare Healthcare Services, Inc. with and into Advocat Inc. (incorporated by reference to Exhibit 3.1 to the Company's current report on Form 8-K filed March 14, 2013).
4.1	Form of Common Stock Certificate (incorporated by reference to Exhibit 4 to the Company's Registration Statement No. 33-76150 on Form S-1).
4.2	Amended and Restated Rights Agreement dated as of December 7, 1998 (incorporated by reference to Exhibit 1 to Form 8-A/A filed December 7, 1998).
4.3	Amendment No. 1 to the Amended and Restated Rights Agreement, dated March 19, 2005, by and between Advocat Inc. and SunTrust Bank, as Rights Agent (incorporated by reference to Exhibit 2 to Form 8-A/A filed on March 24, 2005).
4.4	Second Amendment to the Amended and Restated Rights Agreement, dated August 15, 2008, by and between Advocat Inc. and ComputerShare Trust Company, N.A., as successor to SunTrust Bank (incorporated by reference to Exhibit 3 to Form 8-A/A filed on August 18, 2008).
4.5	Third Amendment to Amended and Restated Rights Agreement, dated August 14, 2009, between Advocat Inc. and Computershare Trust Company, N.A, as successor to SunTrust Bank, (incorporated by reference to Exhibit 4 to the Company's Registration Statement on Form 8-A/A filed on August 14, 2009).
*10.1	Master Agreement and Supplemental Executive Retirement Plan (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement No. 33-76150 on Form S-1).
10.2	Form of Director Indemnification Agreement (incorporated by reference to Exhibit 10.8 to the Company's Registration Statement No. 33-76150 on Form S-1).
10.3	Advocat Inc. Guaranty in favor of Omega Healthcare Investors, Inc. dated May 10, 1994 (incorporated by reference to Exhibit 10.11 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 1994).
10.4	Settlement and Restructuring Agreement dated as of October 1, 2000 among Registrant, Diversicare Leasing Corp., Sterling Health Care Management, Inc., Diversicare Management Services Co., Advocat Finance, Inc., Omega Healthcare Investors, Inc. and Sterling Acquisition Corp. (incorporated by reference to Exhibit 10.83 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).

10.5	Consolidated Amended and Restated Master Lease dated November 8, 2000, effective October 1, 2000, between Sterling Acquisition Corp. (as Lessor) and Diversicare Leasing Corp. (as Lessee) (incorporated by reference to Exhibit 10.84 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).
10.6	Management Agreement effective October 1, 2000, between Diversicare Leasing Corp. and Diversicare Management Services Co. (incorporated by reference to Exhibit 10.85 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).
10.7	Amended and Restated Security Agreement dated as of November 8, 2000 between Diversicare Leasing Corp. and Sterling Acquisition Corp. (incorporated by reference to Exhibit 10.86 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).
10.8	Security Agreement dated as of November 8, 2000 between Sterling Health Care Management, Inc. and Sterling Acquisition Corp. (incorporated by reference to Exhibit 10.87 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).
10.9	Guaranty given as of November 8, 2000 by Registrant, Advocat Finance, Inc., and Diversicare Management Services Co., in favor of Sterling Acquisition Corp. (incorporated by reference to Exhibit 10.88 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000).
10.10	First Amendment to Consolidated Amended and Restated Master Lease dated September 30, 2001 by and between Sterling Acquisition Corp. and Diversicare Leasing Corporation (incorporated by reference to Exhibit 10.126 to the Company's Annual Report on Form 10-K for the year ended December 31, 2001).
10.11	Second Amendment to Consolidated Amended and Restated Master Lease dated as of June 15, 2005 by and between Sterling Acquisition Corp. and Diversicare Leasing Corporation (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2005).
10.12	Restructuring Stock Issuance and Subscription Agreement dated as of October 20, 2006 between Advocat Inc. and Omega Healthcare Investors, Inc. (incorporated by reference to Exhibit 10.1 to the Company's current report on Form 8-K filed October 24, 2006).
10.13	Third Amendment to Consolidated Amended and Restated Master Lease executed as of October 20, 2006, to be effective as of October 1, 2006 by and between Sterling Acquisition Corp. and Diversicare Leasing Corporation (incorporated by reference to Exhibit 10.2 to the Company's current report on Form 8-K filed October 24, 2006).
10.14	Subordinated Promissory Note in the amount of $2,533,614.53 issued to Omega HealthCare Investors Inc. dated as of October 1, 2006 (incorporated by reference to Exhibit 10.3 to the Company's current report on Form 8-K filed October 24, 2006).
10.15	Fourth Amendment to Consolidated Amended and Restated Master Lease executed and delivered as of April 1, 2007 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2007).
10.16	Fifth Amendment to Consolidated Amended and Restated Master Lease dated as of August 10, 2007 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.7 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2007).
10.17	Sixth Amendment to Consolidated Amended and Restated Master Lease dated as of March 14, 2008 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2008).
10.18	Seventh Amendment to Consolidated Amended and Restated Master Lease dated as of October 24, 2008 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2008).
*10.19	Advocat Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Appendix A to the Company's Definitive Proxy Statement on Schedule 14A filed on April 20, 2006).
*10.20	First Amendment to the Advocat Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.63 to the Company's annual report on Form 10-K for the year ended December 31, 2008).

10.21	Ninth Amendment to Consolidated Amended and Restated Master Lease dated as of May 5, 2009 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2009).
10.22	Tenth Amendment to Consolidated Amended and Restated Master Lease dated as of September 8, 2009 by and between Sterling Acquisition Corp., a Kentucky corporation, and Diversicare Leasing Corp., a Tennessee corporation (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2009).
10.23	Lease Agreement dated as of July 14, 2010 by and between Diversicare Rose Terrace, LLC, a subsidiary of the registrant, and A.B.E., LLC (incorporated by reference to Exhibit 10.4 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2010).
10.24	Eleventh Amendment to the Amended and Restated Master Lease between the Company and Sterling Acquisition Corp., an affiliate of Omega Healthcare Investors, Inc. (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2011).
10.25	Swap Agreement between the Company and The PrivateBank and Trust Company dated as of March 1, 2011 (incorporated by reference to Exhibit 10.6 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2011).
*10.26	Amended and Restated Employment Agreement effective as of April 1, 2012, by and between Advocat Inc., a Delaware corporation, and Kelly Gill (incorporated by reference to Exhibit 10.2 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2012).
*10.27	Amended and Restated Retention Bonus Agreement entered into as of March 15, 2012, by and between Advocat Inc., a Delaware corporation, and L. Glynn Riddle, Jr. (incorporated by reference to Exhibit 10.3 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2012).
*10.28	Employment Agreement effective August 20, 2012, between James R. McKnight, Jr. and Advocat Inc. (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2012).
*10.29	Employment Agreement effective January 1, 2013, between Leslie Campbell and Advocat Inc. (incorporated by reference to Exhibit 10.49 to the Company’s annual report on Form 10-K for the year ended December 31, 2012).
*10.30	Amendment No. 1 to Amended and Restated Employment Agreement effective as of March 1, 2013 by and between Advocat Inc., a Delaware corporation, and Kelly Gill (incorporated by reference to Exhibit 10.50 to the Company's annual report on Form 10-K for the year ended December 31, 2012).
10.31	Asset Purchase Agreement effective March 6, 2013 between the Company and Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. (incorporated by reference to Exhibit 10.3 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2013).
10.32	Operations Transfer Agreement effective March 6, 2013 by and between certain subsidiaries of the Company and the Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. (incorporated by reference to Exhibit 10.4 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2013).
10.33	Amended and Restated Revolving Loan and Security Agreement dated April 30, 2013 among the Company and a syndicate of financial institutions and banks, including The PrivateBank as the Administering Agent (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2013).
10.34	Amended and Restated Term Loan and Security Agreement dated April 30, 2013 among the Company and a syndicate of financial institutions and banks, including The PrivateBank as the Administering Agent (incorporated by reference to Exhibit 10.6 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2013).
10.35	Amended and Restated Guaranty (Revolver) dated as of April 30, 2013, by the Company to and for the benefit of The PrivateBank in its capacity as administrative agent (incorporated by reference to Exhibit 10.7 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2013).

10.36		Amended and Restated Guaranty (Term Loan) dated as of April 30, 2013, by the Company to and for the benefit of The PrivateBank in its capacity as administrative agent (incorporated by reference to Exhibit 10.8 to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2013).
10.37		Thirteenth Amendment to Consolidated Amended and Restated Master Lease effective September 1, 2013 by and between Sterling Acquisition Corp. and Diversicare Leasing Corp. (incorporated by reference to Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2013).
**10.38		First Amendment and Consent to Amended and Restated Revolving Loan and Security Agreement dated as of November 1, 2013 among the Company and a syndicate of financial institutions and banks, including The PrivateBank as the Administering Agent.
21		Subsidiaries of the Registrant.
23.1		Consent of BDO USA.
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
32		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b).
	*	Indicates management contract or compensatory plan or arrangement.
	**	Confidential treatment has been requested for portions of this exhibit

EX-10.38

FIRST AMENDMENT AND CONSENT TO

AMENDED AND RESTATED REVOLVING LOAN AND SECURITY AGREEMENT

THIS FIRST AMENDMENT AND CONSENT TO AMENDED AND RESTATED REVOLVING LOAN AND SECURITY AGREEMENT (this “Amendment”) dated as of November 1, 2013 is by and among THE PRIVATEBANK AND TRUST COMPANY, an Illinois banking corporation (together with its successors and assigns, “Administrative Agent”) in its capacity as administrative agent for the Lenders (as defined below), the Lenders, DIVERSICARE MANAGEMENT SERVICES CO., a Tennessee corporation, and certain of its affiliates parties hereto identified on the signature pages as “Original Borrower” (individually and collectively, “Original Borrower”), and DIVERSICARE LEASING COMPANY II, LLC, a Delaware limited liability company(“DLC II”), DIVERSICARE OF SENECA PLACE, LLC, a Delaware limited liability company (“Seneca”), DIVERSICARE OF BRADFORD PLACE, LLC, DIVERSICARE OF PROVIDENCE, LLC, DIVERSICARE OF SIENA WOODS, LLC and DIVERSICARE OF ST. THERESA, LLC, each a Delaware limited liability company (individually and collectively, “CHP Entities”), and together with DLC II and Seneca, individually and collectively, “New Borrower”). New Borrower and Original Borrower are hereinafter referred to individually and collectively as, “Borrower”.

RECITALS:

WHEREAS, Original Borrower, Administrative Agent, and the financial institutions signatories thereto (the “Lenders”) are parties to that certain Amended and Restated Revolving Loan and Security Agreement dated as of April 30, 2013 (as amended or modified from time to time, the “Loan Agreement”); all capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Loan Agreement; and

WHEREAS, Borrower, Administrative Agent and Lenders desire to amend the Loan Agreement as provided in and subject to the terms and conditions of this Amendment.

NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto (intending to be legally bound) hereby agree as follows:

1.Consent. Subject to the satisfaction of the conditions set forth in Section 6 below and in reliance upon the representations and warranties set forth in Section 5 below, Administrative Agent and the Lenders (as the Required Lenders pursuant to the Loan Agreement) hereby consent to the formation by DLC II of Seneca and the CHP Entities, each a wholly-owned subsidiary of DLC II, for the purpose of entering into the Aviv Twinbrook Lease Documents to lease and operate the

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

Twinbrook Facility and the CHP Lease Documents to lease and operate the CHP Facilities, respectively (each as hereinafter defined).

2.Joinder and Assumption. From and after the date hereof, New Borrower hereby absolutely and unconditionally (i) joins as and becomes a party to the Loan Agreement as a Borrower thereunder and to each Financing Agreement to which Original Borrower is a party, (ii) assumes, as a joint and several obligor thereunder, all of the obligations, liabilities and indemnities of a Borrower under the Loan Agreement and all other Financing Agreements, (iii) covenants and agrees to be bound by and adhere to all of the terms, covenants, waivers, releases, agreements and conditions of or respecting a Borrower with respect to the Loan Agreement and the other Financing Agreements and all of the representations and warranties contained in the Loan Agreement and the other Financing Agreements with respect to New Borrower, and (iv) collaterally assigns and transfers to Administrative Agent (for the benefit of Lenders and itself) and hereby grants to Administrative Agent (for the benefit of Lenders and itself) a continuing first-priority security interest in all of New Borrower’s now owned and existing and hereafter acquired and arising Collateral, as collateral security for the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of all of the Liabilities, subject to the Aviv Twinbrook Intercreditor Agreement and the Aviv CHP Intercreditor Agreement. New Borrower hereby authorizes Administrative Agent to file at any time uniform commercial code financing statements in such jurisdictions and offices as Administrative Agent deems necessary in connection with the perfection of a security interest in all of New Borrower’s now owned or hereafter arising or acquired Collateral, including, without limitation, Accounts and Deposit Accounts of New Borrower, and all proceeds and products thereof. From and after the date hereof, any reference to the term “Borrower” in the Loan Agreement and the Financing Agreements shall also include New Borrower.

3.Supplementation of Certain Disclosure Schedules. In connection with the joinder of New Borrower to the Loan Agreement, Schedule 1 (Borrowers), Schedule 1.1(a) (Facilities), Schedule 7.8 (Names), Schedule 7.12 (Organizational Chart), Schedule 7.33 (Capitalization) and Schedule 7.36 (Commercial Leases) of the Loan Agreement shall be supplemented from and after the date of this Amendment as set forth on the applicable and respective schedules attached hereto and made a part hereof so that such schedules shall reflect the matters intended to be shown thereon as of the date of this Amendment.

4.Amendments to Loan Agreement. Subject to the terms and conditions contained herein, Borrower, Administrative Agent and Lenders hereby amend the Loan Agreement as follows:

(a)The following definitions shall be inserted in correct alphabetical order into Section 1.1 of the Loan Agreement:

(i)“Aviv CHP” means Ohio Indiana Property, L.L.C., a Delaware limited liability company.

(ii)“Aviv CHP Intercreditor Agreement” means the Subordination and Intercreditor Agreement dated as of November 1, 2013 by Aviv CHP, the Lessors and owners of the real estate on which the CHP Facilities operate, in favor of Administrative Agent, as amended or modified from time to time.

(iii)“Aviv CHP Lease Documents” means, collectively, the Lease dated as of September 27, 2013 between Aviv CHP and the CHP Entities, and the security agreements, documents, instruments and agreements executed in connection therewith, in each case as the same may be amended or modified in conformity with Section 9.16 of the Loan Agreement.

(iv)“Aviv Twinbrook” means Louisville Dutchmans Property, L.L.C., a Delaware limited liability company.

(v)“Aviv Twinbrook Intercreditor Agreement” means the Subordination and Intercreditor Agreement dated as of November 1, 2013 by Aviv Twinbrook, the Lessor and owner of the real estate on which the Twinbrook Facility operates, in favor of Administrative Agent, as amended or modified from time to time.

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

(vi)“Aviv Twinbrook Lease Documents” means, collectively, the Lease dated as of July 31, 2013 between Aviv Twinbrook and Seneca, and the security agreements, documents, instruments and agreements executed in connection therewith, in each case as the same may be amended or modified in conformity with Section 9.16 of the Loan Agreement.

(vii)“CHP Facilities” means, collectively, the nursing home and assisted living facilities located in Ohio and Indiana listed on Exhibit A attached hereto.

(viii)“Twinbrook Facility” means Diversicare of Seneca Place, a nursing home facility located at 3526 Dutchman’s Lane, Louisville, Kentucky.

(b)The definition of “Financing Agreements” in Section 1.1 of the Loan Agreement shall hereafter be deemed to also include this Amendment, the Aviv CHP Intercreditor Agreement, the Aviv Twinbrook Intercreditor Agreement and each of the documents identified in Sections 7(c), (d), (e), and (n) below;

(c)The definition of “EBITDAR” in Section 1.1 of the Loan Agreement is hereby amended and restated in its entirety as follows:

“EBITDAR” means with respect to the Borrower, for any period of determination, the sum of the net earnings of the consolidated Borrower before nonrecurring items (in accordance with GAAP and as reasonably agreed to by the Administrative Agent), interest, taxes, depreciation, amortization and rent, plus up to an amount of One Million Six Hundred Thousand Dollars ($1,600,000), as applicable, in the aggregate, through December 31, 2013, for costs actually incurred in connection with Borrower terminating its real estate leases with respect to all of the skilled nursing facilities located in the State of Arkansas formally operated by certain of the Borrowers, plus up to an amount of ** -REDACTED- in the aggregate per Fiscal Quarter through June 30, 2014 of professional liability payments, all as determined in accordance with GAAP, consistently applied.

(d)The definition of “Fixed Charges” in Section 1.1 of the Loan Agreement is hereby amended and restated in its entirety as follows:

“Fixed Charges” means, for any period of determination, the sum of, without duplication: (a) regularly scheduled payments of principal with respect to all Indebtedness for borrowed money; plus (b) cash interest expense of Borrower for its Indebtedness that has been paid during such period (including, without limitation, interest attributable to issued and outstanding Letters of Credit); plus (c) Net Capital Expenditures; plus (d) cash rent expense that has been paid during such period; plus (e) dividends on stock; plus (f) the Required Dividends and Redemption Amounts (except for amounts paid to redeem the Series C Preferred Stock pursuant to the Restructuring Stock Issuance and Subscription Agreement, which amounts shall be excluded from the calculation of Fixed Charges), plus (g) cash paid income taxes of Borrower during such period, plus (h) for the period from July 1, 2013 through and including December 31, 2013 up to an amount of Eight Hundred Thousand Dollars ($800,000) of Capital Expenditures relating to the Facilities of New Borrower for upgrades to their electronic medical records systems, all of the foregoing as determined in accordance with GAAP, consistently applied.

(e)The definition of “Intercreditor Agreements” in Section 1.1 of the Loan Agreement is hereby amended and restated in its entirety as follows:

“Intercreditor Agreements” means (i) that certain Subordination and Intercreditor Agreement dated as of the Original Closing Date, as amended by that certain First Amendment to Subordination and Intercreditor Agreement dated as of February 28, 2011, each by and among certain of the Borrowers, Administrative Agent and Sterling Acquisition, as amended and restated by that certain Amended and Restated Subordination and Intercreditor Agreement dated as of even date herewith, by and among the Borrower, Administrative Agent and Sterling Acquisition (the “Omega Intercreditor Agreement”), (ii) that certain Subordination and Intercreditor Agreement by and among the Aviv

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

Lessor, Diversicare Highlands, LLC, and Administrative Agent dated as of September 24, 2012 (the “Aviv Intercreditor Agreement”), (iii) the Aviv CHP Intercreditor Agreement, and (iv) the Aviv Twinbrook Intercreditor Agreement, as the same may be modified, supplemented or amended from time to time.

(f)The definition of “Restricted Agreements” in Section 1.1 of the Loan Agreement shall hereafter be deemed to also include the Aviv CHP Lease Documents and the Aviv Twinbrook Lease Documents.

(g)Section 9.1 of the Loan Agreement shall be amended by inserting the following at the end thereof: “ , and (xi) Liens in favor of Aviv CHP in accordance with the Aviv CHP Lease Documents and Aviv Twinbrook in accordance with the Aviv Twinbrook Lease Documents, subject in all cases to the provisions of the Aviv CHP Intercreditor Agreement and the Aviv Twinbrook Intercreditor Agreement, respectively.

(h)Section 9.10(a) of the Loan Agreement is hereby amended and restated in its entirety as follows:

“Borrower shall not make any payment, directly or indirectly, to the Aviv Lessor, Aviv CHP, Aviv Twinbrook, Omega (or any Affiliate or Subsidiary thereof) in contravention of any of the Intercreditor Agreements.”

5.No Other Amendments. Borrower acknowledges and expressly agrees that this Amendment is limited to the extent expressly set forth herein and shall not constitute a modification or amendment of the Loan Agreement or any other Financing Agreements or a course of dealing at variance with the terms or conditions of the Loan Agreement or any other Financing Agreements (other than as expressly set forth in this Amendment, the First Note Modification, the First Pledge Amendment (each as defined below) and the signed Reaffirmation attached hereto).

6.Representations and Warranties. Borrower hereby represents and warrants to and in favor of Administrative Agent and Lenders, which representations and warranties shall survive the execution and delivery hereof, as follows:

(a)Each of the representations and warranties of each Borrower (including Original Borrower and New Borrower) contained in the Loan Agreement and the other Financing Agreements to which Borrower is a party are true and correct in all material respects (without duplication of any materiality carve out already provided therein) on and as of the date hereof, in each case as if made on and as of such date, other than representations and warranties that expressly relate solely to an earlier date (in which case such representations and warranties were true and correct on and as of such earlier date); the principal place of business and chief executive office for New Borrower is as set forth on Schedule 1 (as revised pursuant to Section 3 hereof);

(b)New Borrower has the limited liability company power and authority (i) to enter into the Loan Agreement as amended by this Amendment and (ii) to do all acts and things as are required or contemplated hereunder to be done, observed and performed by New Borrower;

(c)This Amendment has been duly authorized, validly executed and delivered by one or more Duly Authorized Officers of Borrower, and each of this Amendment, the Loan Agreement as amended hereby, and each of the other Financing Agreements to which Borrower is a party, constitutes the legal, valid and binding obligations of Borrower, enforceable against Borrower in accordance with their respective terms, subject to bankruptcy, insolvency or other similar laws affecting the enforcement of creditor’s rights and remedies generally;

(d)The execution and delivery of this Amendment and performance by Borrower under this Amendment, the Loan Agreement and each of the other Financing Agreements to which Borrower is a party do not and will not require the consent or approval of any regulatory authority or governmental authority or agency having jurisdiction over Borrower that has not already been obtained, nor be in contravention of

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

or in conflict with the organizational documents of Borrower, or any provision of any statute, judgment, order, indenture, instrument, agreement, or undertaking, to which Borrower is party or by which Borrower’s respective assets or properties are bound; and

(e)No Default or Event of Default will result after giving effect to this Amendment, and no event has occurred that has had or could reasonably be expected to have a Material Adverse Effect after giving effect to this Amendment.

7.Conditions Precedent to Effectiveness of this Amendment. The consent set forth in Section 1 hereof and the amendments contained in Section 4 of this Amendment shall become effective on the date hereof as long as each of the following conditions precedent is satisfied as determined by Administrative Agent:

(a)all of the representations and warranties of Borrower under Section 6 hereof, which are made as of the date hereof, are true and correct;

(b)receipt by Administrative Agent of duly executed signature pages to this Amendment from Borrower;

(c)receipt by Administrative Agent of duly executed signature pages to (collectively, the “First Note Modifications”) the First Modifications to Amended and Restated Revolving Credit Notes dated as of the date hereof from Borrower (to, respectively, PrivateBank and Bankers Trust Company) and to the First Modifications to Revolving Credit Notes dated as of the date hereof from Borrower (to, respectively, Bank of Oklahoma and CIT Finance LLC);

(d)receipt by Administrative Agent of a duly executed signature page to the Reaffirmation of Amended and Restated Guaranty from Guarantor, as provided in the attachment hereto (“Guaranty Reaffirmation”);

(e)receipt by Administrative Agent of duly executed signature pages to (i) the First Amendment to Amended and Restated Pledge Agreement dated as of the date hereof, among Advocat Finance, Inc., DLC II, Borrower Agent and Administrative Agent (the “First Pledge Amendment”), and (ii) the Pledge Agreement dated as of the date hereof, among DLC II, New Borrower, Borrower Agent and Administrative Agent (the “Pledge Agreement”);

(f)receipt by Administrative Agent of copies of resolutions of the governing body of New Borrower authorizing the execution, delivery and performance by New Borrower of the Loan Agreement, as amended by this Amendment, and each of the other instruments, agreements and documents entered into in connection with this Amendment to which New Borrower is a party (including with respect to the security interest and equity pledge provided in favor of Administrative Agent), certified by a Duly Authorized Officer of New Borrower;

(g)receipt by Administrative Agent of copies of resolutions of the governing body of Original Borrower authorizing the execution, delivery and performance by Original Borrower of this Amendment and each of the other instruments, agreements and documents entered into in connection with this Amendment to which Original Borrower is a party, certified by a Duly Authorized Officer of Original Borrower;

(h)receipt by Administrative Agent of UCC tax, lien, pending suit, bankruptcy and judgment searches against New Borrower (and each of its trade names and assumed names), as of a recent date, the results of which must be in form and substance acceptable to Administrative Agent;

(i)receipt by Administrative Agent of good standing certificates for New Borrower from the Delaware Secretary of State and certificates of authorization for New Borrower from the Secretary of State of the States of Indiana, Kentucky and Ohio, respectively (as of a recent date);

(j)receipt by Administrative Agent of an opinion of Harwell Howard Hyne Gabbert & Manner, the legal counsel to Borrower and Guarantor, in form and substance reasonably satisfactory to Administrative Agent;

(k)receipt by Administrative Agent of a certified copy of New Borrower’s certificate of formation, certified by the Delaware Secretary of State (as of a recent date);

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

(l)receipt by Administrative Agent of a true, correct and complete copy of the operating agreement of New Borrower, certified by a Duly Authorized Officer of New Borrower;

(m)UCC Financing Statements, as requested by Administrative Agent, naming New Borrower as debtor and Administrative Agent as secured party with respect to the Collateral, together with such UCC termination statements necessary to release all Liens (other than Permitted Liens) in any of the Collateral except Administrative Agent, and other documents as Administrative Agent deems necessary or appropriate, shall have been filed in all jurisdictions that Administrative Agent deems necessary or advisable;

(n)receipt of a First Amendment to the Blocked Account Agreement, in form and substance reasonably acceptable to Administrative Agent;

(o)receipt of certificates from Borrower’s insurance carriers evidencing Administrative Agent as additional insured with respect to New Borrower’s general liability insurance;

(p)receipt by Administrative Agent of a true, correct and complete copy of the Management Agreements of New Borrower, certified by a Duly Authorized Officer of New Borrower;

(q)receipt by Administrative Agent of a true, correct and complete copy of the Aviv CHP Lease Documents and the Aviv Twinbrook Lease Documents, certified by a Duly Authorized Officer of New Borrower;

(r)receipt by Administrative Agent of the duly executed and delivered Aviv CHP Intercreditor Agreement and the Aviv Twinbrook Intercreditor Agreement;

(s)receipt by Administrative Agent of duly signed and completed Perfection Certificates with respect to New Borrower;

(t)UCC Financing Statements, as requested by Administrative Agent, naming DLC II as debtor and Administrative Agent as secured party with respect to the equity of New Borrower pledged pursuant to the Pledge Agreement, and a UCC Financing Statement (or UCC Amendment Statement), as requested by Administrative Agent, naming Advocat Finance, Inc. as debtor and Administrative Agent as secured party with respect to the equity of DLC II pledged pursuant to the First Pledge Amendment, shall have been filed in all jurisdictions that Administrative Agent deems necessary or advisable;

(u)receipt by Administrative Agent of copies of resolutions of the governing body of Advocat Finance, Inc. authorizing the execution, delivery and performance by Advocat Finance, Inc. of the First Pledge Amendment, certified by a Duly Authorized Officer of Advocat Finance, Inc.;

(v)receipt by Administrative Agent of copies of resolutions of the governing body of Guarantor authorizing the execution, delivery and performance by Guarantor of the Guaranty Reaffirmation, certified by a Duly Authorized Officer of Guarantor;

(w)receipt by Administrative Agent of copies of the supplemented Schedule 1 (Borrowers), Schedule 1.1(a) (Facilities), Schedule 7.8 (Names), Schedule 7.12 (Organizational Chart), Schedule 7.33 (Capitalization) and Schedule 7.36 (Commercial Leases) of the Loan Agreement;

(x)receipt by Administrative Agent of a First Amendment to the Term Loan Agreement dated of even date herewith by and among the Affiliated Term Borrowers, the Lenders and the Administrative Agent, and the Reaffirmation and Consent thereto from Guarantor as provided in the attachment thereto;

(y)receipt of any applicable Letter of Credit Document (including an amendment to the Master Letter of Credit Agreement or an entirely new Master Letter of Credit Agreement) as Administrative Agent may require in connection with this Amendment;

(z)receipt of a fully completed Borrowing Base Certificate, signed on behalf of Borrower by a Duly Authorized Officer; and

(aa)receipt by Administrative Agent of such other certificates, schedules, exhibits, documents, opinions, instruments, reaffirmations, amendments or consents Administrative Agent may reasonably require, if any.

8.Reaffirmation; References to Loan Agreement; Etc.

(a)Borrower acknowledges and agrees that all of Borrower’s obligations and Liabilities under the Loan Agreement and the other Financing Agreements, as amended hereby, are and shall be valid

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

and enforceable and shall not be impaired or limited by the execution or effectiveness of this Amendment. The first priority perfected security interests and Liens and rights in the Collateral securing payment of the Liabilities are hereby ratified and confirmed by Borrower in all respects.

(b)Upon the effectiveness of this Amendment, each reference in the Loan Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import shall mean and be a reference to the Loan Agreement, as amended by this Amendment.

(c)The failure by Administrative Agent, at any time or times hereafter, to require strict performance by any Borrower of any provision or term of the Loan Agreement, this Amendment or any of the Financing Agreements shall not waive, affect or diminish any right of Administrative Agent hereafter to demand strict compliance and performance herewith or therewith. Any suspension or waiver by Administrative Agent of a breach of this Amendment or any Event of Default under or pursuant to the Loan Agreement shall not, except as expressly set forth in a writing signed by Administrative Agent, suspend, waive or affect any other breach of this Amendment or any Event of Default under or pursuant to the Loan Agreement, whether the same is prior or subsequent thereto and whether of the same or of a different kind or character. None of the undertakings, agreements, warranties, covenants and representations of any Borrower contained in this Amendment, shall be deemed to have been suspended or waived by Administrative Agent unless such suspension or waiver is (i) in writing and signed by Administrative Agent (and, if applicable, the Required Lenders) and (ii) delivered to Borrower by Administrative Agent or its counsel.

(d)In no event shall Administrative Agent’s execution and delivery of this Amendment establish a course of dealing among Administrative Agent, any Borrower, pledgor or Guarantor or any other obligor, or in any other way obligate Administrative Agent to hereafter provide any amendments or modifications or, if at any time applicable, consents or waivers with respect to the Loan Agreement or any other Financing Agreement. The terms and provisions of this Amendment shall be limited precisely as written and shall not be deemed (x) to be a consent to any amendment or modification of any other term or condition of the Loan Agreement or of any of the Financing Agreements (except as expressly provided herein or in the other documents entered into in connection herewith, including the First Note Modifications, the First Pledge Amendment, the Pledge Agreement and the Guaranty Reaffirmation); or (y) to prejudice any right or remedy which Administrative Agent may now have under or in connection with the Loan Agreement or any of the other Financing Agreements. In the event an ambiguity or question of intent or interpretation arises, this Amendment shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Amendment.

(e)Except as expressly provided herein (or in the other documents entered into in connection herewith, including the First Note Modifications, the First Pledge Amendment, the Pledge Agreement and the Guaranty Reaffirmation), the Loan Agreement and all of the other Financing Agreements shall remain unaltered, and the Loan Agreement and all of the other Financing Agreements shall remain in full force and effect and are hereby ratified and confirmed in all respects.

(f)Borrower shall deliver to Administrative Agent when available a true, correct and complete copy of the applicable nursing home licenses and assisted living facility licenses, as applicable, for New Borrower.

9.Release.

(a)In consideration of, among other things, the consent and amendments provided for herein, and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, Borrower (on behalf of themselves and their respective subsidiaries, Affiliates, successors and assigns), and, to the extent permitted by applicable law and the same is claimed by right of, through or under the above, for their past, present and future employees, directors, members, managers, partners, agents, representatives, officers, directors, and equity holders (all collectively, with Borrower, the “Releasing Parties”), do hereby unconditionally, irrevocably, fully, and forever remise, satisfy, acquit, release and discharge Administrative Agent, Issuing Lender, and Lenders and each of Administrative Agent’s, Issuing

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

Lender’s and Lender’s past, present and future officers, directors, agents, employees, attorneys, parent, shareholders, successors, assigns, subsidiaries and Affiliates and all other persons and entities to whom Administrative Agent or Lenders would be liable if such persons or entities were found in any way to be liable to any of the Releasing Parties (collectively, the “Lender Parties”), of and from any and all manner of action and actions, cause and causes of action, claims, cross-claims, charges, demands, counterclaims, suits, proceedings, disputes, debts, dues, sums of money, accounts, bonds, covenants, contracts, controversies, damages, judgments, liabilities, damages, costs, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys’ fees, or any other compensation, recovery or relief on account of any liability, obligation, demand, proceedings or cause of action of whatever nature, whether in law, equity or otherwise (including, without limitation, those arising under 11 U.S.C. §§ 541-550 and interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses, and incidental, consequential and punitive damages payable to third parties), whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may have heretofore accrued against any or all of Lender Parties, whether held in a personal or representative capacity, that the Releasing Parties (or any of them) have or may have against the Lender Parties or any of them (whether directly or indirectly) and which are based on any act, fact, event, action or omission or any other matter, condition, cause or thing occurring at or from any time prior to and including the date hereof in any way, directly or indirectly arising out of, connected with or relating to this Amendment, the Loan Agreement or any other Financing Agreement and the transactions contemplated hereby and thereby, the Collateral or the Liabilities, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing, other than any applicable good faith claim as to which a final determination is made in a judicial proceeding (in which Administrative Agent and any of the Released Parties have had an opportunity to be heard) which determination includes a specific finding that Administrative Agent acted in a grossly negligent manner or with actual willful misconduct or illegal activity. Borrower acknowledges that Administrative Agent and Lenders are specifically relying upon the representations, warranties and agreements contained herein and that such representations, warranties and agreements constitute a material inducement to Administrative Agent and Lenders in entering into this Amendment.

(b)Borrower understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.

(c)To the furthest extent permitted by law, Borrower hereby knowingly, voluntarily, intentionally and expressly waives and relinquishes any and all rights and benefits that it respectively may have as against Lender Parties under any law, rule or regulation of any jurisdiction that would or could have the effect of limiting the extent to which a general release extends to claims which a Lender Party or Releasing Party does not know or suspect to exist as of the date hereof. Borrower hereby acknowledges that the waiver set forth in the prior sentence was separately bargained for and that such waiver is an essential term and condition of this Amendment (and without which the consent in Section 1 and the amendments in Section 4 hereof would not have been agreed to by Administrative Agent and Lenders).

10.Costs and Expenses. Without limiting the obligation of Borrower to reimburse Administrative Agent for all costs, fees, disbursements and expenses incurred by Administrative Agent as specified in the Loan Agreement, Borrower agrees to and shall pay on demand all reasonable costs, fees, disbursements and expenses of Administrative Agent in connection with the preparation, negotiation, revision, execution and delivery of this Amendment and the other agreements, amendments, modifications, reaffirmations, instruments and documents contemplated hereby, including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses.

11.Financing Agreement. This Amendment shall constitute a Financing Agreement.

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

12.Titles. Titles and section headings herein shall be without substantive meaning and are provided solely for the convenience of the parties.

13.Severability; Etc. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Amendment shall be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Amendment. The parties hereto have participated jointly in the negotiation and drafting of this Amendment. In the event an ambiguity or question of intent or interpretation arises, this Amendment shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Amendment.

14.Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided, however, no Borrower may assign any of its respective rights or obligations under this Amendment without the prior written consent of Administrative Agent.

15.Further Assurances. Borrower shall, at its own cost and expense, cause to be promptly and duly taken, executed, acknowledged and delivered all such further acts, certificates, instruments, reaffirmations, amendments, documents and assurances as may from time to time be necessary or as Administrative Agent may from time to time reasonably request in order to more fully carry out the intent and purposes of this Amendment and the other documents entered into in connection herewith, including, without limitation, the First Note Modifications, the First Pledge Amendment, the Pledge Agreement and the Guaranty Reaffirmation.

16.Counterparts; Faxes. This Amendment may be executed in multiple counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.

17.Governing Law. This Amendment shall be governed by and construed and enforced in accordance with the internal laws of the State of Illinois, without regard to conflict of law principles.

[Signature Page Follows]

First Amendment and Consent to Amended and Restated Revolving Loan and Security Agreement

First Amendment and Consent to Amended and Restated Revolving Loan and Security Agreement

IN WITNESS WHEREOF, the parties hereto have duly executed this First Amendment and Consent to Amended and Restated Revolving Loan and Security Agreement as of the day and year first above written.

ORIGINAL BORROWER:

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

BORROWER: Diversicare Management Services Co. ADVOCAT ANCILLARY SERVICES, INC. ADVOCAT FINANCE, INC. DIVERSICARE MANAGEMENT SERVICES CO. ADVOCAT DISTRIBUTION SERVICES, INC. DIVERSICARE ASSISTED LIVING SERVICES, INC. DIVERSICARE ASSISTED LIVING SERVICES NC, LLC DIVERSICARE LEASING CORP. STERLING HEALTH CARE MANAGEMENT, INC.
By:	/s/James R. McKnight, Jr.
Name:		James R. McKnight, Jr.
Its:		Executive Vice President & Chief Financial Officer

SENIOR CARE CEDAR HILLS, LLC SENIOR CARE GOLFCREST, LLC SENIOR CARE GOLFVIEW, LLC SENIOR CARE SOUTHERN PINES, LLC
BY:	SENIOR CARE FLORIDA LEASING, LLC, its sole member
BY:		DIVERSICARE LEASING CORP., its sole member
By:		/s/James R. McKnight, Jr.
	Name:		James R. McKnight, Jr.
	Its:		Executive Vice President & Chief Financial Officer

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

SENIOR CARE FLORIDA LEASING, LLC DIVERSICARE AFTON OAKS, LLC DIVERSICARE BRIARCLIFF, LLC DIVERSICARE CHISOLM, LLC DIVERSICARE HARTFORD, LLC DIVERSICARE HILLCREST, LLC DIVERSICARE LAMPASAS, LLC DIVERSICARE PINEDALE, LLC DIVERSICARE WINDSOR HOUSE, LLC DIVERSICARE YORKTOWN, LLC DIVERSICARE ROSE TERRACE, LLC DIVERSICARE THERAPY SERVICES, LLC DIVERSICARE HIGHLANDS, LLC
BY:	DIVERSICARE LEASING CORP., its sole member
	By:	/s/James R. McKnight, Jr.
	Name:		James R. McKnight, Jr.
	Its:		Executive Vice President & Chief Financial Officer
DIVERSICARE ASSISTED LIVING SERVICES NC I, LLC DIVERSICARE ASSISTED LIVING SERVICES NC II, LLC
BY:	DIVERSICARE ASSISTED LIVING SERVICES NC, LLC, its sole member
	By:	/s/James R. McKnight, Jr.
	Name:		James R. McKnight, Jr.
	Its:		Executive Vice President & Chief Financial Officer
DIVERSICARE BALLINGER, LLC DIVERSICARE DOCTORS, LLC DIVERSICARE ESTATES, LLC DIVERSICARE HUMBLE, LLC DIVERSICARE KATY, LLC DIVERSICARE NORMANDY TERRACE, LLC DIVERSICARE TREEMONT, LLC DIVERSICARE PARIS, LLC
BY:	DIVERSICARE TEXAS I, LLC, its sole member
	By:	/s/James R. McKnight, Jr.
	Name:		James R. McKnight, Jr.
	Its:		Executive Vice President & Chief Financial Officer

Diversicare Texas I, LLC
By:	/s/James R. McKnight, Jr.
Name:		James R. McKnight, Jr.
Its:		Executive Vice President & Chief Financial Officer

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

DIVERSICARE OF CHANUTE, LLC DIVERSICARE OF COUNCIL GROVE, LLC DIVERSICARE OF HAYSVILLE, LLC DIVERSICARE OF SEDGWICK, LLC DIVERSICARE OF LARNED, LLC
BY:	Diversicare Kansas, LLC its sole member
	By:	/s/James R. McKnight, Jr.
	Name:		James R. McKnight, Jr.
	Its:		Executive Vice President & Chief Financial Officer

DIVERSICARE HOLDING COMPANY, LLC

By:/s/James R. McKnight, Jr.

Name:	James R. McKnight, Jr.
Its:	Executive Vice President & Chief Financial Officer

DIVERSICARE KANSAS, LLC

By:/s/James R. McKnight, Jr.

Name:	James R. McKnight, Jr.
Its:	Executive Vice President & Chief Financial Officer

NEW BORROWER:

DIVERSICARE LEASING COMPANY II, LLC

By:/s/James R. McKnight, Jr.

Name: James R. McKnight, Jr.

Its: Executive Vice President and

Chief Financial Officer

DIVERSICARE OF SENECA PLACE, LLC

DIVERSICARE OF BRADFORD PLACE, LLC

DIVERSICARE OF PROVIDENCE, LLC

DIVERSICARE OF SIENA WOODS, LLC

DIVERSICARE OF ST. THERESA, LLC

By: Diversicare Leasing Company II, LLC, its sole member

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

By:/s/James R. McKnight, Jr.

Name:	James R. McKnight, Jr.
Its:	Executive Vice President & Chief Financial Officer

Acknowledged and Agreed: DIVERSICARE HEALTHCARE SERVICES, INC. (f/k/a ADVOCAT INC.)
/s/Kelly J. Gill
Name:	Kelly J. Gill
Its:	President and Chief Executive Officer

ADMINISTRATIVE AGENT:

THE PRIVATEBANK AND TRUST COMPANY, in its capacity as administrative agent

By:/s/Adam D. Panos

Name: Adam D. Panos

Its: Managing Director

LENDER:

THE PRIVATEBANK AND TRUST COMPANY

By:/s/Adam D. Panos

Name: Adam D. Panos

Its: Managing Director

LENDER: BANKERS TRUST COMPANY
By: /s/Jon M. Doll
Name:	Jon M. Doll
Its:	Vice President

LENDER: BOKF, NA D/B/A BANK OF OKLAHOMA
By: /s/Ryan Kirk
Name:	Ryan Kirk
Its:	Vice President

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

LENDER: CIT FINANCE LLC
By: /s/Barbara Perich
Name:	Barbara Perich
Its:	Director

REAFFIRMATION OF AMENDED AND RESTATED GUARANTY

The undersigned (“Guarantor”) hereby (i) confirms and agrees with The PrivateBank and Trust Company, an Illinois banking corporation in its capacity as administrative agent (together with its successors and assigns, “Administrative Agent”) that Guarantor’s Amended and Restated Guaranty dated as of April 30, 2013 made in favor of Administrative Agent (as amended or modified, “Guaranty”), remains in full force and effect and is hereby ratified and confirmed in all respects, including with regard to the Amended and Restated Revolving Loan and Security Agreement dated as of April 30, 2013 as amended by the foregoing First Amendment and Consent to Amended and Restated Revolving Loan and Security Agreement (“Amendment”), and each reference to the term “Borrower” in the Guaranty shall also include New Borrower and each reference to the “Loan Agreement” shall refer to the Loan Agreement as amended by the Amendment; (ii) represents and warrants to Administrative Agent, which representations and warranties shall survive the execution and delivery hereof, that Guarantor’s representations and warranties contained in the Guaranty are true and correct as of the date hereof, with the same effect as though made on the date hereof, except to the extent that such representations expressly related solely to an earlier date, in which case such representations were true and correct on and as of such earlier date (and except for the representations in Section 10(b) thereof which were true and correct on and as of the date when made); (iii) agrees and acknowledges that such ratification and confirmation is not a condition to the continued effectiveness of the Amendment or the Guaranty; and (iv) agrees that neither such ratification and confirmation, nor Administrative Agent’s solicitation of such ratification and confirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or confirmation from the undersigned with respect to subsequent amendments or modifications, if any, to the Loan Agreement, as amended by the Amendment or any other Financing Agreement (as defined in the Loan Agreement, as amended by the Amendment). The execution, delivery and effectiveness of this instrument shall not operate as a waiver of any right, power or remedy of Administrative Agent under or pursuant to the Guaranty. Guarantor acknowledges and agrees that Guarantor has received and reviewed a fully-executed copy of the Amendment (and any other instrument, document or agreement executed or delivered in connection therewith) and understands the contents thereof. A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes. This instrument shall be governed by and construed and enforced in accordance with the internal laws of the State of Illinois, without regard to conflict of law principles.

Dated as of: November 1, 2013

DIVERSICARE HEALTHCARE SERVICES, INC. (f/k/a ADVOCAT INC.)

By:/s/ Kelly J. Gill

Name:Kelly J. Gill

President and Chief Executive Officer

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

EXHIBIT A

CHP Facilities

Entity Name	Facility Name	Facility Address
Diversicare of Bradford Place, LLC	Diversicare of Bradford Place	1302 Millville Avenue Hamilton, OH 45013 (Butler County)
Diversicare of Providence, LLC	Diversicare of Providence	4915 Charlestown Road New Albany, IN 47150 (Floyd County)
Diversicare of Siena Woods, LLC	Diversicare of Siena Woods	6125 North Main Street Dayton, OH 45415 (Montgomery County)
Diversicare of St. Theresa, LLC	Diversicare of St. Theresa	7010 Rowan Hill Drive Cincinnati, OH 45227 (Hamilton County)

**    Redacted information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and has been filed separately with the Securities and Exchange Commission.

EX-21

Exhibit 21

Subsidiaries

Advocat Ancillary Services, Inc.

Advocat Distribution Services, Inc.

Advocat Finance, Inc.

Diversicare Afton Oaks, LLC

Diversicare Assisted Living Services, Inc.

Diversicare Assisted Living Services NC, LLC

Diversicare Assisted Living Services NC I, LLC

Diversicare Assisted Living Services NC II, LLC

Diversicare Ballinger, LLC

Diversicare Briarcliff, LLC

Diversicare Chisolm, LLC

Diversicare Clinton, LLC

Diversicare Doctors, LLC

Diversicare Estates, LLC

Diversicare Hartford, LLC

Diversicare Highlands, LLC

Diversicare Hillcrest, LLC

Diversicare Holding Company, LLC

Diversicare Humble, LLC

Diversicare Kansas, LLC

Diversicare Katy, LLC

Diversicare Lampasas, LLC

Diversicare Leasing Company II, LLC

Diversicare Leasing Corp.

Diversicare Management Services Co.

Diversicare Normandy Terrace, LLC

Diversicare of Big Springs, LLC Formed as of January 13, 2014

Diversicare of Bradford Place, LLC

Diversicare of Chanute, LLC

Diversicare of Council Grove, LLC

Diversicare of Haysville, LLC

Diversicare of Larned, LLC

Diversicare of Providence, LLC

Diversicare of Sedgwick, LLC

Diversicare of Seneca Place, LLC

Diversicare of Siena Woods, LLC

Diversicare of St. Theresa, LLC

Diversicare Paris, LLC

Diversicare Pharmacy Holdings, LLC

Diversicare Pinedale, LLC

Diversicare Rose Terrace, LLC

Diversicare Texas I, LLC

Diversicare Therapy Services, LLC

Diversicare Treemont, LLC

Diversicare Windsor House, LLC

Diversicare Yorktown, LLC

Senior Care Cedar Hills, LLC

Senior Care Florida Leasing, LLC

Senior Care Golfcrest, LLC

Senior Care Golfview, LLC

Senior Care Southern Pines, LLC

SHC Risk Carriers Inc.

Sterling Health Care Management, Inc.

EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Diversicare Healthcare Services, Inc.

Brentwood, Tennessee

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Numbers 333-134905, 333-151565 and 333-167630) of Diversicare Healthcare Services, Inc. of our report dated March 6, 2014, relating to the consolidated financial statements and financial statement schedule which appears in this Form 10-K.

/s/ BDO USA, LLP

Nashville, Tennessee

March 6, 2014

EX-31.1

Exhibit 31.1

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

(i) CERTIFICATION

I, Kelly J. Gill, certify that:

1. I have reviewed this annual report on Form 10-K of Diversicare Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 6, 2014

/s/ Kelly J. Gill

Kelly J. Gill

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

(ii) CERTIFICATION

I, James R. McKnight, Jr., certify that:

1. I have reviewed this annual report on Form 10-K of Diversicare Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 6, 2014

/s/ James R. McKnight, Jr.

James R. McKnight, Jr.

Executive Vice President and Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION OF ANNUAL REPORT ON FORM 10-K

OF DIVERSICARE HEALTHCARE SERVICES, INC.

FOR THE YEAR ENDED DECEMBER 31, 2013

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the undersigned's best knowledge and belief, the Annual Report on Form 10-K for Diversicare Healthcare Services, Inc. (the “Company”) for the period ending December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”):

(a)    fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This Certification is executed as of March 6, 2014.

/s/ Kelly J. Gill

Kelly J. Gill

President and Chief Executive Officer

/s/ James R. McKnight, Jr.

James R. McKnight, Jr.

Executive Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Summary of Significant Accounting Policies (Schedule of Estimated Useful Lives) (Details)	12 Months Ended
	Dec. 31, 2013
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	5 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	40 years
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	2 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	10 years
Furniture, fixtures and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	2 years
Furniture, fixtures and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	15 years

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Schedule of Principal Payments of Long Term Debt Instruments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013
Debt Disclosure [Abstract]
2014	$ 4,211
2015	1,268
2016	6,119
2017	1,145
2018	40,167
Thereafter	0
Total	$ 52,910

XML

Property and Equipment (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 103,689	$ 82,675
Less: accumulated depreciation	(50,699)	(43,938)
Net property and equipment	52,990	38,737
Land
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	4,644	2,364
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	70,572	55,371
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 28,473	$ 24,940

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Scheduled Payments of Capital Lease Obligations) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013
Debt Disclosure [Abstract]
2014	$ 575
2015	47
2016	47
2017	27
2018	0
Total	696
Amounts related to interest	(29)
Principal payments on capitalized lease obligation	$ 667

XML

Schedule II - Valuation of Qualifying Accounts (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Allowance for doubtful accounts
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 3,143		$ 2,233		$ 2,277
Charged to Costs and Expenses	4,191		3,064		1,780
Charged to Other Accounts	0		0		0
Other	0		0		0
(Write-offs) net of Recoveries	(3,335)		(2,154)		(1,824)
Balance at End of Period	3,999		3,143		2,233
Professional Liability Reserve
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	22,740		19,357		17,251
Charged to Costs and Expenses	6,530		5,617		3,069
Charged to Other Accounts	3,163	[1]	448	[1]	2,848	[1]
Other	0		0		0
Payments	(5,366)	[2]	(2,682)	[2]	(3,811)	[2]
Balance at End of Period	27,067		22,740		19,357
Workers Compensation Reserve
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	287		309		346
Charged to Costs and Expenses	473		142		1,323
Charged to Other Accounts	0	[1]	0	[1]	0	[1]
Other	(87)		311		(257)
Payments	(497)	[2]	(475)	[2]	(1,103)	[2]
Balance at End of Period	176		287		309
Health Insurance Reserve
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	679		853		1,003
Charged to Costs and Expenses	9,095		7,207		7,247
Charged to Other Accounts	105	[1]	0	[1]	0	[1]
Other	0		0		0
Payments	(9,036)	[2]	(7,381)	[2]	(7,397)	[2]
Balance at End of Period	$ 843		$ 679		$ 853

[1] As discussed in Note 4 of the Consolidated Financial Statements, the Company has presented the results of certain divestiture and lease termination transactions as discontinued operations. The amounts charged to Other Accounts represent the amounts charged to discontinued operations.

[2] Payments for the Professional Liability Reserve include amounts paid for claims settled during the period as well as payments made under structured arrangements for claims settled in earlier periods.

XML

Receivables (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013 Center	Oct. 02, 2013 Center	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other receivables	$ 1,118		$ 1,397
Number of nursing centers	47	4
Renovation Projects
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other receivables	843		982
Skilled Nursing Center
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of nursing centers		4
Louisville, KY | Skilled Nursing Center
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other receivables	$ 5,100
Ohio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of nursing centers		3
Indiana
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of nursing centers		1

XML

Earnings (Loss) Per Common Share (Tables)

12 Months Ended

Dec. 31, 2013

Earnings Per Share [Abstract]

Basic and diluted net income (loss) per common share

Information with respect to the calculation of basic and diluted net income (loss) per common share is presented below:

	Years Ended December 31,
	2013			2012			2011
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
Income (loss) from continuing operations	$	(5,477,000	)	$	(3,675,000	)	$	438,000
Less: net income attributable to noncontrolling interests	(72,000		)	(126,000		)	—
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.	(5,549,000		)	(3,801,000		)	438,000
Preferred stock dividends	(344,000		)	(344,000		)	(344,000		)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Denominator: Basic Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,774,000
Basic net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.16
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.16
Basic net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.18

	2013			2012			2011
Numerator: Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Basic weighted average common shares outstanding	5,899,000			5,821,000			5,774,000
Incremental shares from assumed exercise of options, SOSARS and Restricted Stock Units	—			—			132,000
Denominator: Diluted Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,906,000
Diluted net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.15
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.15
Diluted net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.17

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table reflects the weighted average outstanding SOSARs and Options that were excluded from the computation of diluted earnings per share, as they would have been anti-dilutive:

	2013	2012	2011
SOSARs/Options Excluded	310,000	348,000	202,000

XML

Commitments and Contingencies (Narrative) (Details) (USD $)	12 Months Ended				12 Months Ended		0 Months Ended		12 Months Ended			12 Months Ended				1 Months Ended	12 Months Ended	1 Months Ended
	Dec. 31, 2013 Lawsuit Center Bed Multiple	Dec. 31, 2012	Dec. 31, 2011	Oct. 02, 2013 Center	Dec. 31, 2013 Medicare Total patient and resident revenues Medicare and Medicaid programs	Dec. 31, 2013 Medicaid Programs Total patient and resident revenues Medicare and Medicaid programs	Aug. 13, 2012 Chief Financial Officer	Aug. 13, 2012 Chief Operating Officer	Dec. 31, 2013 Professional malpractice liability insurance	Dec. 31, 2013 Prefunded deductible policy	Dec. 31, 2013 Scheduled for trial or arbitration over next 12 months Lawsuit	Dec. 31, 2013 Minimum	Dec. 31, 2013 Maximum	Dec. 31, 2013 Omega Healthcare Investors, Inc Multiple	Sep. 02, 2013 Omega Healthcare Investors, Inc	Jan. 31, 2013 Omega Healthcare Investors, Inc Leases, Acquired-in-Place	Dec. 31, 2013 Omega Healthcare Investors, Inc Leases, Acquired-in-Place Bed	Aug. 31, 2009 Omega Healthcare Investors, Inc Texas	Dec. 31, 2013 Omega Healthcare Investors, Inc Texas	Dec. 31, 2013 Leased Center	Dec. 31, 2013 Leased Leases, Acquired-in-Place Center	Dec. 31, 2013 Leased Omega Healthcare Investors, Inc Center	Dec. 31, 2013 Leased Omega Healthcare Investors, Inc Leases, Acquired-in-Place Center Facility	Jan. 31, 2013 Leased Omega Healthcare Investors, Inc Leases, Acquired-in-Place Center	Aug. 31, 2009 Leased Omega Healthcare Investors, Inc Texas Bed	Aug. 02, 2009 Leased Omega Healthcare Investors, Inc Texas Bed	Aug. 11, 2007 Leased Omega Healthcare Investors, Inc Texas Facility	Sep. 02, 2013 Arkansas Omega Healthcare Investors, Inc Facility
Commitments and Contingencies [Line Items]
Lease and rent expense	$ 21,542,000	$ 19,050,000	$ 18,064,000															$ 789,000
Accrued liability related to straightline rent	10,759,000	11,389,000
Number of nursing centers	47			4																34	7	25	1	2			7
Capital lease renewal period														12 years
Multiple of increase in consumer price index														2
Annual increase in consumer price index														300.00%					2.50%
Number of nursing centers that leases were terminated																												11
Amount of reduction in annual rent payable															5,000,000
Annual capital expenditures related to leased facilities per licensed bed														427
Total required capital expenditures during remaining lease term														7,336,000
Letters of credit security deposit for a lease														6,957,000	4,551,000
Number of licensed nursing beds	5,318																15								119	102
Percentage of total cost of replacement facility																		10.25%
Total cost of replacement facility																		7,702,000
Insurance policy coverage limits per claim									500,000	500,000
Renovation funding amount																5,000,000	20,000,000
Percentage of amount financed																10.25%
Number of nursing center facilities under renovation																							14
Maximum claim amount on insurance									5,000,000
Workers compensation insurance, maximum annual aggregate self-insured amount	1,000,000
Liability for reported and estimated future claims									27,067,000
Number of professional liability lawsuits	54										5
Cash expenditures for self-insured professional liability costs	5,367,000	2,682,000	3,811,000
Non-current receivables for workers' compensation policy	440,000	1,238,000
Professional liability insurance, annual coverage limit per facility										3,000,000
Liability for workers compensation claims	176,000
Workers compensation insurance, non current receivable for excess premiums paid	833,000
Health insurance, maximum self-insured annual amount per individual	175,000
Liability for reported claims and estimates for incurred but unreported claims										843,000
Salary multiple	2
Maximum contingent liability	1,260,000
Employee termination agreement term												1 year	3 years
Renewal period for employee agreements	1 year
Base salary							$ 225,000	$ 275,000
Number of legal actions	1
Percentage of total patient and residential revenues					27.30%	53.50%

XML

Variable Interest Entity (Details Textual)	12 Months Ended
	Dec. 31, 2013	Dec. 27, 2011 Bed
Variable Interest Entity, Not Primary Beneficiary [Abstract]
Number of licensed nursing beds	5,318
Lease agreement with the real estate developing period	20 years
Maximum number of capital lease renewal periods	2
Minimum
West Virginia Facility (Textual) [Abstract]
Agreement provides company right to purchase	110.00%
Maximum
West Virginia Facility (Textual) [Abstract]
Agreement provides company right to purchase	120.00%
Variable Interest Entity, Not Primary Beneficiary | Culloden, WV
Variable Interest Entity, Not Primary Beneficiary [Abstract]
Number of licensed nursing beds		90
Capital lease renewal period	5 years

XML

Subsequent Event (Details) (USD $) In Millions, unless otherwise specified						0 Months Ended
	Dec. 31, 2013 Center Bed	Oct. 02, 2013 Center	Oct. 02, 2013 Skilled Nursing Center Center	Mar. 01, 2014 Subsequent Event Skilled Nursing Center Alabama Center	Dec. 31, 2013 Subsequent Event Skilled Nursing Center Alabama Bed	Mar. 01, 2014 Subsequent Event Scenario, Forecast Skilled Nursing Center Alabama
Subsequent Event [Line Items]
Number of nursing centers	47	4	4	1
Number of licensed nursing beds	5,318				135
Annual revenues						$ 10.5
Annual rent expense						$ 1.2

XML

Quarterly Financial Information (Unaudited) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended																12 Months Ended
	Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2012		Mar. 31, 2012		Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Information Disclosure [Abstract]
Net revenues	$ 81,417		$ 70,353		$ 66,869		$ 63,280		$ 63,492		$ 61,824		$ 60,510		$ 60,464		$ 281,919	$ 246,290	$ 245,877
Professional liability expense	1,654	[1]	1,382	[1]	2,315	[1]	1,985	[1]	2,499	[2]	1,348	[2]	1,122	[2]	1,133	[2]	7,336	6,102	3,618
Income (loss) from continuing operations	(141)		(2,344)		(2,002)		(990)		(874)		(498)		(807)		(1,496)		(5,477)	(3,675)	438
Income (loss) from discontinued operations, net of tax	(430)		(2,421)		(177)		43		(258)		518		374		121		(2,985)	755	929
Net income (loss)	$ (678)		$ (4,868)		$ (2,281)		$ (1,051)		$ (1,234)		$ (82)		$ (534)		$ (1,540)		$ (8,534)	$ (3,046)	$ 1,367
Per common share - basic
Continuing operations (in dollars per share)	$ (0.03)		$ (0.42)		$ (0.36)		$ (0.19)		$ (0.17)		$ (0.10)		$ (0.15)		$ (0.29)		$ (1.00)	$ (0.71)	$ 0.02
Discontinued operations (in dollars per share)	$ (0.08)		$ (0.41)		$ (0.03)		$ 0.01		$ (0.04)		$ 0.09		$ 0.06		$ 0.02		$ (0.51)	$ 0.13	$ 0.16
Net income (loss) (in dollars per share)	$ (0.11)		$ (0.83)		$ (0.39)		$ (0.18)		$ (0.21)		$ (0.01)		$ (0.09)		$ (0.27)		$ (1.51)	$ (0.58)	$ 0.18
Per common share - diluted
Continuing operations (in dollars per share)	$ (0.03)		$ (0.42)		$ (0.36)		$ (0.19)		$ (0.17)		$ (0.10)		$ (0.15)		$ (0.29)		$ (1.00)	$ (0.71)	$ 0.02
Discontinued operations (in dollars per share)	$ (0.08)		$ (0.41)		$ (0.03)		$ 0.01		$ (0.04)		$ 0.09		$ 0.06		$ 0.02		$ (0.51)	$ 0.13	$ 0.15
Net income (loss) (in dollars per share)	$ (0.11)		$ (0.83)		$ (0.39)		$ (0.18)		$ (0.21)		$ (0.01)		$ (0.09)		$ (0.27)		$ (1.51)	$ (0.58)	$ 0.17

[1] The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2013 is set forth in the table above.

[2] The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2012 is set forth in the table above.

XML

Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current deferred tax assets:
Credit carryforwards	$ 0	$ 251
Net operating loss and other carryforwards	643	352
Allowance for doubtful accounts	1,788	1,447
Accrued liabilities	5,126	4,236
Subtotal	7,557	6,286
Less valuation allowance	(377)	(242)
Total current deferred tax assets	7,180	6,044
Current deferred tax liabilities:
Prepaid expenses	(601)	(739)
Net deferred tax assets, current	6,579	5,305
Noncurrent deferred tax assets:
Net operating loss and other carryforwards	3,389	1,365
Credit carryforwards	2,210	964
Deferred lease costs	289	356
Depreciation	(634)	(2,036)
Tax goodwill and intangibles	(879)	(739)
Stock-based compensation	882	1,238
Accrued rent	4,219	4,538
Kansas acquisition costs	125	0
Impairment of long-lived assets	472	659
Interest rate swap	349	564
Noncurrent self-insurance liabilities	6,422	6,062
Subtotal	16,844	12,971
Less valuation allowance	(932)	(619)
Total noncurrent deferred tax assets	$ 15,912	$ 12,352

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives

Property and equipment are recorded at cost with depreciation and amortization being provided over the shorter of the remaining lease term (where applicable) or the assets' estimated useful lives on the straight-line basis as follows:

Buildings and improvements	-	5 to 40 years
Leasehold improvements	-	2 to 10 years
Furniture, fixtures and equipment	-	2 to 15 years

Property and equipment, at cost, consists of the following:

	December 31,
	2013			2012
Land	$	4,644,000		$	2,364,000
Buildings and leasehold improvements	70,572,000			55,371,000
Furniture, fixtures and equipment	28,473,000			24,940,000
	103,689,000			82,675,000
Less: accumulated depreciation	(50,699,000		)	(43,938,000		)
Net property and equipment	$	52,990,000		$	38,737,000

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

The carrying value of the acquired leasehold interest intangible and the accumulated amortization are as follows:

	December 31,
	2013			2012
Intangible assets	$	10,652,000		$	10,652,000
Accumulated amortization	(2,424,000		)	(2,040,000		)
Net intangible assets	$	8,228,000		$	8,612,000

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The expected amortization expense for the acquired leasehold interest intangible asset is as follows:

2014	$	384,000
2015	384,000
2016	384,000
2017	384,000
2018	384,000
Thereafter	6,308,000
	$	8,228,000

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table presents by level, within the fair value hierarchy, assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012:

December 31, 2013	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(918,000	)	$	—	$	(918,000	)	$	—
December 31, 2012	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(1,484,000	)	$	—	$	(1,484,000	)	$	—

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Interest Rate Swap Cash Flow Hedge) (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Derivative [Line Items]
Long-term debt fixed based on the interest rate swap	6.87%
Accumulated other comprehensive loss	$ (569)	$ (920)
Interest rate swap
Derivative [Line Items]
Notional amount of interest rate swap	22,217
Long-term debt fixed based on the interest rate swap	6.87%
Net liability of interest rate swap	918
Accumulated other comprehensive loss	569
Net of the income tax benefit, interest rate swap	$ (349)

XML

Summary of Significant Accounting Policies (Schedule of Fair Value Measurements - Assets and Liabilities) (Details) (Interest rate swap, Fair Value, Measurements, Recurring, USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets (liabilities) at fair value	$ (918)	$ (1,484)
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets (liabilities) at fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets (liabilities) at fair value	(918)	(1,484)
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets (liabilities) at fair value	$ 0	$ 0

XML

Commitments and Contingencies (Schedule of Leasehold Improvement) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Acquired Finite-Lived Intangible Assets [Line Items]
Net Intangible	$ 8,228	$ 8,612
Omega Healthcare Investors, Inc
Acquired Finite-Lived Intangible Assets [Line Items]
Leasehold improvement	921,000	921,000
Accumulated amortization	(421,000)	(316,000)
Net Intangible	$ 500,000	$ 605,000

XML

Company and Organization (Details)	Dec. 31, 2013 Center Bed State	Oct. 02, 2013 Bed Center	Oct. 02, 2013 Skilled Nursing Center Center	Oct. 02, 2013 Kansas Bed	May 31, 2013 Kansas Bed Center	May 01, 2013 Kansas Skilled Nursing Center Center	Oct. 02, 2013 Ohio Center	Aug. 01, 2013 Louisville, KY Skilled Nursing Center Bed	Oct. 02, 2013 Indiana Center	Dec. 31, 2013 Owned Center	Dec. 31, 2013 Leased Center	Dec. 31, 2013 Leased Louisville, KY Bed
Entity Location [Line Items]
Number of states in which entity operates	9
Number of nursing centers	47	4	4		5	5	3		1	13	34
Number of licensed nursing beds	5,318			442	418			107				154
Number of beds not included in recently leased skilled nursing center		270

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Schedule of Long-term Debt) (Details) (USD $) In Thousands, unless otherwise specified						12 Months Ended				12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Interest rate swap	Dec. 31, 2013 Mortgages Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below.	Dec. 31, 2012 Mortgages Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below.	Dec. 31, 2013 Mortgages Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below. Interest rate swap	Dec. 31, 2013 Mortgages Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below. LIBOR	Dec. 31, 2013 Revolving credit facility Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR.	Dec. 31, 2012 Revolving credit facility Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR.	Dec. 31, 2013 Revolving credit facility Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR. LIBOR	Dec. 31, 2013 Commercial loan Commercial loan of consolidated VIE, payable by variable interest entity landlord to a bank; issued in January 2011; payable monthly, fixed interest rate of 5.3%.	Dec. 31, 2012 Commercial loan Commercial loan of consolidated VIE, payable by variable interest entity landlord to a bank; issued in January 2011; payable monthly, fixed interest rate of 5.3%.
Debt Instrument [Line Items]
Long-term debt	$ 52,910			$ 44,434	$ 22,313			$ 3,000	$ 0
Long term debt, VIE											5,476	5,678
Total long term debt	52,910	27,991
Less current portion	(4,211)	(631)
Long-term debt, excluding current maturities	$ 48,699	$ 27,360
Long-term debt, interest rate						6.87%	4.50%			4.50%
Long-term debt fixed based on the interest rate swap	6.87%		6.87%								5.30%

XML

Earnings (Loss) Per Common Share (Schedule of Antidilutive Securities Excluded from the Computation of Earnings Per Share) (Details) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]
SOSARs/Options Excluded	310,000	348,000	202,000

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Schedule of Weighted Average Grant Date Fair Value and Total Intrinsic Value of Exercises) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012	Dec. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Weighted average grant date fair value	$ 0.00	[1]	$ 2.29	$ 2.19
Total intrinsic value of exercises	$ 53	[1]	$ 12	$ 87

[1] The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

XML

Receivables (Schedule of Other Receivables and Advances) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables before the allowance for doubtful accounts	$ 39,118	$ 27,774
Other receivables	1,118	1,397
Medicare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables before the allowance for doubtful accounts	13,806	8,606
Medicaid and other non-federal government programs
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables before the allowance for doubtful accounts	14,121	11,128
Other patient and resident receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables before the allowance for doubtful accounts	$ 11,191	$ 8,040

XML

Company and Organization

12 Months Ended

Dec. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

COMPANY AND ORGANIZATION

COMPANY AND ORGANIZATION

Diversicare Healthcare Services, Inc. (together with its consolidated subsidiaries, “Diversicare” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast and Southwest. The Company’s centers provide a range of health care services to their patients and residents. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers offer a variety of comprehensive rehabilitation services as well as nutritional support services.

As of December 31, 2013, the Company’s continuing operations consist of 47 nursing centers with 5,318 licensed nursing beds. The Company owns 13 and leases 34 of its nursing centers. The nursing center and licensed nursing bed count includes the Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013. The nursing center and licensed bed count includes the 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicaid and Medicare certification processes for this facility are currently in progress and expected to be completed in the first quarter of 2014. The nursing center and licensed nursing bed count also includes 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes are currently under way for these four leased facilities. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Ohio, Tennessee, Texas and West Virginia.

BUSINESS DEVELOPMENT

Kansas Acquisition

On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities commenced on May 1, 2013. The five facilities acquired under the Agreement include the following:

• 77-bed skilled nursing facility known as Chanute HealthCare Center

• 80-bed skilled nursing facility known as Council Grove HealthCare Center

• 119-bed skilled nursing facility known as Haysville HealthCare Center

• 80-bed skilled nursing facility known as Larned HealthCare Center

• 62-bed skilled nursing facility known as Sedgwick HealthCare Center

As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired identifiable net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The Company also incurred $338,000 in acquisition-related expenses that were expensed as incurred. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

	As of May 1, 2013
Purchase Price	$	15,500,000
Land	2,130,000
Buildings	12,127,000
Furniture, fixtures, and equipment	1,200,000
Inventory	43,000
Less: Liabilities assumed	758,000
Total cash paid	$	14,742,000

Since finalizing the purchase, the aforementioned facilities have contributed $15,440,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Lease Agreements

On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT and the lease provides for an initial 15-year lease term with a 5-year renewal option. This additional skilled nursing center increases the Company's footprint in Kentucky to nine nursing centers. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center. Since assuming operations at this facility, the aforementioned facility has contributed $3,487,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Additionally, on October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana, and increasing our presence in Ohio to four nursing centers. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. Since assuming operations at this facility, the aforementioned facilities have contributed $9,225,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

In April 2012, the Company entered into a lease agreement to operate an 88-bed skilled nursing center in Clinton, Kentucky. The center is subject to a mortgage insured through the United States Department of Housing and Urban Development. The lease has an initial ten-year term with twofive-year renewal options and contains an option to purchase the property for $3.3 million during the first five years. The center had not had residents since April 2011 after being de-certified by Medicare and Medicaid. The lease agreement called for a $125,000 lease commencement fee and the transaction is considered a lease agreement.

Separate from the above lease transaction, in September 2012, the Company announced it entered into a lease agreement to operate a 154-bed skilled nursing center in Louisville, Kentucky. The nursing center is owned by a real estate investment trust and the lease provides for an initial fifteen-year lease term with a five-year renewal option. This additional skilled nursing center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Schedule of Stock Options Outstanding and Exercisable) (Details) (Stock Options and Stock Appreciation Rights (SARs), USD $) In Thousands, except Per Share data, unless otherwise specified			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 $10.40 to $11.59	Dec. 31, 2013 $2.37 to $6.21
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, lower range limit (in dollars per share)			$ 10.40	$ 2.37
Range of Exercise Prices, upper range limit (in dollars per share)			$ 11.59	$ 6.21
Weighted Average Exercise Prices (in dollars per share)	$ 6.64	$ 6.62	$ 11.14	$ 5.37
Grants Outstanding, shares	333		73	260
Intrinsic Value- Grants Outstanding			$ 0	$ 48
Grants Exercisable (in shares)	273		73	200
Intrinsic Value - Grants Exercisable			$ 0	$ 48

XML

Business Development (Narrative) (Details) (USD $)	12 Months Ended							1 Months Ended			1 Months Ended	12 Months Ended				12 Months Ended	0 Months Ended	12 Months Ended	0 Months Ended
	Dec. 31, 2013 Option Center Bed	Dec. 31, 2012	Dec. 31, 2011	Oct. 02, 2013 Center	Dec. 31, 2013 Leased Center	Oct. 02, 2013 Kansas Bed	May 31, 2013 Kansas Bed Center	Sep. 30, 2012 Louisville, KY Leased	Dec. 31, 2013 Louisville, KY Leased Bed	Dec. 31, 2013 Kentucky Center	Apr. 30, 2012 Clinton Kentucky Leased Option Bed	Dec. 31, 2013 Skilled Nursing Center	Oct. 02, 2013 Skilled Nursing Center Center	May 01, 2013 Skilled Nursing Center Kansas Center	Aug. 01, 2013 Skilled Nursing Center Louisville, KY Bed	Dec. 31, 2013 Skilled Nursing Center Kentucky	May 01, 2013 Kansas Skilled Nursing Center	Dec. 31, 2013 Kansas Skilled Nursing Center	Oct. 04, 2013 Louisville, KY	Aug. 03, 2013 Louisville, KY Skilled Nursing Center	Oct. 02, 2013 Ohio Skilled Nursing Center Center	Oct. 02, 2013 Indiana Skilled Nursing Center Center	May 01, 2013 Chanute HealthCare Center Kansas Skilled Nursing Center Bed	May 01, 2013 Council Grove HealthCare Center Kansas Skilled Nursing Center Bed	May 01, 2013 Haysville HealthCare Center Kansas Skilled Nursing Center Bed	May 01, 2013 Larned HealthCare Center Kansas Skilled Nursing Center Bed	May 01, 2013 Sedgwick HealthCare Center Kansas Skilled Nursing Center Bed
Business Development and Discontinued Operations [Line Items]
Number of nursing centers	47			4	34		5			9			4	5							3	1
Purchase Price																	$ 15,500,000
Acquisition related expenses																	338,000
Number of licensed nursing beds	5,318					442	418		154		88				107								77	80	119	80	62
Less: Liabilities assumed																	758,000
Revenues contributed to consolidated statement of operations from acquired facilities												9,225,000				3,487,000		15,440,000
Term of lease																			15 years	15 years
Term of renewal option of lease																			5 years	5 years
Capital lease maturity period								15 years			10 years
Maximum number of capital lease renewal periods	2										2
Capital lease renewal period								5 years			5 years
Period from capital lease inception for purchase option											5 years
Commencement fee											125,000
Total cash paid	14,742,000	0	0														14,742,000
Purchase options, land											$ 3,300,000

XML

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

Property and Equipment, at cost

Property and equipment are recorded at cost with depreciation and amortization being provided over the shorter of the remaining lease term (where applicable) or the assets' estimated useful lives on the straight-line basis as follows:

Buildings and improvements	-	5 to 40 years
Leasehold improvements	-	2 to 10 years
Furniture, fixtures and equipment	-	2 to 15 years

Property and equipment, at cost, consists of the following:

	December 31,
	2013			2012
Land	$	4,644,000		$	2,364,000
Buildings and leasehold improvements	70,572,000			55,371,000
Furniture, fixtures and equipment	28,473,000			24,940,000
	103,689,000			82,675,000
Less: accumulated depreciation	(50,699,000		)	(43,938,000		)
Net property and equipment	$	52,990,000		$	38,737,000

XML

Receivables (Tables)

12 Months Ended

Dec. 31, 2013

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

Receivables, before the allowance for doubtful accounts, consist of the following components:

	December 31,
	2013		2012
Medicare	$	13,806,000	$	8,606,000
Medicaid and other non-federal government programs	14,121,000		11,128,000
Other patient and resident receivables	11,191,000		8,040,000
	$	39,118,000	$	27,774,000
Other receivables and advances	$	1,118,000	$	1,397,000

XML

Variable Interest Entity (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Summarizes the accounts and amounts included real estate developer's interests
Total assets	$ 137,744	$ 114,963
Notes payable, including current portion	48,811	28,026
Non-controlling interests	1,437	1,573
Total liabilities and shareholder's equity	137,744	114,963
Variable Interest Entity, Not Primary Beneficiary | Culloden, WV
Summarizes the accounts and amounts included real estate developer's interests
Land	787	787
Building and improvements, net	5,613	5,857
Furniture, fixtures and equipment, net	431	501
Other assets	80	107
Total assets	6,911	7,252
Current accruals	0	1
Notes payable, including current portion	5,476	5,678
Non-controlling interests	1,435	1,573
Total liabilities and shareholder's equity	6,911	7,252
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning non-controlling interests	1,573	1,654
Comprehensive income attributable to non-controlling interests	72	126
Distributions to non-controlling interest owners	(208)	(207)
Ending non-controlling interests	$ 1,437	$ 1,573

XML

Business Development (Schedule of Assets Acquired) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended			0 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	May 01, 2013 Skilled Nursing Center Kansas
Business Acquisition [Line Items]
Purchase Price				$ 15,500
Land				2,130
Buildings				12,127
Furniture, fixtures, and equipment				1,200
Inventory				43
Less: Liabilities assumed				758
Total cash paid	$ 14,742	$ 0	$ 0	$ 14,742

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Tables)

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Schedule of Long Term Debt

Long-term debt consists of the following:

	December 31,
	2013			2012
Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below.	$	44,434,000		$	22,313,000
Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR.	3,000,000			—
Commercial loan of consolidated VIE, payable by variable interest entity landlord to a bank; issued in January 2011; payable monthly, fixed interest rate of 5.3%.	5,476,000			5,678,000
	52,910,000			27,991,000
Less current portion	(4,211,000		)	(631,000		)
	$	48,699,000		$	27,360,000

Schedule of Deferred Financing Costs

In connection with the Company's 2013 and 2012 financing agreements the Company recognized the following debt retirement costs related to the write off of deferred financing on the existing financing agreements and recorded new deferred loan costs related the new financing agreements as follows:

	2013		2012
Write-off of deferred financing costs	$	320,000	$	—
Deferred financing costs capitalized	$	1,341,000	$	34,000

Scheduled Principal Payments of Long-term Debt

Scheduled principal payments of long-term debt are as follows:

2014	$	4,211,000
2015	1,268,000
2016	6,119,000
2017	1,145,000
2018	40,167,000
Thereafter	—
Total	$	52,910,000

Scheduled payments of Capitalized Lease Obligations

Scheduled payments of the capitalized lease obligations are as follows:

2014	$	575,000
2015	47,000
2016	47,000
2017	27,000
2018	—
Total	696,000
Amounts related to interest	(29,000		)
Principal payments on capitalized lease obligation	$	667,000

XML

Variable Interest Entity (Tables)

12 Months Ended

Dec. 31, 2013

Business Combinations [Abstract]

Summarizes the accounts and amounts included real estate developer's interests

The following table summarizes the accounts and amounts included in the Company’s Consolidated Balance Sheet that are associated with the real estate developer’s interests in the VIE. These assets can be used only to settle obligations of the VIE and none of these liabilities provide creditors with recourse to the general assets of the Company.

	December 31, 2013		December 31, 2012
Land	$	787,000	$	787,000
Building and improvements, net	5,613,000		5,857,000
Furniture, fixtures and equipment, net	431,000		501,000
Other assets	80,000		107,000
	$	6,911,000	$	7,252,000
Current accruals	$	—	$	1,000
Notes payable, including current portion	5,476,000		5,678,000
Non-controlling interests	1,435,000		1,573,000
	$	6,911,000	$	7,252,000

	Year Ended December 31, 2013			Year Ended December 31, 2012
Beginning non-controlling interests	$	1,573,000		$	1,654,000
Comprehensive income attributable to non-controlling interests	72,000			126,000
Distributions to non-controlling interest owners	(208,000		)	(207,000		)
Ending non-controlling interests	$	1,437,000		$	1,573,000

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
NET INCOME (LOSS)	$ (8,462)	$ (2,920)	$ 1,367
Discontinued operations	(2,985)	755	929
Income (loss) from continuing operations	(5,477)	(3,675)	438
Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities:
Depreciation and amortization	6,972	6,276	5,607
Provision for doubtful accounts	4,191	3,064	1,780
Deferred income tax provision (benefit)	(5,068)	(1,412)	801
Provision for self-insured professional liability, net of cash payments	1,162	2,935	(742)
Stock based compensation	950	573	528
Debt retirement costs	320	0	0
Provision for leases net of cash payments	(631)	(148)	320
Asset impairment	0	0	344
Equity in net losses of unconsolidated affiliate	(67)	(420)	0
Other	516	455	415
Changes in other assets and liabilities affecting operating activities:
Receivables, net	(14,313)	(6,404)	(4,904)
Prepaid expenses and other assets	862	(447)	1,128
Trade accounts payable and accrued expenses	6,672	155	1,389
Net cash provided (used) by continuing operations	(3,911)	952	7,104
Discontinued operations	2,685	2,266	2,937
Net cash provided (used) by operating activities	(1,226)	3,218	10,041
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(5,293)	(4,353)	(12,386)
Acquisition of property and equipment through business combination	(14,742)	0	0
Proceeds from sale of discontinued operations	0	3,632	0
Change in restricted cash	(3,480)	752	(1,029)
Deposits and other deferred balances	0	(319)	(31)
Net cash used in continuing operations	(23,515)	(288)	(13,446)
Discontinued operations	1,904	(497)	(970)
Net cash used in investing activities	(21,611)	(785)	(14,416)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of debt obligations	(30,385)	(1,364)	(24,583)
Proceeds from issuance of debt and sale leaseback transaction	54,500	634	29,554
Financing costs	(1,341)	(118)	(797)
Issuance and redemption of employee equity awards	22	55	194
Payment of common stock dividends	(972)	(1,282)	(1,272)
Payment of preferred stock dividends	(344)	(344)	(344)
Distributions to noncontrolling interests	(208)	(206)	0
Payment for preferred stock restructuring	(581)	(563)	(546)
Net cash (used in) provided by financing activities	20,691	(3,188)	2,206
NET DECREASE IN CASH AND CASH EQUIVALENTS	(2,146)	(755)	(2,169)
CASH AND CASH EQUIVALENTS, beginning of period	5,930	6,685	8,854
CASH AND CASH EQUIVALENTS, end of period	3,784	5,930	6,685
SUPPLEMENTAL INFORMATION:
Cash payments of interest, net of amounts capitalized	2,937	1,776	1,875
Cash payments of income taxes	88	176	627
Capital lease obligations incurred	$ 0	$ 293	$ 527

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Tables)

12 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The table below shows the weighted average assumptions the Company used to develop the fair value estimates under its option valuation model:

	Year Ended December 31,
	2013	2012	2011
Expected volatility (range)	N/A(1)	58% - 59%	59% - 60%
Risk free interest rate (range)	N/A(1)	0.80% - 1.03%	1.02% - 1.30%
Expected dividends	N/A(1)	3.75%	3.93%
Weighted average expected term (years)	N/A(1)	6	6

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The table below describes the resulting weighted average grant date fair values calculated as well as the intrinsic value of options exercised under the Company's equity awards during each of the following years:

	Year Ended December 31,
	2013(1)		2012		2011
Weighted average grant date fair value	—		$	2.29	$	2.19
Total intrinsic value of exercises	$	53,000	$	12,000	$	87,000

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

The following table summarizes information regarding stock options and SOSAR grants outstanding as of December 31, 2013:

	Weighted
	Average			Intrinsic			Intrinsic
Range of	Exercise		Grants	Value-Grants		Grants	Value-Grants
Exercise Prices	Prices		Outstanding	Outstanding		Exercisable	Exercisable
$10.40 to $11.59	$	11.14	73,000	$	—	73,000	$	—
$2.37 to $6.21	$	5.37	260,000	48,000		200,000	48,000
			333,000			273,000

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

Summarized activity of the equity compensation plans is presented below:

			Weighted
			Average
	Shares		Exercise Price
Outstanding, December 31, 2012	461,000		$	6.62
Granted	—		—
Exercised	(18,000	)	2.37
Expired or cancelled	(110,000	)	7.25
Outstanding, December 31, 2013	333,000		$	6.64
Exercisable, December 31, 2013	273,000		$	6.84

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

			Weighted
			Average
	Restricted		Grant Date
	Shares		Fair Value
Outstanding, December 31, 2012	94,000		$	6.00
Granted	69,000		5.01
Dividend Equivalents	6,000		4.85
Vested	(37,000	)	6.02
Cancelled	(14,000	)	5.53
Outstanding December 31, 2013	118,000		$	5.41

Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:

			Weighted
			Average
	Restricted		Grant Date
	Share Units		Fair Value
Outstanding, December 31, 2012	52,000		$	6.24
Granted	23,000		5.01
Dividend Equivalents	2,000		4.85
Vested	(36,000	)	6.40
Cancelled	—		—
Outstanding December 31, 2013	41,000		$	5.35

Schedule of Auction Market Preferred Securities by Stock Series

The following table reflects activity in the Series C Preferred Stock:

Series C Preferred Stock
	2013	2012	2011
Balance at the beginning of the period	$4,918,000	$4,918,000	$4,918,000
Amortization of preferred stock premium	—	—	—
Balance at the end of the period	$4,918,000	$4,918,000	$4,918,000

XML

Summary of Significant Accounting Policies (Schedule of Acquired Leasehold Interest Intangible) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Net Intangible	$ 8,228	$ 8,612
Leases, Acquired-in-Place
Finite-Lived Intangible Assets [Line Items]
Intangible assets	10,652	10,652
Accumulated amortization	(2,424)	(2,040)
Net Intangible	$ 8,228	$ 8,612

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Schedule of Deferred Loan Costs) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Debt Disclosure [Abstract]
Write-off of deferred financing costs	$ 320	$ 0	$ 112
Deferred financing costs capitalized		$ 34

XML

Income Taxes (Schedule of Unrecognized Tax Benefits Rollforward) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at the beginning of the period	$ 0	$ 86	$ 84
Changes in tax positions for prior years	0	(86)	2
Balance at the end of the period	$ 0	$ 0	$ 86

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:
Cash and cash equivalents	$ 3,784	$ 5,930
Receivables, less allowance for doubtful accounts of $3,999,000 and $3,143,000, respectively	35,119	24,631
Other receivables	1,118	1,397
Prepaid expenses and other current assets	2,507	3,729
Income tax refundable	763	1,215
Current assets of discontinued operations	341	4,649
Deferred income taxes	6,579	5,305
Total current assets	50,211	46,856
PROPERTY AND EQUIPMENT, at cost	103,689	82,675
Less accumulated depreciation and amortization	(50,699)	(43,938)
Discontinued operations, net	1,053	3,185
Property and equipment, net (variable interest entity restricted – 2013: $6,831,000; 2012: $7,144,000)	54,043	41,922
OTHER ASSETS:
Deferred income taxes	15,912	12,352
Deferred financing and other costs, net	2,071	1,438
Investment in unconsolidated affiliate	487	420
Other noncurrent assets	6,782	3,317
Acquired leasehold interest, net	8,228	8,612
Noncurrent assets of discontinued operations	10	46
Total other assets	33,490	26,185
Total assets	137,744	114,963
CURRENT LIABILITIES:
Current portion of long-term debt and capitalized lease obligations (variable interest entity nonrecourse – 2013: $217,000; 2012: $206,000)	4,766	1,436
Trade accounts payable	7,545	3,603
Current liabilities of discontinued operations	236	2,209
Accrued expenses:
Payroll and employee benefits	12,633	11,048
Self-insurance reserves, current portion	11,711	9,175
Other current liabilities	5,276	3,722
Total current liabilities	42,167	31,193
NONCURRENT LIABILITIES:
Long-term debt and capitalized lease obligations, less current portion (variable interest entity nonrecourse – 2013: $5,259,000; 2012: $5,472,000)	48,811	28,026
Self-insurance reserves, noncurrent portion	16,375	14,531
Other noncurrent liabilities	15,907	17,544
Total noncurrent liabilities	81,093	60,101
Series C redeemable preferred stock, $.10 par value, 5,000 shares authorized, issued and outstanding	4,918	4,918
SHAREHOLDERS’ EQUITY:
Series A preferred stock, authorized 200,000 shares, $.10 par value, none issued and outstanding	0	0
Common stock, authorized 20,000,000 shares, $.01 par value, 6,307,000 and 6,161,000 shares issued, and 6,075,000 and 5,929,000 shares outstanding, respectively	63	62
Treasury stock at cost, 232,000 shares of common stock	(2,500)	(2,500)
Paid-in capital	19,570	18,757
Retained earnings (accumulated deficit)	(8,435)	1,779
Accumulated other comprehensive loss	(569)	(920)
Total shareholders’ equity of Diversicare Healthcare Services, Inc.	8,129	17,178
Noncontrolling interests	1,437	1,573
Total shareholders’ equity	9,566	18,751
Total liabilities and shareholder's equity	$ 137,744	$ 114,963

XML

Discontinued Operations (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2013 Bed	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013 Bed	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 Leased Skilled Nursing Centers	Dec. 31, 2012 Leased Skilled Nursing Centers	Dec. 31, 2011 Leased Skilled Nursing Centers	Dec. 31, 2012 Arkansas	Dec. 31, 2013 Arkansas Leased Skilled Nursing Centers	Dec. 31, 2012 Arkansas Leased Skilled Nursing Centers	Dec. 31, 2011 Arkansas Leased Skilled Nursing Centers	Dec. 31, 2013 North Carolina	Sep. 02, 2013 Omega Healthcare Investors, Inc. Arkansas Facility Bed
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of nursing centers that leases were terminated																				11
Number of licensed nursing beds	5,318								5,318											1,181
Income (loss) from discontinued operations, net of tax	$ (430)	$ (2,421)	$ (177)	$ 43	$ (258)	$ 518	$ 374	$ 121	$ (2,985)	$ 755	$ 929	$ (2,865)	$ 457	$ 540		$ (85)	$ 68	$ 198
Restructuring									1,446	0	0
Gain on disposal net of taxes									0	174	0				174
Discontinued operations, net	1,053				3,185				1,053	3,185									1,053
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net revenues									40,151	65,245	68,838	40,151	61,782	63,589		0	3,463	5,249
Operating expenses									(44,890)	(64,373)	(67,568)
Gain from disposal of assets									0	281	0
Income (loss) from discontinued operations									(4,739)	1,153	1,270
Benefit (provision) for income taxes									1,754	(398)	(341)
Discontinued operations									$ (2,985)	$ 755	$ 929

XML

Consolidated Statements of Comprehensive Income (Loss) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
NET INCOME (LOSS)	$ (8,462)	$ (2,920)	$ 1,367
OTHER COMPREHENSIVE INCOME (LOSS):
Change in fair value of cash flow hedge, net of tax	666	354	(661)
Less: reclassification adjustment for amounts recognized in net income	315	329	284
Total other comprehensive income (loss)	351	25	(945)
COMPREHENSIVE INCOME (LOSS)	(8,111)	(2,895)	422
Less: net income attributable to noncontrolling interests	(72)	(126)	0
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.	$ (8,183)	$ (3,021)	$ 422

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Preferred Stock) (Narrative) (Details) (USD $) In Thousands, except Share data, unless otherwise specified				12 Months Ended	1 Months Ended			1 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Series A Preferred Stock	Dec. 31, 2013 Omega Healthcare Investors, Inc	Oct. 31, 2006 Omega Healthcare Investors, Inc Series B Preferred Stock	Nov. 30, 2000 Omega Healthcare Investors, Inc Series B Preferred Stock	Dec. 31, 2013 Omega Healthcare Investors, Inc Series B Preferred Stock	Oct. 31, 2006 Omega Healthcare Investors, Inc Series C Preferred Stock	Dec. 31, 2013 Omega Healthcare Investors, Inc Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized (shares)	200,000	200,000	200,000
Preferred stock, shares issued (shares)	0	0				393,658
Preferred stock issued	$ 0	$ 0				$ 3,300	$ 4,918		$ 4,918
Dividend rate percentage						7.00%		7.00%
Recorded value of preferred stock					4,918
Shared converted to common stock					792,000
Number of shares of preferred stock								5,000
Shares received upon conversion					393,658
Additional rental payments				687
Capital lease renewal period				12 years
Net present value of rental payments	667			6,701
Value of preferred stock									11,619
Value of conversion feature									$ 6,701

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Contractual Obligation, Fiscal Year Maturity Schedule

Minimum annual rentals, including renewal option periods (exclusive of taxes, insurance, and maintenance costs) under these leases beginning January 1, 2014, are as follows:

2014	$	26,165,000
2015	27,077,000
2016	27,825,000
2017	28,521,000
2018	29,459,000
Thereafter	467,387,000
	$	606,434,000

Schedule of Finite-Lived Intangible Assets

The leasehold improvement asset and accumulated amortization are as follows:

	December 31
	2013			2012
Leasehold improvement	$	921,000		$	921,000
Accumulated Amortization	(421,000		)	(316,000		)
Net Intangible	$	500,000		$	605,000

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Schedule of Preferred Stock) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at the beginning of the period	$ 4,918	$ 4,918	$ 4,918
Amortization of preferred stock premium	0	0	0
Balance at the end of the period	$ 4,918	$ 4,918	$ 4,918

XML

Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL INFORMATION (Unaudited)

QUARTERLY FINANCIAL INFORMATION (Unaudited)

Selected quarterly financial information for each of the quarters in the years ended December 31, 2013 and 2012 is as follows:

	Quarter
2013	First			Second			Third			Fourth
Net revenues	$	63,280,000		$	66,869,000		$	70,353,000		$	81,417,000
Professional liability expense (1)	1,985,000			2,315,000			1,382,000			1,654,000
Loss from continuing operations	(990,000		)	(2,002,000		)	(2,344,000		)	(141,000		)
Income (loss) from discontinued operations	43,000			(177,000		)	(2,421,000		)	(430,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,051,000	)	$	(2,281,000	)	$	(4,868,000	)	$	(678,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2013 is set forth in the table above.

	Quarter
2012	First			Second			Third			Fourth
Net revenues	$	60,464,000		$	60,510,000		$	61,824,000		$	63,492,000
Professional liability expense (1)	1,133,000			1,122,000			1,348,000			2,499,000
Loss from continuing operations	(1,496,000		)	(807,000		)	(498,000		)	(874,000		)
Income (loss) from discontinued operations	121,000			374,000			518,000			(258,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,540,000	)	$	(534,000	)	$	(82,000	)	$	(1,234,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2012 is set forth in the table above.

XML

Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Selected quarterly financial information for each of the quarters in the years ended December 31, 2013 and 2012 is as follows:

	Quarter
2013	First			Second			Third			Fourth
Net revenues	$	63,280,000		$	66,869,000		$	70,353,000		$	81,417,000
Professional liability expense (1)	1,985,000			2,315,000			1,382,000			1,654,000
Loss from continuing operations	(990,000		)	(2,002,000		)	(2,344,000		)	(141,000		)
Income (loss) from discontinued operations	43,000			(177,000		)	(2,421,000		)	(430,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,051,000	)	$	(2,281,000	)	$	(4,868,000	)	$	(678,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.19	)	$	(0.36	)	$	(0.42	)	$	(0.03	)
Income (loss) from discontinued operations	0.01			(0.03		)	(0.41		)	(0.08		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.18	)	$	(0.39	)	$	(0.83	)	$	(0.11	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2013 is set forth in the table above.

	Quarter
2012	First			Second			Third			Fourth
Net revenues	$	60,464,000		$	60,510,000		$	61,824,000		$	63,492,000
Professional liability expense (1)	1,133,000			1,122,000			1,348,000			2,499,000
Loss from continuing operations	(1,496,000		)	(807,000		)	(498,000		)	(874,000		)
Income (loss) from discontinued operations	121,000			374,000			518,000			(258,000		)
Net loss attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(1,540,000	)	$	(534,000	)	$	(82,000	)	$	(1,234,000	)
Basic net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

Diluted net income (loss) per common share for Diversicare Healthcare Services, Inc. shareholders:
Loss from continuing operations	$	(0.29	)	$	(0.15	)	$	(0.10	)	$	(0.17	)
Income (loss) from discontinued operations	0.02			0.06			0.09			(0.04		)
Net loss per common share for Diversicare Healthcare Services, Inc. shareholders	$	(0.27	)	$	(0.09	)	$	(0.01	)	$	(0.21	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 12. The amount of expense recorded for professional liability in each quarter of 2012 is set forth in the table above.

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Consolidation

Consolidation

The consolidated financial statements include the financial position, operations and accounts of Diversicare and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (“VIEs”) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company has one variable interest entity and it relates to a nursing center in West Virginia described in Note 7.

The investment in unconsolidated affiliate reflected on the consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns a 50% interest. The joint venture partnership is accounted for using the equity method. An equity method investment is the Company’s investment in an entity over which the Company lacks control, but otherwise has the ability to exercise significant influence over operating and financial policies. The Company’s share of the profits and losses from this investment are reported in equity in earnings of unconsolidated affiliates in the accompanying consolidated statement of operations. The Company monitors this investment for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the company and will record reductions in carrying value when or if necessary. Under the equity method, the investment, originally recorded at cost, is adjusted to recognize the Company’s share of the net earnings or losses of the affiliate as they occur.

Patient Revenues

Patient Revenues

The fees charged by the Company to patients in its nursing centers are recorded on an accrual basis. These rates are contractually adjusted with respect to individuals receiving benefits under federal and state-funded programs and other third-party payors. Rates under federal and state-funded programs are determined prospectively for each facility and may be based on the acuity of the care and services provided. These rates may be based on facility's actual costs subject to program ceilings and other limitations or on established rates based on acuity and services provided as determined by the federal and state-funded programs. Amounts earned under federal and state programs with respect to nursing home patients are subject to review by the third-party payors which may result in retroactive adjustments. In the opinion of management, adequate provision has been made for any adjustments that may result from such reviews. Retroactive adjustments, if any, are recorded when objectively determinable, generally within three years of the close of a reimbursement year depending upon the timing of appeals and third-party settlement reviews or audits.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company's allowance for doubtful accounts is estimated utilizing current agings of accounts receivable, historical collections data and other factors. Management monitors these factors and determines the estimated provision for doubtful accounts. Historical bad debts have generally resulted from uncollectible private balances, some uncollectible coinsurance and deductibles and other factors. Receivables that are deemed to be uncollectible are written off. The allowance for doubtful accounts balance is assessed on a quarterly basis, with changes in estimated losses being recorded in the Consolidated Statements of Operations in the period identified.

The Company includes the provision for doubtful accounts in operating expenses in its Consolidated Statements of Operations.

Lease Expense

Lease Expense

As of December 31, 2013, the Company operates 34 nursing centers under operating leases, including 25 owned by Omega REIT, six owned by AVIV REIT, and three owned by other parties. The Company's operating leases generally require the Company to pay stated rent, subject to increases based on changes in the Consumer Price Index, a minimum percentage increase, or increases in the net revenues of the leased properties. The Company's Omega leases require the Company to pay certain scheduled rent increases. Such scheduled rent increases are recorded as additional lease expense on a straight-line basis recognized over the term of the related leases and the difference between the amounts recorded for rent expense as compared to rent payments as an accrued liability.

See Notes 3, 4, and 12 for a discussion regarding the Company's Master Lease with Omega, the termination of leases for certain facilities and the addition of certain leased facilities.

Classification of Expenses

Classification of Expenses

The Company classifies all expenses (except lease, interest, depreciation and amortization expenses) that are associated with its corporate and regional management support functions as general and administrative expenses. All other expenses (except lease, professional liability, interest, depreciation and amortization expenses) incurred by the Company at the facility level are classified as operating expenses.

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost with depreciation and amortization being provided over the shorter of the remaining lease term (where applicable) or the assets' estimated useful lives on the straight-line basis as follows:

Buildings and improvements	-	5 to 40 years
Leasehold improvements	-	2 to 10 years
Furniture, fixtures and equipment	-	2 to 15 years

Interest incurred during construction periods for qualifying expenditures is capitalized as part of the building cost. Maintenance and repairs are expensed as incurred, and major betterments and improvements are capitalized. Property and equipment obtained through business combinations are stated at their estimated fair value determined on the respective dates of acquisition.

In accordance with the Financial Accounting Standards Board ("FASB") guidance on “Property, Plant and Equipment,” specifically the discussion around the accounting for the impairment or disposal of long-lived assets, the Company routinely evaluates the recoverability of the carrying value of its long-lived assets, including when significant adverse changes in the general economic conditions and significant deteriorations of the underlying undiscounted cash flows or fair values of the property indicate that the carrying amount of the property may not be recoverable. The need to recognize impairment is based on estimated undiscounted future cash flows from a property compared to the carrying value of that property.

On July 29, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its final rule for skilled nursing facilities effective October 1, 2011, reducing Medicare reimbursement rates for skilled nursing facilities by 11.1% and also making changes to rehabilitation therapy regulations. This final rule had a negative effect on the Company's revenue and costs in Medicare's fiscal year ended September 30, 2012 as compared to Medicare's fiscal year ended September 30, 2011. As a result of this negative impact, an interim impairment analysis was conducted in 2011, and the Company determined that the carrying value of the long-lived assets of one of its leased nursing centers exceeded the fair value.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with banks and all highly liquid investments with original maturities of three months or less when purchased. Our cash on deposit with banks was subject to the Federal Deposit Insurance Corporation ("FDIC") minimum insurance levels. Effective January 1, 2013, the coverage provided by the FDIC that had been unlimited under the Dodd-Frank Deposit Insurance Provision is limited to the legal maximum which is generally $250,000 per ownership category.

Deferred Financing and Other Costs

Deferred Financing and Other Costs

The Company records deferred financing and lease costs for direct and incremental expenditures related to entering into or amending debt and lease agreements. These expenditures include lenders and attorneys fees. Financing costs are amortized using the effective interest method over the term of the related debt. The amortization is reflected as interest expense in the accompanying consolidated statements of operations. Deferred lease costs are amortized on a straight-line basis over the term of the related leases. See Note 7 for further discussion.

Acquired Leasehold Interest

Acquired Leasehold Interest

The Company has recorded an acquired leasehold interest intangible asset related to an acquisition completed during 2007. The intangible asset is accounted for in accordance with the FASB's guidance on goodwill and other intangible assets, and is amortized on a straight-line basis over the remaining life of the acquired lease, including renewal periods, the original period of which is approximately 28 years from the date of acquisition. The lease terms for the seven centers this intangible relates to provide for an initial term and renewal periods at the Company's option through May 31, 2035. As the renewal periods of the acquired leased facilities are solely based on the Company's option, it is expected that costs (if any) to renew the lease through its current amortization period would be nominal and the decision to continue to lease the acquired facilities lies solely within the Company's intent to continue to operate the seven facilities. Any renewal costs would be included in deferred lease costs and amortized over the renewal period. Amortization expense of approximately $384,000 related to this intangible asset was recorded during each of the years ended December 31, 2013, 2012 and 2011, respectively.

The carrying value of the acquired leasehold interest intangible and the accumulated amortization are as follows:

	December 31,
	2013			2012
Intangible assets	$	10,652,000		$	10,652,000
Accumulated amortization	(2,424,000		)	(2,040,000		)
Net intangible assets	$	8,228,000		$	8,612,000

The Company evaluates the recoverability of the carrying value of the acquired leasehold intangible in accordance with the FASB's guidance on accounting for the impairment or disposal of long-lived assets. Included in this evaluation is whether significant adverse changes in general economic conditions, and significant deteriorations of the underlying cash flows or fair values of the intangible asset, indicate that the carrying amount of the intangible asset may not be recoverable. The need to recognize an impairment charge is based on estimated future undiscounted cash flows from the asset compared to the carrying value of that asset. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying amount of the intangible asset exceeds the fair value of the intangible asset.

Self Insurance

Self-Insurance

Self-insurance liabilities primarily represent the unfunded accrual for self insured risks associated with general and professional liability claims, employee health insurance and workers' compensation. The Company's health insurance liability is based on known claims incurred and an estimate of incurred but unreported claims determined by an analysis of historical claims paid. The Company's workers' compensation liability relates primarily to periods of self insurance prior to May 1997 and consists of an estimate of the future costs to be incurred for the known claims.

Final determination of the Company's actual liability for incurred general and professional liability claims is a process that takes years. The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this unfunded accrual. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished by the Company. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company's past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company's ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company's insurers and a third party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator's estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company's evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual has an unfavorable impact on results of operations in the period and any reduction in the accrual increases results of operations during the period.

All losses are projected on an undiscounted basis. The self-insurance liabilities include estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of related legal costs incurred and expected to be incurred.

One of the key assumptions in the actuarial analysis is that historical losses provide an accurate forecast of future losses. Changes in legislation such as tort reform, changes in our financial condition, changes in our risk management practices and other factors may affect the severity and frequency of claims incurred in future periods as compared to historical claims.

The facts and circumstances of each claim vary significantly, and the amount of ultimate liability for an individual claim may vary due to many factors, including whether the case can be settled by agreement, the quality of legal representation, the individual jurisdiction in which the claim is pending, and the views of the particular judge or jury deciding the case.

Although the Company adjusts its unfunded accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company's actual liability for claims incurred in any given period is a process that takes years. As a result, the Company's actual liabilities may vary significantly from the unfunded accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company's reported earnings and financial position for the period in which the change in accrual is made.

Income Tax

Income Taxes

The Company follows the FASB's guidance on Accounting for Income Taxes, which requires the asset and liability method of accounting for income taxes whereby deferred income taxes are recorded for the future tax consequences attributable to differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided against any estimated non-realizable deferred tax assets where necessary.

Where the Company believes that a tax position is supportable for income tax purposes, the item is included in its income tax returns. Where treatment of a position is uncertain, liabilities are recorded based upon the Company’s evaluation of the “more likely than not” outcome considering the technical merits of the position. While the judgments and estimates made by the Company are based on management’s evaluation of the technical merits of a matter, historical experience and other assumptions that management believes are appropriate and reasonable under current circumstances, actual resolution of these matters may differ from recorded estimated amounts, resulting in charges or credits that could materially affect future financial statements. See Note 11 for additional information related to the provision for income taxes.

Disclosure of Fair Value of Financial Instruments

Disclosure of Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. The carrying amounts of cash and cash equivalents, receivables, trade accounts payable and accrued expenses approximate fair value because of the short-term nature of these accounts. The Company's self-insurance liabilities are reported on an undiscounted basis as the timing of estimated settlements cannot be determined.

The Company follows the FASB's guidance on Fair Value Measurements and Disclosures which provides rules for using fair value to measure assets and liabilities as well as a fair value hierarchy that prioritizes the information used to develop the measurements. It applies whenever other guidance requires (or permits) assets or liabilities to be measured at fair value and gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

A summary of the fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels is described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

The Company has not elected to expand the use of fair value measurements for assets and liabilities. It is noted that the assessment of carrying value compared to fair value for impairment analysis, as discussed in Note 2 “Property and Equipment,” follow these fair value principles and hierarchy.

As further discussed in Note 7, in conjunction with the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The applicable guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value in a company's balance sheets.

As the Company's interest rate swap, a cash flow hedge, is not traded on a market exchange, the fair value is determined using a valuation model based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The fair value of the Company's interest rate swap is the net difference in the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates and are observable inputs available to a market participant. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy. The debt balances as presented in the consolidated balance sheets approximate the fair value of the respective instruments, the estimates of which are considered Level 2 fair value calculations within the fair value hierarchy.

The following table presents by level, within the fair value hierarchy, assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012:

December 31, 2013	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(918,000	)	$	—	$	(918,000	)	$	—
December 31, 2012	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(1,484,000	)	$	—	$	(1,484,000	)	$	—

The change in fair value of the Company's cash flow hedge is detailed in the Company's Consolidated Statements of Comprehensive Income (Loss).

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Net Income per Common Share

Net Income (Loss) per Common Share

The Company follows the FASB's guidance on Earnings Per Share for the financial reporting of net income (loss) per common share. Basic earnings per common share excludes dilution and restricted shares and is computed by dividing income available to common shareholders by the weighted-average number of common shares, excluding restricted shares, outstanding for the period. Diluted earnings per common share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise resulted in the issuance of common stock that then shared in the earnings of the Company. See Note 9 for additional disclosures about the Company's Net Income (Loss) per Common Share.

Stock-based Compensation

Stock Based Compensation

The Company follows the FASB's guidance on Stock Compensation to account for share-based payments granted to employees and recorded non-cash stock based compensation expense of $950,000, $573,000 and $528,000 during the years ended December 31, 2013, 2012 and 2011, respectively. Such amounts are included as components of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. See Note 8 for additional disclosures about the Company's stock based compensation plans.

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

Accumulated other comprehensive income consists of other comprehensive income (loss). Comprehensive income (loss) is a more inclusive financial reporting method that includes disclosure of financial information that historically has not been recognized in the calculation of net income (loss). The Company has chosen to present the components of other comprehensive income in a separate statement of comprehensive income (loss). Currently, the Company's other comprehensive income (loss) consists of the change in fair value of the Company's interest rate swap transaction accounted for as a cash flow hedge.

Recent Accounting Guidance

Recent Accounting Guidance

In June 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Comprehensive Income – Presentation of Comprehensive Income,” to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The update eliminates the option to present the components of other comprehensive income as part of the statement of equity. The Company adopted this guidance effective January 1, 2012 and has applied it retrospectively. There was no significant impact to the Company’s consolidated financial statements.

In July 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Health Care Entities: Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities.” This guidance impacts health care entities that recognize significant amounts of patient service revenue at the time the services are rendered even though they do not assess the patient’s ability to pay. This updated guidance requires an impacted health care entity to present its provision for doubtful accounts as a deduction from revenue, similar to contractual discounts. Accordingly, patient service revenue for entities subject to this updated guidance will be required to be reported net of both contractual discounts and provision for doubtful accounts. The updated guidance also requires certain qualitative disclosures about the entity’s policy for recognizing revenue and bad debt expense for patient service transactions. The guidance was effective for the Company starting January 1, 2012. Based on the Company’s assessment of its admission procedures, the Company is not an impacted health care entity under this guidance since it assesses each patient’s ability or the patient’s payor source’s ability to pay. As a result of this assessment, the Company will continue to record bad debt expense as a component of operating expense, and adoption did not have an impact on the Company’s consolidated financial statements.

In July 2012, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Intangibles-Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment.” This guidance is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. This new guidance is an extension of guidance from September 2011 related to the testing of goodwill for impairment. The updated guidance allows an entity the option to first qualitatively assess whether it is more likely than not (that is, a likelihood of more than 50-percent) that an indefinite-lived intangible asset is impaired. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test for other non-amortized intangible assets is required. An entity is not required to perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. It is an entity's option to bypass the qualitative assessment and proceed directly to performing the quantitative impairment test for other non-amortized intangible assets.The guidance is effective for annual and interim impairment tests performed by the Company after January 1, 2013, with earlier implementation permitted. The Company is currently assessing the potential impact and timing of the implementation and believes the adoption will not have a material impact on the Company's consolidated financial statements.

Reclassifications

Reclassifications

As discussed in Note 4, the consolidated financial statements of the Company have been retroactively reclassified for all periods presented to reflect as discontinued operations certain divestitures and lease terminations.

XML

Income Taxes (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended			36 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Income Tax Disclosure [Line Items]
Benefit (provision) of income taxes	$ (3,305)	$ (2,027)	$ 162
Cumulative pre-tax loss from continuing operations	(8,782)	(5,702)	600	(13,884)
Net operating losses	15,148			15,148
Deferred tax benefit to reverse valuation allowance	(448)	7	8
Valuation allowance	1,309			1,309
Hiring Incentives to Restore Employment
Income Tax Disclosure [Line Items]
Employment tax credit			400
Work Opportunity Tax Credit
Income Tax Disclosure [Line Items]
Employment tax credit	1,124	130	600
IRS
Income Tax Disclosure [Line Items]
Operating loss carryforwards limited by change in ownership provisions	$ 10,282			$ 10,282

XML

Consolidated Statements of Shareholders' Equity (USD $) In Thousands, unless otherwise specified	Total	Common Stock	Treasury Stock	Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss	Total Shareholders' Equity of Diversicare Healthcare Services, Inc.	Non- Controlling Interests
Balance at Dec. 31, 2010	$ 22,205	$ 60	$ (2,500)	$ 17,896	$ 6,749	$ 0	$ 22,205	$ 0
Balance, shares at Dec. 31, 2010		5,976	232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
NET INCOME (LOSS)	1,367				1,367		1,367
Preferred stock dividends	(344)				(344)		(344)
Common stock dividends declared	(1,271)			21	(1,292)		(1,271)
Issuance/redemption of equity grants, net (shares)		85
Issuance/redemption of equity grants, net	40	1		39			40
Interest rate cash flow hedge	(945)					(945)	(945)
Tax impact of equity grant exercises	(162)			(162)			(162)
Distributions to noncontrolling interest	1,654							1,654
Stock based compensation	425			425			425
Balance at Dec. 31, 2011	22,969	61	(2,500)	18,219	6,480	(945)	21,315	1,654
Balance, shares at Dec. 31, 2011		6,061	232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
NET INCOME (LOSS)	(2,920)			0	(3,046)		(3,046)	126
Preferred stock dividends	(344)			0	(344)		(344)
Common stock dividends declared	(1,282)			29	(1,311)		(1,282)
Issuance/redemption of equity grants, net (shares)		100
Issuance/redemption of equity grants, net	55	1		54			55
Interest rate cash flow hedge	25			0		25	25
Tax impact of equity grant exercises	(26)			(26)			(26)
Distributions to noncontrolling interest	(207)			0			0	(207)
Stock based compensation	481			481			481
Balance at Dec. 31, 2012	18,751	62	(2,500)	18,757	1,779	(920)	17,178	1,573
Balance, shares at Dec. 31, 2012		6,161	232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
NET INCOME (LOSS)	(8,462)				(8,534)		(8,534)	72
Preferred stock dividends	(344)				(344)		(344)
Common stock dividends declared	(1,301)			35	(1,336)		(1,301)
Issuance/redemption of equity grants, net (shares)		146
Issuance/redemption of equity grants, net	22	1		21			22
Interest rate cash flow hedge	351					351	351
Tax impact of equity grant exercises	(20)			(20)			(20)
Distributions to noncontrolling interest	(208)				0		0	(208)
Stock based compensation	777			777			777
Balance at Dec. 31, 2013	$ 9,566	$ 63	$ (2,500)	$ 19,570	$ (8,435)	$ (569)	$ 8,129	$ 1,437
Balance, shares at Dec. 31, 2013		6,307	232

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts receivable	$ 3,999	$ 3,143
Property and equipment, net (variable interest entity restricted)	6,831	7,144
Current portion of long-term debt and capitalized lease obligations (variable interest entity nonrecourse)	217	206
Long-term debt and capitalized lease obligations, less current portion (variable interest entity non recourse)	$ 5,259	$ 5,472
Redeemable preferred stock, par value (dollars per share)	$ 0.10	$ 0.10
Redeemable preferred stock, shares authorized (shares)	5,000	5,000
Redeemable preferred stock, shares issued (shares)	5,000	5,000
Redeemable preferred stock, shares outstanding (shares)	5,000	5,000
Preferred stock, par value (dollars per share)	$ 0.10	$ 0.10
Preferred stock, shares authorized (shares)	200,000	200,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common stock, par value (dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	20,000,000	20,000,000
Common stock, shares issued (shares)	6,307,000	6,161,000
Common stock, shares outstanding (shares)	6,075,000	5,929,000
Treasury stock, shares (shares)	232,000	232,000

XML

Shareholders' Equity, Stock Plans and Preferred Stock

12 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

SHAREHOLDERS' EQUITY, STOCK PLANS AND PREFERRED STOCK

SHAREHOLDERS' EQUITY, STOCK PLANS AND PREFERRED STOCK

Shareholders' Rights Plan

On August 14, 2009, the Company's Board of Directors amended its current Amended and Restated Rights Agreement (the “Rights Agreement”) which was originally adopted in 1995. The amendment changes the definition of “Acquiring Person” to be such person that acquires 20% or more of the shares of Common Stock of the Company up from the 15% that previously defined an acquiring person. On August 1, 2008, another amendment was approved which provided for an increase of the exercise price of the rights under the Rights Agreement (the “Rights”) to $50 from $15 and for the extension of the expiration date of the Rights to August 2, 2018.

In addition, the amendment includes a share exchange feature that provides the Company's Board of Directors the option of exchanging, in whole or in part, each Right, other than those of the hostile acquiring holder, for one share of the Company's common stock. This provision is intended to avoid requiring Rights holders to pay cash to exercise their Rights and to alleviate the uncertainty as to whether holders will exercise their Rights. The Plan is designed to protect the Company's shareholders from unfair or coercive takeover tactics. The rights may be exercised only upon the occurrence of certain triggering events, including the acquisition of, or a tender offer for, 20% or more of the Company's common stock without the Company's prior approval.

Stock Based Compensation Plans

The Company follows the FASB's guidance on Stock Compensation to account for stock based payments granted to employees and non-employee directors.

Overview of Plans

In December 2005, the Compensation Committee of the Board of Directors adopted the 2005 Long-Term Incentive Plan (“2005 Plan”). The 2005 Plan allows the Company to issue stock options and other share and cash based awards. Under the 2005 Plan, 700,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted thereunder. All grants under this plan expire 10 years from the date the grants were authorized by the Board of Directors.

In June 2008, the Company adopted the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel (“Stock Purchase Plan”). The Stock Purchase Plan provides for the granting of rights to purchase shares of the Company's common stock to directors and officers and 150,000 shares of the Company's common stock has been reserved for issuance under the Stock Purchase Plan. The Stock Purchase Plan allows participants to elect to utilize a specified portion of base salary, annual cash bonus, or director compensation to purchase restricted shares or restricted share units (“RSU's”) at 85% of the quoted market price of a share of the Company's common stock on the date of purchase. The restriction period under the Stock Purchase Plan is generally two years from the date of purchase and during which the shares will have the rights to receive dividends, however, the restricted share certificates will not be delivered to the shareholder and the shares cannot be sold, assigned or disposed of during the restriction period. No grants can be made under the Stock Purchase Plan after April 25, 2018.

In April 2010, the Compensation Committee of the Board of Directors adopted the 2010 Long-Term Incentive Plan (“2010 Plan”), followed by approval by the Company's shareholders in June 2010. The 2010 Plan allows the Company to issue stock appreciation rights, stock options and other share and cash based awards. Under the 2010 Plan, 380,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted.

Equity Grants and Valuations

During 2013, the Compensation Committee of the Board of Directors approved grants totaling approximately 69,000 shares of restricted common stock to certain employees and members of the Board of Directors. These restricted shares vest one-third on the first, second and third anniversaries of the grant date. Also during 2012, the Compensation Committee of the Board of Directors approved grants of shares of restricted common stock to certain employees and members of the Board of Directors. A portion of these restricted shares vest 33% on the first, second and third anniversaries of the grant date, while another portion vested 33% upon grant and on the first and second anniversaries of the grant date. Unvested shares may not be sold or transferred. During the vesting period, dividends accrue on the restricted shares, but are paid in additional shares of common stock upon vesting, subject to the vesting provisions of the underlying restricted shares. The restricted shares are entitled to the same voting rights as other common shares. Upon vesting, all restrictions are removed.

During 2012 and 2011, the Compensation Committee of the Board of Directors approved the grant of Stock Only Stock Appreciation Rights (“SOSARs”) at the market price of the Company's common stock on the grant date. The SOSARs vest one-third on the first, second and third anniversaries of the grant date. The SOSARs are valued and recorded in the same manner as stock options, and will be settled with issuance of new stock for the difference between the market price on the date of exercise and the exercise price.

The Company recorded non-cash stock-based compensation expense from continuing operations for equity grants and RSU's issued under the Plans of $950,000, $573,000, and $528,000 during the years ended December 31, 2013, 2012, and 2011, respectively. Such amounts are included as components of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. As of December 31, 2013, there was $254,000 in unrecognized compensation costs related to stock-based compensation to be recognized over the applicable remaining vesting periods. The Company estimated the total recognized and unrecognized compensation using the Black-Scholes-Merton equity grant valuation model.

The table below shows the weighted average assumptions the Company used to develop the fair value estimates under its option valuation model:

	Year Ended December 31,
	2013	2012	2011
Expected volatility (range)	N/A(1)	58% - 59%	59% - 60%
Risk free interest rate (range)	N/A(1)	0.80% - 1.03%	1.02% - 1.30%
Expected dividends	N/A(1)	3.75%	3.93%
Weighted average expected term (years)	N/A(1)	6	6

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

In computing the fair value estimates using the Black-Scholes-Merton valuation model, the Company took into consideration the exercise price of the equity grants and the market price of the Company's stock on the date of grant. The Company used an expected volatility that equals the historical volatility over the most recent period equal to the expected life of the equity grants. The risk free interest rate is based on the U.S. treasury yield curve in effect at the time of grant. The Company used the expected dividend yield at the date of grant, reflecting the level of annual cash dividends currently being paid on its common stock.

In computing the fair value of these equity grants, the Company estimated the equity grants' expected term based on the average of the vesting term and the original contractual terms of the grants, consistent with the Securities and Exchange Commission's interpretive guidance often referred to as the “Simplified Method.” The Company continues to use the Simplified Method since the Company's exercise history is not representative of the expected term of the equity granted in 2011. The Company's recent exercise history is primarily from options granted in 2005 that were vested at grant date and were significantly in-the-money due to an increase in stock price during the period between grant date and formal approval by shareholders, and from older options granted several years ago that had fully vested.

The table below describes the resulting weighted average grant date fair values calculated as well as the intrinsic value of options exercised under the Company's equity awards during each of the following years:

	Year Ended December 31,
	2013(1)		2012		2011
Weighted average grant date fair value	—		$	2.29	$	2.19
Total intrinsic value of exercises	$	53,000	$	12,000	$	87,000

___________

(1) The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the year ended December 31, 2013. All current year equity grants were restricted common shares which are valued using an intrinsic valuation method.

The following table summarizes information regarding stock options and SOSAR grants outstanding as of December 31, 2013:

	Weighted
	Average			Intrinsic			Intrinsic
Range of	Exercise		Grants	Value-Grants		Grants	Value-Grants
Exercise Prices	Prices		Outstanding	Outstanding		Exercisable	Exercisable
$10.40 to $11.59	$	11.14	73,000	$	—	73,000	$	—
$2.37 to $6.21	$	5.37	260,000	48,000		200,000	48,000
			333,000			273,000

As of December 31, 2013, the outstanding equity grants have a weighted average remaining life of 5.33 years and those outstanding equity grants that are exercisable have a weighted average remaining life of 4.79 years. During the year ended December 31, 2013, approximately 18,000 stock option and SOSAR grants were exercised under these plans. All of the equity grants exercised were net settled, therefore no proceeds were contributed.

Summarized activity of the equity compensation plans is presented below:

			Weighted
			Average
	Shares		Exercise Price
Outstanding, December 31, 2012	461,000		$	6.62
Granted	—		—
Exercised	(18,000	)	2.37
Expired or cancelled	(110,000	)	7.25
Outstanding, December 31, 2013	333,000		$	6.64
Exercisable, December 31, 2013	273,000		$	6.84

			Weighted
			Average
	Restricted		Grant Date
	Shares		Fair Value
Outstanding, December 31, 2012	94,000		$	6.00
Granted	69,000		5.01
Dividend Equivalents	6,000		4.85
Vested	(37,000	)	6.02
Cancelled	(14,000	)	5.53
Outstanding December 31, 2013	118,000		$	5.41

Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:

			Weighted
			Average
	Restricted		Grant Date
	Share Units		Fair Value
Outstanding, December 31, 2012	52,000		$	6.24
Granted	23,000		5.01
Dividend Equivalents	2,000		4.85
Vested	(36,000	)	6.40
Cancelled	—		—
Outstanding December 31, 2013	41,000		$	5.35

Series A Preferred Stock

The Company is authorized to issue up to 200,000 shares of Series A Preferred Stock. The Company's Board of Directors is authorized to establish the terms and rights of each series, including the voting powers, designations, preferences, and other special rights, qualifications, limitations, or restrictions thereof.

Series B and Series C Redeemable Preferred Stock

As part of the consideration paid to Omega for restructuring the terms of the Omega Master Lease in November 2000, the Company issued to Omega 393,658 shares of the Company's Series B Redeemable Convertible Preferred Stock (“Series B Preferred Stock”) with a stated value of $3,300,000 and an annual dividend rate of 7% of the stated value. In October 2006, the Company and Omega entered into a Restructuring Stock Issuance and Subscription Agreement (“Restructuring Agreement”) to restructure the Series B Preferred Stock, eliminating the option of Omega to convert the Series B Preferred Stock into shares of Diversicare (formerly Advocat) common stock.

At the time of the Restructuring Agreement, the Series B Preferred Stock had a recorded value (including accrued dividends) of approximately $4,918,000 and was convertible into approximately 792,000 shares of common stock. The Company issued 5,000 shares of a new Series C Redeemable Preferred Stock (“Series C Preferred Stock”) to Omega in exchange for the 393,658 shares of Series B Preferred Stock held by Omega. The new Series C Preferred Stock has a stated value of approximately $4,918,000 and an annual dividend rate of 7% of its stated value payable quarterly in cash. The Series C Preferred Stock is not convertible, but has been redeemable at its stated value at Omega's option since September 30, 2010, and since September 30, 2007, has been redeemable at its stated value at the Company's option. Redemption under the Company's or Omega's option is subject to certain limitations.

In connection with the termination of the conversion feature, the Company agreed to pay Omega an additional $687,000 per year under the Lease Amendment. The additional annual payments of $687,000 were discounted over the twelve year term of the renewal to arrive at a net present value of $6,701,000, the preferred stock premium. The Company recorded the fair value of the elimination of the conversion feature as a reduction in Paid In Capital with an offsetting increase to record a premium on the Series C Preferred Stock. As a result, the Series C Preferred Stock was initially recorded at a total value of $11,619,000, equal to the stated value of the Series B Preferred Stock, $4,918,000, plus the value of the conversion feature, $6,701,000 which was fully amortized in 2010. The stated value of the preferred stock is classified as temporary equity and the additional obligation is classified as a noncurrent in the accompanying consolidated balance sheet. As the related cash payments were made, the preferred stock premium was reduced and interest expense was recorded.

The Series C Preferred Stock shares have preference in liquidation but do not have voting rights. The total redemption value is equal to the stated value plus any accrued but unpaid dividends. The liquidation preference value is equal to the redemption value. The following table reflects activity in the Series C Preferred Stock:

Series C Preferred Stock
	2013	2012	2011
Balance at the beginning of the period	$4,918,000	$4,918,000	$4,918,000
Amortization of preferred stock premium	—	—	—
Balance at the end of the period	$4,918,000	$4,918,000	$4,918,000

XML

Document and Entity Information (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Feb. 14, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	DIVERSICARE HEALTHCARE SERVICES, INC.
Entity Central Index Key	0000919956
Document Type	10-K
Document Period End Date	Dec. 31, 2013
Amendment Flag	false
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY
Document Fiscal Period Focus	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,086,344
Entity Public Float			$ 18,480

XML

Earnings (Loss) Per Common Share

12 Months Ended

Dec. 31, 2013

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER COMMON SHARE

NET INCOME (LOSS) PER COMMON SHARE

Information with respect to the calculation of basic and diluted net income (loss) per common share is presented below:

	Years Ended December 31,
	2013			2012			2011
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
Income (loss) from continuing operations	$	(5,477,000	)	$	(3,675,000	)	$	438,000
Less: net income attributable to noncontrolling interests	(72,000		)	(126,000		)	—
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.	(5,549,000		)	(3,801,000		)	438,000
Preferred stock dividends	(344,000		)	(344,000		)	(344,000		)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Denominator: Basic Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,774,000
Basic net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.16
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.16
Basic net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.18

	2013			2012			2011
Numerator: Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders	(5,893,000		)	(4,145,000		)	94,000
Income (loss) from discontinued operations, net of income taxes	(2,985,000		)	755,000			929,000
Net income (loss) attributable to Diversicare Healthcare Services, Inc. Shareholders	$	(8,878,000	)	$	(3,390,000	)	$	1,023,000
Basic weighted average common shares outstanding	5,899,000			5,821,000			5,774,000
Incremental shares from assumed exercise of options, SOSARS and Restricted Stock Units	—			—			132,000
Denominator: Diluted Weighted Average Common Shares Outstanding:	5,899,000			5,821,000			5,906,000
Diluted net income per common share
Income (loss) from continuing operations	$	(1.00	)	$	(0.71	)	$	0.02
Income from discontinued operations
Operating income, net of taxes	(0.51		)	0.10			0.15
Gain (loss) on disposal, net of taxes	—			0.03			—
Discontinued operations, net of taxes	(0.51		)	0.13			0.15
Diluted net income (loss) per common share	$	(1.51	)	$	(0.58	)	$	0.17

The dilutive effects of the Company's stock options, SOSARs, Restricted Shares and Restricted Share Units are included in the computation of diluted income per common share during the periods they are considered dilutive.

The following table reflects the weighted average outstanding SOSARs and Options that were excluded from the computation of diluted earnings per share, as they would have been anti-dilutive:

	2013	2012	2011
SOSARs/Options Excluded	310,000	348,000	202,000

The weighted average common shares for basic and diluted earnings for common shares were the same due to the losses in 2013 and 2012.

XML

Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
PATIENT REVENUES, net	$ 281,919	$ 246,290	$ 245,877
EXPENSES:
Operating	228,342	197,960	194,152
Lease and rent expense	21,542	19,050	18,064
Professional liability	7,336	6,102	3,618
General and administrative	20,940	19,515	21,024
Depreciation and amortization	6,972	6,276	5,607
Asset impairment	0	0	344
Restructuring	1,446	0	0
Total expenses	286,578	248,903	242,809
OPERATING INCOME (LOSS)	(4,659)	(2,613)	3,068
OTHER INCOME (EXPENSE):
Equity in net losses of unconsolidated affiliate	(183)	(280)	0
Interest expense, net	(3,620)	(2,809)	(2,356)
Debt retirement costs	(320)	0	(112)
Total other income (expense)	(4,123)	(3,089)	(2,468)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(8,782)	(5,702)	600
BENEFIT (PROVISION) FOR INCOME TAXES	3,305	2,027	(162)
INCOME (LOSS) FROM CONTINUING OPERATIONS	(5,477)	(3,675)	438
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating income (loss), net of tax provision (benefit) of $(1,754,000), $291,000 and $341,000, respectively	(2,985)	581	929
Gain on disposal and impairment, net of tax provision of $0, $107,000 and $0, respectively	0	174	0
DISCONTINUED OPERATIONS	(2,985)	755	929
NET INCOME (LOSS)	(8,462)	(2,920)	1,367
Less: net income attributable to noncontrolling interests	(72)	(126)	0
NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.	(8,534)	(3,046)	1,367
PREFERRED STOCK DIVIDENDS	(344)	(344)	(344)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS	$ (8,878)	$ (3,390)	$ 1,023
Per common share – basic
Continuing operations (in dollars per share)	$ (1.00)	$ (0.71)	$ 0.02
Discontinued operations (in dollars per share)	$ (0.51)	$ 0.13	$ 0.16
Net income (loss) (in dollars per share)	$ (1.51)	$ (0.58)	$ 0.18
Per common share – diluted
Continuing operations (in dollars per share)	$ (1.00)	$ (0.71)	$ 0.02
Discontinued operations (in dollars per share)	$ (0.51)	$ 0.13	$ 0.15
Net income (loss) (in dollars per share)	$ (1.51)	$ (0.58)	$ 0.17
DIVIDENDS DECLARED PER SHARE OF COMMON STOCK	$ 0.22	$ 0.22	$ 0.215
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	5,899	5,821	5,774
Diluted (shares)	5,899	5,821	5,906

XML

Discontinued Operations

12 Months Ended

Dec. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

Effective September 1, 2013, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in the state of Arkansas, and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Thirteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.

As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying consolidated financial statements. These centers contributed revenues of $40,151,000, $61,782,000, and $63,589,000 during the twelve months ended December 31, 2013, 2012, and 2011, respectively. Further, these centers contributed net loss of $2,865,000 during the twelve months ended December 31, 2013, and net income of $457,000 and $540,000 during the twelve months ended December 31, 2012 and 2011, respectively.  The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations. In addition to the expenses associated with the discontinued operations, the Company also incurred $1,446,000 in restructuring expenses that represent corporate expenses and exit costs associated with the Arkansas lease termination, but not classified as discontinued operations.

Effective September 1, 2012, we sold an owned skilled nursing center in Arkansas to an unrelated party and have reclassified the operations of this facility as discontinued operations for all periods presented in the accompanying consolidated financial statements. The operating margins and the long-term business prospects of the nursing center did not meet our strategic goals. This skilled nursing center contributed revenues of $0, $3,463,000, and $5,249,000, and net income (loss) of $(85,000), $68,000, and $198,000 during the twelve months ended December 31, 2013, 2012, and 2011, respectively.  The net income (loss) for the nursing center included in discontinued operations does not reflect any allocation of regional or corporate general and administrative expense or any allocation of corporate interest expense. We considered these additional costs along with the future prospects of this nursing center when determining the contribution of the skilled nursing center to our operations. The gain on disposal, net of taxes, of $174,000 was primarily the amount of sales price in excess of the net carrying value of the fixed assets sold.

The Company owns land related to a North Carolina assisted living facility it closed in April 2006. The net assets of discontinued operations presented in property and equipment on the accompanying consolidated balance sheet of $1,053,000 represents the real estate related to this assisted living facility. The Company is continuing its efforts to sell this land. The fair value of the subject property was determined based on comparable properties in the area and considered a level 2 calculation under the fair value hierarchy as discussed in Note 2.

A summary of the discontinued operations for the periods presented is as follows (in thousands):

	December 31,
	2013			2012			2011
Net revenues	$	40,151,000		$	65,245,000		$	68,838,000
Operating expenses	(44,890,000		)	(64,373,000		)	(67,568,000		)
Gain from disposal of assets	—			281,000			—
Income (loss) from discontinued operations	(4,739,000		)	1,153,000			1,270,000
Benefit (provision) for income taxes	1,754,000			(398,000		)	(341,000		)
Income (loss) from discontinued operations, net of tax	$	(2,985,000	)	$	755,000		$	929,000

XML

Business Development

12 Months Ended

Dec. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BUSINESS DEVELOPMENT AND DISCONTINUED OPERATIONS

COMPANY AND ORGANIZATION

Diversicare Healthcare Services, Inc. (together with its consolidated subsidiaries, “Diversicare” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast and Southwest. The Company’s centers provide a range of health care services to their patients and residents. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers offer a variety of comprehensive rehabilitation services as well as nutritional support services.

As of December 31, 2013, the Company’s continuing operations consist of 47 nursing centers with 5,318 licensed nursing beds. The Company owns 13 and leases 34 of its nursing centers. The nursing center and licensed nursing bed count includes the Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013. The nursing center and licensed bed count includes the 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicaid and Medicare certification processes for this facility are currently in progress and expected to be completed in the first quarter of 2014. The nursing center and licensed nursing bed count also includes 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes are currently under way for these four leased facilities. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Ohio, Tennessee, Texas and West Virginia.

BUSINESS DEVELOPMENT

Kansas Acquisition

On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities commenced on May 1, 2013. The five facilities acquired under the Agreement include the following:

• 77-bed skilled nursing facility known as Chanute HealthCare Center

• 80-bed skilled nursing facility known as Council Grove HealthCare Center

• 119-bed skilled nursing facility known as Haysville HealthCare Center

• 80-bed skilled nursing facility known as Larned HealthCare Center

• 62-bed skilled nursing facility known as Sedgwick HealthCare Center

As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired identifiable net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The Company also incurred $338,000 in acquisition-related expenses that were expensed as incurred. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

	As of May 1, 2013
Purchase Price	$	15,500,000
Land	2,130,000
Buildings	12,127,000
Furniture, fixtures, and equipment	1,200,000
Inventory	43,000
Less: Liabilities assumed	758,000
Total cash paid	$	14,742,000

Since finalizing the purchase, the aforementioned facilities have contributed $15,440,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Lease Agreements

On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT and the lease provides for an initial 15-year lease term with a 5-year renewal option. This additional skilled nursing center increases the Company's footprint in Kentucky to nine nursing centers. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center. Since assuming operations at this facility, the aforementioned facility has contributed $3,487,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

Additionally, on October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana, and increasing our presence in Ohio to four nursing centers. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. Since assuming operations at this facility, the aforementioned facilities have contributed $9,225,000 in revenue to the consolidated statement of operations during the twelve-month period ended December 31, 2013.

In April 2012, the Company entered into a lease agreement to operate an 88-bed skilled nursing center in Clinton, Kentucky. The center is subject to a mortgage insured through the United States Department of Housing and Urban Development. The lease has an initial ten-year term with twofive-year renewal options and contains an option to purchase the property for $3.3 million during the first five years. The center had not had residents since April 2011 after being de-certified by Medicare and Medicaid. The lease agreement called for a $125,000 lease commencement fee and the transaction is considered a lease agreement.

Separate from the above lease transaction, in September 2012, the Company announced it entered into a lease agreement to operate a 154-bed skilled nursing center in Louisville, Kentucky. The nursing center is owned by a real estate investment trust and the lease provides for an initial fifteen-year lease term with a five-year renewal option. This additional skilled nursing center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.

XML

Schedule II - Valuation of Qualifying Accounts

12 Months Ended

Dec. 31, 2013

Valuation and Qualifying Accounts [Abstract]

SCHEDULE II - VALUATION OF QUALIFYING ACCOUNTS

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

OF CONTINUING OPERATIONS

(in thousands)

Column A	Column B		Column C			Column D	Column E
			Additions			Deductions
Description	Balance at Beginning of Period	Charged to Costs and Expenses		Charged to Other Accounts	Other	(Write-offs) net of Recoveries	Balance at End of Period
Year ended December 31, 2013: Allowance for doubtful accounts	$3,143		$4,191	$—	$—	$(3,335)	$3,999
Year ended December 31, 2012: Allowance for doubtful accounts	$2,233		$3,064	$—	$—	$(2,154)	$3,143
Year ended December 31, 2011: Allowance for doubtful accounts	$2,277		$1,780	$—	$—	$(1,824)	$2,233

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Column A	Column B	Column C			Column D	Column E
			Additions		Deductions
Description	Balance at Beginning of Period	Charged to Costs and Expenses	Charged to Other Accounts (2)	Other	Payments (1)	Balance at End of Period
Year ended December 31, 2013:
Professional Liability Reserve	$22,740	$6,530	$3,163	$—	$(5,366)	$27,067
Workers Compensation Reserve	$287	$473	$—	$(87)	$(497)	$176
Health Insurance Reserve	$679	$9,095	$105	$—	$(9,036)	$843
Year ended December 31, 2012:
Professional Liability Reserve	$19,357	$5,617	$448	$—	$(2,682)	$22,740
Workers Compensation Reserve	$309	$142	$—	$311	$(475)	$287
Health Insurance Reserve	$853	$7,207	$—	$—	$(7,381)	$679
Year ended December 31, 2011:
Professional Liability Reserve	$17,251	$3,069	$2,848	$—	$(3,811)	$19,357
Workers Compensation Reserve	$346	$1,323	$—	$(257)	$(1,103)	$309
Health Insurance Reserve	$1,003	$7,247	$—	$—	$(7,397)	$853

(1) Payments for the Professional Liability Reserve include amounts paid for claims settled during the period as well as payments made under structured arrangements for claims settled in earlier periods.

(2) As discussed in Note 4 of the Consolidated Financial Statements, the Company has presented the results of certain divestiture and lease termination transactions as discontinued operations. The amounts charged to Other Accounts represent the amounts charged to discontinued operations.

XML

Income Taxes

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

Overview

For the year ended December 31, 2013, the Company recorded a benefit for income taxes from continuing operations of $3,305,000 compared to a benefit of $2,027,000 in 2012 and a provision of $162,000 in 2011. The provision (benefit) for income taxes of continuing operations is composed of the following components:

	Year Ended December 31,
	2013			2012			2011
Current provision (benefit) :
Federal	$	(61,000	)	$	(349,000	)	$	55,000
State	23,000			13,000			171,000
	(38,000		)	(336,000		)	226,000
Deferred provision (benefit):
Federal	(3,467,000		)	(1,450,000		)	(76,000		)
State	200,000			(241,000		)	12,000
	(3,267,000		)	(1,691,000		)	(64,000		)
Provision (benefit) for income taxes of continuing operations
	$	(3,305,000	)	$	(2,027,000	)	$	162,000

A reconciliation of taxes computed at statutory income tax rates on income (loss) from continuing operations is as follows:

	Year Ended December 31,
	2013			2012			2011
Provision (benefit) for federal income taxes at statutory rates	$	(2,986,000	)	$	(1,967,000	)	$	277,000
Provision (benefit) for state income taxes, net of federal benefit	(147,000		)	(175,000		)	128,000
Resolution with tax authorities	—			—			(79,000		)
Valuation allowance changes affecting the provision for income taxes	448,000			(7,000		)	(8,000		)
Employment tax credits	(1,124,000		)	(130,000		)	(1,000,000		)
Nondeductible expenses	334,000			254,000			437,000
Stock based compensation expense	9,000			13,000			410,000
Other	161,000			(15,000		)	(3,000		)
Provision (benefit) for income taxes of continuing operations	$	(3,305,000	)	$	(2,027,000	)	$	162,000

Deferred Taxes

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets are reduced by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will realize only some portion of the deferred tax assets. The net deferred tax assets and liabilities, at the respective income tax rates, are as follows:

	December 31,
	2013			2012
Current deferred tax assets:
Credit carryforwards	$	—		$	251,000
Net operating loss and other carryforwards	643,000			352,000
Allowance for doubtful accounts	1,788,000			1,447,000
Accrued liabilities	5,126,000			4,236,000
	7,557,000			6,286,000
Less valuation allowance	(377,000		)	(242,000		)
	7,180,000			6,044,000
Current deferred tax liabilities:
Prepaid expenses	(601,000		)	(739,000		)
	$	6,579,000		$	5,305,000

	December 31,
	2013			2012
Noncurrent deferred tax assets:
Net operating loss and other carryforwards	$	3,389,000		$	1,365,000
Credit carryforwards	2,210,000			964,000
Deferred lease costs	289,000			356,000
Depreciation	(634,000		)	(2,036,000		)
Tax goodwill and intangibles	(879,000		)	(739,000		)
Stock-based compensation	882,000			1,238,000
Accrued rent	4,219,000			4,538,000
Kansas acquisition costs	125,000			—
Impairment of long-lived assets	472,000			659,000
Interest rate swap	349,000			564,000
Noncurrent self-insurance liabilities	6,422,000			6,062,000
	16,844,000			12,971,000
Less valuation allowance	(932,000		)	(619,000		)
	$	15,912,000		$	12,352,000

Deferred Tax Valuation Allowance

The assessment of the amount of value assigned to our deferred tax assets under the applicable accounting standards is highly judgmental. We are required to consider all available positive and negative evidence in evaluating the likelihood that we will be able to realize the benefit of our deferred tax assets in the future. Such evidence includes scheduled reversals of deferred tax assets and liabilities, projected future taxable income, tax-planning strategies, and the results of recent operations. Since this evaluation requires consideration of historical and future events, there is significant judgment involved, and our conclusion could be materially different should certain of our expectations not transpire.

When assessing all available evidence, we consider the weight of the evidence, both positive and negative, based on the objectivity of the underlying evidence and the extent to which it can be verified. For the three-year period ended December 31, 2013, the Company has a cumulative pre-tax loss from continuing operations of $13,884,000, of which $8,782,000 is attributable to the year ended December 31, 2013. Additionally, the Company recognized governmental and regulatory changes have put downward revenue pressure on the long-term care industry as a piece of negative evidence in our analysis. As a result of this negative evidence, the Company performed a thorough assessment of the available positive and negative evidence in order to ascertain whether it is more-likely-than-not that in future periods the Company will generate sufficient pre-tax income to utilize all of our federal deferred tax assets and our net operating loss and other carryforwards and credits. State deferred tax assets are considered for valuation separately and on a state-by-state basis.

The Company also identified several pieces of objective positive evidence which were considered and weighed in the analysis performed regarding the valuation of deferred tax assets, including, but not limited to the degree to which nonrecurring expenses caused the last three year cumulative pre-tax loss, the expected accretive strategic acquisitions completed by us during 2012 and 2013, corporate and regional restructuring expected to reduce costs while maintaining revenue levels, our results from operations for the fourth quarter of 2013, the long-term expiration dates of a majority of the net operating losses and credits, our history of not having carryforwards or credits expire unutilized, and the completed divestiture of the facilities in Arkansas in 2013. The operations in the state of Arkansas demonstrated a trend of growing losses in recent years primarily as a result of disproportionate amount of professional liability expense relative to the revenue contributed.

In performing the analysis, the Company contemplated utilization of the deferred tax assets under multiple scenarios. After consideration of these factors, the Company determined that it was more likely than not that future taxable income would be sufficient to realize substantially all of the recorded value of the Company's deferred tax assets for federal income tax purposes.

Realization of the deferred tax assets is not assured and future events could result in a change in judgment. If future events result in a conclusion that realization is no longer more likely than not to occur, the Company would be required to establish a valuation allowance on the deferred tax assets at that time, which would result in a charge to income tax expense and a potentially material decrease in net income in the period in which the factors change our judgment.

At December 31, 2013, the Company had $15,148,000 of net operating losses, which expire at various dates beginning in 2019 and continue through 2033. The use of a portion of these loss carryforwards is limited by change in ownership provisions of the Federal tax code to a maximum of approximately $10,282,000. The Company has reduced the deferred tax asset and the corresponding valuation allowances for net operating loss deductions permanently lost as a result of the change in ownership provisions.

With respect to state deferred tax assets, the Company recorded an additional valuation allowance of approximately $448,000 in 2013, primarily related to existing deferred tax assets for the state of Arkansas that will not be utilized as a result of our exit from the state as explained in Note 4. In 2012 and 2011, the Company recorded a deferred tax benefit to reverse approximately $7,000 and $8,000, respectively, of the valuation allowance on state deferred tax assets. The changes in valuation allowance were based on the Company's assessment of the realization of certain individual tax assets. The Company has recorded a total valuation allowance of approximately $1,309,000 at December 31, 2013 to reduce the deferred tax assets by the amount management believes is more likely than not to not be realized through the turnaround of existing temporary differences, future earnings, or a combination thereof.

During 2011, the Company recorded an estimated $400,000 in employment tax credits under the Hiring Incentives to Restore Employment (HIRE) Act which provided a one-time tax credit. In addition, under the Work Opportunity Tax Credit ("WOTC") program the Company recorded $1,124,000, $130,000 and $600,000 in Work Opportunity Tax Credits during 2013, 2012 and 2011, respectively. In January 2013, the American Taxpayer Relief Act of 2012 (Act) was signed into law. The Act retroactively reinstated the federal Work Opportunity Tax Credit for qualifying costs paid during 2012. Pursuant to ASC 740-10-25-47 the effect of changes in the tax laws including retroactive changes are recognized in the period the law was enacted. As a result of the retroactive treatment, the Company claimed the WOTC on its 2012 tax return, and the benefit of the credit was recognized in the financial statements during 2013. The remaining WOTC credit carryforwards expire at various dates beginning in 2030 and continue through 2033.

Unrecognized Tax Benefits and Liabilities

The Company follows the FASB's guidance on financial statement recognition and measurement of tax positions taken, or expected to be taken, in tax returns evaluating the need to recognize or unrecognize uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2013		2012			2011
Balance at the beginning of the period	$	—	$	86,000		$	84,000
Changes in tax positions for prior years	—		(86,000		)	2,000
Balance at the end of the period	$	—	$	—		$	86,000

The Company records the liabilities associated with our unrecognized tax benefits in “other current liabilities” on the consolidated balance sheet. The net change in the amount of unrecognized tax benefits during the years ended December 31, 2012 and 2011 was related primarily to the adjustment of the estimated liability. Further, the Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statements of operations.

As of December 31, 2013, the Company has no open or pending audits underway by regulatory authorities.

XML

Long-Term Debt, Interest Rate Swap, and Capitalized Lease Obligations

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

LONG-TERM DEBT, INTEREST RATE SWAP AND CAPITALIZED LEASE OBLIGATIONS

LONG-TERM DEBT, INTEREST RATE SWAP AND CAPITALIZED LEASE OBLIGATIONS

Long-term debt consists of the following:

	December 31,
	2013			2012
Mortgage loan with a syndicate of banks; issued in March 2011, amended May 2013; payable monthly, interest at 4.5% above LIBOR, a portion of which is fixed at 6.87% based on the interest rate swap described below.	$	44,434,000		$	22,313,000
Revolving credit facility borrowings payable to a bank; entered into in March 2010; amended in March 2011 and further amended May 2013 as described below; secured by receivables of the Company; interest at 4.5% above LIBOR.	3,000,000			—
Commercial loan of consolidated VIE, payable by variable interest entity landlord to a bank; issued in January 2011; payable monthly, fixed interest rate of 5.3%.	5,476,000			5,678,000
	52,910,000			27,991,000
Less current portion	(4,211,000		)	(631,000		)
	$	48,699,000		$	27,360,000

As of December 31, 2013, the Company's weighted average interest rate on long-term debt, including the impact of the interest rate swap, was approximately 6.61%.

The Company has agreements with a syndicate of banks for a mortgage term loan ("Original Mortgage Loan") and the Company’s revolving credit agreement ("Original Revolver"). On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to $65,000,000 allocated between a $45,000,000 Mortgage Loan ("Amended Mortgage Loan") and a $20,000,000 Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of $1,341,000 and are being amortized over the 5-year term of the agreements. Loan acquisition costs of $320,000 associated with the Original Mortgage Loan were written off as a result of this transaction, and are recorded in Debt Retirement Costs in the Consolidated Statement of Operations.

Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of $45,000,000 with a 5-year maturity through April 30, 2018, and a $20,000,000 Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of 5 years, with principal and interest payable monthly based on a 25-year amortization. Interest is based on LIBOR plus 4.5%. A portion of the Amended Mortgage Loan is effectively fixed at 6.87% pursuant to an interest rate swap with a notional amount of $22,217,000. As of December 31, 2013, the interest rate related to the Amended Mortgage Loan was 4.67%. The Amended Mortgage Loan is secured by 13 owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized.

The Amended Revolver is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions. As of December 31, 2013, the Company had $3,000,000 borrowings outstanding under the revolving credit facility. Annual fees for letters of credit issued under this Revolver are 3.00% of the amount outstanding. The Company has five letters of credit with a total value of $6,957,000 outstanding as of December 31, 2013. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $20,000,000, the balance available for borrowing under the revolving credit center is $10,043,000 at December 31, 2013. The Company’s Amended Revolver has an interest rate of LIBOR plus 4.5%.

The Company’s debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. Compliance with financial covenants restricts the Company's ability to pay dividends. The Company is in compliance with all such covenants at December 31, 2013.

The Company has consolidated $5,476,000 and $5,678,000 at December 31, 2013 and 2012, respectively, in debt that is owed by the variable interest entity that owns the West Virginia nursing center described in Note 8. The borrower is subject to covenants concerning total liabilities to tangible net worth as well as current assets compared to current liabilities. The borrower is in compliance with all such covenants at December 31, 2013. The borrower’s liabilities do not provide creditors with recourse to the general assets of the Company.

In connection with the Company's 2013 and 2012 financing agreements the Company recognized the following debt retirement costs related to the write off of deferred financing on the existing financing agreements and recorded new deferred loan costs related the new financing agreements as follows:

	2013		2012
Write-off of deferred financing costs	$	320,000	$	—
Deferred financing costs capitalized	$	1,341,000	$	34,000

Scheduled principal payments of long-term debt are as follows:

2014	$	4,211,000
2015	1,268,000
2016	6,119,000
2017	1,145,000
2018	40,167,000
Thereafter	—
Total	$	52,910,000

Interest Rate Swap Cash Flow Hedge

As part of the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The Company entered into the interest rate swap agreement to mitigate the variable interest rate risk on its outstanding mortgage borrowings. The Company designated its interest rate swap as a cash flow hedge and the effective portion of the hedge, net of taxes, is reflected as a component of other comprehensive income (loss). In conjunction with the aforementioned amendment to the Credit Agreement that occurred in May 2013, the Company retained the previously agreed upon interest rate swap modifying the terms of the swap to reflect the amended Credit Agreement. The Company redesignated the interest rate swap as a cash flow hedge. The interest rate swap agreement has the same effective date and maturity date as the Amended Mortgage Loan, and carries a notional amount of $22,217,000 as of December 31, 2013. The interest rate swap agreement requires the Company to make fixed rate payments to the bank calculated on the applicable notional amount at an annual fixed rate of 6.87% while the bank is obligated to make payments to the Company based on LIBOR on the same notional amounts. The applicable guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value in a company's balance sheets.

The Company assesses the effectiveness of its interest rate swap on a quarterly basis and at December 31, 2013, the Company determined that the interest rate swap was effective. The interest rate swap valuation model indicated a net liability of $918,000 at December 31, 2013. The fair value of the interest rate swap is included in “other noncurrent liabilities” on the Company's consolidated balance sheet. The balance of accumulated other comprehensive loss at December 31, 2013, is $569,000 and reflects the liability related to the interest rate swap, net of the income tax benefit of $349,000. As the Company's interest rate swap is not traded on a market exchange, the fair value is determined using a valuation model based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The fair value of the Company's interest rate swap is the net difference in the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates and are observable inputs available to a market participant. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy, in accordance with the FASB's guidance on Fair Value Measurements and Disclosures.

Capitalized Lease Obligations

In September 2012, we assumed a lease which financed furniture and equipment for our new facility in Louisville, Kentucky. During 2011, the Company entered into a series of lease agreements to finance the purchase of certain equipment primarily for the implementation of Electronic Medical Records (“EMR”) in its nursing centers. The Company determined the leases were capital in nature, and as a result, we have recorded the underlying lease assets and capitalized lease obligations of $667,000 and $1,471,000 as of December 31, 2013 and 2012, respectively. These lease agreements provide three to five year terms.

Scheduled payments of the capitalized lease obligations are as follows:

2014	$	575,000
2015	47,000
2016	47,000
2017	27,000
2018	—
Total	696,000
Amounts related to interest	(29,000		)
Principal payments on capitalized lease obligation	$	667,000

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value) (Details)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 Minimum	Dec. 31, 2012 Minimum	Dec. 31, 2013 Maximum	Dec. 31, 2012 Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility (range)			58.00%	59.00%	59.00%	60.00%
Risk free interest rate (range)			0.80%	1.02%	1.03%	1.30%
Expected dividends	3.75%	3.93%
Weighted average expected term (years)	6 years	6 years

XML

Receivables

12 Months Ended

Dec. 31, 2013

Receivables [Abstract]

RECEIVABLES

RECEIVABLES

Receivables, before the allowance for doubtful accounts, consist of the following components:

	December 31,
	2013		2012
Medicare	$	13,806,000	$	8,606,000
Medicaid and other non-federal government programs	14,121,000		11,128,000
Other patient and resident receivables	11,191,000		8,040,000
	$	39,118,000	$	27,774,000
Other receivables and advances	$	1,118,000	$	1,397,000

The other receivables and advances balance are composed of $843,000 and $982,000 related to renovation projects funded by Omega at December 31, 2013 and 2012, respectively. See Note 12 for additional discussion of these receivables and leased facility construction projects.

Our accounts receivable at December 31, 2013 included approximately $5.1 million of accounts for the newly leased facility in Louisville, Kentucky for which we assumed operations in August 2013, and also the four facilities, three in Ohio and one in Indiana, for which we assumed operations in October 2013.  During the change of ownership process, we are required to hold these accounts while waiting for final Medicare and Medicaid approvals.  We expect these accounts to be collectible as soon as we are able to submit them for payment.

The Company provides credit for a substantial portion of its revenues and continually monitors the credit-worthiness and collectability from its patients, including proper documentation of third-party coverage. The Company is subject to accounting losses from uncollectible receivables in excess of its reserves.

Substantially all receivables are pledged as collateral on the Company's debt obligations.

XML

Property and Equipment

12 Months Ended

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

Property and equipment, at cost, consists of the following:

	December 31,
	2013			2012
Land	$	4,644,000		$	2,364,000
Buildings and leasehold improvements	70,572,000			55,371,000
Furniture, fixtures and equipment	28,473,000			24,940,000
	103,689,000			82,675,000
Less: accumulated depreciation	(50,699,000		)	(43,938,000		)
Net property and equipment	$	52,990,000		$	38,737,000

As discussed further in Note 7, the property and equipment of certain skilled nursing centers are pledged as collateral for mortgage debt obligations. In addition, the Company has assets recorded as capital leased assets purchased through capitalized lease obligations. The Company capitalizes leasehold improvements which will revert back to the lessor of the property at the expiration or termination of the lease, and depreciates these improvements over the shorter of the remaining lease term or the assets' estimated useful lives.

As discussed further in Note 8, the Company has consolidated the assets and liabilities of a real estate developer's interest in a center the Company leases.

XML

Variable Interest Entity

12 Months Ended

Dec. 31, 2013

Business Combinations [Abstract]

VARIABLE INTEREST ENTITY

VARIABLE INTEREST ENTITY

On December 28, 2011, the Company completed construction of Rose Terrace Health and Rehabilitation Center (“Rose Terrace”), its third health care center in West Virginia. The 90-bed skilled nursing center is located in Culloden, West Virginia, along the Huntington-Charleston corridor, and offers 24-hour skilled nursing care designed to meet the care needs of both short and long term nursing patients. The Rose Terrace nursing center utilizes a Certificate of Need the Company obtained in June 2009, when the Company completed the acquisition of certain assets of a skilled nursing center in West Virginia. The new nursing center is licensed to operate by the state of West Virginia and obtained itsMedicare and Medicaidcertifications in the first quarter of 2012.

The Company has a lease agreement with the real estate developer that constructed, furnished, equipped and currently owns Rose Terrace that provides an initial lease term of 20 years and the option to renew the lease for two additional five-year periods. The agreement provides the Company the right to purchase the center beginning at the end of the first year of the initial term of the lease and continuing through the fifth year for a purchase price ranging from 110% to 120% of the total project cost.

The Company has no equity interest in the entity that constructed the new facility and does not guarantee any debt obligations of the entity. The owners of the facility have provided guarantees of the debt of the entity and, based on those guarantees, the entity is considered to be a variable interest entity (“VIE”). The Company owns the underlying Certificate of Need that is required for operation as a skilled nursing center. During 2011, the Company determined it is the primary beneficiary of the VIE based primarily on the ownership of the Certificate of Need, the fixed price purchase option described above, the Company’s ability to direct the activities that most significantly impact the economic performance of the VIE and the right to receive potentially significant benefits from the VIE. Accordingly, as the primary beneficiary, the Company consolidates the balance sheet and results of operations of the VIE.

The following table summarizes the accounts and amounts included in the Company’s Consolidated Balance Sheet that are associated with the real estate developer’s interests in the VIE. These assets can be used only to settle obligations of the VIE and none of these liabilities provide creditors with recourse to the general assets of the Company.

	December 31, 2013		December 31, 2012
Land	$	787,000	$	787,000
Building and improvements, net	5,613,000		5,857,000
Furniture, fixtures and equipment, net	431,000		501,000
Other assets	80,000		107,000
	$	6,911,000	$	7,252,000
Current accruals	$	—	$	1,000
Notes payable, including current portion	5,476,000		5,678,000
Non-controlling interests	1,435,000		1,573,000
	$	6,911,000	$	7,252,000

	Year Ended December 31, 2013			Year Ended December 31, 2012
Beginning non-controlling interests	$	1,573,000		$	1,654,000
Comprehensive income attributable to non-controlling interests	72,000			126,000
Distributions to non-controlling interest owners	(208,000		)	(207,000		)
Ending non-controlling interests	$	1,437,000		$	1,573,000

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Restricted Stock and Restricted Stock Units Activity) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding at beginning of period (shares)	94
Granted (shares)	69
Dividend Equivalents (shares)	6
Vested (shares)	(37)
Cancelled (shares)	(14)
Outstanding at beginning of period (shares)	118
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted-Average Grant Date Fair Value, Outstanding at beginning of period	$ 6.00
Weighted-average fair value of grants	$ 5.01
Weighted Average Grant Date Fair Value, Dividend Equivalents	$ 4.85
Weighted Average Grant Date Fair Value, Vested	$ 6.02
Weighted-Average Grant Date Fair Value, Cancelled	$ 5.53
Weighted-Average Grant Date Fair Value, Outstanding at end of period	$ 5.41
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding at beginning of period (shares)	52
Granted (shares)	23
Dividend Equivalents (shares)	2
Vested (shares)	(36)
Cancelled (shares)	0
Outstanding at beginning of period (shares)	41
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted-Average Grant Date Fair Value, Outstanding at beginning of period	$ 6.24
Weighted-average fair value of grants	$ 5.01
Weighted Average Grant Date Fair Value, Dividend Equivalents	$ 4.85
Weighted Average Grant Date Fair Value, Vested	$ 6.40
Weighted-Average Grant Date Fair Value, Cancelled	$ 0.00
Weighted-Average Grant Date Fair Value, Outstanding at end of period	$ 5.35

XML

Earnings (Loss) Per Common Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
Income (loss) from continuing operations	$ (141)	$ (2,344)	$ (2,002)	$ (990)	$ (874)	$ (498)	$ (807)	$ (1,496)	$ (5,477)	$ (3,675)	$ 438
Less: net income attributable to noncontrolling interests									(72)	(126)	0
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.									(5,549)	(3,801)	438
PREFERRED STOCK DIVIDENDS									(344)	(344)	(344)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. shareholders									(5,893)	(4,145)	94
Income (loss) from discontinued operations, net of income taxes									(2,985)	755	929
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS									$ (8,878)	$ (3,390)	$ 1,023
Weighted Average Common Shares Outstanding:
Basic (shares)									5,899	5,821	5,774
Incremental shares from assumed exercise of options, SOSARS and Restricted Stock Units									0	0	132
Diluted (shares)									5,899	5,821	5,906
Per common share - basic
Income (loss) from continuing operations (in dollars per share)	$ (0.03)	$ (0.42)	$ (0.36)	$ (0.19)	$ (0.17)	$ (0.10)	$ (0.15)	$ (0.29)	$ (1.00)	$ (0.71)	$ 0.02
Income from discontinued operations Operating income (loss), net of taxes (in dollars per share)									$ (0.51)	$ 0.10	$ 0.16
Gain (loss) on disposal, net of taxes (in dollars per share)									$ 0.00	$ 0.03	$ 0.00
Discontinued operations (in dollars per share)	$ (0.08)	$ (0.41)	$ (0.03)	$ 0.01	$ (0.04)	$ 0.09	$ 0.06	$ 0.02	$ (0.51)	$ 0.13	$ 0.16
Net income (loss) (in dollars per share)	$ (0.11)	$ (0.83)	$ (0.39)	$ (0.18)	$ (0.21)	$ (0.01)	$ (0.09)	$ (0.27)	$ (1.51)	$ (0.58)	$ 0.18
Per common share - diluted
Income (loss) from continuing operations (in dollars per share)	$ (0.03)	$ (0.42)	$ (0.36)	$ (0.19)	$ (0.17)	$ (0.10)	$ (0.15)	$ (0.29)	$ (1.00)	$ (0.71)	$ 0.02
Income (loss) from discontinued operations Operating income (loss), net of taxes (in dollars per share)									$ (0.51)	$ 0.10	$ 0.15
Discontinued operations, net of taxes (in dollars per share)	$ (0.08)	$ (0.41)	$ (0.03)	$ 0.01	$ (0.04)	$ 0.09	$ 0.06	$ 0.02	$ (0.51)	$ 0.13	$ 0.15
Diluted net income (loss) (in dollars per share)	$ (0.11)	$ (0.83)	$ (0.39)	$ (0.18)	$ (0.21)	$ (0.01)	$ (0.09)	$ (0.27)	$ (1.51)	$ (0.58)	$ 0.17

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable) (Details) (Stock Options and Stock Appreciation Rights (SARs), USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Options and Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period (shares)	333	461
Granted (shares)	0
Exercised (shares)	(18)
Cancelled/Expired (shares)	(110)
Outstanding at end of period (shares)	333	461
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding at beginning of period	$ 6.62
Weighted-Average Exercise Price, Granted	$ 0.00
Weighted-Average Exercise Price, Exercised	$ 2.37
Weighted-Average Exercise Price, Cancelled/Expired	$ 7.25
Weighted-Average Exercise Price, Outstanding at end of period	$ 6.64
Number of Shares, Exercisable (shares)	273
Weighted-Average Exercise Price, Exercisable	$ 6.84

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

The provision (benefit) for income taxes of continuing operations is composed of the following components:

	Year Ended December 31,
	2013			2012			2011
Current provision (benefit) :
Federal	$	(61,000	)	$	(349,000	)	$	55,000
State	23,000			13,000			171,000
	(38,000		)	(336,000		)	226,000
Deferred provision (benefit):
Federal	(3,467,000		)	(1,450,000		)	(76,000		)
State	200,000			(241,000		)	12,000
	(3,267,000		)	(1,691,000		)	(64,000		)
Provision (benefit) for income taxes of continuing operations
	$	(3,305,000	)	$	(2,027,000	)	$	162,000

Schedule of Components of Income Tax Expense (Benefit)

A reconciliation of taxes computed at statutory income tax rates on income (loss) from continuing operations is as follows:

	Year Ended December 31,
	2013			2012			2011
Provision (benefit) for federal income taxes at statutory rates	$	(2,986,000	)	$	(1,967,000	)	$	277,000
Provision (benefit) for state income taxes, net of federal benefit	(147,000		)	(175,000		)	128,000
Resolution with tax authorities	—			—			(79,000		)
Valuation allowance changes affecting the provision for income taxes	448,000			(7,000		)	(8,000		)
Employment tax credits	(1,124,000		)	(130,000		)	(1,000,000		)
Nondeductible expenses	334,000			254,000			437,000
Stock based compensation expense	9,000			13,000			410,000
Other	161,000			(15,000		)	(3,000		)
Provision (benefit) for income taxes of continuing operations	$	(3,305,000	)	$	(2,027,000	)	$	162,000

Schedule of Deferred Tax Assets and Liabilities

The net deferred tax assets and liabilities, at the respective income tax rates, are as follows:

	December 31,
	2013			2012
Current deferred tax assets:
Credit carryforwards	$	—		$	251,000
Net operating loss and other carryforwards	643,000			352,000
Allowance for doubtful accounts	1,788,000			1,447,000
Accrued liabilities	5,126,000			4,236,000
	7,557,000			6,286,000
Less valuation allowance	(377,000		)	(242,000		)
	7,180,000			6,044,000
Current deferred tax liabilities:
Prepaid expenses	(601,000		)	(739,000		)
	$	6,579,000		$	5,305,000

	December 31,
	2013			2012
Noncurrent deferred tax assets:
Net operating loss and other carryforwards	$	3,389,000		$	1,365,000
Credit carryforwards	2,210,000			964,000
Deferred lease costs	289,000			356,000
Depreciation	(634,000		)	(2,036,000		)
Tax goodwill and intangibles	(879,000		)	(739,000		)
Stock-based compensation	882,000			1,238,000
Accrued rent	4,219,000			4,538,000
Kansas acquisition costs	125,000			—
Impairment of long-lived assets	472,000			659,000
Interest rate swap	349,000			564,000
Noncurrent self-insurance liabilities	6,422,000			6,062,000
	16,844,000			12,971,000
Less valuation allowance	(932,000		)	(619,000		)
	$	15,912,000		$	12,352,000

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2013		2012			2011
Balance at the beginning of the period	$	—	$	86,000		$	84,000
Changes in tax positions for prior years	—		(86,000		)	2,000
Balance at the end of the period	$	—	$	—		$	86,000

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Capital Lease Obligations) (Narrative) (Details) (USD $) In Thousands, unless otherwise specified			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Minimum	Dec. 31, 2013 Maximum
Capital Leased Assets [Line Items]
Capital lease obligations	$ 667	$ 1,471
Lease agreement term			3 years	5 years

XML

Subsequent Event

12 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

SUBSEQUENT EVENT

SUBSEQUENT EVENT

Effective March 1, 2014, the Company assumed operations of one skilled nursing center in Huntsville, Alabama. The 135-bed nursing center is expected to produce annual revenues of $10.5 million and annual rent expense of $1.2 million.

XML

Business Development (Tables)

12 Months Ended

Dec. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The allocation for the net assets acquired is as follows:

	As of May 1, 2013
Purchase Price	$	15,500,000
Land	2,130,000
Buildings	12,127,000
Furniture, fixtures, and equipment	1,200,000
Inventory	43,000
Less: Liabilities assumed	758,000
Total cash paid	$	14,742,000

XML

Long-Term Debt, Interest Rate Swap and Capitalized Lease Obligations (Narrative) (Details) (USD $)	12 Months Ended						12 Months Ended
	Dec. 31, 2013 Letter_Of_Credit Center	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 Omega Healthcare Investors, Inc	Sep. 02, 2013 Omega Healthcare Investors, Inc	Dec. 31, 2013 LIBOR	Dec. 31, 2013 Revolving credit facility	Dec. 31, 2013 Commercial loan	Dec. 31, 2013 Variable Interest Entity, Not Primary Beneficiary Culloden, WV	Dec. 31, 2012 Variable Interest Entity, Not Primary Beneficiary Culloden, WV	Dec. 31, 2013 Credit Agreement	May 01, 2013 Credit Agreement	Dec. 31, 2013 Interest rate swap	Dec. 31, 2013 Revolving credit facility Revolving Credit Facility Interest 4.5% above LIBOR	Dec. 31, 2012 Revolving credit facility Revolving Credit Facility Interest 4.5% above LIBOR
Long-Term Debt and Interest Rate Swap (Textual) [Abstract]
Weighted average interest rate of long term debt	6.61%
Revolving credit facility and the maximum loan												$ 65,000,000
Long-term debt for syndicate of banks mortgage debt	45,000,000
Long-term debt revolving credit facility							20,000,000
Deferred financing costs capitalized		34,000									1,341,000
Long-term debt five year maturity	5 years
Write-off of deferred financing costs	320,000	0	112,000
Mortgage loan with principal and interest payable monthly based	25 years
Long-term debt interest based on LIBOR						4.50%
Long-term debt fixed based on the interest rate swap	6.87%												6.87%
Notional amount of interest rate swap													22,217,000
Interest rate								4.67%
Number of owned nursing centers	13
Long-term debt	52,910,000													3,000,000	0
Letters of credit issued under Revolver outstanding	3.00%
Number of Letters of Credit	5
Letters of credit security deposit for a lease				6,957,000	4,551,000
Borrowing under the revolving credit facility							10,043,000
Notes payable, including current portion	$ 48,811,000	$ 28,026,000							$ 5,476,000	$ 5,678,000

XML

Summary of Significant Accounting Policies (Schedule of Expected Amortization Expense for Acquired Leasehold Interest Intangible Asset) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
2014	$ 384
2015	384
2016	384
2017	384
2018	384
Thereafter	6,308
Net Intangible	$ 8,228	$ 8,612

XML

Consolidated Statements of Operations (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Statement [Abstract]
Tax effect on operating income	$ (1,754)	$ 291	$ 341
Tax effect on gain on disposal	$ 0	$ 107	$ 0

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation

The consolidated financial statements include the financial position, operations and accounts of Diversicare and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (“VIEs”) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company has one variable interest entity and it relates to a nursing center in West Virginia described in Note 7.

The investment in unconsolidated affiliate reflected on the consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns a 50% interest. The joint venture partnership is accounted for using the equity method. An equity method investment is the Company’s investment in an entity over which the Company lacks control, but otherwise has the ability to exercise significant influence over operating and financial policies. The Company’s share of the profits and losses from this investment are reported in equity in earnings of unconsolidated affiliates in the accompanying consolidated statement of operations. The Company monitors this investment for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the company and will record reductions in carrying value when or if necessary. Under the equity method, the investment, originally recorded at cost, is adjusted to recognize the Company’s share of the net earnings or losses of the affiliate as they occur. The investment in unconsolidated affiliate balance relates to this partnership and was $487,000 at December 31, 2013, and $420,000 at December 31, 2012 .

Revenues

Patient Revenues

The fees charged by the Company to patients in its nursing centers are recorded on an accrual basis. These rates are contractually adjusted with respect to individuals receiving benefits under federal and state-funded programs and other third-party payors. Rates under federal and state-funded programs are determined prospectively for each facility and may be based on the acuity of the care and services provided. These rates may be based on facility's actual costs subject to program ceilings and other limitations or on established rates based on acuity and services provided as determined by the federal and state-funded programs. Amounts earned under federal and state programs with respect to nursing home patients are subject to review by the third-party payors which may result in retroactive adjustments. In the opinion of management, adequate provision has been made for any adjustments that may result from such reviews. Retroactive adjustments, if any, are recorded when objectively determinable, generally within three years of the close of a reimbursement year depending upon the timing of appeals and third-party settlement reviews or audits. During the years ended December 31, 2013, 2012 and 2011, the Company recorded $151,000, $(273,000) and $630,000 of net favorable (unfavorable) estimated settlements from federal and state programs for periods prior to the beginning of fiscal 2013, 2012 and 2011, respectively.

Allowance for Doubtful Accounts

The Company's allowance for doubtful accounts is estimated utilizing current agings of accounts receivable, historical collections data and other factors. Management monitors these factors and determines the estimated provision for doubtful accounts. Historical bad debts have generally resulted from uncollectible private balances, some uncollectible coinsurance and deductibles and other factors. Receivables that are deemed to be uncollectible are written off. The allowance for doubtful accounts balance is assessed on a quarterly basis, with changes in estimated losses being recorded in the Consolidated Statements of Operations in the period identified.

The Company includes the provision for doubtful accounts in operating expenses in its Consolidated Statements of Operations. The provisions for doubtful accounts of continuing operations were $4,191,000, $3,064,000, and $1,780,000 for 2013, 2012 and 2011, respectively. The provision for doubtful accounts of continuing operations was 1.5%, 1.2%, and 0.7% of net revenue during 2013, 2012, and 2011, respectively.

Lease Expense

As of December 31, 2013, the Company operates 34 nursing centers under operating leases, including 25 owned by Omega REIT, six owned by AVIV REIT, and three owned by other parties. The Company's operating leases generally require the Company to pay stated rent, subject to increases based on changes in the Consumer Price Index, a minimum percentage increase, or increases in the net revenues of the leased properties. The Company's Omega leases require the Company to pay certain scheduled rent increases. Such scheduled rent increases are recorded as additional lease expense on a straight-line basis recognized over the term of the related leases and the difference between the amounts recorded for rent expense as compared to rent payments as an accrued liability.

See Notes 3, 4, and 12 for a discussion regarding the Company's Master Lease with Omega, the termination of leases for certain facilities and the addition of certain leased facilities.

Classification of Expenses

The Company classifies all expenses (except lease, interest, depreciation and amortization expenses) that are associated with its corporate and regional management support functions as general and administrative expenses. All other expenses (except lease, professional liability, interest, depreciation and amortization expenses) incurred by the Company at the facility level are classified as operating expenses.

Property and Equipment

Property and equipment are recorded at cost with depreciation and amortization being provided over the shorter of the remaining lease term (where applicable) or the assets' estimated useful lives on the straight-line basis as follows:

Buildings and improvements	-	5 to 40 years
Leasehold improvements	-	2 to 10 years
Furniture, fixtures and equipment	-	2 to 15 years

Interest incurred during construction periods for qualifying expenditures is capitalized as part of the building cost. Maintenance and repairs are expensed as incurred, and major betterments and improvements are capitalized. Property and equipment obtained through business combinations are stated at their estimated fair value determined on the respective dates of acquisition.

In accordance with the Financial Accounting Standards Board ("FASB") guidance on “Property, Plant and Equipment,” specifically the discussion around the accounting for the impairment or disposal of long-lived assets, the Company routinely evaluates the recoverability of the carrying value of its long-lived assets, including when significant adverse changes in the general economic conditions and significant deteriorations of the underlying undiscounted cash flows or fair values of the property indicate that the carrying amount of the property may not be recoverable. The need to recognize impairment is based on estimated undiscounted future cash flows from a property compared to the carrying value of that property.

On July 29, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its final rule for skilled nursing facilities effective October 1, 2011, reducing Medicare reimbursement rates for skilled nursing facilities by 11.1% and also making changes to rehabilitation therapy regulations. This final rule had a negative effect on the Company's revenue and costs in Medicare's fiscal year ended September 30, 2012 as compared to Medicare's fiscal year ended September 30, 2011. As a result of this negative impact, an interim impairment analysis was conducted in 2011, and the Company determined that the carrying value of the long-lived assets of one of its leased nursing centers exceeded the fair value. As a result, the Company recorded a fixed asset impairment charge during 2011 of $344,000 to reduce the carrying value of these assets.

Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with banks and all highly liquid investments with original maturities of three months or less when purchased. Our cash on deposit with banks was subject to the Federal Deposit Insurance Corporation ("FDIC") minimum insurance levels. Effective January 1, 2013, the coverage provided by the FDIC that had been unlimited under the Dodd-Frank Deposit Insurance Provision is limited to the legal maximum which is generally $250,000 per ownership category.

Deferred Financing and Other Costs

The Company records deferred financing and lease costs for direct and incremental expenditures related to entering into or amending debt and lease agreements. These expenditures include lenders and attorneys fees. Financing costs are amortized using the effective interest method over the term of the related debt. The amortization is reflected as interest expense in the accompanying consolidated statements of operations. Deferred lease costs are amortized on a straight-line basis over the term of the related leases. See Note 7 for further discussion.

Acquired Leasehold Interest

The Company has recorded an acquired leasehold interest intangible asset related to an acquisition completed during 2007. The intangible asset is accounted for in accordance with the FASB's guidance on goodwill and other intangible assets, and is amortized on a straight-line basis over the remaining life of the acquired lease, including renewal periods, the original period of which is approximately 28 years from the date of acquisition. The lease terms for the seven centers this intangible relates to provide for an initial term and renewal periods at the Company's option through May 31, 2035. As the renewal periods of the acquired leased facilities are solely based on the Company's option, it is expected that costs (if any) to renew the lease through its current amortization period would be nominal and the decision to continue to lease the acquired facilities lies solely within the Company's intent to continue to operate the seven facilities. Any renewal costs would be included in deferred lease costs and amortized over the renewal period. Amortization expense of approximately $384,000 related to this intangible asset was recorded during each of the years ended December 31, 2013, 2012 and 2011, respectively.

The carrying value of the acquired leasehold interest intangible and the accumulated amortization are as follows:

	December 31,
	2013			2012
Intangible assets	$	10,652,000		$	10,652,000
Accumulated amortization	(2,424,000		)	(2,040,000		)
Net intangible assets	$	8,228,000		$	8,612,000

The Company evaluates the recoverability of the carrying value of the acquired leasehold intangible in accordance with the FASB's guidance on accounting for the impairment or disposal of long-lived assets. Included in this evaluation is whether significant adverse changes in general economic conditions, and significant deteriorations of the underlying cash flows or fair values of the intangible asset, indicate that the carrying amount of the intangible asset may not be recoverable. The need to recognize an impairment charge is based on estimated future undiscounted cash flows from the asset compared to the carrying value of that asset. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying amount of the intangible asset exceeds the fair value of the intangible asset.

The expected amortization expense for the acquired leasehold interest intangible asset is as follows:

2014	$	384,000
2015	384,000
2016	384,000
2017	384,000
2018	384,000
Thereafter	6,308,000
	$	8,228,000

Self-Insurance

Self-insurance liabilities primarily represent the unfunded accrual for self insured risks associated with general and professional liability claims, employee health insurance and workers' compensation. The Company's health insurance liability is based on known claims incurred and an estimate of incurred but unreported claims determined by an analysis of historical claims paid. The Company's workers' compensation liability relates primarily to periods of self insurance prior to May 1997 and consists of an estimate of the future costs to be incurred for the known claims.

Final determination of the Company's actual liability for incurred general and professional liability claims is a process that takes years. The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this unfunded accrual. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished by the Company. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company's past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company's ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company's insurers and a third party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator's estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company's evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual has an unfavorable impact on results of operations in the period and any reduction in the accrual increases results of operations during the period.

All losses are projected on an undiscounted basis. The self-insurance liabilities include estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of related legal costs incurred and expected to be incurred.

One of the key assumptions in the actuarial analysis is that historical losses provide an accurate forecast of future losses. Changes in legislation such as tort reform, changes in our financial condition, changes in our risk management practices and other factors may affect the severity and frequency of claims incurred in future periods as compared to historical claims.

The facts and circumstances of each claim vary significantly, and the amount of ultimate liability for an individual claim may vary due to many factors, including whether the case can be settled by agreement, the quality of legal representation, the individual jurisdiction in which the claim is pending, and the views of the particular judge or jury deciding the case.

Although the Company adjusts its unfunded accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company's actual liability for claims incurred in any given period is a process that takes years. As a result, the Company's actual liabilities may vary significantly from the unfunded accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company's reported earnings and financial position for the period in which the change in accrual is made.

Income Taxes

The Company follows the FASB's guidance on Accounting for Income Taxes, which requires the asset and liability method of accounting for income taxes whereby deferred income taxes are recorded for the future tax consequences attributable to differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided against any estimated non-realizable deferred tax assets where necessary.

Where the Company believes that a tax position is supportable for income tax purposes, the item is included in its income tax returns. Where treatment of a position is uncertain, liabilities are recorded based upon the Company’s evaluation of the “more likely than not” outcome considering the technical merits of the position. While the judgments and estimates made by the Company are based on management’s evaluation of the technical merits of a matter, historical experience and other assumptions that management believes are appropriate and reasonable under current circumstances, actual resolution of these matters may differ from recorded estimated amounts, resulting in charges or credits that could materially affect future financial statements. See Note 11 for additional information related to the provision for income taxes.

Disclosure of Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. The carrying amounts of cash and cash equivalents, receivables, trade accounts payable and accrued expenses approximate fair value because of the short-term nature of these accounts. The Company's self-insurance liabilities are reported on an undiscounted basis as the timing of estimated settlements cannot be determined.

The Company follows the FASB's guidance on Fair Value Measurements and Disclosures which provides rules for using fair value to measure assets and liabilities as well as a fair value hierarchy that prioritizes the information used to develop the measurements. It applies whenever other guidance requires (or permits) assets or liabilities to be measured at fair value and gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

A summary of the fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels is described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

The Company has not elected to expand the use of fair value measurements for assets and liabilities. It is noted that the assessment of carrying value compared to fair value for impairment analysis, as discussed in Note 2 “Property and Equipment,” follow these fair value principles and hierarchy.

As further discussed in Note 7, in conjunction with the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The applicable guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value in a company's balance sheets.

As the Company's interest rate swap, a cash flow hedge, is not traded on a market exchange, the fair value is determined using a valuation model based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The fair value of the Company's interest rate swap is the net difference in the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates and are observable inputs available to a market participant. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy. The debt balances as presented in the consolidated balance sheets approximate the fair value of the respective instruments, the estimates of which are considered Level 2 fair value calculations within the fair value hierarchy.

The following table presents by level, within the fair value hierarchy, assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012:

December 31, 2013	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(918,000	)	$	—	$	(918,000	)	$	—
December 31, 2012	Fair Value Measurements - Assets (Liabilities)
	Total			Level 1		Level 2			Level 3
Interest rate swap	$	(1,484,000	)	$	—	$	(1,484,000	)	$	—

The change in fair value of the Company's cash flow hedge is detailed in the Company's Consolidated Statements of Comprehensive Income (Loss).

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Net Income (Loss) per Common Share

The Company follows the FASB's guidance on Earnings Per Share for the financial reporting of net income (loss) per common share. Basic earnings per common share excludes dilution and restricted shares and is computed by dividing income available to common shareholders by the weighted-average number of common shares, excluding restricted shares, outstanding for the period. Diluted earnings per common share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise resulted in the issuance of common stock that then shared in the earnings of the Company. See Note 9 for additional disclosures about the Company's Net Income (Loss) per Common Share.

Stock Based Compensation

The Company follows the FASB's guidance on Stock Compensation to account for share-based payments granted to employees and recorded non-cash stock based compensation expense of $950,000, $573,000 and $528,000 during the years ended December 31, 2013, 2012 and 2011, respectively. Such amounts are included as components of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. See Note 8 for additional disclosures about the Company's stock based compensation plans.

Accumulated Other Comprehensive Loss

Accumulated other comprehensive income consists of other comprehensive income (loss). Comprehensive income (loss) is a more inclusive financial reporting method that includes disclosure of financial information that historically has not been recognized in the calculation of net income (loss). The Company has chosen to present the components of other comprehensive income in a separate statement of comprehensive income (loss). Currently, the Company's other comprehensive income (loss) consists of the change in fair value of the Company's interest rate swap transaction accounted for as a cash flow hedge.

Recent Accounting Guidance

In June 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Comprehensive Income – Presentation of Comprehensive Income,” to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The update eliminates the option to present the components of other comprehensive income as part of the statement of equity. The Company adopted this guidance effective January 1, 2012 and has applied it retrospectively. There was no significant impact to the Company’s consolidated financial statements.

In July 2011, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Health Care Entities: Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities.” This guidance impacts health care entities that recognize significant amounts of patient service revenue at the time the services are rendered even though they do not assess the patient’s ability to pay. This updated guidance requires an impacted health care entity to present its provision for doubtful accounts as a deduction from revenue, similar to contractual discounts. Accordingly, patient service revenue for entities subject to this updated guidance will be required to be reported net of both contractual discounts and provision for doubtful accounts. The updated guidance also requires certain qualitative disclosures about the entity’s policy for recognizing revenue and bad debt expense for patient service transactions. The guidance was effective for the Company starting January 1, 2012. Based on the Company’s assessment of its admission procedures, the Company is not an impacted health care entity under this guidance since it assesses each patient’s ability or the patient’s payor source’s ability to pay. As a result of this assessment, the Company will continue to record bad debt expense as a component of operating expense, and adoption did not have an impact on the Company’s consolidated financial statements.

In July 2012, the FASB issued updated guidance in the form of a FASB Accounting Standards Update on “Intangibles-Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment.” This guidance is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. This new guidance is an extension of guidance from September 2011 related to the testing of goodwill for impairment. The updated guidance allows an entity the option to first qualitatively assess whether it is more likely than not (that is, a likelihood of more than 50-percent) that an indefinite-lived intangible asset is impaired. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test for other non-amortized intangible assets is required. An entity is not required to perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. It is an entity's option to bypass the qualitative assessment and proceed directly to performing the quantitative impairment test for other non-amortized intangible assets.The guidance is effective for annual and interim impairment tests performed by the Company after January 1, 2013, with earlier implementation permitted. The Company is currently assessing the potential impact and timing of the implementation and believes the adoption will not have a material impact on the Company's consolidated financial statements.

Reclassifications

As discussed in Note 4, the consolidated financial statements of the Company have been retroactively reclassified for all periods presented to reflect as discontinued operations certain divestitures and lease terminations.

XML

Shareholders' Equity, Stock Plans and Preferred Stock (Shareholders' Equity and Stock Plans) (Narrative) (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Aug. 14, 2009	Aug. 13, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares of Common Stock purchased				20.00%	15.00%
Options exercise price (in dollars per share)				50	15
Stock based compensation	$ 950	$ 573	$ 528
Total unrecognized stock-based compensation expense	$ 254
Stock Options and Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining life of outstanding equity grants (years)	5 years 3 months 29 days
Weighted average remaining life of grants that are exercisable (years)	4 years 9 months 15 days
Stock option and SOSAR grants exercised	18,000
Stock Only Stock Appreciation Rights (SOSARS) | Ratably over 3 Years
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vest of restricted stock on each year (shares)	33.00%
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants approved by the Board of Directors (shares)	69,000
Restricted Stock | Ratably over 3 Years
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vest of restricted stock on each year (shares)	33.00%	33.00%
2005 Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term of option (years)	10 years
Shares available for future issuance (shares)	700,000
2008 Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance (shares)	150,000
Percentage of fair market value at date of grant (percentage)	85.00%
Restriction period	2 years
2010 Long Term Incentive Plan | Stock Only Stock Appreciation Rights (SOSARS)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance (shares)	380,000

XML

Income Taxes (Schedule of Components of Income Tax Expense (Benefit)) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current provision (benefit) :
Federal	$ (61)	$ (349)	$ 55
State	23	13	171
Total current	(38)	(336)	226
Deferred provision (benefit):
Federal	(3,467)	(1,450)	(76)
State	200	(241)	12
Total deferred	(3,267)	(1,691)	(64)
Provision (benefit) for income taxes of continuing operations	$ (3,305)	$ (2,027)	$ 162

XML

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures

A summary of the discontinued operations for the periods presented is as follows (in thousands):

	December 31,
	2013			2012			2011
Net revenues	$	40,151,000		$	65,245,000		$	68,838,000
Operating expenses	(44,890,000		)	(64,373,000		)	(67,568,000		)
Gain from disposal of assets	—			281,000			—
Income (loss) from discontinued operations	(4,739,000		)	1,153,000			1,270,000
Benefit (provision) for income taxes	1,754,000			(398,000		)	(341,000		)
Income (loss) from discontinued operations, net of tax	$	(2,985,000	)	$	755,000		$	929,000

XML

Commitments and Contingencies (Schedule of Future Operating Lease Payments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
2014	$ 26,165
2015	27,077
2016	27,825
2017	28,521
2018	29,459
Thereafter	467,387
Total committed under long term operating leases	$ 606,434

XML

Summary of Significant Accounting Policies (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended				12 Months Ended
	Dec. 31, 2013 Center Entity	Dec. 31, 2012	Dec. 31, 2011	Oct. 02, 2013 Center	Dec. 31, 2013 Leases, Acquired-in-Place	Dec. 31, 2013 Leased Center	Dec. 31, 2013 Leased Leases, Acquired-in-Place Center	Dec. 31, 2013 Omega Healthcare Investors, Inc Leased Center	Dec. 31, 2013 Omega Healthcare Investors, Inc Leased Leases, Acquired-in-Place Facility	Jan. 31, 2013 Omega Healthcare Investors, Inc Leased Leases, Acquired-in-Place Center	Dec. 31, 2013 Aviv REIT Leased Center	Dec. 31, 2013 Other Parties Leased Center	Dec. 31, 2013 Pharmacy Partnership
Accounting Policies [Line Items]
Number of variable interest entities	1
Percentage of owned joint venture Investment in nonconsolidated affiliate													50.00%
Investment in unconsolidated affiliate	$ 487	$ 420
Period of retroactive adjustment for reimbursements	3 years
Net favorable (unfavorable) estimated settlements from federal and state programs	151	(273)	630
Provision for doubtful accounts	4,191	3,064	1,780
Provision for doubtful accounts as a percentage of net revenue	1.50%	1.20%	0.70%
Number of nursing centers	47			4		34	7	25	1	2	6	3
Asset impairment	0	0	344
Remaining life of the acquired lease					28 years
Amortization of intangible asset	384	384	384
Stock based compensation	$ 950	$ 573	$ 528

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Lease Commitments

The Company is committed under long-term operating leases with various expiration dates and varying renewal options. Minimum annual rentals, including renewal option periods (exclusive of taxes, insurance, and maintenance costs) under these leases beginning January 1, 2014, are as follows:

2014	$	26,165,000
2015	27,077,000
2016	27,825,000
2017	28,521,000
2018	29,459,000
Thereafter	467,387,000
	$	606,434,000

Under lease agreements with Omega and others, the Company's lease payments are subject to periodic annual escalations as described below and in Note 2. Total lease expense for continuing operations was $21,542,000, $19,050,000 and $18,064,000 for 2013, 2012 and 2011, respectively. The accrued liability related to straight line rent was $10,759,000 and $11,389,000 at December 31, 2013 and 2012, respectively, and is included in “Other noncurrent liabilities” on the accompanying consolidated balance sheets.

Omega Leases

General Terms

The Company leases 25 nursing centers from Omega under a Master Lease. On October 20, 2006, the Company and Omega entered into a Third Amendment to Consolidated Amended and Restated Master Lease (“Lease Amendment”) to extend the term of its facilities leased from Omega. The Lease amendment extended the term to September 30, 2018 and provided a renewal option of an additional twelve years. Consistent with prior terms, the lease provides for annual increases in lease payments equal to the lesser of two times the increase in the consumer price index or 3 percent. Under generally accepted accounting principles, the Company is required to report these scheduled rent increases on a straight line basis over the term of the lease including the 12 year term of the renewal period. These scheduled increases had no effect on cash rent payments at the start of the lease term and only result in additional cash outlay as the annual increases take effect each year.

As previously mentioned in Note 4, the Company entered into an agreement with Omega Healthcare Investors, Inc. ("Omega") to terminate its lease with respect to eleven nursing centers located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. In connection with the closing of this transaction, the Company and Omega entered into the Thirteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.

The Master Lease requires the Company to fund annual capital expenditures related to the leased facilities at an amount currently equal to $427 per licensed bed. These amounts are subject to adjustment for increases in the Consumer Price Index. The Company is in compliance with the capital expenditure requirements. Total required capital expenditures during the remaining lease term and renewal options are $7,336,000. These capital expenditures are being depreciated on a straight-line basis over the shorter of the asset life or the appropriate lease term.

Upon expiration of the Master Lease or in the event of a default under the Master Lease, the Company is required to transfer all of the leasehold improvements, equipment, furniture and fixtures of the leased facilities to Omega. The assets to be transferred to Omega are being amortized on a straight-line basis over the shorter of the remaining lease term or estimated useful life, and will be fully depreciated upon the expiration of the lease. All of the equipment, inventory and other related assets of the facilities leased pursuant to the Master Lease have been pledged as security under the Master Lease. In addition, the Company has a letter of credit of $4,551,000 as a security deposit for the Company's leases with Omega, as described in Note 7.

Brentwood Terrace

In August 2009, the Company completed the construction of a 119-bed skilled nursing facility, Brentwood Terrace, located in Paris, Texas, replacing an existing 102-bed facility leased from Omega. The new facility was financed with funding from Omega and is leased from Omega under a long-term operating lease with renewal options through 2035. Annual rent was $789,000 initially, equal to 10.25% of $7,702,000, the total cost of the replacement facility, and is subject to the annual escalation provisions described above.

Texas Leased Nursing Centers

Effective August 11, 2007, the Company acquired the leases and leasehold interests of seven facilities which are leased from a subsidiary of Omega. In connection with this acquisition, the Company amended the Master Lease to include these seven facilities. The substantive terms of the lease of these centers, including payment provisions and lease period including renewal options were not changed by the amendment. The lease terms for the seven facilities provide for an initial term and renewal periods at the Company's option through May 31, 2035. The lease provides for annual increases in lease payments equal to the increase in the consumer price index, not to exceed 2.5%.

Renovation Funding

In January 2013, we entered into an amendment to the Master lease with Omega under which Omega agreed to provide an additional $5,000,000 to fund renovations to two nursing centers located in Texas that are leased from Omega. The annual base rent related to these facilities will be increased to reflect the amount of capital improvements to the respective facilities as the related expenditures are made. The increase is based on a rate of 10.25% per year of the amount financed under this amendment. This arrangement is similar to amendments entered into in previous years that provided financing totaling $20,000,000 that was used to fund renovations at fourteen nursing centers leased from Omega.

The Company completed an expansion to one of its facilities by making use of fifteen licensed beds it acquired in 2005. This expansion project was funded by Omega with the renovation funding previously described. This project increased capacity and footprint compared to the Company's previous lessor-funded facility projects which included renovations of existing facilities, but did not increase capacity. Accordingly, the costs incurred to expand the facility are recorded as a leasehold improvement asset with the amounts reimbursed by Omega for this project included as a long-term liability and amortized to rent expense over the remaining term of the lease. The capitalized leasehold improvements and lessor reimbursed costs are being amortized over the initial lease term ending in September 2018. The leasehold improvement asset and accumulated amortization are as follows:

	December 31
	2013			2012
Leasehold improvement	$	921,000		$	921,000
Accumulated Amortization	(421,000		)	(316,000		)
Net Intangible	$	500,000		$	605,000

Insurance Matters

Professional Liability and Other Liability Insurance

The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”), to replace some of the expiring commercial policies. SHC covers losses up to specified limits per occurrence. All of the Company's nursing centers in Florida, Ohio, Tennessee, and West Virginia are now covered under the captive insurance policies along with most of the nursing centers in Alabama, Kentucky, and Texas. The insurance coverage provided for these centers under the SHC policy includes coverage limits of at least $500,000 per medical incident with a sublimit per center of $1,000,000 and total annual aggregate policy limits of $5,000,000. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers. 

Reserve for Estimated Self-Insured Professional Liability Claims

Because the Company’s actual liability for existing and anticipated professional liability and general liability claims will exceed the Company’s limited insurance coverage, the Company has recorded total liabilities for reported and estimated future claims of $27,067,000 as of December 31, 2013. This accrual includes estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of legal costs related to these claims. All losses are projected on an undiscounted basis and are presented without regard to any potential insurance recoveries. Amounts are added to the accrual for estimates of anticipated liability for claims incurred during each period, and amounts are deducted from the accrual for settlements paid on existing claims during each period.

The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of this reserve. Since May 2012, Merlinos & Associates, Inc. (“Merlinos”) has assisted management in the preparation of the appropriate accrual for incurred but not reported general and professional liability claims based on data furnished as of November 30. Merlinos primarily utilizes historical data regarding the frequency and cost of the Company’s past claims over a multi-year period, industry data and information regarding the number of occupied beds to develop its estimates of the Company’s ultimate professional liability cost for current periods. The Actuarial Division of Willis of Tennessee, Inc. assisted the Company with all estimates prior to May 2012.

On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company’s insurers and a third party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator’s estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company’s evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual decreases results of operations in the period and any reduction in the accrual increases results of operations during the period.

The Company’s cash expenditures for self-insured professional liability costs from continuing operations were $5,367,000, $2,682,000, and $3,811,000 for the years ended December 31, 2013, 2012 and 2011, respectively.

The Company follows the FASB Accounting Standards Update, “Presentation of Insurance Claims and Related Insurance Recoveries,” that clarifies that a health care entity should not net insurance recoveries against a related professional liability claim and that the amount of the claim liability should be determined without consideration of insurance recoveries. Accordingly, the Company has assets and equal liabilities of $440,000 at December 31, 2013 and $1,238,000 at December 31, 2012, respectively.

Although the Company adjusts its accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company’s actual liability for claims incurred in any given period is a process that takes years. As a result, the Company’s actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company’s reported earnings and financial position for the period in which the change in accrual is made.

Other Insurance

With respect to workers’ compensation insurance, substantially all of the Company’s employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. The Company is completely self-insured for workers’ compensation exposures prior to May 1997. The Company has been and remains a non-subscriber to the Texas workers’ compensation system and is, therefore, completely self-insured for employee injuries with respect to its Texas operations. From June 30, 2003 until June 30, 2007, the Company’s workers’ compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July 1, 2008 through December 31, 2013, the Company is covered by a prefunded deductible policy. Under this policy, the Company is self-insured for the first $500,000 per claim, subject to an aggregate maximum of $3,000,000. The Company funds a loss fund account with the insurer to pay for claims below the deductible. The Company accounts for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred. The liability for workers’ compensation claims is $176,000 at December 31, 2013. The Company has a non-current receivable for workers’ compensation policies covering previous years of $833,000 as of December 31, 2013. The non-current receivable is a function of payments paid to the Company’s insurance carrier in excess of the estimated level of claims expected to be incurred.

As of December 31, 2013, the Company is self-insured for health insurance benefits for certain employees and dependents for amounts up to $175,000 per individual annually. The Company provides reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate. The liability for reported claims and estimates for incurred but unreported claims is $843,000 at December 31, 2013. The differences between actual settlements and reserves are included in expense in the period finalized.

Employment Agreements

Current Employment Agreements

The Company has employment agreements with certain members of management that provide for the payment to these members of amounts up to 2.0 times their annual salary in the event of a termination without cause, a constructive discharge (as defined in each employee agreement), or upon a change in control of the Company (as defined in each employee agreement). The maximum contingent liability under these agreements is $1,260,000 as of December 31, 2013. The terms of such agreements are from 1 to 3 years and automatically renew for 1 year if not terminated by the employee or the Company. In addition, upon the occurrence of any triggering event, these certain members of management may elect to require the Company to purchase equity awards granted to them for a purchase price equal to the difference in the fair market value of the Company's common stock at the date of termination versus the stated equity award exercise price. Based on the closing price of the Company's common stock on December 31, 2013, there is no contingent liability for the repurchase of the equity grants. No amounts have been accrued for these contingent liabilities for members of management the Company currently employs.

Changes in Executive Officers

On August 13, 2012, the Company appointed James R. McKnight, Jr. as Executive Vice President and Chief Financial Officer. In connection with the appointment of Mr. McKnight, the Company entered into an employment agreement which provides for an initial base salary of $225,000.

On January 2, 2013, the Company announced the appointment of Leslie Campbell as Executive Vice President and Chief Operating Officer. In connection with the appointment of Ms. Campbell, the Company entered into an employment agreement which provides for an initial base salary of $275,000.

Health Care Industry and Legal Proceedings

The health care industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government health care program participation requirements, reimbursement for patient services, quality of resident care and Medicare and Medicaid fraud and abuse. Over the last several years, government activity has increased with respect to investigations and allegations concerning possible violations by health care providers of fraud and abuse statutes and regulations as well as laws and regulations governing quality of care issues in the skilled nursing profession in general. Violations of these laws and regulations could result in exclusion from government health care programs together with the imposition of significant fines and penalties, as well as significant repayments for patient services previously billed. Compliance with such laws and regulations is subject to ongoing government review and interpretation, as well as regulatory actions which may be unknown or unasserted at this time. The Company is involved in regulatory actions of this type from time to time.

All of the Company's nursing centers must be licensed by the state in which they are located in order to accept patients, regardless of payor source. In most states, nursing homes are subject to certificate of need laws, which require the Company to obtain government approval for the construction of new nursing homes or the addition of new licensed beds to existing homes. The Company's nursing centers must comply with detailed statutory and regulatory requirements on an ongoing basis in order to qualify for licensure, as well as for certification as a provider eligible to receive payments from the Medicare and Medicaid programs. Generally, the requirements for licensure and Medicare/Medicaid certification are similar and relate to quality and adequacy of personnel, quality of medical care, record keeping, dietary services, resident rights, and the physical condition of the facility and the adequacy of the equipment used therein. Each facility is subject to periodic inspections, known as “surveys” by health care regulators, to determine compliance with all applicable licensure and certification standards. Such requirements are both subjective and subject to change. If the survey concludes that there are deficiencies in compliance, the facility is subject to various sanctions, including but not limited to monetary fines and penalties, increased staffing requirements, suspension of new admissions, non-payment for new admissions and loss of licensure or certification. Generally, however, once a facility receives written notice of any compliance deficiencies, it may submit a written plan of correction and is given a reasonable opportunity to take mutually agreeable measures to correct the deficiencies. There can be no assurance that, in the future, the Company will be able to maintain such licenses and certifications for its facilities or that the Company will not be required to expend significant sums in order to comply with regulatory requirements. Recently, the Company has experienced an increase in the severity of survey citations and the size of monetary penalties, consistent with industry trends.

As of December 31, 2013, the Company is engaged in 54 professional liability lawsuits. Five lawsuits are currently scheduled for trial or mediation during the next year, and it is expected that additional cases will be set for trial. The ultimate results of any of the Company's professional liability claims and disputes cannot be predicted. The Company has limited, and sometimes no, professional liability insurance with regard to most of these claims. A significant judgment entered against the Company in one or more of these legal actions could have a material adverse impact on the Company's financial position and cash flows.

On May 16, 2012, a purported stockholder class action complaint was filed in the U.S. District Court for the Middle District of Tennessee, against the Company's Board of Directors. This action alleges that the Board of Directors breached its fiduciary duties to stockholders related to its response to certain expressions of interest in a potential strategic transaction from Covington Investments, LLC (“Covington”). The complaint asserts that the Board failed to negotiate or otherwise appropriately consider Covington's proposals. In November, 2012, the lawsuit was dismissed without prejudice for lack of subject matter jurisdiction. The action was refiled in the Chancery Court for Williamson County, Tennessee (21^st Judicial District) on November 30, 2012. The lawsuit remains in its early stages and has not yet been certified by the court as a class action. We intend to defend the matter vigorously.

In June 2012, a collective action complaint was filed in the U.S. District Court for the U.S. District Court for the Western District of Arkansas against us and certain of our subsidiaries.  The complaint alleges that the defendants violated the Fair Labor Standards Act (FLSA) and seeks unpaid overtime wages as well as liquidated damages.  The Court conditionally certified a nationwide class of all of the Company's hourly employees.  The Company will defend the lawsuit vigorously.

In January 2009, a purported class action complaint was filed in the Circuit Court of Garland County, Arkansas against the Company and certain of its subsidiaries and Garland Nursing & Rehabilitation Center (the “Facility”). The complaint alleges that the defendants breached their statutory and contractual obligations to the patients of the Facility over the past five years.The lawsuit remains in its early stages and has not yet been certified by the court as a class action. The Company intends to defend the lawsuit vigorously.

We cannot currently predict with certainty the ultimate impact of any of the above cases on our financial condition, cash flows or results of operations. Our reserve for professional liability expenses does not include any amounts for the collective actions, the purported class action against the Facility or the lawsuit filed against our directors. An unfavorable outcome in any of these lawsuits or any of our professional liability actions, any regulatory action, any investigation or lawsuit alleging violations of fraud and abuse laws or of elderly abuse laws or any state or Federal False Claims Act case could subject us to fines, penalties and damages, including exclusion from the Medicare or Medicaid programs, and could have a material adverse impact on our financial condition, cash flows or results of operations.

Reimbursement

The Company is unable to predict what, if any, reform proposals or reimbursement limitations will be implemented in the future, or the effect such changes would have on its operations. For the year ended December 31, 2013, the Company derived 27.3% and 53.5% of its total patient and resident revenues related to continuing operations from the Medicare and Medicaid programs, respectively.

The Company will attempt to increase revenues from non-governmental sources to the extent capital is available to do so, if at all. However, private payors, including Managed Care payors, are increasingly demanding that providers accept discounted fees or assume all or a portion of the financial risk for the delivery of health care services. Such measures may include capitated payments, which can result in significant losses to health care providers if patients require expensive treatment not adequately covered by the capitated rate.